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Abstract
Inside the cell, ribonucleotide reductases (RNRs) are responsible for the conversion of
nucleotides to 2'-deoxynucleotides, an essential step in DNA biosynthesis and repair. The E.
coli RNR is the best studied RNR to date and consists of two protein subunits, a2 and P2. a2 is
the site of nucleotide reduction and 02 contains a diiron tyrosyl radical (Y122*) cofactor. Each
turnover requires radical propagation from the Y1 22* in 32 to the active site of a2 over 35 A. The
mechanism of this unprecedented, long-range radical propagation step is poorly understood.
Based on structural studies, a pathway of aromatic residues has been proposed to participate in
this process. Site-directed mutants of these residues have been uninformative. In an effort to
understand radical propagation, we have employed expressed protein ligation and suppressor
tRNA/aminoacyl-tRNA synthetase (RS) methodologies to site-specifically insert unnatural
tyrosine analogues into 12 and a2, at residues believed to be involved. On the basis of results
with the radical traps 3,4-dihydroxyphenylalanine (DOPA) and 3-aminotyrosine (NH2Y), which
we have incorporated into 32 and a2, respectively, and a series of fluorotyrosines (FnYs, n=2, 3,
4), which we have established as probes for proton-coupled electron transfer reactions and
incorporated into 12, we propose a mechanism for radical transfer in RNR. We show that
binding of substrate and effector are essential for control and gating of radical propagation. We
further demonstrate that three Ys, 12-Y 356, a2-Y 731 and a2-Y 730, are redox-active and
participate in hole propagation. The NH2Y. observed with NH2Y-a2s likely constitutes the first
observation of a transiently oxidized intermediate during active radical propagation. In 12, Y356
participates in radical transfer by an orthogonal proton-coupled electron transfer mechanism,
where long-range electron transfer is coupled to short-range, off-pathway proton transfer.
Within a2, Y731 and Y730o participate by a hydrogen atom transfer mechanism where the proton
and electron originate from and arrive at the same moiety. We also establish the positions of
these three Ys in the a2/32 complex and present direct evidence for the reversible nature of
radical propagation.

TABLE OF CONTENTS
Dedication 5
Acknowledgements 7
Abstract 11
Table of Contents 13
List of Figures 23
List of Tables 30
List of Schemes 33
Abbreviations 35
Chapter 1 - Introduction to Ribonucleotide Reductases 39
General Introduction 40
The Class Ia RNR from E. coli 41
Protein Subunits of Class Ia E. coli RNR 42
Nucleotide Reduction Mechanism 45
Mechanism of C4 39* Formation 47
Interaction between a2 and 12 48
The Radical Propagation Pathway 49
Evidence for Radical Transfer 52
Electron Transfer in Proteins 54
PCET and Oxidation of Amino Acids 59
Analysis of the PCET Pathway in RNR 64
Our Approach to Studying Radical Transfer 69
Chapter Preview 75
References 80
Chapter 2 - Site-Specific Insertion of 3,4-Dihydroxyphenylalanine into 87
the 132 Subunit of E. coli Ribonucleotide Reductase
INTRODUCTION 88
MATERIALS AND METHODS 93
Materials 93
MALDI-TOF MS 94
Synthesis of DOPA-22mer peptide 94
Cleavage of peptide from solid-phase resin 95
Analytical and semi-preparative RP-HPLC 96
Removal of the t-buthio-protecting group 97
Growth and expression of 32-intein-CBD 97
Semisynthesis of DOPA-12 98
MonoQ purification of ligation mixture 99
Electron spray ionization (ESI) MS analysis of DOPA-12 99
Quantitation of radical content by UV-vis and EPR spectroscopies. 100
Quantitation of Fe content by the ferrozine assay 100
Growth, expression and purification of wt P2 101
Growth, expression and purification of a2 103
Growth, expression and purification of E. coli thioredoxin 105
Growth, expression and purification of E. coli thioredoxin reduductase 106
TR and TRR activity assays 107
Spectrophotometric RNR assay 107
Radioactive RNR assay 107
Binding of DOPA-P2 to a2. 108
Pre-reduction of ax2 109
Monitoring reactions of DOPA-P2 by stopped-flow (SF) UV-vis 109
spectroscopy
Reconstruction of the DOPA*-f2 UV-vis spectrum 110
Monitoring reactions of DOPA-P2 by EPR spectroscopy 110
Generation of DOPA* and catechol* 112
Generation of apo DOPA-P2 with lithium 8-hydroxyquinoline-6- 112
sulfonate
Reconstitution of apo DOPA-P2 112
Preparation of high-field EPR and PELDOR samples 112
RESULTS 114
Synthesis of DOPA-22mer 114
Generation of semisynthetic DOPA-02 115
Activty sssays of DOPA-02 118
Trapping of a DOPA356 "--2 120
Kinetics of DOPA* with various substrate/effecotor pairs 123
X-Band EPR characterization 126
180 GHz EPR spectroscopy and simulation of DOPA356* 131
X-Band PELDOR measurements 134
DISCUSSION 138
DOPA as a probe for the radical initiation pathway 138
Semisynthesis and characterization of DOPA-02 139
Trapping of DOPA356* 141
Asymmetry in DOPA* formation 142
Environmental differences induced by NDP/(d)NTPs around DOPA* 144
REFERENCES 148
Chapter 3 - Reversible Radical Transfer and Asymmetric Complex 151
Formation with the Y356DOPA-32 Heterodimer of E. coli Ribonucleotide
Reductase
INTRODUCTION 152
METHODS 155
Semisynthesis of DOPA-pp' 155
MonoQ purification of the ligation mixture 155
Analysis of the diiron Y122* center of DOPA-P3' 155
Interaction between DOPA-pp' and a2 155
Activity assays of 13' and DOPA-p1' 156
Formation of DOPA*-1p' monitored by SF UV-vis spectroscopy 156
Formation of DOPA.-Pp' monitored by EPR spectroscopy 156
Kinetic simulations 157
Rapid freeze-quench (RFQ) EPR spectroscopy 157
Preparation of high-field EPR and PELDOR samples 158
Sequential-mix SF UV-vis spectroscopy 158
Reduction of Y122* by hydroxyurea monitored by UV-vis spectorsocpy 158
Increasing the radical content of DOPA-pp' 159
RESULTS 161
Purification and general characterization of DOPA-j30' 161
Interaction between DOPA-PI' and a2 161
Formation of DOPA*-P3' monitored by SF UV-vis spectroscopy 162
Formation of DOPA*-PP' monitored by EPR spectroscopy 165
Kinetic simulations 167
SF UV-vis analysis of DOPA* formation with other substrate/effector pairs 168
RFQ EPR spectroscopy with ADP/dGTP 172
EPR analysis of DOPA* formation with other substrate/effector pairs 174
PELDOR spectroscopy to determine the distance between DOPA* and Y122* 177
in DOPA-pp'/a2
The fate of DOPA*-3pp3'/a2 179
Reaction of DOPA*-I3'/ca2 with hydroxyurea 179
The fate of DOPA*-13P'/I2 studied by EPR spectroscopy 184
Enhancing the radical content of DOPA-pp' 186
Oxidation of Y122 by DOPA* 186
DISCUSSION 191
An asymmetric model for a2/42 interaction 191
Sources of asymmetry in the a2/42 complex 192
Y 122* distribution and aggregation state 195
Initial asymmetric interaction in DOPA-P2/a2 and DOPA-3PP'/I2 197
Structural source of initial asymmetric interaction 199
Evidence for asymmetry from other experiments 200
Cooperativity in dCDP formation 202
Multiple conformations and fast interconversion 203
Testing the asymmetry model 204
Reverse radical migration in DOPA*--3p3'/a2 204
REFERENCES 207
Chapter 4 - Site-Specific Insertion of 3-Aminotyrosine into Subunit a2 209
of E. coli Ribonucleotide Reductase: Direct Evidence for Involvement of
Y730 and Y731 in Radical Propagation
INTRODUCTION 210
MATERIALS AND METHODS 214
Materials 214
Qualitative assay for cellular uptake of NH2Y by LC-MS 214
Directed evolution of NH2Y-RS in E. coli 215
Expression of K7NH2Y-Z-domain 216
Cloning of pTrc-nrdA 218
Generation of pTrc-nrdA73oTAG and pTrc-nrdA731TAG 218
Cloning of pAC-NH2Y-RS 219
Attempts at expression of Y730NH2Y-a2 219
Successful expression of Y730NH 2Y-a2 and Y731NH 2Y-a2 220
Purification of Y730NH2Y-a2 and Y731NH2Y-a2 221
Reaction of NH 2Y-a2 with 02, CDP, and ATP monitored by EPR 222
spectroscopy
Kinetics of NH2Y*-a2 formation with 32, CDP and ATP by stopped-flow 222
(SF) UV-vis spectroscopy
Spectrophotometric and radioactive activity assays for RNR 223
Reaction of NH 2Y-a2 with 32, N3ADP and dGTP monitored by EPR 223
spectroscopy
RESULTS 225
Toxicity and uptake of NH2Y 225
Evolution of an NH2Y-specific RS 225
Expression of K7NH2Y-Z-domain 226
Expression and purification of NH2Y-a2s 227
Reaction of NH2Y-a2s with wt P2, CDP and ATP monitored by EPR 229
spectroscopy
Kinetics of NH2Y*-a2 formation monitored by SF UV-vis spectroscopy 231
Kinetics of NH2Y*-a2 decay monitored by EPR spectroscopy 237
Activities of NH 2Y-a2s 241
Kinetics of NH2Y731* decay in the presence of N3UDP/ATP monitored by 243
EPR spectroscopy
DISCUSSION 247
Generation of Y73oNH 2Y-a2 and Y73 1NH2Y-a2 247
Structural assignment of the new radical 247
Kinetics of NH2Y*-a2 formation 248
Activity Assays of NH2Y-a2s 249
Rate of decay of NH2Y*-a2 249
Implications for mechanism of oxidation 251
REFERENCES 255
Chapter 5 - Detailed Kinetic and Spectroscopic Examination of NH 2Y* 261
Formation with NH 2Y-a2s
INTRODUCTION 262
MATERIALS AND METHODS 266
Materials 266
Synthesis of 3-[15N]-nitrotyrosine, [15N]-NO2Y 266
Synthesis of 3-[15N]-aminotyrosine, [15N]-NH 2Y 267
Growth, expression and purification of [15N]-NH2Y730-a2 268
Activity assays 268
Reaction of Y730NH2Y-a2 with 02, NDP/(d)NTP monitored by EPR 268
spectroscopy
Reaction of [15N]-Y730NH2Y-a2 with P2 and NDP/(d)NTP monitored by 268
EPR spectroscopy
Reaction of Y730NH2Y-a2 or [15N]-Y 73oNH 2Y-a2 with [2, NDP/(d)NTP 268
in deuterated buffer monitored by EPR spectroscopy
Preparation of high-field EPR and PELDOR samples 269
Simulation of X-band EPR spectra 269
Computational studies 270
Reaction of Y731NH2Y-a2 with P2, NDP/(d)NTP monitored by EPR 270
spectroscopy
Reaction of Y730NH2Y-xa2 (or Y731NH2Y-x2) with HiS6-Y356F-P2 270
monitored by EPR spectroscopy
SF UV-vis spectroscopy of NH2Y-a2/p2 with various NDP/(d)NTP pairs 270
Temperature-dependent SF UV-vis spectroscopy of Y730NH 2Y-aC2/2 with 271
CDP/ATP
RESULTS 272
Isotope labeling of NH2Y to examine the new signal with NH2Y-a2s by 272
EPR spectroscopy
Preparation of [15N]-NH2Y 275
Preparation of [15N]-NH2Y-a2 277
Generation of [14N]-NH 2Y 730* and [15N]-NH2Y 730* with various 277
NDP/(d)NTP pairs
Analysis of NH2Y7 30* by 180 GHz EPR spectroscopy 281
Spectral simulations 282
Formation of NH2Y731* with other substrate/effector pairs 290
Distance measurements using PELDOR spectroscopy with NH2Y-a2s 293
Reaction of NH2Y-a2 with Y356F-P2 296
SF UV-vis spectroscopy of NH2Y-a2/032 with various NDP/(d)NTP 298
combinations
Temperature dependence in formation of NH 2Y730o 305
DISCUSSION 309
Examination of the structure of NH 2Y730* 309
Positions of NH2Y730o and NH2Y73 1* within the radical transfer pathway 314
Kinetics of NH2Y* formation with various NDP/(d)NTP combinations 316
REFERENCES 319
Chapter 6 - Mono-, Di-, Tri-, and Tetra-Substituted Fluorotyrosines: New 323
Probes for Enzymes that Use Tyrosyl Radicals in Catalysis
INTRODUCTION 324
MATERIALS AND METHODS 327
Materials 327
Synthesis of F.Ys 327
Synthesis of Fn-tyrosine methyl ester hydrochloride (FnY-OMe.HC1) 328
Synthesis of N-acetyl-Fa-tyrosinamide (Ac-FnY-NH 2) 329
4-Benzoyl-L-phenylalanyl-FnY methyl ester trifluoroacetic acid (BPA- 331
FnY-OMe*CF 3COOH)
Physical measurements 332
?Ka determination of Ac-FnY-NH2 analogues using UV spectroscopy and 3339F NMR spectroscopy
Differential pulse voltammetry (DPV) 333
Generation of oxidized FnYs and EPR measurements 334
Transient absorption (TA) spectroscopy 335
Computational methods 336
Global incorporation of 3-FY into P2 336
Extent of incorporation of 3-FY into P2 336
RESULTS AND DISCUSSION 338
pKa determination of FnYs by UV and 19F NMR spectroscopy 338
pH Dependent oxidation of Ac-FaY-NH2s 343
Electronic structure calculations of Ac-FnY-NH 2s 346
Spectroscopic characterization of FnY*s 349
Incorporation of 3-FY into 32 355
CONCLUSION 358
REFERENCES 359
Chapter 7 - pH Rate Profiles of FY 3s6-02s (n = 2, 3, 4) in E. coli Ribonucleotide 363
Reductase: Further Evidence that Y356 is a Redox-Active Amino Acid Along the
Radical Propagation Pathway and Elucidation of its Mechanism of Oxidation
INTRODUCTION 364
MATERIALS AND METHODS 369
Materials 369
Physical measurements 369
Synthesis of Fmoc-FnYs 369
Peptide synthesis 370
Semisynthesis of 12 and FnY 356-02s 372
Purification of a2 and removal of contaminating 32 374
Determination of pH rate profiles of FnY 356-p2s 374
RESULTS 375
Synthesis and characterization of FnY 356N353G/S354C-02s 375
Problems encountered in the RNR activity assay 376
pH rate profiles for wt and FnY 356-02s 376
DISCUSSION 378
CONCLUSION 385
REFERENCES
Chapter 8 - Switching the Rate-Determining Step from a Conformational 391
Change to Radical Propagation with 2,3,5-F 3Y-32 of E. coli Ribonucleotide
Reductase
INTRODUCTION 392
MATERIALS AND METHODS 397
Materials 397
Semisynthesis of FnY-32 and FnY-PP' 397
Growth, expression and purification of His6-V353G/S 354C-I2 397
Monitoring dCDP formation by RCQ studies 397
Data analysis of RCQ experiments 398
Generation of apo Y-32, 2,3,5-F 3Y-P2 or 2,3,5-F 3Y-PP' with lithium 398
8-hydroxy-quinoline-6-sulfonate
Reconstitution of apo FnY-P2 399
Spectrophotometric and radioactive RNR Assay 399
Single wavelength and diode array SF UV-vis spectroscopy 399
RFQ-EPR spectroscopy 399
Kinetic simulations 400
pH rate profile for NH 2Y* formation in the reaction of 2,3,5-F 3Y-p2 with 400
NH 2Y- a2s and CDP/ATP monitored by SF UV-vis spectroscopy
RESULTS 401
Rationale for pre-steady state experiments 401
Pre-steady state analysis of His6-V353G/S 354C-32 by RCQ 402
Pre-steady state analysis of FnY-I32s by RCQ 405
Increasing the radical content of semisynthetic FnY-32s 410
Diode array SF UV-vis spectroscopy with 2,3,5-F 3Y-PP3'/a2 412
SF UV-vis spectroscopy with 2,3,5-F 3Y-P2/a2 414
RFQ EPR spectroscopy with 2,3,5-F 3Y-j32 and 2,3,5-F 3Y-13j3' 414
Rationale for kinetic simulations of the a2/FnY-32 catalytic cycle 419
Kinetic simulations: forward or reverse radical propagation? 421
Kinetic simulations: reproducing the effect of pH on kcat with 2,3,5-F 3 Y-132 429
387
SF UV-vis spectroscopy with 2,3,5-F 3Y-p32, NH2Y-(2 and CDP/ATP as a 432
readout for forward radical transfer
DISCUSSION 440
REFERENCES 445
List of Figures
Figure 1-1
Figure 1-2
Figure 1-3
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
1-4
1-5
1-6
1-7
1-8
1-9
1-10
1-11
1-12
1-13
1-14
1-15
1-16
1-17
1-18
1-19
Figure 1-20
Figure 1-21
Figure 2-1
Figure 2-2
Figure 2-3
Reaction catalyzed by RNR
Four classes of RNRs
Structural basis for allosteric regulation in the T. maritima class II
RNR
The diiron Y122• cofactor of E. coli RNR
Proposed mechanism for nucleotide reduction
Docking model for the interaction between a2 and 32
The proposed radical transfer pathway of E. coli RNR
Structures of mechanism-based inhibitors of RNR
PELDOR spectroscopy with N3UDP and wt a2/32
Parabolic driving force dependence for kET
Tunneling time table in Ru-modified proteins
PCET model systems
Square scheme for PCET
Two classes of PCET reactions
Peak potentials of Ac-Y-NH2 and Ac-W-NH2 as a function of pH.
Working model for cofactor assembly in E. coli P2
Superimposition of the active sites of RNRs from three different
classes
Unnatural Y analogues incorporated into 32 or (2 in this Thesis.
Proposed mechanism of intein self-expulsion for the S. cerevisiae
Vma intein
Semisynthesis of 12 via EPL
Chemical mechanism for long-range radical transfer in E. coli RNR
Low reduction potential Y analogues considered for insertion at
position 356 of 32
The radical generation pathway with site-specific insertion of DOPA
at residue 356
Reactions of catechol, catechol* and o-benzoquinone
Figure 2-4
Figure 2-5
Figure 2-6
Figure 2-7
Figure 2-8
Figure 2-9
Figure 2-10
Figure 2-11
Figure 2-12
Figure 2-13
Figure 2-14
Figure 2-15
Figure 2-16
Figure 2-17
Figure
Figure
2-18
2-19
Figure 2-20
Figure 2-21
Figure 2-22
Figure 2-23
Figure 2-24
Figure 2-25
Figure 2-26
Characterization of Fmoc-19mer peptide
Structures of Fmoc-DOPA(acetonide)-OH and
Fmoc-Cys(t-Buthio)-OPfp
Characterization of purified DOPA-22mer
Generation of semisynthetic DOPA-132
Characterization of the Y1220 in DOPA-032
Binding of DOPA-32 to a2
Kinetics of DOPA356* formation and Y122* disappearance
Control experiments for the SF UV-vis reactions of DOPA-032
UV-vis spectrum of DOPA356* using point-by-point spectral
reconstruction
Trapping of DOPA356* with different substrate effector pairs
Kinetics of DOPA356* formation and Y122* disappearance with ADP
alone
EPR spectrum of DOPA356*-P2/a2 in the presence of GDP/TTP
Microwave power dependence of Y122* and DOPA356*
X-band EPR spectra of DOPA* and catechol* generated by
anaerobic photolysis at 77 K
EPR spectrum of DOPA356*-p2/a2 in the presence of CDP/ATP
Comparison of DOPA356*-02/a2 as a function of substrate/effector
pairs
180 GHz EPR spectrum of DOPA356*
Simulation of 180 GHz EPR spectrum of DOPA356*
Simulation of X-band DOPA356* spectra
X-band PELDOR spectroscopy of Y122*-DOPA356* and
DOPA356*-D0PA3 56*
PELDOR studies with the mechanism-based inhibitor N3UDP
Delocalization of the unpaired spin on Y1220 over residues of the
radical transfer pathway
PELDOR studies with DOPA-32/ca2
115
115
116
119
119
121
121
122
122
124
124
127
128
129
130
130
133
133
134
137
146
146
147
Figure 3-1
Figure 3-2
Figure 3-3
Figure 3-4
Figure 3-5
Figure 3-6
Figure 3-7
Figure 3-8
Figure 3-9
Figure 3-10
Figure 3-11
Figure 3-12
Figure 3-13
Figure 3-14
Figure 3-15
Figure 3-16
Figure 3-17
Figure 3-18
Figure 3-19
Figure 3-20
Figure 3-21
Figure 3-22
Figure 3-23
Figure 3-24
Figure 3-25
Figure 3-26
Figure 3-27
Diagrammatic view of the P32 subunits discussed in this chapter
Lack of Y122* redistribution observed within P3p'
SDS PAGE Analysis of DOPA-P33'
Characterization of the diiron Y122* of DOPA-131'
Binding of DOPA-PP' to a2
Kinetics of DOPA356 -PP3' formation with a2, CDP and ATP
Point-by-point Reconstruction of the UV-vis Spectrum of DOPA356*-PP1 '
by SF Spectroscopy
EPR spectrum of DOPA356"-j•3'/a2 with CDP/ATP
DOPA356* formation as a function of initial [DOPA-[i3'/a2]
Kinetic Simulation of DOPA356• formation with DOPA-PP3''a2
Kinetics of DOPA3 56*-PP/'/a2 formation with UDP/ATP
Kinetics of DOPA 356*-••'l/a2 formation with GDP/TTP
Kinetics of DOPA356*-PI3'I/a2 formation with ADP/dGTP
RFQ EPR Spectroscopy with DOPA-3•'/A2 in the presence of ADP/dGTP
Comparison of DOPA356*-03'/a2 as a function of substrate/effector pairs
Comparison of the EPR spectrum of DOPA356* in DOPA-f32/a2 vs.
DOPA-13'/a2 as a function of NDP/(d)NTP
X-band PELDOR spectroscopy of Y122*-DOPA356* with DOPA-P•3'fA2
Sequential-mix SF UV-vis spectroscopy monitoring reduction of
DOPA356* by HU
Kinetics of HU-mediated reduction of Y122* with wt and Y356F-32
Decay Kinetics of DOPA356.-PP/3'702 with CDP/ATP
Summary of procedures used to generate DOPA-33' with a radical content
1.2 Y122* per heterodimer
Purification of DOPA-33' with 1.2 Y1 220 per heterodimer
Asymmetric model for RNR turnover
Sources of asymmetry in E. coli RNR
Diagram of the asymmetric a22/I2 complex structure from S. typhimurium
determined by Uppsten et al at 4 A resolution
Statistical distribution of Y122* in DOPA-f02, DOPA-P3' and wt P32
Current working hypothesis to explain yields of DOPA356* with DOPA-pp'3
and DOPA-02
154
154
163
163
163
164
166
166
167
169
169
170
171
174
175
177
178
180
183
185
187
189
193
194
194
198
198
Figure 3-28
Figure 4-1
Figure 4-2
Figure 4-3
Figure 4-4
Figure 4-5
Figure 4-6
Figure 4-7
Figure 4-8
Figure 4-9
Figure 4-10
Figure 4-11
Figure 4-12
Figure 4-13
Figure 4-14
Figure 4-15
Figure 4-16
Figure 4-17
Figure 4-18
Figure 4-19
Figure 4-20
Figure 4-21
Pictorial presentation of PELDOR measurements with DOPA356*-032/oa2
and DOPA356*-5'/a2
The putative radical initiation pathway generated from the docking model
of a2 and j32
MALDI-TOF MS and SDS PAGE analysis of K7NH2Y-Z-domain
Expression of Y731NH2Y-a2
Expression of Y730NH2Y-a2
SDS PAGE analysis of purified Y730NH2Y-a2
SDS PAGE analysis of purified Y731NH2Y-ca2
Reaction of Y730NH2Y-a2/ATP with wt U2/CDP monitored by EPR
spectroscopy
Microwave power dependence of Y122* and NH2Y730* signal intensities
Reaction of Y731NH2Y-a2/ATP with wt 32/CDP monitored by EPR
spectroscopy
Comparison between NH2Y730* from Fig. 4-7 and NH2Y731* from Fig. 4-9
Point-by-point reconstruction of the UV-vis spectrum of NH2Y730* and
NH2Y7319
Kinetics of formation for NH2Y730* and NH 2Y 731*
Stability of NH2Y730. probed by EPR spectroscopy
Stability of NH2Y731* probed by EPR and UV-vis spectroscopy
N3ADP assay for Y730NH2Y-a2
EPR spectral comparison of N*, Y122* and NH2Y730*
N3ADP Assay for Y731NH2Y-a2
Stability of NH2Y731* in the presence of N3UDP/ATP probed by EPR
spectroscopy
Working model for loss of spin during reaction of NH2Y-a2s with
CDP/ATP
Working model for loss of spin during reaction of NH2Y-a2s with
N3ADP/dGTP
Mechanistic options for oxidation of C439 by NH2Y730*
206
213
228
230
230
232
232
233
233
234
234
236
237
239
240
244
244
245
246
253
253
254
Figure 5-1
Figure 5-2
Figure 5-3
Figure 5-4
Figure 5-5
Figure 5-6
Figure 5-7
Figure 5-8
Figure 5-9
Figure 5-10
Figure 5-11
Figure 5-12
Figure 5-13
Figure 5-14
Figure 5-15
Figure 5-16
Figure 5-17
Figure 6-1
Figure 6-2
Figure 6-3
Figure 6-4
Figure 6-5
Figure 6-6
Figure 6-7
Figure 6-8
Figure 6-9
Figure 6-10
Figure 6-11
Figure 6-12
The proposed radical initiation pathway within an xp pair
Numbering scheme for o-aminophenol radicals data in Table 5-1
15N-' 3C J-couplings observed with ['5N]-NO2Y and ["5N]-NH2Y
Normalized EPR spectra of isotopically substituted NH2Y730"
EPR spectra of NH2Y730* at 180 GHz in the presence of CDP/ATP
Numbering scheme, g tensor axis orientation and conformations of NH2Y*
Simulation of ['5N]-NH2Y730* EPR spectra in deuterated assay buffer
Simulation of NH2Y730* EPR spectra in protonated assay buffer
EPR spectra of NH2Y 731* in the presence of various NDP/(d)NTPs
EPR spectra of NH2Y 731* at 180 GHz
PELDOR spectroscopy with NH2Y-a2s
Distances between Y1229 and other residues in the radical transfer pathway
Pathway dependence for NH2Y* formation
Kinetics of NH2Y730* formation monitored by SF UV-vis spectroscopy
Kinetics of NH2Y731* formation monitored by SF UV-vis spectroscopy
Temperature-dependence of NH2Y730* formation
Structure of the NH2Y730*
UV spectra of phenol and phenolate forms of Ac-FnY-NH2Ys
UV spectra of Ac-2,3-F 2Y-NH2 as a function of pH
Dependence of 19F NMR chemical shifts on pH
Differential pulse voltammogram for Ac-FnY--NH2/Ac-FnY*-NH 2s
Reduction potential vs. NHE as a function of pH for Ac-FnY-NH 2
derivatives
DFT calculations for Eps and pKas of Ac-F.Y-NH2Ys
Energy level diagram for frontier molecular orbitals of the phenolates of
Ac-FnY-NH2s
Normalized EPR spectra of FY*s
TA spectroscopy with BPA-Y-OMe
UV-vis spectra of BPA-FnY*-OMe derivatives
SDS PAGE analysis of 3-FY-P2
EPR spectrum and simulation of 3-FY1 22*-02
263
274
275
280
281
282
285
288
291
293
295
296
298
299
301
307
313
339
340
341
344
345
348
349
352
353
354
356
357
Figure 7-1
Figure 7-2
Figure 7-3
Figure 7-4
Figure 7-5
Figure 8-1
Figure 8-2
Figure 8-3
Figure 8-4
Figure 8-5
Figure 8-6
Figure 8-7
Figure 8-8
Figure 8-9
Figure 8-10
Figure 8-11
Figure 8-12
Figure 8-13
Figure 8-14
Figure 8-15
Figure 8-16
Figure 8-17
Putative PCET pathway of E. coli RNR based on the docking model
pH rate profiles of FaY 356-f2s
Peak reduction potential of Ac-FnY-NH2s as a function of pH
Redox potential regimes of RNR activity
Mechanism of Y356 oxidation during radical transfer
The proposed radical initiation pathway within an apx pair
Kinetic model for the reaction of wt RNR
RCQ analysis of [14C]-dCDP formation with His6-V 353G/S354C-|2 (1.1
Y122*/dimer)
RCQ analysis of [14C]-dCDP formation with Y-032 (0.35 Y122*/dimer) at
pH 6.8
RCQ analysis of [14C]-dCDP formation with 2,3,5-F 3Y-132 (0.4
Y122*/dimer)
RCQ analysis of [14C]-dCDP formation with F4Y-P32 (0.37 Y122*/dimer)
Increasing the radical content of Y-f32 and 2,3,5-F 3 Y-f32
SDS PAGE analysis of 2,3,5-F 3Y-f32 and 2,3,5-F 3Y-PP3' after
chelation/reconstitution
Diode Array SF UV-vis spectroscopy of 2,3,5-F 3Y-37'/a2 (1.2
Y122*/dimer) in the presence of CDP/ATP at pH 8.4
Single wavelength SF UV-vis spectroscopy of 2,3,5-F 3Y-02/a2 (1.2
Y122*/dimer) in the presence of CDP/ATP at pH 8.4
RFQ EPR spectroscopy of the reaction of 2,3,5-F 3Y-PP' (1.2 Y122*/dimer)
and CDP with a2 and ATP
RFQ EPR spectroscopy of the reaction of 2,3,5-F 3Y-J32 (1.2 Y122*/dimer)
and CDP with a2 and ATP
RFQ EPR spectroscopy of the reaction of 2,3,5-F 3Y-32 (1.2 Y122*/dimer)
and CDP with a2 and ATP
Kinetic model and result of simulation for the reaction of Y-P32
Kinetic model and result of simulation for the reaction of 2,3,5-F 3Y-132 in
which reverse radical transfer is rate-limiting
Kinetic model and result of simulation for the reaction of 2,3,5-F 3Y-32 in
which forward radical transfer is rate-limiting
Kinetic model and result of simulation for the reaction of 2,3,5-F 3Y-32 in
which forward radical transfer is rate-limiting with an altered Y122*
reformation rate constant
368
377
379
380
386
392
395
404
405
407
408
411
412
413
414
415
416
418
420
422
424
425
Figure 8-18
Figure 8-19
Figure 8-20
Figure 8-21
Kinetic model and result of simulations for the reaction of 2,3,5-F 3Y-32 in
which forward and reverse radical transfer are partially rate-limiting
Representative time courses for the reaction of NH2Y-a2s with
2,3,5-F 3Y-f2 and CDP/ATP monitored by SF UV spectroscopy
SF UV spectroscopy of NH2Y-a2s with 2,3,5-F 3Y-32 and CDP/ATP as a
function of pH
pH rate profile for NH2Y* formation in the reaction of NH2Y-a2 with
2,3,5-F 3Y-p2
428
434
435
439
List of Tables
Table 2-1
Table 2-2
Table 2-3
Table 2-4
Table 2-5
Table 3-1
Table 3-2
Table 3-3
Table 3-4
Table 3-5
Table 3-6
Table 3-7
Table 3-8
Relevant properties for the Y analogues DOPA, NH2Y and MeS-Y
Specific activities of wt 32, intein-wt 12 and DOPA-12 in nmol/min
mg
Kinetics of DOPA356*-P2/a2 formation with various
substrate/effector combinations using SF UV-vis spectroscopy
Comparison of X-band EPR parameters and stoichiometry of
DOPA356* formation with substrate only vs. substrate and effector
Parameters used for simulation of DOPA356* spectra in Figure 2-22
Summary of kinetic parameters for DOPA356*-Pp'/a2 formation as a
function of substrate/effector pairs
Comparison of X-band EPR parameters for DOPA356*-42/a2 and
DOPA356*-PP'/a2 as a function of substrate/effector pairs
Comparison of the extent of DOPA356* formation with DOPA-P2/a2
and DOPA-PP'/a2 as a function of substrate/effector pairs
Summary of kinetic parameters in the reaction of DOPA356*-pp' with
HU obtained using sequential SF UV-vis spectroscopy
Determination of [DOPA.] and [Y122*] in the reaction of
DOPA-P3'/GDP with a2/TTP on the minute time scale
Determination of [DOPA*] and [Y122*] in the reaction of
DOPA-p13pCDP with a2 on the minute time scale
Determination of [DOPA*] and [Y122*] in the reaction of
DOPA-13'/CDP with a2/ATP on the minute time scale
Determination of [DOPA.] and [Y122*] in the reaction of
DOPA-12/CDP with a2/ATP on the minute time scale
Vectors used in this study
Summary of kinetic data for formation of NH2Y*-ca2
Monitoring the activity of NH2Y-a2s by measuring deoxynucleotide
and N. formation
Analysis of the reaction of wt a2 or NH2Y-a2s with 12 and
N3ADP/dGTP after 20 s
Table 4-1
Table 4-2
Table 4-3
Table 4-4
89
120
125
131
135
172
176
176
182
188
188
190
190
217
238
241
245
Table 5-1
Table 5-2
Table 5-3
Table 5-4
Table 5-5
Table 5-6
Table 5-7
Table 5-8
Table 5-9
Table 5-10
Table 5-11
Table 6-1
Table 6-2
Table 7-1
Table 7-2
Table 7-3
Table 7-4
Table 8-1
Summary of EPR parameters (in MHz) previously reported for an
o-aminophenol radical
UV spectral properties of authentic 14N-NH 2Ya and synthetic
S1 N-NH2Y determined in H20 at 25"C
Yield of NH2Y* and total spin after reacting Y73oNH 2Y-a2 with 102
and various NDP/(d)NTP pairs for 20 s
Hyperfine coupling constants (in MHz) calculated for NH 2Y*. See
Figures 5-6A and 5-6B for numbering scheme and conformation of
NH2Y*
Hyperfine coupling constants (in MHz) calculated for NH2Y* in an
alternative conformation
Parameters (in MHz) used for simulation of [14N]-NH 2Y 730* and
[15N]-NH2Y730* EPR spectra in protonated or deuterated buffer
Yield of NH 2Y* and total spin after reacting Y731NH2Y-a2 with 132
and various NDP/(d)NTP pairs for 20 s
Summary of kinetic parameters for reaction of Y730NH 2Y-a2 with
02 and various substrate/effector combinations at 250 C
Summary of kinetic parameters for reaction of Y731NH2Y-a2 with
02 and various substrate/effector combinations at 250C
Summary of kinetic parameters for the reaction of Y73oNH2Y-a2/32
with CDP/ATP as a function of temperature
Summary of thermodynamic parameters for NH 2Y* formation with
Y730NH2Y- a2 in the presence of CDP/ATP
A-tensors of nuclei with significant hyperfine interaction in 3-
FY122*-02
Physical data for tyrosine and fluorotyrosine derivatives
Fluorotyrosine derivatives used to substitute Y356 of 12 and their
physical properties
Purification and yield of Fmoc-FnY-COOH
RP-HPLC and MALDI-TOF MS characterization of FnY-22mers
Physical and biochemical characterization of FnY 356-12s
Summary of kinetic parameters from RCQ experiments monitoring
[14C]-dCDP formation
274
276
279
283
283
286
292
300
302
308
308
342
357
367
371
372
373
409
Measured and simulated kcat for 2,3,5-F 3Y-p2 as a function of pH
using the kinetic model in Figure 8-17
Measured and simulated kcat for 2,3,5-F 3Y-32 as a function of pH
using the kinetic models in Figures 8-17 and 8-18
Summary of the kinetic parameters for NH 2Y* formation in the
reaction of Y730NH2Y-a2 or Y731NH2Y-a2 with 2,3,5-F 3Y356-P2 in
the presence of CDP/ATP
Table 8-2
Table 8-3
Table 8-4
430
431
436
List of Schemes
Scheme 2-1
Scheme 4-1
Scheme 5-1
Scheme 5-2
Scheme 5-3
Scheme 6-1
Involvement of DOPA* in melanin biogenesis
One electron oxidation of NH2Y
Synthetic scheme used for preparation of "SN-NH2Y
Different protonation states and pKas of NH2Y
Rotation about the C3-N bond in NH2Y•
Fluorotyrosine analogues prepared in this study
213
275
276
289
326

Abbreviations
ADP Adenosine-5'-diphosphate
Amp Ampicillin
ATP Adenosine-5'-triphosphate
BPA Benzophenone
CBD Chitin binding domain
CAP Calf-intestine alkaline phosphatase
CDP Cytidine-5'-diphosphate
Ches 2-(Cyclohexylamino)ethanesulfonic acid
Cm Chloramphenicol
CV Column volume
dATP 2'-Deoxycytidine-5'-triphosphate
dC 2'-Deoxycytidine
dCDP 2'-Deoxycytidine-5'-diphosphate
DFT Density functional theory
dGTP 2'-Deoxyguanosine-5'-triphosphate
DIPEA N,N-Diisorpropylethylamine
DMF N,N-Dimethylformamide
DOPA 3,4-Dihydroxyphenylalanine
DPV Differential pulse voltammetry
DTT Dithiothreitol
EDTA Ethylenediaminetetraacetic acid
EPR Electron paramagnetic resonance
ESI Electrospray ionization
ET Electron transfer
EtOAc Ethyl acetate
Fmoc 9-Fluorenylmethoxycarbonyl
GDP Guanosine-5'-diphosphate
GFP Green fluorescent protein
GMML Glycerol minimal media leucine
HAT
HATU
Hepes
HOBt
HU
IPTG
Kan
L-Ara
LB
MALTI-TOF
MeCN
MeOH
Mes
Mesna
MeV
MS
NADPH
NMM
NMR
PCET
PELDOR
PLP
PMSF
RCQ
RFQ
RNAP
RP-HPLC
SDS PAGE
TA
Taps
Tet
Hydrogen atom transfer
O-(7-Azabenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium
hexafluorophosphate
4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid
1-Hydroxybenzotriazole
Hydroxyurea
Isopropyl-p-D-thiogalactopyranoside
Kanamycin
L-Arabinose
Luria Bertani
Matrix-assisted laser desorption/ionization time of flight
Acetonitrile
Methanol
2-(N-Morpholino)ethanesulfonic acid
2-Mercaptoethanesulfonic acid
Methyl viologen
Mass spectrometry
f-Nicotinamide adenine dinucleotide phosphate (reduced form)
N-Methylmorpholine
Nuclear magnetic resonance
Proton-coupled electron transfer
Pulsed electron-electron double resonance
Pyridoxal-5'-phosphate
Phenylmethanesulfonyl fluoride
Rapid chemical quench
Rapid freeze quench
RNA polymerase
Reverse-phase high performance liquid chromatography
Sodium dodecylsulfate polyacrylamide gel electrophoresis
Transient absorption
N-[Tris(hydroxylmethyl)methyl]-3-aminopropanesulfonic acid
Tetracycline
TFA Trifluoroacetic acid
TIS Triisopropylsilane
TLCK Tosyl-L-lysyl chloromethane
TPCK Tosyl-L-phenylalanyl chloromethane
TPL Tyrosine phenol lyase
Tris Tris(hydroxymethyl)aminomethane
TTP Thymidine-5'-triphosphate
UDP Uridine-5'-diphosphate
WSC N-Ethyl-N'-(3-dimethylaminopropyl)carbodiimide

CHAPTER 1:
Introduction to Ribonucleotide Reductases
Adapted in part from: Seyedsayamdost, M. R.; Yee, C. S.; Stubbe, J. Nat. Protoc. 2007, 2, 1225.
General Introduction
In all organisms, ribonucleotide reductases (RNRs) play a central role in nucleic acid
metabolism by catalyzing the conversion of nucleotides to 2'-deoxynucleotides (Figure 1-1),
thereby providing all of the monomeric precursors required for DNA replication and repair. 1' 2
To ensure that RNRs provide a balanced pool of deoxynucleotides, which is essential for the
fidelity of DNA synthesis, they are tightly regulated at numerous levels inside the cell.3'4
Because of this central role, RNRs have served as pharmaceutical targets and several RNR
inhibitors are currently in clinical use or trial. 5-12
(P)PPO 0 RNR (P)PPO N
HO OH HO H
N = A, U, C, G
Figure 1-1. Reaction catalyzed by RNR.
RNRs have also served as a paradigm for a wide range of areas of interest in Chemistry
and Biology.' They have been proposed to provide a major connection between the RNA and
DNA worlds.4,13' 15 RNR is also the first enzyme, in which a tyrosyl free radical was discovered,
and in which the chemistry of a protein-bound diiron center with 02 was elucidated. 16-20 This
chemistry involved formation of tryptophan cation radical, which to date is only one of three
functionally relevant tryptophan cation radicals in Biology. 21-23 The nucleotide reduction
mechanism was unprecedented at the time of its discovery and involved formation of the only
known thiyl radical in Biology. 24 Finally research groups interested in the mechanism of
oxidation of amino acids are concerned with RNRs to understand how the concomitant motion of
electrons and protons are coordinated. 25 The work presented in this Thesis will focus on another
hallmark of RNRs: long-range charge transfer using transient amino acid radical intermediates.
The reduction of nucleotides catalyzed by RNR employs complex radical chemistry,
which requires generation of a thiyl radical (C*). Four classes of RNRs have been proposed
based on the mechanism attendant to Co generation (Figure 1-2).1 Class I RNRs, the main focus
of this Thesis, utilize a diiron tyrosyl radical (Yo) cofactor. Class II RNRs use a
5'-deoxyadenosyl radical derived from homolytic cleavage of the C-Co bond in
adenosylcobalamin. Class III RNRs employ a glycyl radical (Go), the formation of which
requires an activase 'radical SAM' enzyme, that harbors a [4Fe-4S] cluster and the cofactor
S-adenosylmethionine. Finally, a recently identified class IV RNR uses a MnW-Fem cofactor to
generate Co. 26
class I class II
0O.CH 2Ad
Fe"LO---Fe"l
So
Fe"! O'MnIv H
class IV? class III
Figure 1-2. Four classes of RNRs. The classes are distinguished based on the metallocofactor used
to generate a Co essesntial for catalysis. Class I RNRs use a diiron tyrosyl radical, class II RNRs use
adenosylcobalamin, and class Ill RNRs employ a glycyl. Recently, a MnW-Fem cluster has been
proposed to generate a Co in C. trachomatis. This likely represents a fourth class of RNR.
The Class la RNR from E. coli
The focus of this Thesis will be the class Ia RNR from E. coli. This RNR is expressed by
the nrdA and nrdB genes in E. coli and is different from the nrdE and nrdF genes, which
comprise the class Ib RNR.27 29 Class Ib differs from class Ia in several aspects. The class Ia
RNR is present in all eukaryotes and some prokaryotes, whereas class Ib RNR is at present
confined to bacteria. In E. coli, the class Ia RNR is essential, whereas class Ib RNR is not.
Under normal growth conditions in E. coli, the class Ia RNR is predominantly expressed,
whereas expression of class Ib RNR is poor. The physiological role of this second RNR is not
understood, although preliminary results indicate it to be involved under Fe limiting or oxidative
stress conditions. At the molecular level, class Ib RNR differs from the class la in the geometry
of its Ye cofactor, as delineated by spectroscopic and structural studies, the requirement for its
disulfide reductant and its regulation of overall activity. 30
Protein Subunits of Class la E. coli RNR
E. coli class la RNR consists of two protein subunits, ac2 and P32. 3 1 a2, a dimer of 172
kDa, is the site of nucleotide reduction. It contains binding sites for the substrates CDP, GDP,
UDP and ADP, and allosteric effectors ATP, dATP, TTP, and dGTP.32,33 A remarkable feature
of a2 is the numerous levels of allosteric regulation which have evolved to ensure that a single
enzyme provides a balanced pool of four deoxynucleotides and is able to respond to the changing
dNTP requirements of the cell. Binding of effectors to the allosteric site causes a conformational
change that reaches the active site and thus governs which substrate is reduced. The structural
basis for this regulation has been studied in the a2 subunit of Salmonella typhimurium,34 a class
Ib RNR, the class II RNR of Thermotoga maritima35 (Figure 1-3) as well as the anaerobic class
III E. coli RNR. 36,37 The model that has emerged from these studies is that allosteric effectors
bind at a four-helix bundle in the dimer interface of a2.4 Each monomer contributes residues to
binding of the effector. Effector binding strongly influences the conformation of a loop at the
dimer interface, loop 2 (Figure 1-3).35 The changes in the structure of loop 2 are propagated to
the active site, where binding of a specific substrate is preferred. In this fashion, effectors ATP
and dATP stimulate reduction of CDP and UDP, TTP codes for GDP and dGTP for ADP. In E.
coli RNR structural studies with various substrate/effector pairs have been unsuccessful due to
the difficulty of obtaining diffractable crystals.
Class la enzymes also contain a second allosteric regulation site in a2, called the activity
site, which controls the overall rate of nucleotide reduction. At the activity site ATP and low
[dATP] stimulate rapid nucleotide reduction, whereas high [dATP] renders RNR inactive in
nucleotide reduction. 32 This site allows the activity of RNR to be stimulated or inhibited based
on the ratio of [dATP] and [ATP] inside the cell. The activity site is known to reside in the
N-terminal domain of a2 and contains a conserved KRDG motif, in which K and R interact with
the phosphate groups of the nucleotide. Structures with ATP and the effector-free form of a2
have not revealed conformational differences; however, soaking experiments have suggested that
the conformational change may not take place due to disruption or prevention of crystal lattice
formation.38 Thus, the structural basis of this mode of regulation is at present not well understood.
It should be noted that the a2 subunits of class Ib RNRs lack an activity site.
Figure 1-3. Structural basis for allosteric regulation in the T. maritima class II RNR.35 Overlaid
structures of T. maritima RNR with the conformation of loop 2 in the allosteric effector site shown as
a function of CDP/dATP (blue), GDP/TTP (yellow) and ADP/dGTP (brown). The loop structure with
UDP/dATP is very similar to that of CDP/dATP and is not shown. Arrows are pointing to loop 2 in
each case
Studies with the mouse RNR have revealed a third allosteric regulation site, where high
ATP concentrations have been postulated to cause hexamerization of X.39 ,40 The location of this
binding site and its mechanism of regulation remain to be established. Prokaryotic RNRs, such
as the E. coli RNR, lack this third ATP binding site.
The second RNR subsunit, 32, is a homodimer of 87 kDa. It is the radical initiator
subunit and contains the Y* cofactor. Seminal experiments in the 1970s demonstrated that the
radical signal observed in 32 was associated with a Ye, which at the time, was the first Yo found
in an enzyme (Figure 1-4).6 This was subsequently located to residue 122.41,42 These
experiments also established a correlation between the [Y122*] and the level of activity suggesting
a role for Y122* in nucleotide reduction.6 The UV-vis spectrum of the cofactor shows major
features at 325, 365, 410 and 600 nm (Figure 1-4). The transition at 410 nm has been associated
with the Y122* with an 8 of 3000-3700 M-Icm-'. 43-46 This is similar to properties of Yo in
solution which also have a sharp peak at 410 nm and an E of -2800 M-lcm-1. 47 The other
UV-vis transitions are related to the diferric center which is adjacent to the Y1220.
Missbauer,48,49 resonance Raman5so and magnetic susceptibility51 studies have shown that this
center consists a gL-oxo-bridged high spin diferric ground state with an S=0 due to
antiferromangetic interaction at -92 cm 1. Structural studies have supported this assignment and
shown that the Y122* is within 5 A of the diferric center.52 Importantly, !32 purified by standard
procedure contains a maximal amount of 1.2 Y122* and 3-3.5 Fe per dimer. The distribution of
the Y122* and the Fe is a major unresolved issue and whether the substiochiometric ratios of Y122'
and Fe are artifacts of the purification procedure is not known. The in vivo levels of Y122* and
Fe are at present also unknown although they have been determined in yeast RNR.53, 54
Tyr122 C O*
wo
U
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Figure 1-4. The diiron Y122* cofactor of E. coli RNR. (Left) Structure of the cofactor from the cystal
structure of Nordlund et al.52 (Right) UV-vis spectrum of the cofactor. The sharp peak at 410 nm and
a hump at 390 nm are due to the Y122*. Transistions at 325 and 365 nm are due to the diiron center.
The transition at 600 nm has a small E and is not shown.
The structure of Y122* has been explored by multiple isotopic substitutions and multi-
frequency EPR and ENDOR methods.55,56 Y122* has been generated with 2H, 13C or 170 isotopic
substitutions using global replacement methods, and the anisotropic hyperfine tensors for the
ring protons, the Cp-protons, the ring C-nuclei and the phenol oxygen have been elucidated.
These have been used to provide a detailed picture of the spin density distribution. Consequently,
the Cp-proton, the 3,5-ring protons and the phenol oxygen show the greatest hyperfine coupling
constants indicative of significant spin density at the Cp, C3/C5 and the phenol oxygen,
respecively. In addition, the conformation of the CO-protons has been established from these
investigations.
High field EPR studies have provided a sensitive measure for H-bonding at Y122*. The
gx value has been found to correlate with the presence of hydrogen bonding to the phenol oxygen
in Y*s of class I 02s.30 A high gx value (-2.0091) has been correlated with absence of an H-bond,
as is the case in E. coli 02, whereas low g, values (-2.0074) are indicative of an H-bond.56 -58 A
physical explanation for the sensitivity of gx to hydrogen bonding has been proposed.
The Y122* is remarkably stable with a half life of -4 days at 40C.48 In comparison, Y*s
generated in solution react on the ms time scale.59 Measurements of the reduction potential of
Y122* have revealed an estimated value of 1.0 ± 0.1 V. 60 This is similar to the potential of YO
measured in solution. 61 66 Thus, the stability of the Y122* is not associated with a lowered
reduction potential. Instead, studies with various reductants have indicated that its stability is
related to the fact that the Y122* is sequestered from solvent and resides in a pocket that is >11 A
from the surface of the protein.52 Thus, steric, rather than electronic factors contribute mostly to
the remarkable stability of Y122o. Consistent with this idea, the Y* of mouse and human 32 are
sterically more exposed to solvent and have a significantly shorter half life than that of E. coli P2.
Nucleotide Reduction Mechanism
Despite evolution of several mechanisms for Co formation, the mechanism of nucleotide
reduction has been proposed to be common to all classes of RNRs.6 7'6 8 This mechanism
presented a mystery for some time, although a number of hypotheses mostly involving
phosphorylation of the 2'-hydroxyl group followed by elimination of the phosphate, had been
presented. 69 Compelling evidence for a homolytic 3'-hydrogen abstraction mechanism was
offered in the early 1980s when reactions with [3'- 3H]-NDPs demonstrated a significant wash
out of 3H into the solution. In addition, a tritium isotope effect on V/K in the range of 1.4-4.7
was observed under various conditions.70,71 Thus, it was suggested that a radical was abstracting
the 3'-hydrogen of the nucleotide. Proposal of the mechanism of ensuing steps in nucleotide
reduction was based on model reactions on the dehydration of ethylene glycol.
68
,
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Figure 1-5. Proposed mechanism for nucleotide reduction. See text for a description of each step.
The current mechanism for nucleotide reduction is shown in Figure 1-5.68 The C*
abstracts a 3'-hydrogen atom from the substrate generating a 3'-nucleotide radical. This
intermediate undergoes elimination of the 2'-hydroxyl group as water, which is proposed to be
the irreversible step in the mechanism and is supported by numerous model studies. The
3'-keto-2'-deoxynucleotide radical then accepts a hydrogen atom from an active site Cys
residue generating a disulfide radical anion, which has been observed spectroscopically, 73 and a
0-
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3'-keto-2'-deoxynucleotide, which is reduced by the disulfide radical anion to give a
2'-deoxy-3'-nucleotide radical. Abstraction of an H-atom from the active site Cys residue
regenerates the Co and yields dNDP. The Co is then reduced by the cofactor; multiple turnover
requires re-reduction of the active site disulfide and reformation of C*.
The evidence for this mechanism will not be reviewed here. It should however be
mentioned that this mechanism has been supported by biochemical studies using site-directed
mutagenesis of the active site residues, substrate analogues and mechanism-based inhibitors, as
well as by theoretical, spectroscopic and structural studies of the different classes of RNRs.6 8
Mechanism of C439* Formation
The mechanism of Co generation has been studied extensively in the class II RNR by
Licht and Stubbe.24,68 ,74 In this system, stopped flow (SF) UV-vis and rapid freeze quench
(RFQ) EPR studies demonstrated formation of cob(II)alamin that was exchange-coupled to
another radical species. 75,76 Isotopic substitution of Cys with CP-[ 2H2]-Cys revealed a narrowing
of the spectrum indicating that the spectrum consisted of a Co exchange-coupled to
cob(II)alamin. 24 This was confirmed by rapid chemical quench (RCQ) experiments revealing
formation of 5'-deoxyadenosine with similar kinetics as that of C*-cob(II)alamin. The Co has
only been detected in the class II RNR, however, due to biochemical and structural similarity of
all RNR active sites, it has been suggested to be involved in all RNRs. In the class II case,
additional studies have revealed that C. formation is entropically driven, 77 that it is required for
every turnover 78 and that its formation occurs in a concerted fashion, i.e. the 5'-deoxyadenosyl
radical is not a distinct intermediate in the reaction pathway.79
In contrast the mechanism of Co formation in the class IV, class III and class I RNRs is
ill-defined. In the class III case, a G* has been postulated to generate the essential C*.36 ,80 This is
consistent with structural studies which show that the G residue is within 5 A of the C that needs
to be oxidized. However, the gating step that initiates Co generation by the stable Go has not
been examined. In the class I case, C. formation is much more complicated and is the topic of
this Thesis. To begin to address the mechanism of C* formation in the E. coli class I RNR, the
interaction between a2 and 32 must first be considered.
Interaction between ac2 and 32
The interaction between a2 and 132 has been explored by several groups. Initial studies
using ultracentrifugation were carried out by Reichard and Thelander and showed that a2 and 132
form a 1:1 complex in the presence of ATP, TTP and dATP.81,82 Biacore methods and inhibition
studies lent further support for a 1:1 complex and revealed a Kd of -0.2 jgM in the presence of
CDP/ATP.838 5 While binding of various substrate/effector combinations to a2 has been
examined,86 a systematic investigation of the Kd between a2/132 in the presence of different
nucleotides has not been undertaken.
More recently, Climent and Sjtoberg have used C-terminal 132 peptides and heterodimeric
132 to study the a2/12 interaction.83 '84'8 7 These studies have found that a peptide consisting of the
last 19-37 residues of the C-terminal tail of 132 is a good inhibitor of RNR activity with Kis in
the range of 20-40 RiM. Binding of heterodimeric 132, 133', in which one 13-monomer is
full-length and the 3'-monomer is missing the last 30 residues, occurrs with a Kd similar to that
with the peptides. Accordingly, a two-step binding model has been proposed between a2 and
132. In the first step, the flexible C-terminal tail of 132 is proposed to be solely responsible for the
interaction between a2 and 132 providing an explanation for the similar Kds between the peptides
and 1313'. In the second step, which only occurs with 12, binding of the second protomer was
proposed to occur in a cooperative manner and was 17-fold tighter relative to binding of the first
protomer. It has been proposed that this cooperativity is mediated by the remainder of 132, across
the 132 dimer interface. Consistent with these ideas, only one 30mer peptide was found to bind
each a2.
A structure of the active a2/P12 complex does not exist. However, from the individual
structures of a2 and 12, Uhlin and Eklund have generated a docking model based on shape and
charge complementarity.88 '89 This model is shown in Figure 1-6 and contains several important
features. The C-terminal tail of 132 (residues 345-375) is not resolved in any structures solved to
date.52 It is flexible and responsible for the majority of interaction between P2 and a2. The
C-terminal tail of a2 (738-761) is also not resolved in the a2 structure. To obtain crystals of a2,
a 21mer peptide identical to the C-terminal residues (355-375) of P2 needed to be co-incubated
with a2. Of the peptide, only residues 360-375 are visible in the structure. The most important
insight from the docking model has been that the Y122* in 32 that initiates nucleotide reduction
and the C439 residue in a2, which must be oxidized to a Co, are >35 A removed. Thus, it was
proposed that C. generation in class I RNRs requires long-range radical propagation.
The Radical Propagation Pathway
Based on the docking model and conserved residues, the radical transfer pathway in
Figure 1-7 has been proposed. Interestingly, all residues in this pathway are universally
conserved and play a major role in active site nucleotide reduction (C439, E441) or in assembly of
the diiron Y122* cofactor (W48, D237, H118), except for three Tyr residues, Y356 in P2 and Y730/Y731
in a2, the functions of which are undefined. These residues have been proposed to reversibly
propagate the oxidizing equivalents across the subunit interface from 32 to a2. The proposition
of long-range radical transfer in RNR is highly unusual. In no other systems are amino acids
known to catalyze charge transport over a long distance. The only system known to perform a
similar reaction is DNA photolyase, however, recent results have indicated that long-range
radical transfer is not required for its function in vivo, although it is observed in vitro.22,23 Charge
transport in Biology usually involves metal centers; however, no metal cofactors are involved in
radical propagation in RNR. Also, the vast majority of radical transfer pathways in Biology
catalyze irreversible charge transport, whereas hole propagation in RNR is reversible.
To test the pathway, site-directed mutagenesis of each residue has been carried out. The
Y122F and W48F mutants have been uninformative as they interfere with assembly of the Y122*
cofactor (see below).90,91 Sj6berg and coworkers have previously generated the Y356F-P2 mutant
and have found it to be inactive. 83 The marginal activity measured was associated with
endogenous wt RNR co-purifying with the mutant. In addition, in vivo complementation studies
demonstrated that this residue was required for catalysis inside the cell.92 The roles of Y73o and
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Figure 1-6. Docking model for the interaction between oa2 and 32. This model was generated based
on shape and charge complementarity between the two subunits. The monomers of a2 are shown in
blue and green. Substrate GDP in the active site and effector TTP at the allosteric effector site are
shown as spheres. Each monomer contains a 21mer peptide (shown in pink) consisting of the
C-terminal residues of 132 (355-375). In this structure, only residues 360-375 are visible. Residues
Y730 and Y731 are shown in cyan in a2. The monomeric units of 32 are shown in red and yellow. The
Fe atoms of the diiron cluster are shown as dark blue spheres. Residues Y122, W48 and D237 are shown
in cyan. Residue 340 is the last residue that is observed in the structure. Residues 341-359 in 12 and
residues 733-762 in a2 in absent from this model.
Y731 have also been interrogated by site-directed mutagenesis. Y730F-a2 and Y731F-(a2 mutants
have been generated and their structures have been solved by X-ray crystallography. 93 The
results have shown that both mutants are inactive in vitro and in vivo, and that the mutations
have little effect on the global structure of a2 and on binding to 12, all consistent with
involvement of residues Y730 and Y731 in catalysis. Finally, studies with C4 39S-a2 have
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indicated the importance of this residue in nucleotide reduction, as expected based on the
mechanism in Figure 1-5.94 These studies have highlighted the importance of each residue in
RNR function, however, due to their 'inactive' phenotype, mechanistic investigations,
particularly the intermediacy of amino acid radicals, are precluded. Nevertheless, from these and
other theoretical studies, a chemical mechanism for radical transport has been suggested. 93' 95' 96
This mechanism involves a series of hydrogen transfer steps between Y122 and C439 and involves
formation of H118 and D237 radicals. There are several problems with this model. First, it is
based on the absence of activity and on negative results. Direct positive evidence for the roles of
the residues in Figure 1-7 has been missing. Second, the step between W48 and Y731, according
to the model, gaps a distance of 25 A, which is the majority of the distance between Y122 and
C 439. It is difficult to imagine how hydrogen atom transfer between W48 and Y73 1 can take place
unless a large conformational change is involved. And finally, His and Asp radicals have never
been observed in proteins and are likely to have high reduction potentials.
Y122 32
W48
Fe2
D237
Figure 1-7. The proposed radical transfer pathway of E. coli RNR. Distances on the P2 side are from
the high resolution structure of oxidized P2.89 Distances on the a2 side are from the original
structure.88 Note that Y356 is not observed in any P2 structures and its position is unknown. The
distance between W4 8-Y 73 1 is 25 A.
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Evidence for Radical Transfer
Despite much effort, an oxidized amino acid during radical transfer has not been
observed by means of SF UV-vis or RFQ-EPR spectroscopies.68 As will be described further
below, a slow conformational change that precedes rapid radical transfer is responsible for the
lack of build up of any observable intermediates. 97 However, two additional lines of evidence,
aside from those alluded to above, strongly suggest that the radical is transferred from P2 into a2,
and that the distance between Y122* in 02 and C439 in a2 is relatively long.
Experiments with mechanism-based inhibitors of RNRs have provided compelling
evidence for transfer of the oxidizing equivalents from P2 into a2 (Figure 1-8). Reaction of
RNR with 2'-azido-2'-deoxyuridine-5'-diphosphate (N3UDP) results in destruction of the Y122o
and formation of a new radical (No) in the active site of a2.98 -10 1 Mutagenesis and isotopic
replacement studies have shown that the inhibitor labels the active site of a2 via C225.102 In
addition, with [3'- 2H]-N 3UDP an isotope effect on Y122* is observed directly linking reduction
of Y122* to chemistry in the active site of a2.'00 Recent isotopic substitution and multifrequency
EPR experiments along with computational studies have revealed the structure of the new radical
in the active site of a2.10 3
Similar results are obtained with 2,2'-difluorodeoxycytidine-5'-diphosphate (F2CDP):
disappearance of Y122* is accompanied by appearance of a new nucleotide-based radical. The
mechanism of inhibition is complex and there are probably multiple pathways. 1°4 Nevertheless,
F2CDP provides a second example of nucleotide radical formation in the active site of a2 at the
expense of Y122* in P2.
A third well-studied mechanism-based inhibitor of RNRs has led to a similar conclusion
as the inhibitors above.10 5-107 Reaction of RNR with 2'-fluoromethylene-2'-deoxycytidine-
5'-diphosphate (FMCDP), leads to loss of Y122* and formation of a new active site radical. Thus,
RNR inactivation is a result of rapid Y122* loss in P2 and labeling of the active site in a2
subsequent to production of an active site radical. Isotopic substitution studies have established
that the new radical is nucleotide-derived. In addition, the chemistry that leads to the putative
allylic radical with FMCDP is entirely consistent with C439* formation. EPR power saturation
studies, which reveal a P1/2 of ~0.16 mW are in line with these conclusions, demonstrating a that
the new radical is distant from the diiron center. In comparison the Y122e, ~5 A removed from
the diferric cluster, has a P1/2 value of 47 mW.
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Figure 1-8. Structures of mechanism-based inhibitors of RNR.
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Power saturation studies have been performed with FMCDP and with F2CDP and these
studies suggest that the distance between the active site and Y122° is long. 104'107 This distance has
recently been assessed directly using pulsed electron-electron double resonance (PELDOR)
spectroscopy. This method has emerged as a molecular ruler for distance measurements between
two unpaired spins separated by 15-80 A.108-"0 In PELDOR the weak dipole-dipole coupling
between two paramagnets is detected by application of a double frequency or, more recently, a
4-pulse sequence."' The strength of dipolar coupling is then related to the distance between the
paramagnets. PELDOR spectroscopy has been used to measure the distance between the No
02 N3UDP N3UDP
32t
-33.1,
33.1 A
N1UDP No
Y* )Y
Figure 1-9. PELDOR spectroscopy with N3UDP and wt ax2/42. PELDOR has been used to measure
the distance between N* in one cp pair and the remaining Y122* in the other a43 pair. Note that due to
half-sites reactivity in the first turnover, only one N* forms per (a2/P2 complex. An N*-N* interaction
is not observed. The distances measured by PELDOR between N*-Y 122* is consistent with the
docking model which predicts a diagonal distance of 47-50 A. A distance of 33.1 A between
Y12 2o-Y12 2 * in resting P32 has been measured by PELDOR, which is consistent with the 032 structure.
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generated with N3UDP in the active site of a2 and the remaining Y122* in 32 - the distance
obtained by these studies is consistent with the docking model and establishes that a large
conformational change that positions Y122* in P2 into the vicinity of the a2 active site does not
occur (Figure 1-9).112 Accordingly, these results support the docking model and a pathway for
long-range radical transfer.
Electron Transfer in Proteins
Radical transfer within the putative pathway in Figure 1-7 requires a series of
oxidation/reduction steps. To understand this pathway in more detail, a brief description of
electron transfer (ET) and proton-coupled ET (PCET) theory is necessary. ET in Chemistry and
Biology is described by the Marcus-Levich relation (Eq. 1-1), where kET is the ET rate constant,
h is Planck's constant, kB is the Boltzmann constant, T is temperature, AG' is the reaction
driving force, X is the nuclear reorganization parameter and HAD is electronic coupling between
donor and acceptor in the transition state.113 The equation contains a pre-exponential and an
exponential factor related to electronic and nuclear reaction components, respectively. 114
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Nuclear factors affecting kET. The nuclear factor depends on the driving force, AGo,
and the nuclear reorganization energy, .. The driving force is defined as the reduction potential
of the electron acceptor minus that of the electron donor. Ideally, this is measured in the system
of interest. In cases where metal cofactors, such as Fe-S clusters or hemes, are involved, this is
possible as the EPR, Mi5ssbauer, UV-vis, fluorescence or IR properties are sensitive to the
oxidation state of the metallocofactor. Therefore, AG' can be determined by applying an
external potential and determining the change in the redox state of the cofactor. 115' 116 Small
molecule redox mediators are often necessary if the metal cofactor of interest is embedded within
the protein.
In case of amino acid radicals, measurement of AG' is much more difficult as isolation of
a single residue of interest is impossible given the numerous other residues that are redox active
upon an externally applied potential. Thus, it is standard practice to use solution measurements
to approximate reduction potentials of amino acids within proteins with the caveat that these may
be perturbed. Tommos and Dutton have demonstrated the major effect that the protein medium
can have on AG' by embedding a single W or Y residue within a synthetic three-helix bundle.66
This study showed that the reduction potential of W was elevated by 0.35 V, relative to that
determined for W in solution, whereas that of Y was elevated to an extent (>-0.45 V) that
accurate measurements could not be made. Eq. 1-2, sometimes referred to as the Born equation,
has been proposed to relate reduction potentials in media of varying dielectric constant. 117 In this
equation, AAGo is the increase of reduction potential in the group of interest with radius r, upon
its introduction into a medium with dielectric e. This equation shows that the change in
reduction potential is inversely proportional to the medium dielectric. Thus, the lower the
dielectric constant of the medium, the higher the reduction potential of the group of interest.
However, this correlation depends on the charge distribution of the reactant and product and is
thus reaction-specific.
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, is defined as the energy required to reorganize the nuclei from the equilibrium position
of the reactants to that of the products. There are two contribution to X, often referred to as inner
and outer sphere X (Eq. 1-3), abbreviated ki and ),, respectively. In polar solvents, the major
component is Xo, which arises from reorientation of solvent molecules upon conversion of the
reactant to the product. 118 ?, is diminished when the reaction is carried out in non-protic, apolar
solvents. The second component of X, kh, correlates with changes in bond length and bond angle
of the donor and acceptor after ET. Classical descriptions of the ki are usually not sufficient to
describe ET reactions in model systems and quantum mechanical treatments have been
developed. 114,119
Another main aspect of the nuclear factor in Eq. 1-1 is the predicted free-energy
dependence of kET (Figure 1-10).25 At low driving forces, kET increases with -AGO. The
maximum rate constant is reached when -AG0 = X. At this point, ET is said to be activationless.
Further increase in the driving force results in a decrease of kET. This region, where -AG0 > X, is
called the inverted region. The prediction of the inverted effect by theory has by now been
well-documented experimentally in various small molecule model systems 120-122 and in
proteins.123,124
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Figure 1-10. Parabolic driving force dependence for kET. kE (grey line) is shown as a function of
driving force. kEr increases as a function of -AGO until -AGo=X. Further increase in -AGo leads to
the inverted region, where AGo > X and a drop in kmr is observed. Note that in bimolecular ET
reactions, the diffusion limit, kdff (dotted line), can mask kEr. In this case, kob = kdiff when -AGo - X.
Electronic factors affecting kET. The electronic factor in Eq. 1-1 is primarily a function
of HAD, the strength of coupling between the redox partners. ET within proteins is characterized
by weak electronic coupling (HAD << kBT). HAD2 in Eq. 1-1 is the probability that the electron
will transfer when the transition state is reached. In nonadiabatic ET reactions, the transition
state must be reached many times before reaction can occur.
HAD has been treated by homogenous barrier models. In this model, the electronic
coupling results from direct overlap of the wave functions of the redox partners which are
separated by a homogenous medium. 125 This model was first developed by Hopfield and
independently by Levich, 126 and indicates that, similar to overlap of molecular wave function, the
electronic coupling drops off exponentially with increasing distance between the redox partners.
Eq. 1-4, describes HAD as a function of distance: 3 is the distance decay constant, HADO is the
electronic coupling at contact, R is the distance between the redox partners and Ro is the distance
at van der Waal contact. 3 is a measure of the height of the tunneling barrier and a value of
3.5-5 A-' has been estimated for redox partners separated by vacuum. An intervening medium
will reduce p. The extent of this reduction has been of interest to several research groups and is
important for kET inside proteins. 127 Hopfield estimated a P value of 1.4 A-' inside proteins;
however, direct measurements have only been made in recent years (see below).
HAD = HADO exp- (R- Ro) (1-4)
To explain the effect of the intervening medium on HAD, McConnell has developed a
superexchange coupling model, in which structural units between redox partners mediate
coupling and effectively stretch out the wave functions of the electron donor and acceptor to
reduce 3.128 In this case HAD is a function of the homologous structural units, or the 'bridge', that
separates the redox partners. Beratan and coworkers have elaborated on this model and have
suggested that the intervening medium between redox partners in proteins can be broken down
into covalent bonds, hydrogen bonds and through-space jumps, each with its own P value. 129,130
In this case, the medium is not homogenous, as assumed by Hopfield, or homologous as
described by McConnell, but inhomogenous with various 3 values, where electronic coupling is
mediated to different extents by these various components. This model, known as the tunneling
pathway model, has made a testable prediction that a P sheet is more effective at mediating
electronic coupling between redox partners than a2 helices. The model has predicted a P value
of 1.0 A-' and 1.26 A-' for P sheets and a helices respectively. However, the strength of the
hydrogen bonds can further change these P values. Treating hydrogen bonds as covalent bonds
reduces the 0 value in a helices to 0.94 A-1.114 Thus, the strength of hydrogen bonds appears to
determine whether a helices are similar or vastly inferior to P sheets in mediating electronic
coupling between two redox partners.
To measure O-values in proteins, Gray and coworkers have turned to small model
proteins and determination of so called tunneling time tables (Figure 1-11).114 A small protein,
such as P. aeruginosa azurin, is appended with a Run photooxidant at various distances from the
natural Cu cofactor in this protein."118 Using flash-quench methodologies and transient
absorption spectroscopy, the activationless or coupling-limited (-AGo=X) kET is determined.
Plotting the rate constant, or time constant for the reaction as a function of distance yields 3.
Time
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Distance (A)
Figure 1-11. Tunneling time table in Ru-modified proteins.! 18 Data for azuin (o), cytochrome C (o),
myoglobin (A), cytochrome b562 (o) and hiPIP (0) are shown and are consistent with a tunneling model
and a p of 1.1 A-'. ET along a P strand and a helix with 3 values of 1.0 and 1.26 -1', respectively is
also shown. ET through water and vacuum are represented by the thin black and thick grey wedges,
respectively.
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These experiments have been performed with several model proteins and have demonstrated that
3 is a function of the composition of the intervening medium although a P of 1.2 ± 0.2 A-'
appears to hold for nearly all ET reactions in biology.25 Importantly, description of the data
obtained from these studies with several protein systems by the tunneling pathway model
establishes that electrons tunnel inside proteins.
More recently, the importance of intervening aromatic residues that, in effect, reduce the
value and increase the coupling between donor and acceptor, has been recognized. 25"' 8 In
these so called hops, an amino acid may bridge the distance between the electron donor and the
final electron acceptor. This is clearly the case in RNR; however, the extent of rate enhancement
of kET as a result of hopping is yet undefined. Gray and coworkers have begun generating
hopping time tables, in which kET is determined as a function of one, two or three 'hops' between
the donor and final acceptor. In this time table, kET is expected to be proportional to the number
of hops between the redox partners. Initial studies indicate that kET is 103-fold faster when a
distance of 18 A between the donor and final acceptor is bridged by a single hop vs. direct
tunneling through the intervening medium.131 The insight gained from these studies will be of
great importance to RNR, which appears to have separated Y122* from C439, a distance of -38 A
by 4 'hops', one W and three Y residues.
PCET and Oxidation of Amino Acids
ET theory has been useful in dissecting many ET reactions that occur in photosynthetic
and respiratory enzymes, which almost exclusively involve metal cofactors. In RNR, there is an
additional complication in that amino acids, rather than metal cofactors participate in redox
reactions. Thus far one-electron oxidation of amino acids has been limited to Cys, Gly, Tyr and
Trp in enzymatic systems. Oxidation of these residues at neutral pH requires loss of an electron
and a proton. The participation of proton in this reaction invokes proton-coupled ET (PCET) in
oxidation of amino acid side chains. 132-134
The need to account for the affect of the proton on electron movement (and vice versa)
has required new theoretical and experimental models to understand PCET. Such model systems
were first designed and analyzed by Nocera and coworkers. The propensity of dicarboxylates to
form cyclic dimers in non-protic solvents motivated synthesis of the compound in Figure
1-12.135 In this case, a laser is used to excite the Ru"-polypyridyl or Znu-porphyrin oxidant,
which then reversibly transfers and electron to the organic acceptor. The rate constants for
forward and reverse ET are then determined by transient absorption spectroscopy. A kinetic
isotope effect of 1.6 and 1.7 on forward and reverse ET, respectively, when the carboxylates
were deuterated, demonstrated that proton movement accompanied ET.136 Charge redistribution
within this system was negligible, thus, electronic coupling between donor and acceptor
depended directly on the position of the proton at the interface, suggesting that the proton had an
influence on electron flow. Asymmetric complexes shown in Figure 1-12 have also been
generated.'3 7"1 38 In this case kET was found to depend on the organization of the interface: kET
with D-[carboyxlate-ammidinium]-A was 40-fold slower than with D-[ammidinium-
carboxylate]-A. It was concluded that the driving force and reorganization energy depended on
the charge distribution of the electron and proton at the interface.
Model systems such as these have lead to development of theoretical formalisms for
PCET, which express kPCET as a function of AG, X, HAD and the initial and final states of the
electron and proton, indicating that kPCET is a function of the reaction pathway. 132,139 However,
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Figure 1-12. PCET model systems. (Left) A symmetric dicarboxylate hydrogen bonding interface.
(Right) An asymmetric amidinium-carboxylate hydrogen bonding interface. In each case, the donor
transfers an electron to the organic acceptor after photoexcitation. Transient absorption spectroscopy
is used to measure forward and reverse ET.
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an equation that is widely accepted, such as Eq. 1-1, has yet to be developed. Nevertheless,
these studies underline the importance of the position of the proton during the transfer on kPCET,
which is pertinent to understanding the PCET pathway in RNR.
Thermodynamic and kinetic aspects of PCET. As indicated above, oxdiation of Tyr
requires loss of a proton and electron and can occur by several mechanisms, which may be
described by the square scheme in Figure 1-13.132,133 In this scheme the pathways on the edges
of the square correspond to step wise reactions. Accordingly, oxidation of Y may occur by
proton transfer (PT) followed by ET, or in the reverse order, ET followed by PT. These
pathways correspond to simple ET and PT reactions, not PCET. Alternatively, this reaction can
occur in a concerted fashion, in which proton and electron move together, as shown in the
diagonal path. This is the PCET pathway. There are many definitions of PCET. We define
PCET any process in which proton movement affects the kinetics and thermodynamics of ET,
and vice versa. Thus hydrogen atom transfer (HAT) is a subset of PCET.
The diagonal PCET pathway in the square scheme may further be broken down into two
mechanisms. Here, we restrict the discussion to mechanisms that may be distinguished in
protein systems. On the diagonal path, the proton and electron may be unidirectionally coupled
as shown in Figure 1-14. In this case, the electron and proton originate from the same residue
and arrive at the same group. This corresponds to HAT and the relevant property in this reaction
is the bond dissociation energy (BDE). Alternatively, the electron and proton may be
X- H------Y ET X +- H ------ Y
PT PT
X------ H -Y+ ET o X*------ H-Y
Figure 1-13. Square scheme for PCET. The edges of the square describe step wise PT/ET or ET/PT.
The diagonal path corresponds to PCET. PCET is further divided into co-linear and orthogonal PCET
(see Figure 1-14).
orthogonally coupled. In this case, the electron and proton originate from the same residue but
have different destinations. The relevant properties in this case are AGo and pKa.
(A) Co-linear PCET = HAT (B) Orthogonal PCET
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Figure 1-14. Two classes of PCET reactions. (A) Co-linear PCET or HAT involves direct coupling
between proton and electron from the point of origin to the final destination. (B) In orthogonal PCET,
the proton and electron originate from the same group but arrive at different moieties.
Thermodynamically, there is a bias toward the PCET pathway rather than the step wise
ET/PT or PT/ET reactions. 134,140 Because the initial and final states in the square scheme are the
same, all three pathways are isoenergetic. However, the diagonal path avoids charged
intermediates, the formation of which is thermodynamically uphill inside proteins. Thus, AGO for
PCET is always lower than that for the initial ET or PT along the paths on the edges of the
square. On the other hand, avoiding charged intermediates comes at a cost as coordinating the
movement of proton and electron has been proposed to result in a larger k for PCET. Thus, the
competition between a step wise process and PCET is determined by the extent of favorable
energetics vs. larger reorganization energy. This has been demonstrated experimentally by
Sjbdin et al. with the Run-polypyridyl-Y model systems.141143 In this case a covalent
Ru"-polypyridyl-Y model was prepared and used to study the mechanism of Y oxidation by
transient absorption stectroscopy as function of pH, and temperature . The authors concluded
that when the driving force for PCET, AGoPCET, was not great enough to account for its larger k,
step wise ET/PT was observed. Otherwise, the PCET reaction dominated. 143 However, the
simplicity of this conclusion has been contested.144,145
As discussed above, a robust model that relates the rate constant for PCET to the
variables of ET and PCET is currently been developed. Recently, Mayer and coworkers have
approximated kpcET using the Marcus cross relation in Eq. 1-5, where kxy is the rate constant for
the PCET reaction between groups X and Y, kxx and kyy are the self exchange reaction rate
constant for X and Y, respectively, Kxy is the equilibrium constant for the reaction between X
and Y, and fxy is usually -1.146 This relation has been used with some success for a wide range
of PCET reactions. Comparison of predicted kPCET using Eq. 1-5, and knowledge of self
exchange rate constants with experimentally determined kPCET, shows a general agreement
within an one-two orders of magnitude.
kxy = kxx kyy Kxy fxY (1-5)
pH dependence in the driving force. The reduction potentials of Y and W have been
measured in solution and protein maquettes. However, both of these potentials are highly
pH-dependent, because, as noted above, oxidation of amino acids at neutral pH requires loss of
electron and proton. The potential of N- and C-protected Y and W has been measured directly
as a function of pH using differential pulse voltammetry.66 This technique is often used for
irreversible reactions and measures peak potentials that are within 30 mV to reduction potentials
determined by cyclic voltammetry or pulse radiolysis. The results of these experiments are
shown in Figure 1-15. They reveal two distinct regions, one which is pH dependent and one
which is pH independent. The breaks in the curves occur at the pKas of the reduced and oxidized
forms. Below pH 3.7, W is oxidized by simple ET resulting in WH*+ . Above pH 3.7, oxidation
of W shows Nernstian behavior, a 59 mV drop per pH unit, until pH-pKa of the reduced form
(pH~-14). Similarly, oxidation of Tyr above pH 10.1 relates to the Y/Y* couple. Below this pH,
Tyr also displays Nernstian behavior until pH-pKa of the oxidized form (pH- -2). DPV with Y
and W shows that the proton has a major influence on the reduction potential, which is crucial
for the mechanism and directionality of radical transfer as will become apparent below.
Analysis of the PCET Pathway in RNR
Having described ET and PCET in proteins, we return to the analysis of the radical
transfer pathway of RNR. Our model for radical transfer has been hopping from [Y122* . W48
; Y356] within 32 to [Y 73 1 -+ Y 730 - C 4 39 t nucleotide] within a2. The thermodynamics and
kinetics of each of these steps, in models and in RNR, will be discussed below.
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Figure 1-15. Peak potentials of Ac-Y-NH2 and Ac-W-NH2 as a function of pH.
Oxidation of W48 by Y122*. According to our model, the first step in radical transfer
involves oxidation of W48 by Y122*. As discussed above, the thermodynamics of this reaction
will depend on the protonation state of each residue. The reaction is highly unfavorable if the
Y 122 N/Y122- couple generates a W48H*' or W48* as shown in Eqs. 1-6 & 1-7. If, however, Y1220
is protonated upon reduction, then the thermodynamics are more favorable, with AGo of 0.25 and
0.06 V, for W48H*+ and W48o, respectively, as shown in Eqs. 1-8 & 1-9. Thus, the positioning of
the proton determines the thermodynamic and kinetics of this first step. In our model, Y122° is
protonated upon reduction. We have proposed that the water ligated to Fel, the Fei ion closest
to Y 122*, which is 4.1 A removed, acts as the proton donor in forward radial transfer and as the
proton acceptor in the reverse direction. However, we note that the Y1220 in E. coli P2 is not
hydrogen bonded, though this is the case in other RNRs. Further, in our model the D23 7-W 4 8
dyad controls the gating of radical transfer (see below).
Ye + W -- + Y- + WH*+  AGo = 0.42 V (1-6)
Y* + W -* Y- + W* + H AGO = 0.23 V (1-7)
Y9 + W + H+  N- Y + WH+  AGO = 0.25 V (1-8)
Ye + W - Y + W* AGO = 0.06 V (1-9)
Evidence for reversible oxidation of W by Yo has come from dipeptide model systems.
Studies with acylated W-Y (Ac-W-Y) have demonstrated chemical competence for oxidation
of Y by We, and vice versa.147 It was found that We oxidizes Y with a kobs ~9x104 s- ' between
pH 6-10. Above pH 10.9, Ye was found to oxidize W with a kobs of 1.5x10 5 s- 1. As shown in
Figure 1-15, this trend is predicted by the driving force dependence for each residue measured as
a function of pH. Thus, the pH determines the directionality of this reaction. These model
studies provide an answer for how RNR can prompt oxidation of W4 8 by Y122* in forward radical
transfer and catalyze oxidation of Y122 by W48* in the reverse direction. Judicious positioning of
the proton fine-tunes both forward and reverse reactions between Y122* and W48. For example,
if the protein environment can enforce rapid protonation of Y122* upon its reduction and
deprotonation of W48He+ , forward PCET could be favorable. deprotonates the W48He+ , its
reduction potential will be lower and forward PCET will be favorable. Conversely, if it can
enforce WHe+ in the reverse direction, oxidation of Y122 will be most favorable.
Evidence for the oxidation of Y122 by W48H*+ has come from examination of Y122°
cofactor assembly.'19 20 ,148 The model that has emerged for this reaction is shown in Figure
1-16.16,25 Addition of Fen to apo 02, via intermediate p,149 leads to intermediate X-WH*+ which
can partition between two pathways. The outcome of the reaction is a function of [Fe"] used to
assemble the diiron cofactor. When excess Fe" is used, intermediate X oxidizes Y122. However,
in the presence of limiting Fen, WH*+ directly oxidizes Y122. Thus, this reaction provides direct
evidence for communication between Y122e and W48 in P2.
Gating of radical propagation. A major aspect of radical initiation is that it is gated,
that is it relies on another step immediately prior to radical initiation. The Y122* is directly
responsible for nucleotide reduction, therefore, its transfer into the active site of a2 and back
must be exquisitely controlled. Reduction of the Y122" results in an inactive enzyme. The
mechanisms that have evolved to finely manage hole transfer are at present poorly understood.
However, a clue regarding the control over radical transfer has come from pre-steady and steady
state kinetics of RNR.97 These studies have shown that radical propagation is preceded by a
conformational change, which is rate-limiting in turnover at low [RNR] (-3 pM). In wt RNR, a
kobs of 4-16 s- 1 has been measured for this conformational step. The failure to observe
intermediates during radical transfer is directly related to the physical step that precedes rapid
chemistry. A slow step followed by a series of rapid steps avoids build up of any transient
intermediates. However, the detailed physical changes that occur to prompt hole propagation are
not understood.
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(not observed in wt)
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Figure 1-16. Working model for cofactor assembly in E. coli 532. Reaction of apo 132 with Fe" and
02 yields X-WH*o via a putative (Fem')2-peroxo species not observed in E. coli but seen in mouse
132.147 Partitioning from X-WH*÷ depends on the [Fe"]. In the presence of limiting Fen, WHO'
oxidizes Y122. X is subsequently reduces slowly by reductants in solution (ascorbate). In the presence
of excess Fen, WH-* is reduced by Fe". X then oxidizes Y122 to generate Y122°.
We have previously proposed that the D237-W 48 dyad could act as the gatekeeper for hole
transfer. If D237 is distant from W48, such that a hydrogen bond cannot form, then Y122* must
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oxidize W48 to a W48H*+, which is uphill by 0.25-0.42 as shown in Eqs. 1-6 & 1-8. However,
if a conformational change moves D237 close to W48, so that the proton can be transferred to D237 ,
then Y122* is in effect generating a W48* and the energetics of this step are more favorable,
0.06-0.23 V, as shown in Eqs. 1-7 & 1-9. Thus, binding of substrate and effector could trigger
a conformational change in a2 which is structurally conveyed to D237, that lowers the reduction
potential of W48 and allows hole transfer to commence. The experiments in the assembly of
Y122* are consistent with this proposal as they suggest that the reduction potential of W48H*° is
higher than that of Y122*. Experiments performed in this Thesis will add to our knowledge
regarding the changes that take place when substrate and/or effector bind to a2/p2.
Connectivity between W48 and Y356. Next, we propose oxidation of Y356 by W48*. The
former is not visible in any 32 structures, thus its position is unknown. However, the same
thermodynamic and kinetic considerations discussed above also hold for this reaction. At this
juncture in the pathway, two mechanisms of Y356 oxidation may be envisioned: HAT or
orthogonal PCET. In the former case, Y356 would need to be close to W48 and Y731 to participate
in a hydrogen atom relay. This would require significant movement of Y356 to access W48 in 12
and Y731 in a2, as these residues are 25 A apart in the docking model. In the latter case,
conformational changes are not necessary as long range electron transfer would be coupled to
short distance, off-pathway proton transfer. Experiments carried out in this chapter favor the
latter model for Y356 oxidation.
The subunit interface: Y356-Y 731-Y7 30 . The subunit interface is lined with three Y
residues. Whether HAT or orthogonal PCET is the attendant mechanism of radical propagation,
the three tyrosines that bridge the a2/12 interface are likely to form an even energetic landscape.
This design likely ensures that hole transfer occurs smoothly between a2/32 in both directions,
i.e. without a build up of any intermediates, and that the radical spends minimal time at the
subunit interface where it is most exposed and therefore most susceptible to quenching. If Y356
is involved in orthogonal PCET, then it is likely that residue Y731 communicates with Y356 by the
same mechanism and with Y730 by HAT. Thus, Y731 could incorporate both PCET mechanisms
(Figure 1-14) in each radical propagation event.
We have postulated that the mechanism of hole propagation within X2 occurs by HAT.
This proposition is based on the vicinity of residues Y731, Y730, and C439 and on the superposition
of the active site structures of three classes of RNRs shown in Figure 1-17.25,150 In each case the
oxidant that generates C* is adjacent to the Cys residue, and in each case, a HAT mechanism has
been proposed. However, we note that recent computational studies have suggested that the
distinction between HAT and PCET is sometimes difficult to make. Calculations on the
phenoxyl radical/phenol self exchange reaction in the gas phase have indicated that it proceeds
via a PCET mechanism in which the electron is transferred between at orbitals on the phenol and
the proton is transferred between distinct orbitals of o(O-H) symmetry.15' Thus, this reaction is
not derived from a genuine hydrogen atom. This distinction is exceedingly difficult to make
experimentally in a protein. For the purpose of our studies, we may define HAT a process in
Figure 1-17. Superimposition of the active sites of RNRs from three different classes. This view of
the active sites shows that the oxidants that generate Co in each class are superimposible in three-
dimensional space.
which the proton and electron originate from the same moiety and have the same destination,
regardless of the initial or final orbital. Experiments performed in this Thesis will suggest a
mechanism for radical transfer between Y730 and C439.
Connectivity between Y730-C 439. The final step in radical transfer is generation of C439y
by Y731*. Because this reaction is proposed to occur by HAT, the relevant properties to consider
are BDEs. The BDE of aliphatic R-SH is 88-91 kcal/mol, 152' 153 whereas that of phenol is 87
kcallmol. 154 Therefore, oxidation of C439 by Y731 is uphill by 1-4 kcal/mol. This reaction is
compensated for by steps in the nucleotide reduction process which are thermodynamically
downhill, as has been discussed in detail by Licht and Stubbe.68 Note that this reaction would be
uphill by -0.5 V or 11-12 kcal/mol, if orthogonal PCET was the operative mechanism. The
kinetics of thiyl radical formation by a phenol radical have previously been studied by Land and
coworkers. 59'155 They have used decay of a Y*-W in the presence of glutathione to estimate rate
constants for glutathione radical formation. From these experiments they estimated a rate
constant of 2x10 5 M- 1 s-'. Studies that more closely mimick the RNR radical transfer pathway,
i.e. with C-Y dipeptides, were not carried out. Also, the experiments by Land and coworkers
were performed at pH 8.1, where the Cys in glutathione was partially deprotonated. Thus, the
mechanism in these model studies may be different from that proposed in RNR. Nevertheless,
they show that oxidation of Cys by Ye is rapid and feasible under their experimental conditions.
Our Approach to Studying Radical Transfer
The studies above have indicated that the limited repertoire of natural amino acids
accessible by site-directed mutagenesis does not allow a mechanistically informative
perturbation of the radical initiation pathway in RNR. The site-directed mutants are inactive
thus precluding mechanistic investigations. To learn more about this process the rate-limiting
step must be changed from the conformational step to radical transfer. This requires subtle and
direct perturbations at each residue in the pathway. In this Thesis we have taken a focused
approach to site-specifically replace residues Y356, Y730 and Y731 with unnatural amino acids that
are structurally homologous to Y but have altered reduction potential and/or pKas, properties that
are crucial for the mechanism of PCET. The unnatural amino acids that have been incorporated
are shown in Figure 1-18. The Chapters described herein present mechanistic studies performed
with P32 or ao2 site-specifically substituted with one of the analogues in Figure 1-18. This has in
turn required application of sophisticated methods for unnatural amino acid incorporation, which
have only recently been developed. The two methods that are used in this Thesis are briefly
discussed below.
Semisynthesis of f32 using EPL. We have used intein-mediated chemistry to replace
Y35 6 in 32 with unnatural amino acids. An intein is a protein domain that catalyzes its own
post-translational self-excision from a larger polypeptide in addition to splicing of the
N-terminal and C-terminal domains (N-extein and C-extein) that flank the intein domain. 156,157
The first intein, Vma from Saccharomyces cerevisiae, was discovered in the early 1990s. 158 The
potential usefulness of self splicing in protein engineering fueled detailed studies of the
mechanism of action of this multi-step process. This understanding has led to the development
of a number of re-engineered intein constructs that are now commercially available allowing
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Figure 1-18. Unnatural Y analogues incorporated into j32 or a2 in this Thesis.
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semisynthesis of proteins 1 ' 160 and consequently site-specific incorporation of unnatural amino
acids. In this Thesis, we have extensively used one of these techniques, expressed protein
ligation (EPL), to construct P32 semisynthetically.
To demonstrate how EPL works, first the mechanism of intein self-expulsion must be
outlined. The proposed mechanism for the S. cerevisiae Vma intein is shown in Figure
1-19.161,162 Splicing is initiated by an N-S acyl shift that converts a peptide bond into a thioester
at the N-extein junction site. Transthioesterification via the C-extein Cys residue results in a
branched intermediate. This intermediate undergoes excision of the intein domain by attack of
an Asn residue on the peptide bond at the C-extein junction site forming an intein succinimide
and the spliced extein domain. Spontaneous S-N acyl rearrangement generates the ligated N and
C-exteins connected via an amide bond.
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Figure 1-19. Proposed mechanism of intein self-expulsion for the S. cerevisiae Vma intein.
We have applied EPL to make the 32 subunit of E. coli RNR semi-synthetically. 163 02 is
a homodimer with each polypeptide containing 375 amino acids. The C-terminal 35 amino
acids of E. coli 32 are disordered and this region houses Y356, a residue proposed to be important
in the mechanistically unusual radical propagation process described above. The general scheme
that we have used for P2 semi-synthesis is shown in Figure 1-20. Residues 1-353, folded into a
native state, are made via recombinant DNA technology and are ligated to residues 354-375,
made by solid phase peptide synthesis (SPPS). The majority of 02 (residues 1-353) is fused to
an intein-mutant, which lacks the C-extein Asn and Cys residues but contains a purification tag,
the chitin binding domain (CBD). After recombinant expression, the engineered intein-fusion
product catalyzes the first step of the self-cleavage reaction, but not the ensuing splicing steps.
The thioester formed is then captured by a small molecule thiol, such as
2-mercaptoethanesulfonic acid (Mesna), via transthioesterification, resulting in cleavage of the
target protein from the intein-CBD construct. The thioester-activated, truncated P2 is then
ligated to the remainder of 02, a peptide containing residues 354-375 with the unnatural amino
acid at residue 356 and a Cys at its N-terminus (residue 354). Transthioesterification of the
N-terminal Cys residue of the peptide followed by a spontaneous S-N acyl shift yields full
length P2. Wild type 02 contains a Ser at 354 and thus a second mutation, in addition to the
unnatural amino acid, is introduced into P2 at residue 354.
Advantages and limitations of EPL. A number of methods are in the process of being
developed for the incorporation of unnatural amino acids into proteins in a robust fashion. We
have chosen EPL for the semi-synthesis of P2 for a number of reasons. First, 100 mg quantities
of semi-synthetic 02, necessary for mechanistic biophysical experiments, are accessible. Second,
purification with the CBD tag is robust. Third, residue Y356, a member of the radical initiation
chain and of great interest to us mechanistically (Figure 1), is at the disordered C-terminal tail of
the protein, and therefore a good target for substitution by EPL. Finally, a number of inteins are
now commercially available. As shown in Figure 4, we have used the thiol method to cleave the
activated-truncated P2 from the intein-CBD construct, but temperature and pH-induced
cleavage may also be used to generate the desired species. Because of these advantages, the EPL
method has been used by numerous investigators and excellent reviews on its applications are
available. 164,16
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EPL also has a number of limitations. First, site-specific incorporation of probes can
only occur close to the N- or C-termini of the protein because peptides longer than 40-50
residues are difficult to synthesize and purify. Second, the site of ligation must be accessible to
solvent in the native protein. If the site of ligation is buried, then the ligation reaction needs to
be carried out under denaturing conditions, and methods to refold the protein are required. Third,
the thioester-truncated protein undergoes hydrolysis in competition with ligation to the peptide.
The rate of ligation, a bimolecular reaction, is elevated by increasing concentrations. However,
the ligation is still slow and consequently hydrolysis almost always accompanies the desired
reaction. Methods are thus required to separate the truncated protein from the full-length,
ligated protein. This problem is aggravated if the protein of interest is multimeric, as in the case
of 32.
Target Protein O S
ýýAjNH Intein H2NN1-353 -S< Z CBD
o CH C B D
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Figure 1-20. Semisynthesis of 32 via EPL. Residues 1-353 are expressed recombinantly as an
intein-CBD chimera. After the initial N-S acyl shift, the small molecule thiol, Mesna, is used to
cleave the truncated [2 from the intein-CBD domain. The resulting Mesna-activated 32 is ligated to
a 12-22mer which is prepared by SPPS and contains residues 354-375 with an unnatural amino acid
at residue 356. Note that the V353G mutation was necessary to increase cleavage and ligation yields.
Suppressor tRNA/aminoacyl-tRNA synthase method. Schultz and coworkers have
recently developed a robust in vivo method for site-specific incorporation of unnatural amino
acid. 166-170 In this method, an aminoacyl-tRNA synthetase (RS) that is specific for the unnatural
amino acid of interest, is selected from a library of synthetases using a variety of screens. This
RS has a cognate tRNA that contains the amber stop codon and is optimized for interacting with
the library of RSs. Importantly the tRNA/RS pair is orthogonal to those in the host, that is, the
amber suppressor tRNA cannot cross-react with any in vivo RSs, and the evolved RS cannot
charge any in vivo tRNAs with a natural or unnatural amino acids. In addition, the in vivo RSs
are not able to charge their cognate tRNAs with the unnatural amino acid. Finally, the unnatural
amino acid must be taken up by the cells and must not be toxic. If these criteria are met, and the
gene of interest is expressed inside the host with the amber stop codon at the residue where the
unnatural amino acid is to be incorporated along with the tRNA/RS pair specific for that
unnatural amino acid, then expression of the protein of interest results with high fidelity and
specificity. So far, this method has been applied to E. coli, yeast and mammalian expression
hosts. In E. coli the Methanococcus jannaschii tRNA/RS pair has been manipulated to fit the
criteria above. In yeast and mammalian cells, the E. coli tRNA/RS pair has been used. These
pairs have allowed insertion of -30 unnatrual Y analogues into target proteins with high fidelity
and specificity. In this Thesis, we have evolved a RS that is specific for NH 2Y (Figure 1-18)
and used the suppressor tRNA/RS method to site-specifically incorporate NH2Y into residues
730 or 731 in a2.
The advantage of this method is that the unnatural amino acid may be incorporated
anywhere in the protein, not just at the C- or N-termini, as is the case with standard intein
ligation methods. In addition, this method can be used to study target proteins in vivo with a
site-specific unnatural probe. On the other hand, unnatural amino acid that are not taken up by
or are toxic to the cell cannot be used in this method. In addition, each unnatural amino acid
requires evolution of a new tRNA synthetase.
Chapter Preview
At the outset of this work, many aspects regarding radical propagation in RNR were
unknown. Most importantly, there was no direct evidence that this pathway was functional in
hole transport over a long distance. Intermediacy of amino acid radicals had not been
demonstrated and the roles of Y356, Y730 and Y731 were experimentally undefined. It seemed
highly unusual that Nature would choose a seemingly bizarre long-range radical transfer
pathway to perform the essential cellular task of nucleotide reduction. In addition, the
mechanism of oxidation at each residue, if long-range radical transfer occurred, was
undetermined. Models had been proposed by several groups; however, no mechanistic studies
had been undertaken, mostly due to the inactive phenotype of the site-directed pathway mutants.
Finally, the method of regulation of radical transport and the role of substrate and effector in this
process were unknown. No models had been contemplated regarding the timing of radical
transfer, i.e. whether it occurred simultaneously or consecutively within both pathways in the
a2/02 complex.
In this Thesis, we have focused on intein ligation and suppressor tRNA/synthetase
methodologies to site-specifically replace residues Y356, Y730 and Y731 with unnatural amino
acids. In Chapter 2, we describe incorporation of 3,4-dihydroxyphenylalanine (DOPA) into
residue Y356 of the 12 subunit. Our studies demonstrate formation of a DOPA radical (DOPA*),
which we have characterized using UV-vis and EPR spectroscopies. The requirement of
DOPA* formation on the presence of substrate and/or effector implicates pathway dependence.
We find that DOPA* formation is kinetically competent, however, only half of the total Y122*
participates in DOPA* formation, the rest remains unreacted invoking half-sites reactivity in the
cx2/P2 complex. We also show that the substrate/effector pair bound in ca2 determine the kinetics
of DOPA* formation and its conformation at the ac2/2 interface. Finally, in collaboration with
Prof. Marina Bennati, we have used PELDOR spectroscopy to measure the distance between the
DOPA* in one a4 pair with the unreacted Y122* in another o•p pair. This provides the first
structural constraint for residue 356, which is invisible in all structures of P2 solved to date, and
is consistent with radical initiation only within one of two ap pairs in the complex.
In Chapter 3, we examine heterodimeric DOPA-P2, DOPA-Pi', in which the
p-monomer is full-length and contains DOPA at residue 356, but the 3-monomer is truncated at
residue 353. Inspection of this variant also reveals kinetically competent DOPA* formation only
in the presence of substrate and effector. We present characterization of the DOPA* by UV-vis
and EPR spectroscopies and find that the local environment of DOPA* in DOPA--P' is very
similar to that in DOPA-P2. DOPA-PP' maintains the essential conformational changes for
triggering radical migration and formation of a DOPA* in a kinetically competent fashion
suggesting that the second C-terminal tail of P2 is not required for propagation in the first ap
pair. An asymmetric interaction is proposed between 32 and a2 to explain the yields of DOPA*
in DOPA-P2 compared to those in DOPA-PP'. In addition, evidence is obtained for reverse
radical transfer from DOPA* to Y122* with DOPA-PP'/a2. This marks the first direct
observation of reverse hole migration and provides evidence for the reversible nature of the
radical transfer pathway.
In Chapter 4 we demonstrate evolution of a suppressor tRNA/synthetase pair that is
specific for the unnatural amino acid NH2Y, which is 190 mV easier to oxidize than Y. Using
this technology we generate Y730NH2Y-a2 and Y731NH2Y-a2 with high fidelity in yields
comparable to wt a2. Using these constructs, we test the involvement of Y730/Y 73 1 in long-range
radical migration. The results demonstrate kinetically competent radical transfer from Y122°
across the subunit interface and trapping of NH2Y 730* or NH2Y 731* in a2. This event is triggered
by binding of substrate and effector. Steady state activity assays in conjunction with reactions
with the suicide inhibitor N3ADP indicate that Y730NH2Y-a2 and Y731NH2Y-a2 are competent
in nucleotide reduction. These results are consistent with a HAT mechanism for oxidation of
C4 39 by NH2Y 730*. This likely represents the first observation of an radical intermediate during
active hole transfer and nucleotide reduction.
In Chapter 5 we further investigate the structure of the putative NH2Y* using 15N and 2H
isotopic substitution, 9 GHz and 180 GHz EPR spectroscopies, EPR spectral simulations and
DFT calculations. Our results unambiguously demonstrate that the new signal is associated with
the NH2Y probe, provide insight into the conformation of NH2Y7 30* within a2, and yield spin
densities for the major nuclei interacting with the unpaired spin. This is the first detailed
characterization of an NH2Y* within an enzyme. The position of the NH2Y* within the aU2/P2
complex is examined using PELDOR spectroscopy. The results give distances between the
newly formed NH 2Y*, at residue 730 or 731, in one ap pair and the remaining Y122* in the other
ap pair, which are consistent with the distances predicted by the docking model. In addition,
studies with Y356F-02 show that formation of NH 2Y730* and NH2Y731* is pathway-dependent.
Alternative pathways circumventing Y356 do not exist. Finally, X-band EPR and SF UV-vis
spectroscopic methods with various substrate/effector combinations reveal that the substrate
provides the main binding determinants for radical initiation and that the effector redistributes a
larger population of a2/02 into a conformation competent in turnover.
In Chapter 6, we report the synthesis and physical characterization of FnYs (n=l, 2, 3, 4)
and their N- and C-protected derivatives, Ac-FnY-NH 2s. We also develop the methodologies
for determining AGoET and AGorr for the half of the PCET reaction involving fluorotyrosine
oxidation by measuring the reduction potentials for the radical and the pKa of the phenolic
protons for Ac-FnY-NH 2s. The results show that the reduction potential and pKa of a residue
can be varied by 0.32 V and >4 pKa units, respectively, upon insertion of FnY. Thus, FnYs
effectively decouple proton and electron and provide a valuable probe for analysis of PCET
reactions involving oxidation of Ys. Furthermore, we report the spectroscopic properties of the
FnY's using EPR and transient absorption UVIVis spectroscopies.
In Chapter 7, we present the semisynthesis of FnY-p2s (n=2, 3, 4) in which Y356 is
replaced with FnYs (Figure 1-18). These 32 analogues allow us to study the role of Y356 in the
radical propagation process. The results suggest that an increase in the peak reduction potential
of the FnY analogue relative to Y by 80 mV results in a change in the rate-limiting step from a
conformational step to the radical propagation process. These studies support the proposal that
the protonation state of the phenol of this residue is not important in conformational gating, that
the proton can be lost from this pathway without affecting the overall enzymatic activity, and
that Y356 is a redox-active amino acid on the radical propagation pathway. We propose that
during radical propagation with wt P2, the phenolic proton is transferred off-pathway, probably
to E350, which is highly conserved in class I RNRs. Additionally, the rigorous assessment of the
enzymatic activity of FnY 356-p2s establish that the energetics of radical hopping through Y356 is
finely tuned in wt class I RNR and can only operate within a -130 mV window for the Y*/Y
redox couple.
In Chapter 8, we show that no intermediates are observed by SF UV-vis or EPR
spectroscopies in the reaction of 2,3,5-F 3Y-P2 with wt a2, CDP and ATP at high pH, where
radical transfer is proposed to be rate-limiting. Kinetic simulations show that forward or
forward and reverse radical transfer may be slow in turnover without generating a build-up of
intermediates. RCQ experiments are in line with this model, in that no burst of dCDP is
observed, which is predicted by the simulations. Most convincingly, in experiments with
NH2Y-a2s and 2,3,5-F 3Y-P2, the pre-steady state pH rate profile for NH2Y* formation is
similar to the steady state pH rate profile of 2,3,5-F 3Y-[2 for dCDP production. This holds for
Y730NH2Y-a2 and Y731NH2Y-a2. These results support our interpretation of the data in
Chapter 7, where we suggested a switch in the rate-limiting step in radical transfer owing to an
increase in the reduction potential of residue 356. Substitution of FnYs into the radical transfer
pathway provides the required energy barrier to slow hole migration. However, the slow
conformational change that precedes radical transfer and rapid reformation of Y122 ° avoid
build-up of any intermediates.
Based on these results, we propose the following mechanism for radical transport in E.
coli RNR: A conformational change, triggered by binding of substrate and effector, prompts
radical initiation, which in the first turnover occurs in only one of two pathways within an ca2/P2
complex. The radical hops through residues Y356, Y73 1 and Y73 1, which propagate it across the
subunit interface. There appear to be no alternative pathways for radical transport into a2. In 032,
Y356 transfers the oxidizing equivalents by an orthogonal PCET mechanism, where long-range
ET is coupled to short-range, off-pathway PT. At residues Y730/Y 731 in a2, HAT is the
operative mechanism of hole transport (Figure 1-21).133 Thus residue Y731 communicates with
Y356 and Y730 via orthogonal PCET and HAT, respectively. After dCDP formation, the pathway
catalyzes reformation of Y122* using a similar mechanism as in the forward direction.
a2
Uctive Site
To
HN
HS
C439
Figure 1-21. Chemical mechanism for long-range radical transfer in E. coli RNR. Residues Y356,
Y730 and Y731 paticipate in radical propagation. In 32, reversible long-range ET (red arrows) is
coupled to short-distance PT (blue arrows). Accordingly, the proton at Y356 is transferred
off-pathway to a base. In a2, radical transport occurs by reversible HAT.
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CHAPTER 2:
Site-Specific Insertion of 3,4-Dihydroxyphenylalanine into the f32
Subunit of E. coli Ribonucleotide Reductase
Adapted in part from: Seyedsayamdost, M. R.; Stubbe, J. J. Am. Chem. Soc. 2006, 118, 2522.
INTRODUCTION
In this chapter, we considered the incorporation of a thermodynamic trap, a tyrosine
analogue with a low reduction potential, into the radical initiation pathway. In choosing this
unnatural amino acid analogue, several criteria were important. First, the analogue should
sterically resemble tyrosine. Residue 356 is on the disordered C-terminal tail of P~2 and not
visible in any structures. Therefore, its role in binding to a2 is not clearly defined.1 To avoid
changing the interaction with a2 as a result of the probe, steric homology to tyrosine is essential.
Second, the analogue should have known phenolic pKa and one electron reduction potential
appropriate for analysis of PCET. Third, the UV-vis and EPR properties of the one electron
oxidized state of the analogue should be known. And finally, the analogue should be
synthetically readily accessible and stable to the highly basic and acidic conditions used in
solid-phase peptide synthesis. We considered the three unnatural amino acids shown in Figure
2-1: 3-thiomethyltyrosine (MeS-Y),2 3-aminotyrosine (NH2Y)3' 4' 5 and 3,4-dihydroxyphenyl-
alanine (DOPA).6,7,8 The known properties of these are listed in Table 2-1. While all three
analogues would serve as efficient radical traps, based on the electrochemical data in Table 2-1,
the UV-vis and EPR properties for the NH 2Y radical and the MeS-Y radicals are unknown. In
addition, incorporation of NH2Y and MeS-Y proved synthetically difficult and these analogues
were no longer pursued (M. Seyedsayamdost, J. Stubbe, unpublished results). Therefore, only
DOPA fulfilled all four criteria and this chapter describes the insights gained about the radical
propagation event by generating and examining DOPA-032 (Figure 2-2).
The interest in DOPA and DOPA*s stems from its involvement in melanogenesis, the
process that converts DOPA into melanin pigments, which protect the skin from solar UV
radiation (Scheme 2-1).9,10,11 Extensive work on natural and synthetic melanin and its generation,
has lead to a detailed understanding regarding the chemical reactivity of DOPA, DOPA*s and
DOPA-quinones. These properties are shown in Figure 2-3 and are important to consider for
the topic for this chapter. Note that catechol has been used as a model for reactions of DOPA.
OH
OH
H2  OH
0
DOPA
uri
NH2
H2N
e
H2 N
0
NH2Y
0
MeS-Y
Figure 2-1. Low reduction potential Y analogues considered for insertion at position 356 of 132.
Some properties of these unnatural amino acids are summarized in Table 2-1.
Table 2-1. Relevant properties for the Y analogues DOPA, NH2Y and MeS-Y.
Property DOPA NH 2Y MeS-Y
pKa 8.8a, 9 .8b 4.9C, 10.1b 9.9b
E0' (V vs NHE)d 0.57 0.64 0.6
mnax (nm) 305 e
8 (M-lcm - ) 12,000e
a pKa of the 3-hydroxyl substituent. b Phenol pKa. C pKa of the 3-amino
Refs. 6-8, for NH2Y from Refs. 3-5 and for MeS-Y from Ref. 2. d Data
NH2Y and Ref. 2 for MeS-Y. e From Ref. 8.
substituent. Data for DOPA are from
are from Ref. 6 for DOPA, Ref. 5 for
Y122
W48
4.A
1
D237
Y731 I I
Figure 2-2. The radical generation pathway with site-specific insertion of DOPA at residue 356. See
Chapter 1 for a detailed discussion of the pathway.
A1 |
P441
Accordingly, catechol is stable at neutral pH; however, it may react with hydroxyl
radicals (OH.) to give an OH-adduct, which after elimination of water yields a catechol* (Figure
2-3A). 12,13 Superoxide (02 -) may also oxidize catechol to generate a catechol* (Figure 2-3B).
The catechol*, in turn, can react with oxidants, such as H0 2* (Figure 2-3C) and 02- (Figure
2-3D) at rate constants of -109 M-'s - 1, to yield an o-benzoquinone. Reaction of some
o-semiquinones with 02 has also been described, though a catechol* was not tested (Figure
2-3E). Catechol*s may also dismutate to generate catechol and o-benzoquinone (Figure 2-3F).
o-Benzouinones, generated via dismutation or oxidation of a catechol*, are susceptible to
Michael addition nucleophiles in solution (Figure 2-3G).12
HO O
H 0' NH0 hv
HO)O NH2
0
h 0 0
0 - NH2
e, 2H' eDOPA Dopasemiquinone Dopaquinone
Melanin - w -- HOcoo
HO/•" NH
Leucodopachrome
Scheme 2-1. Involvement of DOPA* in melanin biogenesis. UV light generates a DOPA*
(dopasemiquinone), which upon further oxidation yields dopaquinone. Michael addition by the amine
group results in leucodopachrome, which gives rise to melanin in a multi-step process.
The DOPA* is 260 mV, or 6 kcal/mol, more stable than a tyrosyl radical (ye). 6 At the
outset, the main question was whether a 260 mV thermodynamic trap would suffice to generate a
stable radical in the radical transfer pathway at the a2/P2 interface. The structure at the a2/52
interface has not been determined at resiude 356. Further, the factors that modulate the oxidation
potentials of amino acids inside proteins are to date ill-defined. Therefore, a potential of 830
mV and 570 mV, which have been determined in solution for y14 and DOPA,6 respectively, may
not hold in the protein milieu. Previous studies with NO2Y-P2, where the analogue 3-nitroY
was inserted at residue 356, indicated that the pKa at this residue was not perturbed and that a
-200 mV or a 4.6 kcal/mol barrier was sufficient to shut down nucleotide reduction.1 5 Thus, we
expected that DOPA-32 would form rapidly but would be unable to oxidize residue 731
resulting in a block during radical transfer into a2. In addition, Marcus-Levich theory dictates
that the ET rate constant between DOPA356* and Y731 would be -800-fold slower than that
between Y356* and Y731, based on potentials at pH 7 (assuming that both residues are on the
pathway and h = 1.2 eV). 16
OH
OH
OH
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0.
OH
OH
0.
NOH
0.
OH
2IoH
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+ 020-
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Figure 2-3. Reactions of catechol, catecholo and o-benzoquinone. Reliable rate constants have not
been reported in each case, although the reactions have been reported by several groups. (A, B)
Oxidation of catechol to catechol* by hydroxyl radical (HO*) and superoxide radical (O2'),
respectively. This occurs with rate constants of 106 M-1 s- and 109 M- 1 s7', respectively. (C, D, E)
Reaction of catecholo with perhydroxy radical (HO2*, protonated superoxide with pKa -4.9),
superoxide and dioxygen, respectively. Rate constant of 109 M- 1 s- 1 have been estimated for the
reactions in (C) and (D). Note that the primary reaction of the catechol* is via 02 (D). Reaction
with 02 (E) has been reported for some o-semiquinones, although the catechol* was not tested. (F)
Dismutation of two catechol*s to yield catechol and o-benzoquinone. (G) The o-benzoquinone
produced in C-F may react with nucleophiles by Michael addition, covalently modifying catechol.
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Contributing to the stability of a DOPA* in DOPA-02 would be its lack of propensity to
dismutate with another DOPA* or to oxidize to the quinone form, as HOo and 02 - are not
present. On the other hand, DOPA would be stable because redox reactions with nearby residues,
such as C354, would be energetically unfavorable as all natural amino acids have redox potentials
greater than 570 mV. Therefore, we hoped that insertion of DOPA at residue 356 would
generate a stable DOPA* that could be detected by UV-vis and EPR spectroscopic methods,
This would serve as a probe for involvement of residue 356 in radical initiation.
Experiments described in this chapter present the first trapping of a redox-active amino
acid and thereby direct evidence for involvement of a residue in the proposed long-range radical
propagation pathway. Formation of DOPA3 56* is kinetically competent and is gated primarily by
substrate binding, indicative of pathway dependence. The results show that DOPA is a
conformational probe, revealing physical changes that would not be detectable by other available
methods, as well as a reporter of the environment at the a2/02 interface. Finally, the results with
DOPA-P2 implicate subtle asymmetry in the oa2/I2 interaction, which is inconsistent with the
a2/02 docking model.
MATERIALS AND METHODS
Materials. Fmoc-DOPA(acetonide)-OH, Fmoc-Leu-OH, Fmoc-Gln(Trt)-OH, Fmoc-
Phe-OH, Fmoc-Asn(Trt)-OH, Fmoc-Ser(OtBu)-OH, Fmoc-Asp(OtBu)-OH, Fmoc-
Thr(OtBu)-OH, Fmoc-Val-OH, Fmoc-Glu(OtBu)-OH, Fmoc-Ile-OH, Fmoc-Gly-OH, Fmoc-
Asp(OtBu)-Ser(NMe, Mepro)-OH, Fmoc-Cys(tButhio)-OPfp and 1-hydroxybenzotriazole hydrate
(HOBt) were obtained from Novabiochem. Fmoc-L-Leu-PEG-PS (0.2 mmol/g) and 0-(7-
Azabenzotriazole-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate (HATU) were
obtained from Applied BioSystems. N,N-dimethyl formamide (DMF), diisopropyl ethylamine
(DIPEA), piperidine, trifluoroacetic acid (TFA), triisopropyl silane (TIS), 2-mercaptoethane
sulfonic acid (Mesna), ampicillin (Amp), chloramphenicol (Cm), Triton X-100, Sephadex G-25,
Sephadex G-75, Fast Flow DEAE Sepharose, 2',5'-ADP affinity resin, phenylmethanesulfonyl
fluoride (PMSF), glycerol, Bradford Reagent, sodium ascorbate, iron ammonium sulfate
hexahydrate (Fen(NH4)2(S04)2), ethylenediamine tetraacetic acid (EDTA), perchloric acid
(-70 %) a-cyano-4-hydroxycinnamic acid and MALDI-TOF standards for mass spectrometer
calibration: angiotensin (1044.54 Da), P14R synthetic peptide (1531.85 Da), ACTH fragment
(2463.20) and oxidized B chain insulin (3492.65 Da) were all obtained from Sigma-Aldrich.
Methanol (MeOH), ethyl acetate (EtOAc), acetic acid (AcOH), acetonitrile (MeCN),
dichloromethane (CH2C12), diethyl ether, magnesium sulfate (MgSO 4), sodium chloride (NaCl),
ammonium bicarbonate (NH4HCO 3) and potassium phosphate (KPi) were obtained from
Mallinckrodt. Disposable fritted Econo-Pac columns for manual peptide synthesis and Dowex
AG-lx8 resin were from Biorad. BL21(DE3) codon+ cells were from Stratagene.
Luria-Bertani Medium (LB) was from Becton Dickinson. Isopropyl-o3-D-thiogalacto-
pyranoside (IPTG) and DL-dithiothreitol (DTT) were from Promega. Chitin beads were from
NEB. Tris(hydroxymethyl)aminomethane (Tris base) and bovine pancreas DNase I were from
Roche. 4-(2-hydroxyethyl)piperazine-l-ethanesulfonic acid (Hepes) was obtained from EMD
Bioscience. [U- 14C]-Cytidine diphosphate (14CDP, 40-60 mCi/mmol) was obtained from
Moravek. Polypropylene falcon tubes (15 or 50 mL) were from BD Bioscience. Dialysis tubing
(1000 Da cut-off) for anaerobic peptide dialysis was obtained from SpectraPor. Centriprep
protein concentration device (YM-30) and Amicon ultrafiltration device (YM-30) were obtained
from Millipore.
MALDI-TOF MS. MALDI-TOF spectra were acquired on a Bruker OmniFlex
MALDI-TOF Mass Spectrometer equipped with Reflectron accessory at the Department of
Chemistry Instrumentation Facility. Spectra were obtained under negative mode using
a-cyano-4-hydroxycinnamic acid as the matrix. The matrix was prepared by suspending 10 mg
of CHA into a 1 mL solution of 50 % MeCN and 0.1 % TFA - 1 gLL of the peptide (0.5 - 3 mM)
solution was then co-spotted with 1 gLL of the matrix solution onto the MALDI-TOF target and
allowed to dry for 0.5-1 h prior to analysis. The MALDI TOF Mass Spectrometer was
calibrated with a mixture of angiotensin II (1044.5423 Da), P14R synthetic peptide (1531.8582
Da), ACTH fragment (2463.1989 Da) and insulin, oxidized B chain (3492.6513 Da) under
negative ionization mode.
Synthesis of DOPA-22mer peptide. The first 19 residues of the DOPA-22mer peptide
(H2N-CS-DOPA2o-L19VGQID14S13EVDTDDLSNFQLI-COOH) were prepared on a Pioneer
Peptide Synthesizer (Applied Biosystems) as previously described.' 5 Residues 13 (Ser) and 14
(Asp) were added as a pseudoproline dipeptide to avoid peptide aggregation. Automated
deblocking of the 9-fluorenyl methoxycarbonyl (Fmoc) protecting group was carried out in
DMF containing 20 % (v/v) piperidine and 0.1 M HOBt for 10 min with a pre-set instrument
flow rate. The coupling reactions utilized 4 equiv of Fmoc-protected amino acid, 3.6 equiv of
HATU, 8 equiv of DIPEA relative to the amount of peptide at final concentrations of 0.5 M, 0.45
M and 1 M, respectively, and proceeded for 1 h. After synthesis of the 19mer, a small amount of
peptide was cleaved from the resin and its purity and identity established by reverse-phase
HPLC (RP-HPLC) and MALDI-TOF MS (see below for detailed description of these methods).
The resin-bound peptide 19mer was stable at -800C for at least one year.
The remaining three residues, DOPA20, Ser21 and Cys22 were added manually at room
temperature. Manual peptide synthesis was performed in a disposable, fritted Econo-pac
column on a vortexer fitted with an adapter suitable for holding a 50 mL falcon tube, which in
turn holds the Econo-pac column. Removal of the Fmoc protecting group was performed by
shaking the resin-bound peptide twice for 10-12 min each or three times for 7-8 min each in
DMF containing 20 % (v/v) piperidine and 0.1 M HOBt. Fifteen mL of deblocking solution was
used per g of resin. After each deblocking step, the resin-bound peptide was washed 4-5 times
with DMF by adding 7-8 mL of DMF per g of resin, vortexing for -1 min and draining the DMF
from the column by removing the top and bottom caps of the column. After the last wash, N2
gas was passed through the column to completely remove residual DMF.
Manual coupling reactions were carried out by shaking the resin-bound peptide for 1 h
with at least 6 equiv of N-Fmoc-protected amino acid, 5.4 equiv of HATU and 12 equiv of
DIPEA in DMF at final concentrations of 0.5 M, 0.45 M and 1 M, respectively. The coupling
mixture was prepared by first dissolving the Fmoc-protected amino acid in the required volume
of DMF, followed by HATU and DIPEA. The reaction vessel was vortexed for -10-15 sec to
completely dissolve the components before adding it to the resin-bound peptide in the
Econo-pac column. After each coupling reaction, the resin-bound peptide was washed 2-3
times with DMF as described above.
The N-terminal Cys residue was coupled as a pentafluorophenol-activated (OPfp) and
t-Buthio-protected derivative. Coupling of this residue was carried out by vortexing the
resin-bound peptide with 6 equiv of Fmoc-Cys(t-Buthio)-OPfp and 6 equiv of HOBt at final
concentrations of 0.5 M each for 1.5 h. The resin-bound pepide was then washed 2-3 times
with DMF and 2-3 times with CH2C12 as described above. Finally, the Econo-pac column was
capped at the top and connected to a vacuum line at the bottom for 5-10 min to completely dry
the resin.
Cleavage of peptide from solid-phase resin. The resin-bound peptide was vortexed
with a solution consisting of 95 % (v/v) TFA, 2.5 % (v/v) TIS and 2.5 (v/v) % water for 4 h.
Typically, 25 mL of cleavage solution was used per g of resin. After 4 h, the TFA solution was
drained into a 50 mL falcon tube. The resin was washed 2-3 times with a small volume of TFA.
The TFA washes were combined with the original cleavage solution containing the peptide. The
peptide was then concentrated by blowing N2(g) over the solution until precipitation occurred.
At this point, 8-10 volumes of chilled diethyl ether were added and the mixture incubated at 40C
for -45 min. The peptide was collected by centrifugation (-5,000 x g, 10-15 min, 4°C) and the
ether supernatant discarded. The precipitate was washed once with cold diethyl ether by adding
the same volume as before to the precipitate, incubating for -5 min at 40C and discarding the
ether after centrifugation. Residual ether was removed by sitting the falcon tube uncapped in a
fume hood at room temperature overnight. The peptide was stored at -800 C, where it was stable
for at least one year.
Analytical and semi-preparative RP-HPLC. RP-HPLC was performed on a Waters
HPLC system with a 2487 dual absorption detector and 515 HPLC pumps running on Millenium
Software. The peptide was dissolved in a solution of 0.1 M NH 4HCO3, pH 6.8 to a concentration
of 0.5-2 mM. Addition of solid NH4HC0 3 aided in peptide dissolution. Analytical scale
analysis was carried out with a Jupiter Phenomenex C18 5 gm (150 x 4.6 mm) column. Typically
20-100 nmol peptide were loaded (0.2 mL or 0.5 mL injection loop) to assess purity and identity,
monitoring absorbance at 215 and 280 nm (ý,m of DOPA is at 280 nm with 9 = 2760 M- 1
cm-1). 17 The peptide was eluted with a linear gradient from 10 to 75 % MeCN vs. 0.1 M
NH4HCO3, pH 6.8 over 45 min at 1 mlmin. The major peak was collected by hand, lyophilized,
redissolved in a small volume (10-100 ipL) to yield a concentration of 0.3 to 2 mM and analyzed
by MALDI-TOF MS as described above.
Semi-preparative scale purifications were carried out with a Waters XTerra MS C18 5 gLm
(19 x 100 mm) column at a flow rate of 7 ml/min. Up to 2 gLmol peptide were loaded (5 mL
injection loop) in each run. The peptide was eluted with a linear gradient from 10 % to 20 %
MeCN over 5 min, followed by a linear gradient of 20 % to 35 % MeCN vs. 0.1 M NH4HCO 3,
pH 6.8 over 23 min. The desired product was collected by hand in a 50 mL polypropylene
falcon tube, frozen and lyophilized to dryness. The purified t-Buthio-protected DOPA-22mer
peptide was obtained in 70 % yield and was stable at -800 C for at least two years.
Removal of the t-buthio-protecting group. The purified, Cys-blocked peptide was
dissolved in 0.1 M NH4HCO3, pH 6.8 to a concentration of 0.5-2 mM and transferred to a
pear-shaped flask. The mixture was supplemented with 0.1 volumes of a solution of 250 mM
Tris, pH 7.3 and deoxygenated on a Schlenk line by alternating cycles of evacuation followed by
re-addition of argon gas. A total of 6-8 cycles were performed. In each cycle the flask is
degassed by pulling a vacuum for -2-5 min and then flushed with argon with stirring for -5 min.
Then, solid DTT was added to a 15-fold molar excess over peptide. During this addition, the
peptide solution is briefly exposed to atmosphere, therefore, the degassing procedure was
repeated and the mixture stirred at room temperature for 4 h. At this point, the reaction mixture
was transferred to a dialysis bag and dialyzed anaerobically (see below) against 5 mM KPi, pH
6.0 (1 L, 2-3 changes of 4 h each). After dialysis, the solution was transferred to a falcon tube,
frozen and lyophilized to dryness. The dry, purified and fully deprotected peptide was stable at
-800 C for a year. Anaerobic dialysis was performed in an Erlenmeyer flask or a lyophilization
flask at room temperature. Low oxygen concentration during dialysis was maintained by
bubbling the KPi buffer with argon gas for 15 min prior to immersion of the dialysis bag and
continuously thereafter.
Growth and expression of 32-intein-CBD. The vector pp2-intein-CBD 15 was
transformed into BL21(DE3) codon+ (RIL) cells using instructions by the manufacturer.
Growths were carried out on a 10-25 L scale in a 10 L fermentor at 37'C, 500 rpm and, if
necessary, in additional 6 L flasks (each containing 1.5 L media) in a shaker/incubator at 370 C,
200 rpm with Amp (100 gg/mL) and Cm (50 gg/mL). A 5 mL LB/Amp/Cm starter culture (in a
12 mL bacterial culture tube) was inoculated with a single colony and grown to saturation (-12
h). Then, 0.5 mL of the saturated culture was diluted into a 100 mL LB/Amp/Cm solution (in a
500 mL Erlenmeyer flask), which was grown to saturation overnight (-12 h). Finally, the
saturated culture was diluted 200-fold into a 12-25 L large culture consisting of a fermentor
flask and several 6 L Erlenmeyer flasks. When OD600 nm reached 0.7-0.8 (-4 h after inoculation
of the large culture), the temperature setting was lowered to 23 'C. After 15 min, IPTG was
added to a final concentration of 0.5 mM and the expression continued for 5-6 h at 230C. At
that point, cells were harvested by centrifugation (10,000 x g, 15 min, 40C), frozen in liquid Nz
and stored at -800 C. A yield of 4-5 g per L culture was typical. The ligation was performed
within several days of expression of 02-intein-CBD.
Semisynthesis of DOPA-12. Each g of wet cell paste was resuspended in 5 mL of lysis
buffer (30 mM Hepes, 500 mM NaC1, 0.1 % Triton X-100, pH 7.6) supplemented with 1 mM
PMSF and 25 U DNase I. The cells were lysed with a single pass through a French Pressure Cell
operating at 14,000 psi. Then, 5 mg of each sodium ascorbate and Fen(NH 4)2(SO4)2 per g of wet
cell paste were dissolved in -10 mL of lysis buffer and added dropwise over 10 min at 40C with
stirring. The mixture was stirred for an additional 15 min at 40C and the cell debris was removed
by centrifugation (15,000 x g, 35 min, 40 C). The supernatant was loaded onto a chitin column
that had been equilibrated in lysis buffer at a flow rate of -2 mL/min; five mL of chitin resin
were used per g of wet cell paste. For 200 mL of resin, a column with dimensions of 5 x 10 cm
was used. The resin was washed with 30-40 column volumes (CV) of lysis buffer containing
0.2 mM PMSF, then with 2 CV of cleavage buffer (50 mM Hepes, 500 mM NaC1, pH 7.6). Next,
the column was loaded with 1.5 CV of cleavage buffer containing 100 mM Mesna. The reaction
was allowed to proceed for -24 h. At that point, Mesna-activated, truncated P2 was eluted in
cleavage buffer. Elution was continued until no more protein was detected by the Bradford
Reagent assay. Mesna-activated 02 was concentrated to 20-25 mg/mL using an Amicon
concentration device with a YM-30 membrane. Excess Mesna was removed from the
Mesna-activated P2 using a Sephadex G-25 (-200 mL, 2.5 x 40 cm) column equilibrated in
cleavage buffer, now with a pH of 7.3. This desalting step results in dilution of Mesna-activated
32, therefore, it was concentrated again to 20-25 mg/mL using an Amicon concentrator as
before. The concentrated Mesna-activated P2 was then transferred to a 50 mL pear-shaped
flask and deoxygenated on a Schlenk with a total of -10 vacuum-argon fill cycles. Each cycle
consisted of evacuating the flask for 5-10 sec followed by argon fill for 1 min. During the argon
fill the flask was gently swirled. After the 5t cycle, argon gas was blown over the solution on
the Schlenk line for -15-30 min. Then, an additional 5 cycles of vacuum-argon fill were
performed. At that point, the deoxygenated Mesna-activated 32 sample was taken into the glove
box along with the purified and deprotected DOPA-22mer peptide. The ligation reaction
contained 16 p.mol DOPA-22mer and 8 mL of 25 mg/mL (2.3 rpmol) Mesna-activated, truncated
P2. It was supplemented with 0.1 volumes of 1.5 M Hepes, 0.4 mM EDTA, pH 7.3. The
reaction proceeded at 4°C in the anaerobic chamber for -36 h. It was gently swirled 4-5 times
during the incubation period. After 36 h, it was taken out of the anaerobic chamber, aliquoted,
quick-frozen in liquid N2 and stored at -80'C.
MonoQ purification of ligation mixture. Preparative-scale purification of the ligation
mixture was carried out on a MonoQ HR 16/10 Anion Exchange Column (10 plm, 2 x 10.5 cm,
33 mL - Amersham Bioscience) on a Sprint Biocad FPLC System (Applied Biosystems).
Column operation was carried out at a flow rate of 3 mlJmin monitoring the absorbance at 280
nm. The column was equilibrated in 50 mM Tris, 5 % glycerol, 1 mM DTT, pH 7.3 (Buffer Q).
Loading was carried out with a 2 mL injection loop, typically 12-15 mg of the ligation reaction
were loaded per run. After loading, the column was washed for 2 min with Buffer Q. The
protein was then eluted with a linear gradient from 0 to 200 mM NaCI in Buffer Q over 3 min,
followed by a linear gradient from 200 to 440 mM NaCl in Buffer Q over 37 min. Full-length
32 typically elutes at 360-380 mM NaCl in Buffer Q. The desired products (heterodimeric and
homodimeric DOPA-32) were collected on a fraction collector or by hand, concentrated to
70-350 jpM, flash-frozen in liquid N2 and stored at -800 C. The concentration of DOPA-02 was
determined using 6 280 nm = 131 mM- 'cm -1. A column recovery of 80 % was typical.
Electron spray ionization (ESI) MS analysis of DOPA-[2. Purified DOPA-P2
constructs were characterized by ESI-MS at M. I. T. Biopolymers Laboratory on a PE Sciex
API365 Triple Quad Mass Spectrometer from Applied Biosystems. Twenty gLL of DOPA-02
(-60 pM) was exchanged into water using Micro Bio-Spin-30 columns. The samples were
diluted to a final concentration of -5 pM with 50% MeCN, 50% water, and 0.2% acetic acid
immediately before analysis. Approximately 1-5 pmol of the diluted sample was loaded via
direct infusion at 5 plUmin, and data were collected under positive ionization mode.
Quantitation of radical content by UV-vis and EPR spectroscopies. Radical content
is reported per 02 throughout the text. UV-vis spectra were collected on an Agilent 8453 Diode
Array Spectrophotometer or a Varian Cary 3 UV-vis Spectrophotometer. The dropline method
was used to quantitate the amount of Y122* using the following equation (Eq. 2-1):18
Ab411 nm Abs406 nm + AbS416 nm
[Y122.] = x Dilution Factor (2-1)
1783 M-lcm- 1
EPR spectra were recorded at the Department of Chemistry Instrumentation Facility at 77
K on a Bruker ESP-300 X-band (9.4 GHz) spectrometer equipped with an Oxford liquid helium
cryostat and an Oxford ITC 503 temperature controller or alternatively with a quartz finger
dewar filled with liquid N2. EPR parameters were as follows: Power = 50 jtW, modulation
amplitude = 1.5 G, modulation frequency = 100 kHz, time constant = 5.12 ms and scan time =
41.9 s. The microwave frequency was 9.38 GHz with the liquid helium cryostat and 9.34 GHz
with the quartz finger dewar. The normalized double integral (DIN) intensity was obtained on
Bruker WinEPR software, which, by default, corrects for sweep time, gain and sweep width.
The DI/N was further corrected for the number of scans, power and modulation amplitude using
Eq. 2-2 to yield DI/N,. The [Y122*] was then computed by comparison to a known concentration
of Cu" standard, the double integral of which was also corrected using Eq. 2-2 and 2-3.'19 Note
that subscripts 'SAM' and 'STD' refer to unknown sample and Cun standard spectra,
respectively.
Quantitation of Fe content by the ferrozine assay. The previously reported Ferrozine
assay was scaled down with minor modifications: 20 A solution of DOPA-P2 (100 gLL, 20 p.M)
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was mixed with 0.1 volumes of a 50 % trichloroacetic acid solution and inverted several times.
After centrifugation (14,000 x g, 12 min, rt), the supernatant was removed, diluted to 440
DI/Nc = DIN (2-2)
# Scans x Vr[Power (mW)] x Modulation Amp (G)
(DI/Ne)sm (DI/Ne)sAm
= (2-3)
(gave)smTD x [STD (gave)SAM X [ ]SAM
pL with doubly-deionized water and supplemented with 20 pL of each 75 mM sodium ascorbate,
10 mM ferrozine and a saturated solution of NH 40Ac. The absorbance of the (Ferrozine) 3-Fe
complex was recorded at 562 nm (s = 27.9 mM-'cm' 1) and subtracted from the Abs 562 nm of a
blank solution which contained water in place of protein.
Alternatively, DOPA-32 (30 pgL, 80 pM) was mixed with 70 jpM of 2 M HCI in an
eppendorf tube, inverted several times and boiled in a sand bath (95 0 C) for 5 min. Precipitated
protein was pelleted by centrifugation (14,000 x g, 12 min, rt), the supernatant transferred to an
eppendorf tube and the pellet combined with 100 pL of 2 M HCl and boiled again for 15 min as
before. After centrifugation (14,000 x g, 12 min, rt), the two supernatants were combined and
supplemented with 200 gpL of 10 mM ferrozine solution, 40 pLL of 75 mM sodium ascorbate and
200 giL of a saturated NH4OAc solution. The absorbance of the protein sample and the blank
sample were recorded at 562 nm as described above.
Growth, expression and purification of wt 032. Wild type P2 was expressed in
BL21(DE3) E. coli cells from vector pTB2, which contains the f32 gene under control of a T7
promoter and terminator and an AmpR marker. Vector pTB2 was transformed into BL21(DE3)
competent cells using manufacturer's instructions. Flask growth and expression of f32 were
carried out on a -4-8 L scale in a shaker/incubator at 370C and 200 rpm with Amp (100 [tg/mL).
A single colony was inoculated into a 5 mL LB/Amp starter culture (in a 12 mL bacterial culture
tube) and grown to saturation (-12 h). The saturated culture was then diluted 200-fold into a
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100 mL LB/Amp solution (in a 500 mL Erlenmeyer flask) and grown to saturation overnight
(-12 h). The saturated culture was then diluted 200-fold into a large LB/Amp meidum in
Erlenmeyer flasks. When the OD 60 0 nm reached -0.6 (3-4 h), IPTG was added to a final
concentration of 0.5 mM and expression continued at 370C for 4-5 h. The cells were harvested
by centrifugation (10,000 x g, 15 min, 40 C), flash-frozen in liquid N2 and stored at -800 C.
Typically a yield of 4 g wet cell paste per L culture growth was obtained.
02 was usually isolated from -20 g of wet cell paste. All purification steps were carried
out at 40C. Each g of wet cell paste was resuspended in 50 mM Tris, 5 % glycerol, 0.5 mM
PMSF (P2 Buffer). After homogenization, cells were lysed by a single passage through a French
Pressure Cell operating at 14,000 psi. Sodium ascorbate and Fe(NH4) 2SO4 (5 mg each per g cell
paste) were dissolved in -10 mL P2 Buffer and added dropwise to the crude extract over 10 min,
The lysate was stirred for an additional 15 min and the cell debris removed by centrifugation
(15,000 x g, 35 min, 4°C). DNA was precipitated by dropwise addition of 0.2 volumes of 6 %
streptomycin sulfate in 32 Buffer to the crude extract over -15 min. Stirring was continued for
an additional 15 min. Precipitated DNA was removed by centrifugation (15,000 x g, 40 min,
40 C). The supernatant was transferred to a beaker and the protein precipitated by addition of 39
g of solid (NH4)2SO4 per 100 mL supernatant over 20 min (66 % saturation). The mixture was
stirred for an additional 35-45 min. The (NH4)2SO4 precipitate was then isolated by
centrifugation (15,000 x g, 45 min, 4°C). Next, the precipitated protein was redissolved in a
minimal volume of 12 Buffer and desalted on a Sephadex G-25 column (2.5 x 45 cm, 220 mL)
equilibrated in P2 Buffer. The visible brown protein band eluting from the column was collected
by hand and loaded directly onto a DEAE Fast Flow Anion Exchange column (5 x 15 cm, 300
mL), which had been equilibrated in P2 Buffer. The column was washed with 2 CV of Buffer A,
followed by 1.5 CV of 12 Buffer containing 110 mM NaC1. 12 was then eluted with a linear
gradient (500 x 500 mL) from 100 to 500 mM NaCl in 12 Buffer A. 02 containing fractions, as
determined by Y122* absorption at 411 nm, were pooled, diluted with an equal volume of 32
Buffer and loaded onto a Q-Sepharose column (5 x 10 cm, 200 mL) which had been equilibrated
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in 02 Buffer. The column was washed with 1.5 CV of 32 Buffer containing 200 mM NaCI. 02
was then eluted with a linear gradient (500 x 500 mL) from 200 to 700 mM NaCl in P2 Buffer.
Fractions containing 02 were pooled, diluted with an equal volume of 02 Buffer (without PMSF),
concentrated to ~25 mg/mL, aliquoted, flash-frozen in liquid N2 and stored at -80'C. Typically,
30 mg of pure 32 were obtained per g of wet cell paste with a specific activity of -7000
nmol/min mg, as measured by the spectrophotophetric RNR assay, and a radical content of 1.2
per [2 dimer (see above). The concentration of wt P2 was determined using 8280 nm = 131
mM-lcm- 1.
Growth, expression and purification of ac2. Protein a2 was expressed in BL21(DE3) E.
coli cells from plasmid pMJ1-a2, which contains the a2 gene under control of a T7 promoter
and terminator and an AmpR marker. 21 Vector pMJ1-a2 was transformed into BL21(DE3)
competent cells using instructions by the manufacturer. Large-scale growth and expression of
a2 were carried out on a 15-20 L scale in a 10 L fermentor at 370C, 500 rpm and additionally in
6 L Erlenmeyer flasks (each containing 1.5 L media) in a shaker/incubator at 370C, 200 rpm with
Amp (100 gg/mL). A single colony was inoculated into a 5 mL LB/Amp starter culture (in a 12
mL bacterial growth tube) and grown to saturation (-12 h). The saturated culture was then
diluted 200-fold into a 100 mL LB/Amp culture (in a 500 mL Erlenmeyer flask) and grown to
saturation overnight (-12 h). This saturated culture was then diluted 200-fold into a large
LB/Amp culture in the fermentor and Erlenmeyer flasks. When the OD600 nm reached -0.8 (3-4
h), IPTG was added to a final concentration of 0.5 mM and expression continued at 370 C for 5-6
h. The cells were harvested by centrifugation (10,000 x g, 15 min, 40 C), flash-frozen in liquid
N2 and stored at -800 C. Typically a yield of 4 g wet cell paste per L culture growth was
obtained for wt a2.
a2 was usually isolated from 80 g of wet cell paste. All purification steps were carried
out at 40C. Each g of wet cell paste was resuspended in 50 mM Tris, 1 mM EDTA, 5 % glycerol,
5 mM DTT, 1 mM PMSF (a2 Buffer). After homogenization, cells were lysed by a single
passage through a French Pressure Cell operating at 14,000 psi followed by removal of cell
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debris by centrifugation (15,000 x g, 35 min, 4°C). DNA was precipitated by dropwise addition
of 0.2 volumes of 6 % streptomycin sulfate in a2 Buffer to the crude extract over -15 min.
Stirring was continued for an additional 15 min. Precipitated DNA was removed by
centrifugation (15,000 x g, 40 min, 40 C). The supernatant was transferred to a beaker and the
protein precipitated by addition of 39 g of solid (NH4)2SO4 per 100 mL supernatant (66 %
saturation) over 20 min. The mixture was stirred for an additional 35-45 min. The (NH4)2SO4
precipitate was then isolated by centrifugation (15,000 x g, 45 min, 4QC) and stored at 40C
overnight. Next, the precipitated protein was dissolved in a minimal volume of a2 Buffer and
desalted on a Sephadex G-25 column (5 x 50 cm, 1 L) equilibrated in a2 Buffer. The visible
brown protein band eluting from the column was collected by hand and loaded directly onto a
DEAE Fast Flow Anion Exchange column (7 x 12 cm, 500 mL), which had been equilibrated in
a2 Buffer. The column was washed with 4 CV ac2 Buffer or until protein no longer eluted as
judged by the Bradford Reagent Assay. a2 was then eluted with a linear gradient (800 x 800
mL) from 0 to 400 mM NaCl in a2 Buffer. Twenty mL fractions were collected and those
containing a2, as determined by the spectrometric assay (see below), were pooled and loaded
directly onto a dATP column (4 x 8 cm, 100 mL), which had been equilibrated in a2 Buffer
(now containing 0.5 mM PMSF) at a flow rate of 2-3 mL/min. The column was washed with a2
Buffer (plus 0.5 mM PMSF) overnight at a flow rate of -1 mL/min until protein no longer eluted
as judged by the Bradford assay. a2 was then eluted with 50 mM Tris, 15 mM MgSO 4, 1 mM
EDTA, 10 mM ATP, 10 mM DTT, pH 7.6 (Elution Buffer) until no more protein was detected
by the Bradford assay. At that point, a2 was concentrated to 60-80 mL and desalted on a
Sephadex G-25 column (5 x 50 cm, 1 L), which had been equilibrated in Elution Buffer without
ATP. a2-containing fractions were pooled, concentrated to -40 ^LM, divided into 1 mL aliquots,
flash-frozen and stored at -800 C. Typically, 5 mg of pure a2 were obtained per g of wet cell
paste with a specific activity of 2000-2800 nmol/min mg by the spectrophotophetric RNR assay.
The concentration of a2 was determined using 8280 nm = 189 mMT cm1'.
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Growth, expression and purification of E. coli thioredoxin. Thioredoxin (TR) was
expressed from plasmid pTRX under control of the T7 promoter and terminator and an AmpR
marker in BL21(DE3) E. coli cells.22 Growth and expression were carried out with 70 gig/mL
Amp in an incubator/shaker at 37°C and 200 rpm. pTRX was transformed into BL21(DE3) cells
following instructions by the manufacturer. A 5 mL culture of LB/Amp was inoculated with a
single colony and grown overnight (-13 h). A 100 mL culture was then inoculated with 1 mL of
the saturated small culture and grown to saturation (4-5 h), which was diluted 1000-fold into a
large LB/Amp culture. When OD600 nm reached 0.8 (-6 h), IPTG was added to a final
concentration of 1 mM and expression continued for 3 h. At that point, cells were harvested by
centrifugation (10,000 x g, 15 min, 40 C), quick-frozen in liquid N2 and stored at -800 C.
Typically a yield of 2.5 g wet cell paste per L culture was obtained.
TR was isolated from -20 g of wet cell paste. All purification steps were performed at
4°C. Each g of wet cell paste was resuspended in 7 mL of 50 mM Tris, 3 mM EDTA, pH 7.4
(TR Buffer A) containing 0.5 mM TPCK and 1 mM TLCK. After homogenization, cells were
lysed in an ice-water bath by sonication using 20 x 15 sec pulses with 1.5 min intervals between
each pulse. Cell debris was removed by centrifugation (14,000 x g, 30 min, 4°C). The DNA
was precipitated by dropwise addition of 0.2 volumes of 4.8 % streptomycin sulfate in TR Buffer
A to the crude extract over 15 min with stirring. The mixture was stirred for an additional 15
min and precipitated DNA removed by centrifugation (14,000 x g, 30 min, 4oC). The
supernatant was then diluted 3-fold into 50 mM KPi, 3 mM EDTA, pH 7.3 (TR Buffer B) and
loaded onto a DE-52 anion exchange column (4 x 13 cm, 150 mL) which had been equilibrated
in TR Buffer B. The column was washed with 3 CV of TR Buffer B and TR was eluted with a
linear gradient (1.2 x 1.2 L) from 50 mM to 200 mM KPi (with 3 mM EDTA, pH 7.3). Fractions
(20 mL) containing TR, as judged by the TR acitivty assay (see below), were pooled and
concentrated on an Amicon concentrator with a YM-3 membrane to -5 mL (-600 piM) and
loaded onto a Sephadex G-75 column (1.5 x 80 cm, 140 mL) which had been equilibrated in TR
Buffer B at 1 mlJmin. TR was eluted isocratically in TR Buffer B. Fractions containing TR, as
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judged by activity assays, were pooled, concentrated to - 1 mM, aliquoted, flash-frozen in liquid
N2 and stored at -800 C. The yield was -2 mg TR per g of wet cell paste with a specific activity
of 13 gpmollmin*mg. 23 The concentration of TR was determined using 28onm = 13.7 mM-lcmn'.
Growth, expression and purification of E. coli thioredoxin reduductase. E. coli
thioredoxin reductase (TRR) was isolated from strain pMR14-K91, in which vector pMR14
contains the E. coli thioredoxin reductase b gene under control of a lpp promoter and terminator
and an AmpR marker.24 Growth and expression of TRR were carried out in the presence of 100
gLg/mL Amp in an incubator/shaker at 370C and 200 rpm. A glycerol stock of pMR14-K91 was
streaked out onto LB/Amp Agar plates and incubated overnight. A single colony was used to
inoculate a 5 mL LB/Amp starter culture which was grown overnight (-16 h). The saturated
culture was diluted 5000-fold into a 500 mL LB/Amp solution, which was grown to saturation
overnight (-16 h). Each of 8 flasks containing 1.5 L LB/Amp were inoculated with 25 mL of the
overnight culture. The large culture was grown to saturation (9 h), at which point the cells were
harvested by centrifugation (2000 x g, 30 min, 4°C), flash-frozen and stored at -800 C. Five g of
wet cell paste were obtained per L culture.
TRR was isolated from -60 g of wet cell paste. All purification steps were performed at
4°C. Each g of cell paste was resuspended in 4 mL of 50 mM Tris, 1 mM PME, pH 8.0 (TRR
Buffer A), homogenized and lysed with two passages through a French Pressure Cell operating
at 14,000 psi. Cell debris was pelleted by centrifugation (13,000 x g, 45 min, 4VC). The crude
extract was supplemented with a final concentration of 1.2 % (w/v) streptomycin sulfate over 20
min, the mixture stirred for additional 20 min and precipitated DNA removed by centrifugation
(10,000 x g, 25 min, 4 'C). The supernatant was loaded onto a DE-52 column (5 x 15 cm, 300
mL) which had been equilibrated in 0.1 M KPi, 1 mM EDTA, pH 7.0. Bound TRR was eluted
with a linear gradient (2 x 2 L) from 0.1 M to 0.25 M KPi (with 1 mM EDTA, pH 7.0).
Fractions containing TRR, as judged by activity, were pooled and loaded directly onto a
2',5'-ADP Agarose column (2 x 8 cm, 25 mL), which had been equilibrated in 50 mM KPi, 3
mM EDTA, pH 7.6 (TRR Buffer B). The column was washed with 4 CV of TRR Buffer B
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containing 0.2 M NaC1. TRR was then eluted with 3 CV of TRR Buffer B containing 1 mM
NADPH. Fractions containing TRR, as judged by activity, were pooled, concentrated to -40 pM,
aliquoted, flash-frozen and stored at -80'C. A typical yield of -1 mg pure TRR per g wet cell
paste with a specific activity of 1400 nmol/min mg was obtained. The concentration of TRR was
determined with the Lowry Assay using BSA as standard.
TR and TRR activity assays. E. coli TR and TRR were assayed using DTNB as a
substrate. Stocks of DTNB were prepared fresh in EtOH. The assay contained in a final volume
of 300 or 400 gL: 100 mM Tris, pH 8.0, 25 mM EDTA, 0.1 mM NADPH, 0.15 mM DTNB, 25
pM TR and 0.1 pM TRR. The initial reaction rate was determined by monitoring the absorption
change at 412 nm, where the product thiolate has C = 13.6 mM-'cm- 1, on a Varian Cary 3
UV-vis Spectrophotometer. When TR was assayed, it was added to the mixture last and the
observed rate corrected for TR-independent reduction of DTNB; the same procedure was carried
out for TRR assays.
Spectrophotometric RNR assay. The assay contained in a volume of 300 gL: 3 pM a2,
3 pM DOPA-02, 1 mM CDP, 3 mM ATP, 30 pM TR, 0.5 pM TRR, 0.2 mM NADPH in assay
buffer. The reaction was initiated with addition of DOPA-P2 and the absorbance monitored at
340 nm (8 = 6.22 mM-lcm- 1) on a Varian Cary 3 UV-vis Spectrophotometer. The temperature
was maintained at 25°C with a Lauda RC6 circulating water bath. The observed absorbance
change at 340 nm was corrected for the background change prior to addition of DOPA-P2. Each
activity reported is the average of three independent measurements.
When wt a2 was assayed, wt 02 was in 5-fold molar excess. Likewise, assays of wt 02
contained 5-fold molar excess of wt a2. The subunit that was assayed was present at a final
concentration of 0.1-1 pM.
Radioactive RNR assay. The assay contained in a volume of 230 lpL: 3 pM a2, 3 pM
02, 1 mM [2-1 4C]-CDP (8150 cpm/nmol), 3 mM ATP, 30 pM TR, 0.5 pgM TRR and 1 mM
NADPH in assay buffer. For each reaction nucleotides, TR, TRR and a2 were incubated at 250 C
for 1.5-2 min. The reaction was then initiated by addition of DOPA-02 and NADPH. At
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defined timepoints, 40 ýpL were withdrawn and quenched in 25 [LL 2 % (v/v) perchloric acid. At
the end of the timepoint, the reactions were neutralized with 20 jtL 0.5 M KOH. The quenched
and neutralized timepoint samples were incubated at -20 0 C overnight to ensure complete
precipitation of potassium perchlorate. The samples were then thawed on ice and spun down for
3 min in a tabletop centrifuge. Each supernatant was transferred to a 1.5-mL screw-top
microfuge tube, to which was added 14 units of calf-intestine alkaline phosphatase, 120 nmol of
carrier deoxycytidine (dC), and final concentrations of 75 mM Tris, 0.15 mM EDTA (pH 8.5).
The samples were incubated at 370C for 2 h and the amount dC in each sample was quantitated
using the method of Steeper and Steuart.25
Binding of DOPA-32 to oa2. The affinity of DOPA-[32 for a2 was assessed by using it
as a competitive inhibitor of nucleotide reduction. 26 First, the Y122* of DOPA-P2 was reduced by
incubating it (-80 jgM) with 30 mM hydroxyurea at room temperature for 30 min, followed by
desalting on a Sephadex G-25 column (1.5 x 25 cm, 45 mL) equilibrated in assay buffer (50 mM
Hepes, 15 mM MgSO 4, 1 mM EDTA, pH 7.6). The met form of DOPA-02 was then used as an
inhibitor of nucleotide reduction without further modification. The assay mixture consisted of
final concentrations of 0.15 jgM a2 (2300 nmol/min mg), 0.3 pM wt 32 (7200 nmol/min mg), 50
gLM thioredoxin, 1 gLM thioredoxin reductase, 1 mM CDP, 1.6 mM ATP, 0.2 mM NADPH and
varying concentrations of competitive inhibitor, met-DOPA-P2. Nucleotide reduction activity
at each concentration of the inhibitor was determined by monitoring the absorption at 340 nm.
The data was then fit to Eq. 2-4,
[met-DOPA-2]max x [met-DOPA-032]free[met-DOPA-P2]bound = (2-4)
Kd + [met-DOPA-P2]fe
where [met-DOPA-P2]bound is the concentration of the a2/met-DOPA-P2 complex,
[met-DOPA-0I32]ma is the concentration of the a2/met-DOPA-32 complex at maximal
[met-DOPA-02]fre, which equals 0.09 WM in the assay conditions used above, and Kd is the
dissociation constant for interaction of met-DOPA-12 and a2. [met-DOPA--2]bound and [met-
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DOPA-P2]free were computed as previously described.27 Briefly, it is assumed thar the relative
activity is a scaling factor indicative of the amount of wt a2/02 complex present. At the
concentration of a2 and 02 used in these assays, with [met-DOPA-2]total = 0, [a2/02] = 0.09
pM (using a Kd of 0.15 gLM as previously reported for wt a2/02). Inhibition of activity is
assumed to be due to a2/met-DOPA-02 complex formation, the concentration of which is
calculated using Eq. 2-5. Accordingly, [met-DOPA-02]fre is computed using Eq. 2-6.
[met-DOPA-02]bound = 0.09 - relative activity x [a2/02]at [met-DOPA-32]=x (2-5)
[met-DOPA-P2]fre = [met-DOPA-32]tot - [met-DOPA-02]bound (2-6)
Pre-reduction of a2. Pre-reduced a2 was generated by incubation of -40 mg a2 (-40
pM) with 35 mM DTT at room temperature for 40 min. Then, HU and additional DTT were
added to final concentrations of 15 mM, each, and the incubation continued for 15 min. a2 was
desalted on a Sephadex G-25 column (1.5 x 28, 50 mL) column, which had been equilibrated in
assay buffer (50 mM Hepes, 15 mM MgSO 4, 1 mM EDTA, pH 7.6). Fractions containing a2, as
judged by the Bradford Reagent Assay, were pooled, concentrated to -80 pM, aliquoted,
flash-frozen and stored at -800C. 28
Monitoring reactions of DOPA-02 by stopped-flow (SF) UV-vis spectroscopy. SF
kinetics was performed on an Applied Photophysics DX. 17MV instrument using PMT detection
at 410 nm (max of Y122* with , = 3700 M-lcm1) 18 and 305 nm (reported max of DOPA* with & =
12,000 M-'cm-1).8 Because the mx of DOPA*-02 is shifted to 315 nm (see Results), the 6 used
at 305 nm was calculated using Eq. 2-7.
8 Abs 305 nm
305n 315 nm X (2-7)(12,000 M-cm- 1) Abs 315 nm
The temperature was maintained at 250 C with a Lauda RE106 circulating water bath. All
experiments were performed in assay buffer (50 mM Hepes, 15 mM MgSO 4, 1 mM EDTA, pH
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7.6). Pre-reduced a2 and effector in one syringe were mixed with DOPA-12 and substrate from
another syringe in equal volumes to yield final concentrations of 23-30 jPM a2, 1 mM substrate,
23-30 pLM DOPA-132 and 200 VpM effector, respectively. Effector ATP was used at a final
concentration of 3 mM, dNTP effectors were used at a final concentration of 200 pM.
Exerpiemnts were carried out with following substrate/effector combinations: CDP/ATP,
CDP/TTP, GDP/TTP, UDP/ATP, ADP/dGTP, CDP alone, GDP alone, UDP alone, ADP alone,
TTP alone, ATP alone and dGTP alone. In all cases a2 and DOPA-132 were shot against each
other, where the substrate (if present) was in the same syringe as DOPA-32 and the effector (if
present) was in the same syringe as a2 to avoid consumption of pre-reduced a2 due to
background levels of wt 32 in the a2 preparations. Data was collected in split time-base mode,
where the first 500-1000 points were collected in the first 500-1000 ms and the remaining
500-3000 time points were collected over additional 0.5-12 s. Time courses shown are the
average of at least 6 individual traces. Each trace consumed -70 gL of sample from each syringe.
Prior to the experiment, the lines were washed extensively with water, followed by buffer, and
the instrument blanked from 290 nm to 600 nm in assay buffer. Curve fitting was performed
with OriginPro or KaleidaGraph Software.
Reconstruction of the DOPAo-132 UV-vis spectrum. For point-by-point analysis of
the DOPA*-32 UV-vis spectrum, a2 and TTP in one syringe were mixed in a 1:1 ratio with
DOPA-32 and GDP from another syringe to yield final concentrations of 17 [tM, 1 mM, 17 p.M
and 200 pM. The kinetics were monitored between 300 and 380 nm in 5 nm intervals. At each X,
3-4 traces were averaged and the resulting averaged amplitude was corrected for the absorption
change associated with Y122* (using the published F between 300 and 380 nm) and plotted
against ,.29,30
Monitoring reactions of DOPA-Pj2 by EPR spectroscopy. The reaction was carried
out in an Eppendorf tube and contained in a volume of 250 jgL: 20-30 p.M pre-reduced a2 and
DOPA-12, 1 mM CDP and 3 mM ATP in assay buffer. Pre-reduced u2 and effector were
mixed with DOPA-P2 and substrate. At a defined time point, the contents of the tube were
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transferred to an EPR tube. The reaction was hand-quenched in liquid N2 and the EPR spectrum
recorded as described above.
Experiments were also carried out with the substrate effector combinations of UDP/ATP,
GDP/TTP, ADP/dGTP, CDP/dATP (with various dATP concentrations), CDP alone, GDP alone
and TTP alone. Substrate was always at a final concentration of 1 mM. ATP was always at 3
mM, whereas TTP and dGTP were at 200 ,pM. The concentration of dATP was 5 pM or 1 mM.
The final concentrations of nucleotides are listed in figure legends. In all cases, ax2 and effector
(if present) were mixed with DOPA-P2 and substrate (if present).
Spin quantitation was performed using Cun standard as described above. Deconvolution
of the signals observed in these experiments was performed using an Excel program written by
Dr. John Robblee. This program converts the magnetic field values (G) to g values using Eq.
2-8, where h is Planck's constant, v is the resonance wavelength, P is the Bohr magneton and Bo
is the applied magnetic field. This program further allows variation in the amount of Y122•
subtracted, which is judged visually by comparing the overlap of the standard Y122* spectrum
with the observed spectrum in the low field region, where there is no overlap with the DOPA*
signal. The ratio of these signals was assessed by comparing the double integral intensity of
each trace as described above. Spectral subtractions were performed using the Y1229 spectrum of
DOPA-P2 as reference.
g = hv / Bo (2-8)
Simulation of DOPA*-02 EPR spectra with different substrate/effector pairs were carried
out using SimFonia software (Bruker). For all simulations, a Lorentzian/Gaussian ratio of 0.3
was used. For DOPA*-02 spectra in the presence of GDP/TTP and ADP/dGTP, g values
measured by Prof. Marina Bennati at 180 GHz were used. In addition hyperfine couplings from
two 1=1/2 nuclei were varied to yield the best fit to experimental data. For simulation of
DOPA*-02 with CDP/ATP and UDP/ATP, g values were varied along with hyperfine
interactions from two nuclei with 1=1/2.
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Generation of DOPA* and catechol*. DOPA amino acid (Sigma, catalog # D9628) and
catechol (Sigma, catalog # C9510) were dissolved in water to a concentration of 10 mM and the
pH of the solution adjusted to 7. Each sample was transferred to an EPR tube and the contents
sparged with Ar(g) for 10-15 min. The tube was then capped under Ar pressure and immediately
frozen by immersing into liquid N2. Each tube was irradiated with a 1000 W xenon lamp at 77 K
in a liquid N2 finger dewar for 45 s.31,32 The EPR spectrum was then recorded, as described
above, immediately after irradiation.
Generation of apo DOPA-32 with lithium 8-hydroxyquinoline-6-sulfonate. Apo
DOPA-02 was generated using the previously published method of Atkin et al. with minor
modifications.33  Briefly, a solution of 1.5 mL of DOPA-P2 (-10 mg, 77 jgM) was dialyzed
against 400 mL of chelator solution consisiting of 1 M imidazole, 30 mM NH2OH, 50 mM
8-hydroxyquinoline-6-sulfonate (pH 7.0) in a 3 mL-Slide-a-lyzer cassette for 3 h. The
chelator was then removed by dialysis against Hepes buffer (50 mM Hepes, 5 % glycerol, pH
7.6) for 3 h and further by desalting on a Sephadex G-25 column (1.5 x 23, 40 mL), which had
been equilibrated in Hepes buffer.
Reconstitution of apo DOPA-32. The apo protein was concentrated to 60-80 jgM using
a YM-30 centriprep device, transferred to a 25 mL pear-shaped flask, degassed on a Schlenk
line as described above and brought into the anaerobic chamber, where it was reconstituted: A
5-fold molar excess of Fe(NH4)2(SO4)2 (as measured by the ferrozine assay) was added to the
mixture, which was incubated at 4'C in the anaerobic chamber for 5-10 min. Then, the mixture
was taken out of the anaerobic chamber mixed with 0 2-saturated Hepes buffer (3.5-fold excess
02), which was generated by sparging Hepes buffer with 02(g) for 10-15 min at 40 C. Finally, 15
min after addition of 02, sodium ascorbate was added to a final concentration of 10 mM and the
protein was desalted on a Sephadex G-25 column (1.5 x 23, 40 mL), which had been
equilibrated in assay buffer, to remove excess iron.
Preparation of high-field EPR and PELDOR samples. Pre-reduced a2 and
DOPA-02 were combined in equimolar ratio and concentrated at 40C in a minicon concentration
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device (YM-30 membrane) to a final complex concentration of 200-300 jiM (6280 nm (a2+DOPA-J32)
= 320 mM-lcm-1). The concentrated sample was divided into 100 gL aliquots and placed in 1.5
mL Eppendorf tubes, flash-frozen in liquid N2 and shipped on dry ice along with
substrate/effector and glycerol-containing buffer solutions to Prof. Marina Bennati at the
University of Frankfurt (Germany). High-field EPR and PELDOR samples were prepared by
Prof. Marina Bennati by thawing each aliquot on ice and adding 5 [tL of a substrate/effector mix
to yield final concentrations of 2.5 mM substrate (CDP, UDP, ADP or GDP), 6 mM effector
ATP or 0.3 mM effector dNTP (dGTP or TTP). The reaction was allowed to proceed for 30 sec,
at which point 15 gL of glycerol buffer (100 mM Hepes, 30 mM MgSO 4, 2 mM EDTA, 50 %
glycerol, pH 7.6) was added to yield a final glycerol concentration of -6 %. The reaction was
quenched after a total reaction time of 60-90 sec by hand-freezing in liquid N2. High-field (180
GHz) EPR and X-band PELDOR spectra were recorded and analyzed by Prof. Marina Bennati.
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RESULTS
Synthesis of DOPA-22mer. Synthesis of the 22mer peptide containing DOPA was
performed in two steps (Figure 2-1). In the first step, the first 19 residues (H2N-
L19VGQID14S13EVDTDDLSNFQL,-COOH) were made on an automated peptide synthesizer,
where residues S 13 and D14 were incorporated as a pseudo-proline dipeptide, as previously
described. 15 After completion of the Fmoc-19mer synthesis, a small amount of peptide was
cleaved from the resin and its purity and molecular weight assessed by RP-HPLC and MALDI-
TOF MS, respectively. A typical Fmoc-19mer MALDI-TOF mass spectrum and RP-HPLC
elution profile are presented in Figure 2-4. The HPLC elution profile shows peptide migration
with a Rt of 24 min with >90 % purity. The mass spectrum performed under negative mode
shows major peaks at 2351.3 and 2367.1, corresponding to [M-2H+Na]- (exp 2353) and
[M-2H+K]- (exp 2367), respectively. The minor peaks with m/z of 2388.9 and 2403.9 are
related to the [M-3H+Na+K]- (exp 2389) and the [M-3H+2K]- (exp 2405) species.
In the second step of DOPA-22mer synthesis, the remaining three residues, DOPA20, S21
and C22, were attached manually. The catechol functionality of DOPA contained the acid-labile
acetonide protecing group (Figure 2-5). The thiol moiety of C contained a thiol-labile, but acid
and base stable, t-Buthio protecting group. In addition, C was coupled in its pre-activated
pentafluorophenol form (Figure 2-5), obviating the need for a base in the coupling reaction.
Purification of DOPA-22mer was carried out at pH 7.0 to minimize base-catalyzed oxidation of
DOPA. Figure 2-6 presents the characterization of pure DOPA-22mer peptide. A
representative HPLC elution profile, monitored at 215 and 280 nm, is shown in Figures 2-6A
and 2-6B. The profiles demonstrate that DOPA-22mer migrates with a Rt of 18.5 min and is
>95 % pure. The presence of the intact DOPA residue was confirmed by UV spectroscopy
(Figure 2-6C) and MALDI-TOF MS in the t-Buthio-protected (Figure 2-6D) and deprotected
(Figure 2-6E) forms. The UV spectrum of pure DOPA-22mer consists of a relatively narrow
absorption feature with a ),ax at 280 nm and , of -2500 M-lcm - 1 using the mass of lyophilized
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Figure 2-4. Characterization of Fmoc-19mer peptide. (A) Analytical RP-HPLC profile on a
Phenomenex Jupiter column (see Methods). (B) MALDI-TOF mass spectrum of Fmoc-19mer under
negative ionization mode. The peaks correspond to [M-2H+Na]- (exp 2351), [M-2H+Na]- (exp
2367), [M-3H+Na+K]- (exp 2389) and [M-3H+2K]- (exp 2405).
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Figure 2-5. Structures of Fmoc-DOPA(acetonide)-OH (left) and Fmoc-Cys(t-Buthio)-OPfp (right).
DOPA-22mer to calculate peptide concentration. These numbers are similar to those previously
determined for free DOPA amino acid (280 nm and 2760 M-lcm- 1, repectively). In addition,
MALDI-TOF MS in the negative ionization mode for the t-Buthio-protected variant consists of
two peaks at m/z 2585.1 and 2602.1, corresponding to the [M-2H+Na]- (exp 2586) and
[M-2H+K]- (exp 2602) forms, respectively. The spectrum in Figure 2-6E was taken prior to
ligation of DOPA-22mer to truncated, Mesna-activated 32 and contains one major peak with
m/z 2513.3, which corresponds to the [M-2H+K]- (exp 2514) form of the peptide. The
MALDI-TOF data shows that the DOPA probe is in tact after the synthetic procedures. As
described in the introduction, side reactions of DOPA would lead to
addition of water or other nucleophiles to the phenol ring, which would be detected in the mass
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Figure 2-6. Characterization of purified DOPA-22mer. RP-HPLC elution profile of DOPA-22mer
at 215 nm (A) and 280 nm (B) with Rt of 18.5 min. (C) The UV spectrum of DOPA-22mer contains a
single absorption feature with a Xk of 280 nm. (D) MALDI-TOF MS of t-Buthio-protected
DOPA-22mer. The peaks correspond to the Na÷ salt (exp 2586) and K+ salt (exp 2602) of the peptide.
(E) MALDI-TOF MS of free DOPA-22mer immediately before ligation to truncated f32. The single
peak is associated with the K' salt of the peptide (exp 2514).
spectrum. Together, the data in Figure 2-6 illustrate that DOPA-22mer was synthesized with
>95 % purity and that purification and deprotection procedures at neutral pH successfully
avoided side reactions that DOPA may undergo if the precautions above had not been made.
Generation of semisynthetic DOPA-032. Truncated, Mesna-activated 12 was prepared
as previously described. The yield of Mesna-activated 12 is dependent on the Mesna
concentration used to cleave truncated 12 from the 12-intein-CBD construct. With 60 mM
Mesna, -3 mg of truncated j2 per g of cell paste was obtained. Semisynthetic 12 obtained in
this fashion, encompasses a greater radical content (0.45 Y 122*/02) due to the propensity of
thiol-containing compounds to reduce the essential Y122*. At 100 mM Mesna, the yield of
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truncated 12 was increased to -5 mg/g cell paste with a radical content of 0.3 Y122*/P2. In the
present semisynthesis, a high Mesna concentration was used (100 mM) for the cleavage reaction
to obtain the large quantities of DOPA-P2 necessary for biophysical experiments.
After cleavage of truncated 12 from the chitin resin, the protein was exchanged into
neutral pH buffer and ligated to DOPA-22mer peptide under anaerobic conditions. An SDS gel
of the products of the ligation reaction is shown in Figure 2-7A, which reveals that the ligation
yield was -50 %. Presumably, the lower yield, relative to prior ligations, is due to the lower pH
of the reaction, chosen to safeguard the DOPA probe.
Incomplete ligation results in three products, truncated P2, heterodimeric DOPA-12 and
full-length homodimeric DOPA-02. These products can be separated on a MonoQ anion
exchange column due to the presence of six negative charges in the 22mer peptide. Reducing
conditions are employed during MonoQ chromatography to ensure that the cysteine resiudes,
used for the intein ligation reaction, do not form inter or intramolecular disulfide linkages. A
typical elution profile is shown in Figure 2-7B. The first peak, eluting at -300 mM NaC1,
contains truncated 12 homodimer; the second contains the DOPA-12 heterodimer, where one of
the monomers is truncated. Finally, the last peak, eluting at -380 mM NaC1 is the desired
full-length DOPA-12 homodimer. The purity of heterodimeric and homodimeric DOPA-32
was assessed on an SDS gel and demonstrates that each construct was prepared to >95 % purity
(Figure 2-7C).
DOPA-02 was then subjected to ESI-MS and analyzed for its Fe and radical content.
Low resolution ESI-MS under positive detection mode reveals two peaks at m/z [M+H]+ 43771
and 43949 (data not shown). The former represents DOPA-12 (exp 43776); the latter is an +176
Da adduct which has been observed in all 12 preparation that have been analyzed by ESI-MS. 15
The origin of this species is unknown. The UV-vis spectrum of DOPA-P2 shows that the Fe
center is intact, consistent with an Fe content of 3.2 per DOPA-02 as determined by the
ferrozine assay (data not shown). In addition, dropline quantitation of the UV-vis spectrum
shows that low amounts of Y1220, 0.28 per DOPA-12, are present (Figure 2-8A). This result is
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similar to spin quantitation obtained by EPR methods, which yield 0.3 Y122*/DOPA-32,
Importantly, however, the EPR spectral features of Y122*-DOPA-32 are similar to those reported
for wt P2 (Figure 2-8B). In addition, the stability of the Y122*-DOPA-02 is similar to that of wt
02. No loss of Y122* occurs upon storage of DOPA-02 at -800 C or after freeze-thaw cylces.
Together, the data above establish that DOPA-02 has been prepared in >95 % purity and that its
diferric Y122* center is intact, albeit at low Y122* concentrations. The EPR spectrum of this
radical reveals it is unperturbed by substitution of DOPA at residue 356.
Activty sssays of DOPA-02. First the effect of DOPA insertion on the a2/DOPA-32
interaction was considered. Climent et al. have shown that the C-terminal tail of 32 accounts
for most of the binding interaction between 02 and a2. However, assays with Y356F-02
indicated its interaction with a2 was similar to that between wt 32 and a2, demonstrating that
the a2/P2 interaction is tolerant to minimal structural changes at this position. Consequently, we
expected that replacement of residue 356 with DOPA would not significantly perturb the
interaction with a2. To test this hypothesis, we employed the assay used by Climent et al.26 In
this assay, the met form (reduced Y122 form) of the 32 variant of interest is used as a competitive
inhibitor of nucleotide reduction. First, the met form of DOPA-P2 was generated via
hydroxyurea treatment followed by desalting on a Sephadex G-25 column. The UV-vis
spectrum of DOPA-32 after incubation with hydroxyurea is shown in Figure 2-9A. The inset is
a blow-up of the features associated with the di-iron Y122 center. A comparison of Figure 2-8B
with Figure 2-9A reveals that hydroxyurea completely reduces the Y122* leaving the Fe center
intact. This form of DOPA-P2 was then added at increasing concentrations to the assay mixture
containing wt a2 and 32, and the activity subsequently examined. From this analysis, a Kd of
0.34 ± 0.05 pgM was determined. Thus, the KI between DOPA-P2/a2 is 1.5-fold higher than
that reported for by Climent et al. for the interaction between wt 32 and a2. Accordingly,
insertion of DOPA at residue 356 has a minimal effect on subunit interaction.
Next, we investigated whether DOPA-32 was competent in turnover. We suspected that
DOPA356 could be readily oxidized during radical propagation catalyzed by RNR. However, a
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DOPA radical (DOPA*) would be unlikely to oxidize Y731 in a2, thus preventing nucleotide
reduction. Consistent with this model, the spectrophotometric and radioactive assays with
DOPA-32 failed to reveal any turnover (Table 2-2). We therefore estimate that the specific
activity of DOPA-P2 is <1/10 4 that of wt P2 generated by the intein method.
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Figure 2-7. Generation of semisynthetic DOPA-32. (A) SDS gel of after ligation of DOPA-22mer
peptide to truncated, Mesna-activated 32. Lane 1, ligation mixture; lane 2, MW marker. (B) Mono Q
elution profile of the DOPA-02 ligation mixture. The peaks correspond to truncated homodimeric P2
(1), truncated/full-length heterodimer (2) and full-length DOPA-02 homodimer (3). (C) SDS gel
after MonoQ chromatography. Lane 1, pure DOPA-32 homodimer; lane 2, MW marker; lane 3; pure
DOPA-P2 heterodimer.
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Figure 2-8. Characterization of the Y122* in DOPA-32. (A) EPR spectrum of pure DOPA-P2. (B)
UV-vis spectrum showing the diiron Y122* features of DOPA-02.
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Table 2-2. Specific activities of wt 12, intein-wt 32 and DOPA-02 in nmol/min mg.
Assay wt p2a  Intein-wt 32 b DOPA-P2
Spectrometric 7600 + 250 490 ± 15 < 12c
Radioactive 4800 ± 100 450 ± 18 < 0.5c
a wt 32 contained 1.2 Y122*/dimer. b Intein-wt 12 contained 0.3 Y122*/dimer. c Lower limit of detection
by these assays.
Trapping of a DOPA3s56-02. After the extensive characterization of semisynthetic
DOPA-02 presented above, we sought direct evidence for the involvement of residue 356 in 32
during radical migration. First, stopped flow (SF) UV-vis experiments were carried out. In a
typical experiment, DOPA-12 and GDP in one syringe were rapidly mixed with pre-reduced a2
and effector TTP in a second syringe. The reaction was monitored at 305 nm, the reported X
of DOPA* (9 = 12,000 M-lcm-1), and at 410 nm, the X, of Y122* (E = 3700 M-lcm-1).8 1 8 As
shown in Figure 2-10, the Y122* (red) disappears, while a feature absorbing at 305 nm (blue),
grows in with similar kinetics. Analysis of the kinetic traces reveals a fast phase followed by a
slow phase, where each phase can be fit to a single exponential. The rate constants obtained
from the fits are 27 and 1.7 s- 1 at 305 nm and 36 and 1.6 s- 1 at 410 nm. The slower of the two
rate constants is similar to the rate constant determined for the conformational step that gates
radical initiation. Initial analysis shows that the reaction appears to be complete by 2 s and
remains unchanged for 30 s. At the endpoint, only 57 and 51 % of the total initial Y122* appears
to be trapped as determined at 305 nm and 410 nm, respectively.
Several controls were carried out to ensure that formation of the proposed DOPAo is
associated with the pathway for radical propagation. In one control, DOPA-02 was examined
alone (data not shown). In the second control, DOPA-02 and a2 were rapidly mixed in the
absence of substrate and effector and in the third control, met DOPA-P2 and substrate in one
syringe was mixed with pre-reduced a2 and effector from another syringe (Figure 2-11). No
spectral changes were observed in any of these cases.
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Figure 2-9. Binding of DOPA-32 to a2. (A) UV-vis spectrum of met DOPA-P2. The inset shows
a blow-up of the features related to the diferric Y122 center. (B) Complex formation between met
DOPA-02 and a2 as a function of free [met DOPA-02] (see Methods). The red line represents a fit
to the data (Eq. 2-4) yielding a Kd of 0.34 ± 0.05 jpM for the interaction between met DOPA-32 and
a2.
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Figure 2-10. Kinetics of DOPA356* formation and Y122* disappearance. DOPA-P2 (45 pM) and
GDP (2 mM) in one syringe were mixed in a 1:1 ratio with pre-reduced ax2 (45 pM) and TTP (200
pM) from another syringe monitoring DOPA* formation (blue, 305 nm) and Y122* loss (red, 410 nm).
A total of 7 traces were averaged at each X. Black lines describe biexponential fits to the data.
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To confirm the identity of the new radical, analysis of the UV-vis spectrum between 300
and 375 nm at 5 nm intervals was performed with DOPA-P2/a2 and the GDP/TTP pair. The
absorbance change after 2 s, corrected for the changes associated with Y 122*, was then plotted
against X revealing the spectrum in Figure 2-12. This spectrum shows a new species containing
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Figure 2-11. Control experiments for SF UV-vis reactions of DOPA-P2. (A) One syringe contained
pre-reduced o:2 (40 pM) and ATP (6 mM) and was mixed in a 1:1 ratio with met DOPA-f2 (40 p•M)
and CDP (2 mM) from another syringe. (B) Pre-reduced ax2 (40 giM) was mixed in a 1:1 ratio with
DOPA-02 (40 pM) from another syringe.
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Figure 2-12. UV-vis spectrum of DOPA356* using point-by-point spectral reconstruction.
DOPA-02 (40 pM) and GDP (2 mM) were mixed in a 1:1 ratio with pre-reduced ox2 (40 pM) and
TTP (200 pM). The absorbance was monitored in 5-10 nm intervals between 300 and 375 nm. At
each X, 3-4 traces were averaged and the absorbance change plotted against k after correction for
absorbance by Y122* in this region.
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a max at 315 nm and a shoulder at -350 nm. It is identical to the spectrum previously reported
for a DOPA*, as determined by pulse radiolysis, except that it is red-shifted by 10 nm,
suggesting an effect of the protein environment at the a2/DOPA-~32 interface.8
Kinetics of DOPA* with various substrate/effecotor pairs. To examine the generality
of the observations above, additional reactions were carried out with CDP/TTP, CDP/ATP,
UDP/ATP and ADP/dGTP (Figure 2-13). The kinetic parameters obtained from these reactions
are listed in Table 2-3. In all cases, triphasic kinetics was observed. As with the GDP/TTP
reaction, the rate constants determined at 410 and 305 nm were similar. Three main observations
are common to the five reactions with various substrate/effector pairs. First, a slow kinetic phase
that resembles the rate constant expected for the conformational trigger that gates radical
migration is observed in all reactions. This result indicates that DOPA-~32 is a conformational
probe, which allows direct observation of the physical step prior to radical initiation. Second, in
all cases, additional kinetic phases with faster rate constants than that expected for the rate-
limiting conformational change are observed. These additional phases highlight that DOPA is a
conformational probe reporting on different conformational states of the a2/DOPA-32 complex
that do not interconvert. And finally, in all cases 45-54 % of the total initial Y122* is trapped as a
DOPA.. The stoichiometry from these experiments will be discussed below in light of an
asymmetric interaction between a2 and P2.
Additional SF UV-vis experiments were carried out to examine the effect of substrate
(GDP, CDP, UDP, ADP) and effector (TTP, ATP, dGTP) individually. With CDP, GDP and
UDP, the kinetics are similar to those observed in the presence of the respective allosteric
effectors (Table 2-3). That is, in the presence of only CDP, GDP or UDP, the reaction extent
and rate constants are similar to those with CDP/ATP, GDP/TTP or UDP/ATP, respectively. In
the case of ADP, however, the absence of its allosteric effector, dGTP, results in a drastic drop in
the extent and rate of DOPA* formation (Figure 2-14). Only 18 % of total initial Y1220 is
trapped as a DOPA*, which occurs in single kinetic phase with a kobs of 0.12 s- 1. Intriguingly,
the changes at 305 nm and 410 nm in the first 150 ms of the time course are not correlated. At
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315 nm, an increase with a rate constant of 15 s- 1 is observed. At 410 nm, instead of a loss of
absorption, a rise with a rate constant of 33 s- 1 occurs. After this initial phase, the growth at 315
nm is kinetically linked to disappearance at 410 nm indicating formation of DOPA* concomitant
with disappearance of Y 122*. The unusual kinetics with ADP alone cannot be explained at this
point.
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Figure 2-13. Trapping of DOPA356* with different substrate/effector pairs. (A) DOPA-P2 (45 gIM)
and CDP (2 mM) were rapidly mixed in a 1:1 ratio with pre-reduced (X2 (45 tLM) and TTP (200 [iM).
(B) DOPA-12 (58 tM) and CDP (2 mM) were rapidly mixed in a 1:1 ratio with pre-reduced ax2 (58
gLM) and ATP (6 mM).
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Figure 2-14. Kinetics of DOPA356* formation and Y122* disappearance with ADP alone. DOPA-32
(28 pM) and ADP (2 mM) in one syringe were mixed in a 1:1 ratio with pre-reduced a2 (28 gM)
monitoring DOPA* formation (A) and Y122* disappearance (red). A total of 6 traces were averaged at
each X. The inset (bottom) shows a magnified view of the first 150 ms of the time course at 410 nm.
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DOPA* formation with effector alone is inefficient and slow, except in the presence
dGTP. With ATP alone and TTP alone a single, slow kinetic phase and reduced reaction extents
are observed (Table 2-3). With dGTP, however, 38 % of total initial Y122* forms a DOPA* in
Table 2-3. Kinetics of DOPA356*-p2/a2
combinations using SF UV-vis spectroscopy.
formation with various substrate/effector
1 st Phasea 2nd Phasea 3 rd Phasea
Substrate/ RNR kobs (S-1), Amp kobs (s-1), Amp kobs (s-1), Amp
Effector Subunits (%) (%) (%)
a2/GDP/TTP
DOPA-32
a2/GDP
DOPA-32
a2/TTP
DOPA-32
a2/CDP/ATP
DOPA-P2
a2/CDP/TTP
DOPA-02
a2/CDP DOPA-P2
a2/ATP
DOPA-02
a2/UDP/ATP
DOPA-P2
a2/UDP
DOPA-P2
ADP/dGTP
ADP
dGTP
a2/
DOPA-02
a2/
DOPA-A2
a2/
DOPA-32
32 ± 5, 31 ± 2
13 ± 3, 26 ± 2
0.4 ± 0.01, 14 + 1
38 1, 21 ± 1
43 ± 3, 22 ± 2
28 + 0.3, 9 ± 2
0.06 + 0.01, 29 ± 3
16 ± 0.3, 20 ± 2
16.4±0.5, 18 ± 2
46 ± 14, 26 ± 8
0.12 + 0.02, 18 + 1
1.1 ±0.3, 10 ± 1
1.7 + 0.1, 23 ± 1
0.8 + 0.1, 13 + 1
6.8 ± 0.1, 17 ± 1
4.2 ±0.6, 14 ± 1
6.8 + 0.6, 21 ± 0.3
5.0 0.5, 16 ± 3
4.3 + 0.3, 22 + 3
3.8 + 1.5, 15 ± 1
0.7 ± 0.1, 9 2
0.7 ±0.1, 10 ±0.4
0.5 +0.1, 11 2
0.6 ±0.1,9 ± 1
0.5 ± 0.1,9 ± 1
0.8 ±0.3, 10± 2
0.24 + 0.02, 28 ± 1
a2/
DOPA-P2
a2/metCDP/ATP a e - -DOPA-P2
a The rate constants reported are the average of those measured at 410 nm for Y122• loss and 305 or 315 nm for
DOPA356- formation. In case of DOPA* formation at 305 nm, an a of 8500 M-'cm'- was used (see Methods). b
Amp, amplitude; the amount of Y122* trapped as a DOPA* in each kinetic phase is indicated as a % of total initial
Y 122'.' No changes observed.
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biphasic fashion with kobs of 1.1 and 0.24 s-1. As in the ADP alone case, the kinetics at 315 nm
and 410 nm are decoupled in the first 150 ms of the time course (data not shown). A rise in
absorbance occurs at 315 nm and at 410 nm with kobs of 17 s-1 and 22 s-1, respectively. After
this phase, the changes at 315 nm are linked to those at 410 nm. The kinetics of DOPA*-02/a2
with ADP alone and dGTP alone require further studies.
Together, the kinetic experiments show that formation of DOPA* with GDP/TTP,
CDP/TTP, CDP/ATP, UDP/ATP and ADP/dGTP is kinetically competent and is linked to the
disappearance of Y122*. Further, DOPA* formation does not occur in DOPA-P2 alone or in the
DOPA-32/a2 complex without nucleotides and therefore requires substrate and/or effector. The
substrate, not the effector, appears to be the major determinant for gating of radical initiation,
though ADP is an exception to this trend. Further, studies with effector alone indicate that ATP
and TTP are inefficient in DOPA* formation. The cases of ADP alone and dGTP alone require
further examination, as an unusual decoupling of spectral changes at 315 nm and 410 nm are
observed. These observations may be indicative of formation of another intermediate species
that absorbs in this spectral region.
X-Band EPR characterization. To provide further evidence for formation of the
DOPA 356*, an experiment under similar conditions to those described above was carried out.
DOPA-P2 and GDP were mixed with a2 and TTP. After 5 s, the sample was hand-frozen in
liquid N2 and subsequently examined by 9.4 GHz EPR spectroscopy. The observed spectrum is
shown in Figure 2-15. Consistent with the SF UV-vis experiments, the spectrum is a composite
consisting of unreacted Y122* and a newly formed radical. Subtraction of 0.53 equiv of Y122*
gives rise to an isotropic spectrum that with a g value of 2.0045 and a line width of 14 G. These
parameters and the spectrum are highly suggestive of a DOPA*, which has previously been
reported (see below). 10 Importantly, in the absence of substrate/effector, no DOPA* was
observed confirming the results from SF UV-vis experiments (Figure 2-15, inset).
Power saturation studies are in agreement with the assignment of the new species as a
DOPA*. The power dependence of the spectral amplitude of the new radical is shown in Figure
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2-16 along with that of the Y12 2*. This analysis reveals a marked difference in the power
saturation profile of Y122* adjacent to the diiron center, and that of the putative DOPA356*. The
data was fit to Eq. 2-8, where K is a proportionality constant, b is the homogeneity parameter
and P1/2 is the microwave power at half saturation of the integrated EPR signal.34
Signal Amplitude =
K x (IP)
[1+(P/P 1/2)]0.5
xb
This analysis yields a P1/2 of 28 ± 4 mW for the Y12 2*, in decent agreement with previous
measurements of 47 ± 12.35 ,36 For the new signal, a P1/2 of 0.8 + 0.15 mW was obtained
indicating that this species is distant from the diferric cluster.
The EPR spectrum of a free DOPA amino acid radical in water at a variety of pH values
has been reported by several groups as a featureless, nearly isotropic spectrum.10,37,38,39 To
compare the spectrum of our new intermediate with that of an unblocked DOPA* in solution, an
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Figure 2-15. EPR spectrum of DOPA 356*-P2/a2 in the presence of GDP/TTP. DOPA-P2 and GDP
were mixed with pre-reduced a2 and TTP. After 5 s, the reaction was quenched by hand-freezing in
liquid N2. The observed spectrum (red) consists of 53 % Y122* (black) and 47 % DOPA356* (blue).
Inset: DOPA-f2 was reacted with pre-reduced a2 in the absence of substrate and effector. The
reaction was quenched by freezing in liquid N2 after 5 s.
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Figure 2-16. Microwave power dependence of Y122* and DOPA356*. The EPR spectrum of the Y122•
and DOPA356* were recorded as a function of microwave power and the integrated intensity of each
signal plotted against the square root of power. Black lines represent fits to the data using Eq. 2-8 and
yield P1/2 of 28 + 4 mW and 0.8 ± 0.15 mW for Y122* (red) and DOPA356* (blue), respectively.
anaerobic solution of DOPA amino acid was irradiated with a 1000 W xenon lamp at 77 K. The
EPR spectrum recorded immediately after irradiation is shown in Figure 2-17 and consists of a
gay of 2.0045 and is similar to previous reports. 40 The catechol radical was generated in similar
fashion (Figure 2-17B). Its EPR spectrum consists of a gay of 2.0048 and is also consistent with
previous findings. Comparison of the data in Figures 2-16 and 2-17 shows that each radical
consists of a similar gave value and is an isotropic singlet supporting the assignment of the new
feature as a DOPA356*. Nevertheless, the protein-bound DOPA356* has features that are distinct
from the unblocked DOPA* in solution.
For direct comparison with SF UV-vis experiments, we examined the generality of
DOPA* formation with various substrate/effector combinations by EPR spectroscopy. The EPR
spectrum of DOPA356*-02/ax2 in the presence of CDP/ATP is shown in Figure 2-18A.
Comparison of this spectrum with that in the presence of GDP/TTP reveals small, but distinct
changes in the line shape and line width. This may be more clearly discerned when the spectra
128
3300 3320 3340 3360 3380
Field (G)
3300 3320 3340 3360 3380
Field (G)
Figure 2-17. X-band EPR spectra of DOPA* (A) and catechol* (B) generated by anaerobic
photolysis at 77 K. The g values and line widths were 2.0045 and 14 G for DOPA. and 2.0048 with
line widths of - 15 G for the catechol*.
are overlaid (Figure 2-18B). Additional experiments have been carried out with UDP/ATP,
ADP/dGTP and CDP/dATP. These results are shown in Figure 2-19. Subtle differences in the
DOPA* line shapes and line widths may be discerned as a function of substrate/effector pairs.
The parameters of each of these spectra are summarized in Table 2-4. Interestingly with a high
dATP concentration (1 mM), which has been shown to completely inhibit dNDP formation, no
DOPA* was detected.
EPR experiments were also carried out in the presence of substrates only. The spectral
parameters from these experiments are summarized in Table 2-4. Interestingly, EPR spectra
with substrate alone resemble those recorded with substrate and effector (data not shown).
Therefore, the environment generated around DOPA356* appears to be predominantly controlled
by substrate binding. In addition, CDP, UDP and GDP alone suffice to generate similar amounts
of DOPA* as those observed with substrate and effector. In contrast, with ADP alone, 2.5-fold
less DOPA* is generated. These results are consistent with the SF UV-vis experiments
presented in Table 2-3. Note that the extents of DOPA* formation are more accurately measured
by SF UV-vis than by EPR methods, as freezing artifacts may occur in the latter case. The
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interference from these artifacts may be dependent on the substrate and/or effector present in the
a2 subunit.
98 2.
g value g value
Figure 2-18. EPR spectrum of DOPA356*-02/a2 in the presence of CDP/ATP. (A) DOPA-02 and
CDP were mixed with pre-reduced a2 and ATP. After 5 s, the reaction was quenched by
hand-freezing in liquid N2. The observed spectrum (red) consists of 52 % Y122o (black) and 48 %
DOPA356* (blue). (B) Comparison of the spectrum of DOPA356*-02/a2 with GDP/TTP (from Fig.
2-15) to that with the CDP/ATP pair.
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Figure 2-19. Comparison of DOPA356"*-2/a2 as a function of substrate/effector pairs.
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Additional information regarding the structure of the new radical may be obtained by
high-field EPR spectroscopy. This method has previously been used to delineate the structure
and reactivity of Y*s and semiquinones in various systems.41 For example, high field EPR has
been employed to identify hydrogen bonded Y*s in the small subunit of mouse and HSV1 RNRs
as well as the Yz* and YD* of photosystem 1.41 To gain additional insight into the properties of
the new DOPA356* and to facilitate simulation of the spectra in Figure 2-19, high field EPR
spectra of DOPA356* were recorded.
Table 2-4. Comparison of X-band EPR parameters and stoichiometry of DOPA356*
formation with substrate alone vs. substrate and effector.
Substrate/ Spectral % Y122* trapped as % Y122* trapped as
Effector g value width (G) DOPA* by EPR DOPA* by SF
GDP/TrP 2.0045 14 47 54
GDP 2.0045 14 48 39
CDP/ATP 2.0044 13 49 47
CDP 2.0044 13 48 41
UDP/ATP 2.0044 12 48 45
UDP 2.0044 12 47 49
ADP/dGTP 2.0045 13 40 51
ADP 2.0045 13 16 18
180 GHz EPR spectroscopy and simulation of DOPA3s6*. High-field EPR samples
require spin concentrations of -70-100 gM. Initially our efforts focused on increasing the
radical content of DOPA-32 using the method of Atkin et al.33 Apo DOPA-02 was successfully
generated using the 8-hydroxyquinoline-5-sulfonate chelation procedure, as judged by SDS
PAGE and UV-vis analysis (data not shown). However, in vitro reconstitution of apo
DOPA-02 with Fen and sodium ascorbate led to destruction of the DOPA probe indicating that
DOPA356 may participate in diferric Y122* assembly. The only other method to increase the
[DOPA*] for high field EPR experiments is to use high concentrations of the a2/DOPA-32
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complex. Previous studies have revealed that x2 has low solubility which decreases in the
presence of nucleotides. Therefore, our approach was to concentrate a2/DOPA-32 to levels
necessary for high field EPR measurements (-250 jiM) and then initiate DOPA* formation by
addition of nucleotides.
Accordingly, samples of DOPA* were prepared by first concentrating DOPA-P2 (0.3
Y122*/dimer) and (x2 in the absence of nucleotides to -230-280 jtM. The concentrated
DOPA-12/1u2 complex was then mixed with nucleotides, frozen in liquid N2 after 1-1.5 min and
its 180 GHz EPR spectrum recorded (Figure 2-20). The observed spectrum at 10 K (blue trace)
is a composite of the Y 122* and DOPA* signals. Due to differences in relaxation properties
between the DOPAo and the Y 122* (Figure 2-16), which is adjacent to the diiron center, only the
DOPA* is observed at 70 K (red trace). This analysis reveals g anisotropy in the DOPAo signal,
not apparent at X-band frequencies. Subtraction of 0.43 equiv of DOPA356* from the observed
spectrum at 10 K yields the previously reported high-field spectrum of Y122* (black trace).
Simulation of the 180 GHz spectrum of DOPAo, shown in Figure 2-21, yields a g matrix of
[2.00560, 2.00560, 2.00227].
The X-band EPR spectrum of chemically generated DOPAo has previously been studied
by Sealy and colleagues. 37 They showed that a ring proton and a P-methylene proton exhibited
hyperfine interactions of 3.58 G and 5.23 G, respectively. Using the g values obtained by high
field EPR and the hyperfine couplings, determined by Sealy and coworkers as benchmarks, we
attempted to simulate the X-band DOPA356* spectra with different substrate/effector pairs. The
spectra in Figure 2-19 were simulated by varying the hyperfine constants of only two 1=1/2
nuclei.
The simulation of DOPA356* in the presence of the four different substrate/effector pairs
are presented in Figure 2-22; the hyperfine coupling constants and principal g values are
summarized in Table 2-5. The 180 GHz EPR spectrum of DOPA356* shows that it contains
prolate axial symmetry about the unpaired electron. The g values obtained from the simulation
of the high-field spectrum (Figure 2-21) were close to those used in the simulation of X-band
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Figure 2-20. 180 GHz EPR spectrum of DOPA356*. The reaction contained 240 1pM DOPA-132/a2
complex, 2.5 mM GDP and 0.25 mM TTP in assay buffer with 6 % glycerol. The blue spectrum was
recorded at 10 K and is a composite of Y122o and DOPAo profiles. The red trace is the DOPAo
spectrum observed at 70 K. Subtraction of 0.43 equiv of DOPA* from the blue trace obtained at 10 K,
yields the Y122* signal (black trace).
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Figure 2-21. Simulation of 180
trace) with a g values of [2.00560,
K (blue trace).
6420 6425 6430
GHz EPR spectrum of DOPA356*. The simulated spectrum (red
2.00560, 2.00227] is overlaid on top of the observed DOPA* at 70
spectra for purine substrates. For pyrimidine substrates, however, only oblate axial symmetry
resulted in good simulations of the X-band EPR spectra. Further, the g values were significantly
different from those measured with GDP/TTP at 180 GHz (Table 2-5). Therefore, in the
absence of a 180 GHz spectrum and its correlating g values for each substrate/effector pair, the
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X-band simulations indicate, at a qualitative and quantitative level, that the environment and/or
conformation of the DOPA356* is dependent on the nucleotides bound in the active site of a2.
This constitutes a long-distance communication between the active site at a2 and the aX2/
DOPA-P2 interface.
X-Band PELDOR measurements. Recent results with the mechanism-based inhibitor
2'-azido-2'-deoxyuridine-5'-diphosphate (N3UDP), which upon reaction with a2/P2 gives rise
to a stable N-centered radical (No), have implicated asymmetry in the active RNR complex.42
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Figure 2-22. Simulation of X-band DOPA356* spectra. The experimental spectra (black) are from
Figure 2-19 for GDP/TTP (A), CDP/ATP (B), UDP/ATP (C) and ADP/dGTP (D). The simulation is
overlaid on top of each spectrum (red trace). The parameters used for these simulations are
summarized in Table 2-5.
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The results with DOPA-f2 are also consistent with an asymmetric interaction between a2 and
DOPA-[2. Explanation of the observation of asymmetry in DOPA356* formation requires an
understanding of the distribution of Y122* in DOPA-[2, and in 32 in general, which is an
unresolved issue for all class I RNRs. If a significant proportion of the DOPA-32 population
contains 2 Y122*/dimer, then after trapping of DOPA356*, the weak dipolar interaction between
Y122* from one protomer with DOPA356* from the other protomer may be detected by PELDOR
spectroscopy. In addition, the DOPA*-DOPA* interaction may also be detected, if it forms in a
large enough population in solution. Moreover, residue 356 lies within the disordered
C-terminal tail of 32 and is not visible in any structures of [2 that have been solved to date.
Therefore, no structural information is available in this region and PELDOR measurements
would provide the first distance and structural constraints regarding residue 356 at the
C-terminal tail of [2.
Table 2-5. Parameters used for simulation of DOPA3 56* spectra in Figure 2-22.
Substrate/
Effector g matrix [g, gy &g] 1Aso (G) 2Aso (G)
GDP/TTP 2.0052 2.0052 2.0032 4.1 6.25
CDP/ATP 2.0065 2.0037 2.0037 4.0 6.25
UDP/ATP 2.0065 2.0037 2.0037 4.1 5.50
ADP/dGTP 2.0052 2.0052 2.0032 4.0 6.00
To begin addressing some of these issues, PELDOR experiments were carried out with
DOPA-02/a2 and different substrate/effector pairs. DOPA-02 and a2 were first concentrated
to -280 gM. Then, DOPA* formation was initiated by addition of nucleotides. The sample was
supplemented with glycerol, frozen after 1 min and PELDOR measurements performed at 6 K
and 70 K for detection of dipolar coupling between Y*-DOPA* and DOPA*-DOPA*,
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respectively. PELDOR data acquisition and all data analysis including extraction of distance
information were performed by Marina Bennati. 43 The results are shown in Figure 2-23. In
PELDOR, two microwave frequencies must be applied to the sample. In the current case, one of
the MW pulses is at a frequency resonant with the Y122*, while the other is resonant with the
DOPA*. The position of these 'pump' and 'detect' frequencies is shown in Figure 2-23A on top
of the X-band absorption spectrum of the DOPA* with the GDP/TTP pair (black arrows). When
the DOPA*-DOPA* magnetic dipolar interaction was examined, frequencies indicated by the
blue arrows in Figure 2-23A were used. Note that the latter is carried out at 70 K, where the
Y122* signal is not observed owing to its faster relaxation time resulting from its vicinity to the
diiron center.
At 6 K, excitation of Y122* by the MW frequency causes a change in the dipolar field of
the DOPA* resulting in modulation of its spin-echo signal. This dipolar oscillation contains the
desired distance information and is shown for the GDP/TTP and CDP/ATP pairs in Figure
2-23B. This experiment has been carried out with all 4 substrate/effector pairs (data for
UDP/ATP and ADP/dGTP not shown). Analysis of the traces in Figure 2-23B and those for the
UDP/ATP and ADP/dGTP pairs shows that the distance between Y122* and DOPA356• is 30.6 ±
0.5 A for all four substrate/effector pairs. Importantly, when X-band PELDOR was performed
at 70 K, no oscillation was observed indicating that DOPA*-DOPA* pairs, if present, are below
the lower limit of detection by this method. This result shows that each complex generates only
a single DOPA*, eventhough a sufficient population of DOPA-32s harbor 2 Y122* per dimer.
Therefore, only one radical initiation event appears to occur in the complex. These results are
consistent with the SF UV-vis and EPR experiments described above, which show that only
-50 % of the original Y122* generates a DOPA356*.
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Figure 2-23. X-band PELDOR spectroscopy between Y122*-DOPA356* and DOPA356*-DOPA 356°.
(A) EPR absorption spectrum of DOPA*-j32/a2 with GDP/TTP. The observed spectrum (red trace) is
a composite of 0.43 equiv of DOPA356* (blue trace) and 0.57 equiv of unreacted Y122* (black trace).
Pump and detect microwave frequencies (u) used for PELDOR spectra are indicated by arrows. Note
that the detection u is at a higher field value than the perturbation or 'pump' u. Black arrows show the
positions of the frequencies used for Y122*-DOPA356* PELDOR. Blue arrows show frequencies used
for DOPA356*-DOPA356*. (B) Dipolar osciallation observed for Y122*-DOPA356* PELDOR with
GDP/TTP (top trace) and CDP/ATP (bottom trace). This analysis has been performed with all four
substrate/effector pairs. In all cases the distance extracted from fitting the data (red line) is 30.6 ± 0.5
A. (C) No dipolar oscillation is observed in DOPA356*-DOPA356* PELDOR. Spectrum '1' is the
average of 480 scans, spectrum '2' is the average of 1200 scans. The red line is a simple exponential
decay rather than an oscillatory function.
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DISCUSSION
DOPA as a probe for the radical initiation pathway. A major unresolved issue in the
class I RNRs involves the pathway and mechanism of radical propagation, the event that
transfers the oxidizing equivalent from Y122* in [2 to the active site in a2. The working
hypothesis in the field was put forth by Uhlin and Eklund based on in silico docking of the
individual crystal structures of a2 and [2 taking into account their shape and charge
complementarities. 44 This model imposed a distance of >35 A between the Y122* and C439 in a2,
which carries major implications for the mechanism of radical transfer. However, the model
does not exclude a major conformational change that would place Y122* near the active site in a2.
Initially, a large conformational change was dismissed based on the rigid, predominantly
a-helical structure of 32. 45 More recently, results from PELDOR spectroscopy and a
mechanism-based inhibitor, N3UDP, have provided experimental evidence which eliminates this
mechanistic option. Using PELDOR, a distance of 48 A was measured between the N-centered
radical (No) and the remaining Y122* in the second protomer of [2, consistent with the docking
model, which predicts a distance of 47-50 A (Figure 2-24).42 Accordingly, a pathway or
pathways must exist that transport the radical across the subunit interface.
Uhlin and Eklund, based on their docking model, proposed the pathway shown in Figure
2-2. The most intriguing residues in this pathway are Y356 in [2 and Y 730/Y 731 in a2 because
they are the only universally conserved residues, that are not involved in Y122* assembly or
active site chemistry. It has been proposed that they serve to shuttle the radical across the
subunit interface between Y122 and C439 in both directions. Residue Y356 plays an especially
important role in this putative pathway as it gaps the largest distance (25 A) and lies on the
disordered C-terminal tail of 32 rendering it invisible in any 32 structures solved to date. Its
involvement in radical initiation has previously been interrogated by site-directed mutagensis. It
was shown that Y356F-02 is completely inactive and that the mutation did not inversely affect
interaction with a2.26 Importantly, complementation studies demonstrated that it was essential
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for RNR function in vivo. Together, these studies show that Y356 plays an important in
catalysis.46
In this Chapter, an alternative approach was used to examine the function of Y356 in
radical propagation. Intein-mediated semisynthesis of the 32 subunit, recently developed by our
lab, was used to site-specfically replace residue 356 with the unnatural amino acid DOPA.'5
Due to its participation in melanogenesis, the chemical properties of DOPA have been examined
in detail. These studies show that the DOPA* has a reduction potential 260 mV lower that that of
y0.6 Thus, the DOPA* is more stable by 25 kJ/mol (6 kcal/mol). Further, the UV-vis and EPR
absorption profiles of a DOPA* have been reported.8' 37 The reaction kinetics of catechol, the
side chain of DOPA, with bimolecular redox-active compounds has also been examined and
compared to that of phenol. Steenken and Neta have demonstrated that a phenol radical oxidizes
ascorbate >2000-fold faster than a catecholo thereby providing direct evidence for the weak
oxidizing ability of the catechol*.47 The reaction of phenol and catechol* has also been studied
using hydroquinone, which is chemically and thermodynamically very similar to catechol, as an
analogue. These studies show that a phenoxyl radical irreversibly oxidizes hydroquinone with
diffusion limited kinetics, 2x109 M-is - 1. By inference, a catechol* cannot oxidize phenol in a
bimolecular reaction. Together, thermodynamic and kinetic experiments with catechol and
DOPA emphasize their ease of oxidation with moderate oxidants, the stability of their one
electron oxidized product, and show that reaction of a phenol radical with an analogue of
catechol leads to irreversible oxidation of the latter.
Semisynthesis and characterization of DOPA-132. Building on these model chemical
reactions, we reasoned that site-specific insertion of DOPA at residue 356 would lead to
reactions similar to those studied by Steenken and Neta. Accordingly, Y122* would generate a
DOPA*, which would be unable to oxidize Y730 in the ox2 subunit. Thus, radical transfer would
be halted at DOPA3 56* allowing for its detection by various methods, if residue 356 is in fact on
the radical migration pathway.
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Precautions were made to avoid side reactions of the DOPA probe during semisynthesis
of DOPA-P2. MALDI-TOF MS of the peptide immediately before ligation showed that DOPA
was intact (Figure 2-6). Based on the chemical reactivity of DOPA (Figure 2-3), three main
side reactions could have occurred after oxidation of DOPA: first, intramolecular Michael
addition with the N-terminal Cys; second, intermolecular Michael addition with the N-terminal
Cys residue of another peptide; finally, Michael addition by a hydroxyide anion. 12 The first
reaction would yield a modified peptide with a similar mass as unreacted DOPA-22mer.
However, this derivative of DOPA-22mer would not be competent in the ligation reaction. The
second and third side reactions would have resulted in peptide dimers and hydroxylated DOPA,
respectively, which were not detected in the MALDI-TOF spectrum. Thus, based on reactions
that DOPA has been shown to undergo, our results establish that DOPA-22mer was intact before
its ligation to the remainder of truncated 32.
DOPA-P2 was subsequently purified to homogeneity at neutral pH. Analysis of its
diiron Y122* center by Fe quantitation, UV-vis and EPR spectroscopic methods shows that the
diferric center is intact and that the Y122* content is low similar to previous semisynthetic 02s
(Figure 2-8). Importantly, however, the EPR spectrum of the Y122* of DOPA-P2 and the
DOPA-32/a2 complex is identical to that of recombinant wt P2. This is consistent with
previous results, which have failed to reveal changes in the properties of the Y122* upon binding
to a2 using EPR36 and resonance Raman spectroscopies.48 Therefore, insertion of DOPA and
the additional V35 3G/C354S mutations do not affect the EPR properties of the Y122* center.
Binding assays show that these mutations also do not affect the interaction with ca2
(Figure 2-9). A Kd of 0.34 ± 0.05 giM is similar to 0.2 pM previously determined for the wt
a2/42 interaction. 26 Activity assays failed to reveal formation of dNDPs (Table 2-2). The
aforementioned controls demonstrate that the absence of activity is not due to changes in the
Y122* or the interaction with the a2 subunits. It is therefore a direct result of interference by the
DOPA probe with the radical transfer event.
140
Trapping of DOPA35s*. Many investigators have sought direct evidence for
involvement of the Y122* in catalysis. However, pre-steady state experiments with wt and
numerous a2/02 variants by SF UV-vis, SF EPR or RFQ EPR spectroscopies, have never
revealed loss of Y1220.1'49 Therefore, the best evidence for participation of Y122* in catalysis
comes from correlation of activity with [Y122*]50 and from formation of active site nucleotide
radicals with mechanism-based inhibitors at the expense of the Y122'. 51 The inability to observe
changes in [Y122*] has been a major argument for the kinetic model of E. coli RNR, recently
proposed by our lab. The analysis of DOPA-32 above indicated that examination of its pre-
steady state reactions would be interesting. Indeed, SF UV-vis experiments, for the first time,
show disappearance of Y122* concomitant with appearance of a species absorbing at 305 nm.
Compelling evidence has been presented that the feature absorbing at 305 nm is a
DOPA356*. First, its formation requires Y122*, as reactions with met DOPA-02 failed to reveal
changes at 305 or 410 nm (Figure 2-11A). Second, point by point reconstruction of its UV-vis
spectrum reveals an absorption profile very similar to that previously reported for a DOPA*
(Figure 2-12). The 10 nm red shift of its max is an affect of the protein environment on the
electronic absorption properties of the DOPA* at the a2/DOPA-P2 interface. Third, EPR
analysis under similar conditions followed by subtraction of the Y122* yields a spectrum very
similar to that previously reported for a DOPA* (Figures 2-15 and 2-18). 10,37,38 And finally, the
power saturation profile of the EPR signal of the DOPA* shows that it is distant from the diferric
center. A P1/2 of 28 mW was determined for the Y122*, which is >30-fold greater than the P1/2 of
0.8 mW for the DOPA* (Figure 2-16). Interestingly, nucleotide radicals, which form with RNR
mechanism-based inhibitors, have a P1/2 of 0.16 mW, 5-fold lower than the P1/2 value of the
DOPA356*.35 Thus, the DOPA* may still preserve a weak magnetic interaction with the diiron
center. Together, the evidence above shows that with DOPA-P2, a DOPA* forms at the expense
of the Y1220. This represents direct evidence that residue 356 is redox active during radical
propagation.
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Several controls were performed to ensure that DOPA* formation is associated with the
pathway for hole migration (Figure 2-11). First, control experiments with met DOPA-02 by SF
UV-vis show that DOPA* formation requires the presence of Y122*. Second, no DOPA* is
observed with DOPA-02 alone or with DOPA-02/a2 in the absence of nucleotides, even though
solution measurements reveal it to be 25 kJ/mol more stable than a Y*. This conclusion is also
reached with EPR experiments, in which only the Y122 * is observed with DOPA-32 alone or
with DOPA-P2/a2 in the absence of nucleotides. And finally, DOPA* formation is kinectially
competent (see below). The requirements for substrate/effector and Y122* in DOPA* formation
implicate pathway dependence. Nevertheless, insertion of DOPA at another residue, which is
not involved in radical propagation, would represent a more direct control for pathway
dependence and has yet to be performed.
Asymmetry in DOPA* formation. Kinetic analyses of the SF traces show that DOPA*
formation occurs in a kinetically competent fashion. Reactions performed with five
substrate/effector pairs (GDP/TTP, CDP/ATP, CDP/ TTP, UDP/ATP, ADP/dGTP) show that
trapping of a DOPA* with kinetic competence and multiple kinetic phases is a general feature
(Table 2-3). Comparison of these reactions reveals three additional common features.
First, in all cases a slow rate constant is observed, which is characteristic for the rate
determining conformational change that has been proposed to precede radical propagation. Note
that this rate constant is 3-4 fold lower for intein wt P2, which carries the V353G/S 354C mutations,
than for wt 12.15 Thus, DOPA-P2 is a reporter on conformational changes and allows direct
observation of this conformational step.
Second, additional fast kinetic phases are observed, which have not been seen before.
These are reporting on further conformational equilibria, which eliminate a kinetic barrier and/or
affect the thermodynamics of the pathway so as to allow radical migration to commence. At the
same time, these fast kinetic phases may be related to a phenomenon previously observed with
the class II RNR from L. leichmanii. In this case, fast breaking and reforming of the C-Co bond
in the cofactor adenosylcobalamin (AdoCbl) was detected (by loss of 3H from labeled AdoCbl to
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solution); however, no cob(II)alamin was observed in SF UV-vis experiments. 52 Therefore, the
C-Co bond was rapidly breaking and reforming. In analogy, the fast physical changes may
relate to conformations, in which the unpaired electron is delocalized over other residues in the
pathway. In the wt complex, this conformation would lead to rapid reformation of Y122*, but in
the case of DOPA-02, it leads to irreversible generation of DOPA356* (Figure 2-25). It should
be noted that the idea that the unpaired electron of Y122* may delocalize over other residues in
the pathway has been proposed and tested before.53 However, steady state experiments failed to
reveal equilibration of the unpaired spin, presumably to due fast reverse radical migration to Y122.
Finally, in all SF experiments with various substrate/effector pairs, only 45-54 % of total
initial Y122* was trapped as DOPA356* (Table 2-4). Results from EPR experiments are in line
with this quantitation showing that 40-49 % of initial Y122* gives rise to a DOPA*. The
quantitation from these experiments appears to be indicative of asymmetry in the a2/02 complex
as only half of the available Y122* participates in the reaction. The source of asymmetry is
unclear at this point. It could originate from 32 or a2, or alternatively upon a2/02 complex
formation.
PELDOR studies with DOPA-02/a2 agree with quantitations above as they failed to
detect any DOPA*-DOPA* interaction; the only PELDOR interaction observed originated from
pairs of Y122*-DOPA356 * (Figure 2-26). Together, these results indicate that radical propagation
and DOPA* formation occurs only once per a2/DOPA-02 complex. Therefore, regardless of the
distribution of available Y122*, which is a major unresolved aspect of class I RNRs, there appears
to be an inherent asymmetry that allows radical migration along only one of the two
symmetrically related radical transfer pathways.
This complex asymmetry seems at odds with results from steady state and pre-steady
state experiments, which suggest that both active sites of the a2 subunit are active.28 However,
both models are reconciled when considering that the radical may cross from one subunit to the
next, as previously proposed, or, alternatively, that the second radical initiation event does not
require a slow physical step but occurs upon a signal from the first hole migration/active-site
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chemistry event. The former is feasible with 1 or 2 Y122*s / 02, whereas the latter would require
2 Y122*s / 32. The issue of asymmetry is examined further in Chapter 3 using heterodimeric
DOPA-P2, where one of the monomers lacks the last 22 residues and therefore cannot interact
with a2.
Environmental differences induced by NDP/(d)NTPs around DOPA*. There are also
differences in the kinetics of DOPA* formation with various substrate/effector pairs. The
amplitudes and rate constants are influenced by the nucleotide pair bound in the ca2 subunit. The
effects of different substrate/effector pairs on DOPA* formation are also seen in the distinct local
environments generated around the DOPA* (Figure 2-19 and Table 2-4). Two pieces of
information allow us to relate the changes in EPR parameters to variation in the dihedral angle
between the Cp-H bond and the xt system of the aromatic ring, which is perpendicular to the
plane of the ring. First, the reaction of DOPA-02/a2 with GDP/TTP was analyzed by EPR
spectroscopy at 180 GHz yielding the principal g tensors for DOPA356* (Figures 2-20 and 2-21).
These were used in X-band simulations with GDP/TTP and ADP/dGTP (Figure 2-22). With
the CDP/ATP and UDP/ATP pairs, however, the anisotropic g values were varied in the spectral
simulations because those determined with GDP/TTP did not give satisfactory fits (Table 2-5).
Better simulations may result with CDP/ATP and UDP/ATP if the principal g factors are
experimentally determined. Second, Felix and Sealy have demonstrated that the DOPA*
contains two major hyperfine couplings >1 G, which they assigned to one of the ring protons
(3-H) and one of the Cp protons. 37 This demonstrates that the EPR spectra may be simulated
using hyperfine coupling to two I=1/2 nuclei. Thus, the difference in the X-band EPR spectra
with various NDP/(d)NTPs may be simulated as arising from a slight change in the dihedral
angle of one of the two P-protons.
Using the McConnell relation (Eq. 2-9)54,55, where B is an empirical constant with a
value of -57 G, p is the electron spin density at the adjacent ring carbon (CI), and 0 is the
dihedral angle between the Cp-H bond and the it molecular orbital at C1, and assuming a Bp
value of 9.64 G, as previously used by Felix and Sealy,37 the differences in the P-proton
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hyperfine coupling constants result in dihedral angles of 550 (GDP and CDP), 570 (ADP) and
600 (UDP). These 0 angles are similar to that determined for DOPA* in solution (600); however,
they are somewhat speculative as the Bp value used by Felix and Sealy was determined on the
4-methylcatechol radical.
EPR analysis of various class I RNRs has previously demonstrated that the main
differences are hydrogen bonding patterns and P-proton dihedral angles. However, hyperfine
coupling constants from hydrogen bonds would be within the line width of the spectra in Figure
2-19 and require ENDOR spectroscopy for its detection. Therefore, our working model is that
long range communication between the active site in a2 and the subunit interface affects the
local environment of residue 356 leading to minor changes in the dihedral angle, 0. These
experiments also showcase the sensitivity of EPR to small environmental perturbations.
Aiso = Bp x cos2 0 (2-9)
Experiments with substrate alone and effector alone have begun to address the function
of each nucleotide in the gating of radical propagation. EPR experiments indicate that substrate
alone is competent in generating a local environment around DOPA356*, which is very similar to
that generated by substrate and effector (Table 2-4). Consistently, SF UV-vis experiments
show that this holds for the stoichiometry and kinetics of DOPA* formation in all cases except
with ADP/dGTP, where the effector is required for efficient trapping of a DOPA*.
ADP alone displays unusual kinetics in that the spectral changes at 315 nm are not linked
to those at 410 nm in the first 150 ms of the time course. Additional experiments are required to
delineate what these spectral changes are associated with. In contrast, dGTP alone leads to
efficient and rapid trapping of a DOPA*. This is in agreement with experiments from the L.
leichmannii class II RNR, where effector dGTP is sufficient for fast and efficient formation of
cob(II)alamin. With TTP and ATP alone, lower amounts of DOPA* form with slow
mono-exponential kinetics. Therefore, in general, substrate appears to provide the main binding
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determinants that trigger hole propagation. The experiments above show that DOPA-02 offers
an environmentally and conformationally senstitive probe, which indicates whether the complex
is in an active or an inactive state. It may be used to reinvestigate the issue of allosteric
regulation, which, in case of the E. coli RNR, has not been revisited since the initial model was
proposed by Reichard and coworkers almost 40 years ago.
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Figure 2-24. PELDOR studies with the mechanism-based inhibitor N3UDP. (Top) PELDOR has
been used to measure the distance between the two Y122*s and between an N*, generated with N3UDP
and the remaining Y*. These experiments yield distances of 33 A and 48 A, respectively, and are
consistent with the docking model. Temperature and field-dependent experiments show that the
N*-N* pair is not formed. (Bottom) The structure of N3UDP and the N* are shown. The diphosphate
moiety has been omitted for clarity.
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Figure 2-25. Delocalization of the unpaired spin on Y122* over residues of the radical transfer
pathway. (A) The equilibration is not observed in wt oz2/02 due to fast reverse radical transfer to
Y122*, where the radical is stable. (B) With DOPA-f2, this equilibration is observed because it leads
to irreversible formation of DOPA356*.
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Figure 2-26. PELDOR studies with DOPA-2/aI2. PELDOR experiments with all four
NDP/(d)NTP pairs show dipolar coupling between Y122*-DOPA356*, which are separated by 30.6 + 0.5
A. Importantly, no dipolar coupling is detected between DOPA356*-DOPA356* indicating that radical
migration occurs only across one of two radical transfer pathways under pre-steady state conditions in
the DOPA-12/ a2 complex.
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CHAPTER 3:
Reversible Radical Transfer and Asymmetric Complex Formation
with the Y356DOPA-32 Heterodimer of E. coli
Ribonucleotide Reductase
Adapted in part from: Seyedsayamdost, M. R.; Stubbe, J. J. Am. Chem. Soc. 2007, 129, 2226.
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INTRODUCTION
In the previous Chapter, DOPA-32 was semisynthesized and used to uncover several
aspects regarding the mechanism of radical initiation. Most notably, the results showed that
formation of DOPA* occurs only once per a2/DOPA-02 complex implicating an asymmetric
interaction between the two homodimeric subunits. This is inconsistent with to the docking
model, which depicts a symmetric interaction in the a2/P2 complex.1, 2 While there is ample
structural evidence for symmetry in each subunit,3,4,5 biochemical evidence for asymmetry has
been just as abundant, specifically from examination of mechanism-based inhibitors reacting
with RNR.6,7,8,9, 10 However, a model to explain the phenomena indicative of an asymmetric
interaction, which have appeared over several decades, has been missing.
The interaction between a2 and P2 has been studied before by Climent and Sj6berg, who
used a heterodimeric form of P2, PP', in which the P-monomer was full length and the
13'-monomer was proteolyzed and contained residues 1-345 (Figure 3-1)." They proposed a
two step binding in the interaction between a2 and 02. In the first step, the flexible C-terminal
tail of 02 was solely responsible for the interaction between a2 and 32. Accordingly, binding
between PP' and a2 occurred with a Kd similar to that between a peptide identical to the last 30
residues of P2 and a2.12 In 32, binding of the second protomer was proposed to be cooperative,
17-fold tighter relative to binding of the first protomer. Climent and Sjoberg proposed that this
cooperativity was mediated by the remainder of P2, that is, it was communicated across the 02
dimer interface. Consistent with these ideas, only one 30mer peptide was bound per a2.
In a separate study, Sj6berg et al. used the same pp' construct and showed that it was
inactive.' 3 Inconsistent with this observation, 33' was inhibited by N3CDP/ATP - this apparent
contradiction remained unexplained. Interestingly, however, in the reaction of P3P' with
N3CDP/ATP, -50 % of total initial Y122* was lost, whereas with 32, all initial Y122* was
consumed. The kinetics of Y122* loss was similar with 32 and PP'. Using global incorporation of
deuterated Tyr, 3,P3-D 2-Tyr, into the full-length protomer of PP', and protonated Tyr in the
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truncated protomer, Sj6berg et al. also showed that the Y122* does not redistribute within the 3'
and P monomers in the j3j3'/a2 complex in the presence of N3CDP/ATP (Figure 3-2, top), and
that the subunit lacking the C-terminal 30 residues was incompetent in triggering radical
migration. In addition, when p33' was isolated after reacting with a2 and N3CDP/ATP, and was
mixed with CDP/ATP in the presence of a2, no dCDP and no loss of Ye were observed. This
experiment showed that redistribution of Y122* also does not occur in the presence of CDP/ATP
(Figure 3-2, bottom).
The lack of observation of Y122* redistribution carries several caveats: First, migration of
the Y122* to the second protomer may require the C-terminal tail, specifically Y356;14 second, the
C-terminal tail may be involved in transmitting the signal for radical transfer across the dimer
interface.
The foregoing studies demonstrate that 303' is useful in examining the binding between a2
and P32. It would also be useful in studying the early events of radical migration, if it were active.
Our semisynthesis of P2 leads to three protein products: P'2, which consists of two truncated
protomers, 01', in which the n-monomer is full length and the P'-monomer contains residues
1-353, and j32, a full length homodimer (Figure 3-1).15 Thus, our 33' contains 8 more residues
on the f'-monomer than that previously examined.
In this Chapter, the issue of asymmetry, implicated by the results with DOPA-32, is
reinvestigated using heterodimeric DOPA-030'. This construct is a by-product of the ligation
reaction during semisynthesis of DOPA-432. The results show that DOPA-PP' maintains the
essential conformational changes for triggering radical migration and formation of a DOPA* in a
kinetically competent fashion. An asymmetric interaction is proposed between [32 and a2 to
explain the yields of DOPA* in DOPA-1[2 compared to those in DOPA-[3[3'. In addition,
evidence is obtained for reverse radical transfer from DOPA* to Y122 within DOPA-[3[3'0a2.
This is the first direct observation of reverse hole migration and provides further evidence for the
reversitble nature of the radical transfer pathway.
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Figure 3-1. Diagrammatic view of the P2 subunits discussed in this chapter. Shown are (A)
truncated homodimer, P'2, (B) full length-truncated heterodimer, j00', and (C) full length homodimer,
[2. Note that the truncated protomer used in this chapter contains residues 1-353. The truncated
protomer previously used by Sj6berg et al. contains residues 1-345.13
+ N3CDP/ATP
+ a2, CDP/ATP
Figure 3-2. Lack of Y122* redistribution observed within P3'. Selective growth of the full length
protomer with deuterated Tyr and the trunctated protomer with protonated Tyr followed by the
chelation/reconstitution procedure yields the PP' used in these studies. The experiments show that the
Y122* does not redistribute within pp' in the presence of a2 and N3CDP/ATP. Instead, disappearance
of only 3-D2-Y* is observed (top). After this reaction, P3', now containing P-H2-Y* and P-D2-YH
in the truncated and full length protomers, respectively, was isolated and reacted with a2 and
CDP/ATP (bottom). Radical migration and dCDP formation were not observed in this reaction.
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METHODS
Semisynthesis of DOPA-PP'. Solid phase peptide synthesis of Y-22mer and
DOPA-22mer, cleavage from the solid phase resin, peptide purification, removal of the t-buthio
protecting group, growth and expression of P2-intein-CBD and ligation to DOPA-22mer were
carried out as detailed in Chapter 2.
MonoQ purification of the ligation mixture. Preparative-scale purification of the
ligation mixture was carried out on a MonoQ HR 16/10 Anion Exchange Column (10 jtm, 2 x
10.5 cm, 33 mL - Amersham Bioscience) on a Sprint Biocad FPLC System (Applied
Biosystems) as described in detail in Chapter 2. The heterodimers 3p' and DOPA-PP' typically
elute at -320 mM NaC1. The desired products (p3' or DOPA-pp') were collected using a
fraction collector or by hand, concentrated to 70-350 jtM, flash-frozen in liquid N2 and stored at
-80'C. The concentration of pp' and DOPA-pp' were determined using 6280 nm = 131 mM-lcm - 1.
A column recovery of 80 % was typical. Usually, 2-2.5 mg of pure pp' and DOPA-pp' were
obtained per g of wet cell paste.
Analysis of the diiron Y122* center of DOPA-pp'. Fe content determination was
carried out by the ferrozine assay described in Chapter 2. Radical content is reported per
DOPA-•i'. The [Y122*] was determined using UV-vis and EPR spectroscopic methods as
described in detail in Chapter 2 using Eqs. 2-1, 2-2 and 2-3.
Interaction between DOPA-pp' and a2. Binding affinity of DOPA-p3' for a2 was
analyzed using the assumptions described in Chapter 2. Briefly, the Y 122* of DOPA-PP' was
reduced by incubating it (-80 gM) with 30 mM hydroxyurea at room temperature for 30 min,
followed by desalting on a Sephadex G-25 column (45 mL, 1.5 x 25 cm) equilibrated in assay
buffer (50 mM Hepes, 15 mM MgSO4, 1 mM EDTA, pH 7.6). This procedure generates the met
form of DOPA-pp', which was then used as an inhibitor of nucleotide reduction without further
modification. The assay mixture consisted of final concentrations of 0.15 gM a2 (2300
nmol/min mg), 0.3 gM wt 132 (7200 nmol/min mg), 50 jgM thioredoxin, 1 jM thioredoxin
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reductase, 1 mM CDP, 1.6 mM ATP, 0.2 mM NADPH and varying concentrations of
competitive inhibitor, met DOPA-P3'. Nucleotide reduction activity at each concentration of the
inhibitor was determined by monitoring the change in AA340 nm. The Kd was then determined as
described in Chapter 2 using Eqs. 2-4, 2-5 and 2-6.
Activity assays of 03|I' and DOPA-|30'. Spectrometric and radioactive RNR assays were
carried out as described in Chapter 2. The specific activity of [2-1 4C]-CDP was 8150 cpm/nmol,
Formation of DOPA*-pp' monitored by SF UV-vis spectroscopy. Pre-reduction of
a2 was carried out as described in Chapter 2. SF kinetics was performed on an Applied
Photophysics DX. 17MV instrument using PMT detection at 410 nm (max of Y122* with 8 =
3700 M-cm- 1) and at 315 nm (nax of DOPA*-3P13' with 8 = 12,000 M-cm-1) 16 or 305 nm (8 =
8,500 M-lcn - 1 - see Eq. 2-7). The temperature was maintained at 25'C with a Lauda RE106
circulating water bath. All experiments were performed in assay buffer (50 mM Hepes, 15 mM
MgSO 4, 1 mM EDTA, pH 7.6). Pre-reduced a2 and effector in one syringe were mixed with
DOPA-p3|' and substrate from another syringe in equal volumes to yield final concentrations of
24-30 ptM a2, 1 mM substrate, 24-30 gM DOPA-PP3' and 200 pM effector, respectively.
Effector ATP was used at a final concentration of 3 mM, dNTP effectors were used at a final
concentration of 200 LM. Experiments were carried out with CDP/ATP, GDP/TTP, UDP/ATP
and ADP/dGTP. Data acquisition and curve fitting was performed as in Chapter 2,
Reconstruction of the UV-vis spectrum of DOPA*-PP3'/a2 was carried out with CDP/ATP and
GDP/TTP. Data acquisition and analysis, including subtraction of the absorbance associated
with Y1220, was outlined in Chapter 2.
Formation of DOPA*.-P' monitored by EPR spectroscopy. The reaction was carried
out in an Eppendorf tube and contained in a volume of 250 pL: 25-30 R.M pre-reduced a2 and
DOPA-Pp3', 1 mM CDP and 3 mM ATP in assay buffer. Pre-reduced a2 and effector were
mixed with DOPA-P2 and substrate. At a defined time point, the contents of the eppendorf tube
were transferred to an EPR tube. The reaction was hand-quenched in liquid N2 and the EPR
spectrum recorded as described in Chapter 2. Experiments were also carried out with GDP/TTP,
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UDP/ATP, ADP/dGTP, CDP alone and GDP alone. Substrate was always at a final
concentration of 1 mM, whereas ATP, TTP and dGTP were at 3 mM, 200 pM and 200 pM,
respectively. Spin quantitation and deconvolution of the observed signals by spectral subtraction
were carried out as detailed in Chapter 2.
Kinetic simultaions. Kinetc simulations were carried out using KinSim, available free
of charge from the web (http://www.biochem.wustl.edu/cflab/message.html). In all simulations,
a rapid equilibrium for binding between a2 and P2 was assumed.
Rapid freeze-quench (RFQ) EPR spectroscopy. RFQ EPR samples were prepared
using an Update Instruments 1019 Syringe Ram Unit, a Model 715 Syringe Ram Controller and
a quenching bath, which consisted of a large outer stainless steel pot that contained a smaller -7
L liquid isopentane bath. The temperature of the liquid isopentane bath was controlled with a
Fluke 52 Dual Input Thermometer, equipped with an Anritsu Cu Thermocouple probe for the
isopentane bath and the funnel. The volume of reaction loops were determined by filling each
with water and determining the weight on a microbalance. Stainless steel packers were
purchased from McMaster-Carr and were cut to a length of 40 cm and deburred at the MIT
machine shop. A spray nozel with a diameter of 0.33 mm was used in all experiments. The
dead-time of the set-up was determined to be 16 + 2 ms with two independent measurements of
the Myoglobin/NaN 3 test reaction. A packing factor of 0.60 ± 0.05 was reproducibly obtained as
tested with wt 02 samples. Routinely, a ram push velocity of 1.25 or 1.6 cm/s was used and the
displacement was adjusted to expel 300 pL sample after the reaction.
Operation of the apparatus was similar to the procedure previously described. 17'18 Briefly,
the temperature of the isopentane bath was lowered to -135 to -140 0 C with liquid N2 in the
outer bath. One syringe contained 70 pM DOPA-P3' and 3.5 mM ADP in assay buffer and was
mixed with 70 pLM pre-reduced a2 and 0.5 mM dGTP in assay buffer from a second syringe.
When the temperature of the EPR tube-funnel assembly had equilibrated to the bath temperature,
the contents of each syringe were mixed rapidly in a mixing chamber and aged for a
pre-determined time period by traversing the contents through a reaction loop. The sample was
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sprayed into the EPR tube-funnel assembly which was held at a distance of 51 cm from the
spray nozzle. After the sample was squirted into the funnel, the assembly was immediately
returned to the bath and the crystals allowed to settle for 15-30 s. The sample was then packed
into the EPR tube using the stainless steel packers described above. After packing, excess
isopentane was removed with a Pasteur pipette and the EPR tube stored in liquid N2 until the
EPR spectrum was recorded. Acquisition of EPR spectra was carried as detailed in Chapter 2.
Preparation of high-field EPR and PELDOR samples. Pre-reduced a2 and
DOPA-02 were combined in equimolar ratio and concentrated at 4'C in a minicon concentration
device (YM-30 membrane) to a final complex concentration of 250-320 pM (82 80 nm (a2+DOPA-|')
= 320 mM-lcmr-). The concentrated sample was divided into 100 pL aliquots and placed in 1.5
mL Eppendorf tubes, flash-frozen in liquid N2 and shipped on dry ice along with
substrate/effector and glycerol-containing buffer solutions to Prof. Marina Bennati at the
University of Frankfurt (Germany). High-field EPR and PELDOR sample preparations were
performed by Prof. Marina Bennati as described in detail in Chapter 2. High-field (180 GHz)
EPR and X-band PELDOR spectra were recorded and analyzed by Prof. Marina Bennati.
Sequential-mix SF UV-vis spectroscopy. General procedures for performing SF
UV-vis spectroscopy experiments were described in Chapter 2. In sequential mix SF
experiments, one syringe contained 55 pM pre-reduced a2 and 150 pgM TTP and was mixed in a
1:1 ratio with 55 pM DOPA-P1' and 2 mM GDP. After an aging time of 5 s, the contents were
combined with hydroxyurea in assay buffer from a third syringe to yield final concentrations 19
pM Hetero-DOPA-P2/a2, 0.45 mM GDP, 61 ptM TTP and 1.5 or 75 mM hydroxyurea.
Absorbance at 315 nm was monitored, where the DOPA* has an 8 of 12,000 M- 1 cm-1.
Reduction of Y122* by hydroxyurea monitored by UV-vis spectorsocpy. UV-vis
spectra were acquired on a Cary 3 Spectrophotometer equipped with a circulating water bath.
The reaction was carried out at 25 'C and contained in a final volume of 300 pL: 10 pM wt 02 or
Y356F-P2 in assay buffer (50 mM Hepes, 15 mM MgSO 4, 1 mM EDTA, pH 7.6) and 10 mM HU.
After addition of HU, UV-vis spectra were acquired at defined time points. The [Y122*] was
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computed using the dropline procedure described in Chapter 2 and plotted against reaction time.
The decay rate constant was obtained by fitting the data to a mono-exponential decay function
using OriginPro software.
Increasing the radical content of DOPA-pP'. The procedure was carried out on 24 g of
wet cell paste, which was grown and expressed as described in Chapter 2. Cell lysis, CBD
column purification and removal of excess Mesna after elution from the CBD column were also
performed as described in Chapter 2. After removal of excess Mesna, the Mesna-activated,
truncated 02 was concentrated to 25 mg/mL in a centriprep protein concentration device with a
YM-30 membrane. The sample (6.5 mL, 25 mg/mL) was deoxygenated as described in Chapter
2, and transferred into the anaerobic chamber. Solid sodium dithionite (Na2S20 4) and methyl
viologen (MeV) were also brought into the anaerobic chamber, where a stock solution of each
was prepared in water to concentrations of 60 mM and 25 mM, respectively. 19 Mesna-activated,
truncated P2 was then supplemented with final concentrations of 7 mM Na2S20 4 and 30 PM
MeV. The solution was sky-blue as a result the reduced MeV chromophore. The mixture was
incubated for 1 h at 4'C in the anaerobic chamber. Then, the FeI chelator ferrozine was added to
a final concentration of 12 mM. Upon ferrozine addition, the sample turned deep purple. The
mixture was incubated in the anaerobic chamber for 15 min at room temperature. Then, it was
taken out of the anaerobic chamber and the (ferrozine)3Fe complex removed by Sephadex G-25
chromatography (2.5 x 40 cm, 200 mL) in cleavage buffer (50 mM Hepes, 500 mM NaCl, pH
7.6). The apo Mesna-activated, truncated 32 sample was concentrated to ~13 mg/mL, degassed
as outlined in Chapter 2 and transferred into the glove box. Reconstitution was carried out as
previously described with 5-fold excess Fe" and 3.5-fold excess 02 (see Chapter 2). After
reconstitution, excess Fe was removed by adding 8 mM sodium ascorbate to the sample,
incubation for 10 min at 40C, followed by desalting on a Sephadex G-25 column (2.5 x 40 cm,
200 mL) in cleavage buffer. The Mesna-activated 32 was then concentrated to -25 mg/mL
using a YM-30 centriprep device, deoxygenated as before and transferred into the glove box,
where ligation to DOPA-22mer peptide was carried out. The ligation reaction contained 3.5 mL
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of 27 mg/mL holo, Mesna-activated, truncated 32 (1.1 jimol, 1.5 rad/dimer) and 1.6 mM
DOPA-22mer peptide (6 pLmol) supplemented with 400 jiL of ligation buffer (1.5 M Hepes, 0.4
mM EDTA, pH 7.3). The mixture was incubated at 40 C in the anaerobic chamber for 40 h. It
was then taken out of the chamber, aliquoted, flash-frozen in liquid N2 and stored at -800 C.
Subsequently MonoQ purification was carried out as described in Chapter 2 to separate the
truncated homodimer from the DOPA-P3P' fraction.
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RESULTS
Purification and general characterization of DOPA-II'. The results from the
previous chapter suggest that the a2/f02 interaction is asymmetric, which makes specific
predictions that may be tested with DOPA-P3'. Semisynthesis of the 32 subunit results in
formation of a heterodimer as well as the full length and truncated homodimers. We examined
the activity of our intein wt heterodimer construct, P3', in which the 13'-monomer lacks the last
22 residues, and measured a specific activity -25 + 1 % that of the corresponding intein wt
homodimer, 02. Therefore, the additional residues present in our heterodimer construct, but
absent from the construct studied by Climent et al, appear to confer nucleotide reduction activity
in the presence of a2, substrate and effector. We therefore decided to investigate the steady state
and pre-steady state reactions of DOPA-P3' with a2, substrate and effector.
Due to incomplete ligation in the semisynthesis of DOPA-02, the yield of DOPA-P3' is
in fact greater than that of DOPA-02 (Chapter 2, Figure 2-7). The DOPA-P3' fraction was
purified from full length DOPA-52 and truncated P2 using Mono Q anion exchange
chromatography. SDS PAGE analysis of this product, shown in Figure 3-3, demonstrates that it
is >95 % pure and that it consists of a 1:1 ratio of truncated and full length P protomers.
Characterization of the diferric Y122* center in DOPA-PP' is presented in Figure 3-4.
The UV-vis absorption profile indicates that the diiron center is intact, consistent with an Fe
content determination of 3.4/DOPA-P3'. However, as with DOPA-02 and other intein 02
constructs, a low radical content of 0.33-0.37 Y122*/DOPA-PP' was obtained. The EPR
spectrum of this Y122*, shown in Figure 3-4, is identical to that of wt 32 generated by
recombinant methods. Therefore, truncation of the f'-monomer and insertion of DOPA at
residue 356 in the full length protomer in addition to the V353G/S354C mutations do not perturb
the EPR properties of the Y122" cofactor.
Interaction between DOPA-PP' and a2. Design of experiments with DOPA-PP'
requires knowledge of its interaction with the a2 subunit. The dissociation constant, KI, for the
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interaction between DOPA-PP' and a2 was determined using the method first reported by
Climent et al (Figure 3-5).11 In this method, the Y122* of DOPA-pp' is reduced by reaction with
hydroxyurea, and the resulting met DOPA-pp' is used as a competitive inhibitor of nucleotide
reduction, which is measured by the spectrophotometric assay using wt a2 and 32, as outlined in
Chapter 2 (Figure 2-9). Using this method, a Kd of 11 ± 2 ViM was determined for the
interaction between DOPA-pp' and a2, indicating that removal of the C-terminal 22 residues in
one protomer of the DOPA-32 dimer, reduces its affinity for a2 by a factor of -32 (Kd of
DOPA-02/a2 was 0.34 ± 0.05 jtM). This Kd is similar to the IK of 13 [LM measured by Climent
et al. for the interaction of their pp' (where [' contains residues 1-345) with C2.11
Formation of DOPA*-pp' monitored by SF UV-vis spectroscopy. Activity assays of
DOPA-P3' reveal no dCDP formation, similar to results with DOPA-02, using the spectrometric
and radioactive assays. Therefore, the specific activity of DOPA-pp' was <1/104 that of wt p2.
To examine the ability of DOPA-PP' to generate a DOPA*, SF UV-vis experiments were carried
out in which DOPA-pP' and CDP in one syringe was rapidly mixed with a2 and ATP from a
second syringe. The reaction was monitored at 305 nm (Qx of a DOPA*, E = 12000
M-cm-1),16 and at 410 nm (X.ax for Y122*, E = 3700 M-lcm-1).20 As shown in Figure 3-6, the
Y 122 * (red) disappears and the DOPA* (blue) grows in with similar kinetics. The data can be fit to
a single exponential with a kobs of 1 ± 0.2 s-1, which is similar to the rate constant for the slow
conformational change that gates radical propagation. Further, 24 ± 1 % of the total initial Y122*
is trapped as a DOPA3 56*. In contrast, in the absence of CDP and ATP no decay of Y122* and no
formation of a DOPA356* was observed indicating that in the DOPA-i'/aP 2 complex, CDP/ATP
are involved in the conformational event that triggers radical transfer (Figure 3-6B).
A number of differences were found between the results with DOPA-PP' and those with
DOPA-02. First, DOPA* formation with DOPA-02 was multi-phasic with kobsS of 38, 6.8 and
0.7 s-1', in contrast to a single exponential at 1 ± 0.2 s- for DOPA-00'.21 Second, in DOPA-P3',
the yield of DOPA* by SF UV-vis spectroscopy is 24 ± 1 % of total Y122o, whereas with the
homodimer, 47 % of total Y122* formed a DOPAo. The difference in kinetics between the two
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Figure 3-3. SDS PAGE Analysis of DOPA-P•'. The left lane contains a molecular weight marker;
the right lane contains 5 tg of DOPA-P3'. (A) Full length f-protomer containing residues 1-375
with DOPA at 356. (B) Truncated P'-protomer containing residues 1-353.
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Figure 3-4. Characterization of the diiron Y122* Of DOPA-Pp'. (A) UV-vis spectrum of DOPA-P•'.
The inset is a magnified view of the features associated with the cofactor. (B) EPR spectrum of
DOPA-Pp'. The radical and Fe contents were 0.33 and 3.4 per DOPA-Pp', respectively.
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Figure 3-5. Binding of DOPA-PP' to a2. (A) UV-vis spectrum of met DOPA-PP' after treatment
with hydroxyurea. The inset shows a close-up of the spectral region related to the diferric cluster. (B)
Measurement of the affinity of DOPA-PP' to a2 by using its met form as an inhibitor of nucleotide
reductase activity. The red line is a fit according to Eq. 2-4 and yields a IQ of 11 ± 2 [pM.
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Figure 3-6. Kinetics of DOPA3560-Pj' formation with a2, CDP and ATP. (A) DOPA-pp' (55 pM)
and CDP (2 mM) from one syringe were mixed in a 1:1 ratio with pre-reduced x2 (55 vpM) and ATP
(6 mM) from another syringe. Black lines indicate mono-exponential fits to each trace. Each time
course is the average of 7 individual traces. (B) Averaged time course after mixing DOPA-PP' (50
pM) with pre-reduced a2 (50 pM) in the absence of substrate/effector. The radical content in these
experiments was 0.33 per DOPA-p1'.
constructs suggests that deletion of the C-terminal tail in the p'-monomer reduces
conformational flexibility in the a2/DOPA-p3' complex, but can preserve the essential
conformational change gating radical transfer. The difference in the extent of DOPA* formation
is consistent with an asymmetric interaction between a2 and 132 and is discussed further below.
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To ensure that the species absorbing at 305 nm is in fact a DOPAo, point-by-point
analysis of the spectrum at the 5 s time point was carried out by SF spectroscopy. The result of
this reconstructed spectrum is shown in Figure 3-7 in the presence of CDP/ATP. The absorption
profile is very similar to that of DOPA*-P2 with a X. at 315 nm and a shoulder at 350 nm.21
Therefore, the subunit interface generated by the DOPA-PP3'a2 complex appears to be similar to
that generated by the DOPA-32/a2 complex.
Formation of DOPA*-pp' monitored by EPR spectroscopy. DOPA*-P3' was also
characterized by EPR spectroscopy. Pre-reduced a2 and ATP were mixed with DOPA-P3' and
CDP. The reaction was freeze-quenched by hand in liquid N2 after 5 s and its EPR spectrum
recorded. As shown in Figure 3-8, the observed spectrum is a composite of Y122* and DOPA356°.
Subtraction of the Y122* component, which constitutes 74 % of the total signal, yields the blue
spectrum in Figure 3-8, which is identical to the DOPA*-A2 spectrum, with a g value of 2.0044
and a line width of 13 G. Consistent with the SF UV-vis experiments, 26 % of the total initial
Y122* was trapped as a DOPA*. In the absence of CDP/ATP, only Y122* was observed again
underlining the involvement of substrate and effector in the essential conformational change
required for radical propagation (Figure 3-8B).
To ensure that the lower yield of DOPA* with DOPA-P3', relative to that with DOPA-P2,
is not a function of the lower affinity of the a2/DOPA-P3' complex, varying concentrations of
a2/DOPA-PP' were reacted with CDP/ATP, and the amount of DOPAo assessed by EPR. The
amount of initial DOPA-p13'a2 complex formed was varied between 18-60 % based on the IKd
of 11 ViM. If DOPA* formation is in fact determined by the amount of initial DOPA-P3'/a2
complex, then 4-15 % of initial Y122* should be trapped in these experiments. If, however, the
extent of DOPA* formation is a function of the asymmetric nature of the DOPA-P3'0a2 complex,
then similar amounts of DOPA* should be generated in these experiments, regardless of the
concentration of initial a2/DOPA-31' complex. Analysis of this set of experiments shows that
25-30 % of initial Y122* was trapped as a DOPA* indicating a similar yield independent of the
concentration of the initial DOPA-PP'/(a2 complex (Figure 3-9). These results suggest that
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Figure 3-7. Point-by-point Reconstruction of the UV-vis Spectrum of DOPA356*-PP' by SF
Spectroscopy. DOPA-3p' (60 pM) and CDP (2 mM) in one syringe were mixed in a 1:1 ratio with
pre-reduced a2 (60 pM) and ATP (6 mM) from another syringe. A total of 3-4 traces were averaged
at each wavelength. The absorbance change due to the Y122* in this region has been subtracted. The
radical content was 0.37 per DOPA-P3' in this experiment.
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Figure 3-8. EPR spectrum of DOPA356o*-P '/a2 with CDP/ATP. (A) DOPA-00' and CDP were
mixed with pre-reduced a2 and ATP to yield final concentrations of 25 pM, 1 mM, 25 pM and 3 mM,
respectively. The red trace is the observed spectrum after 5 s of reaction time and contains
contributions from Y122* and DOPA*. The spectrum was deconvoluted by subtracting the Y122•
component (green, 74 % of total spin) yielding the DOPA* spectrum (blue, 26 % of total spin) with a g
value of 2.0044 and a spectral width of 13 G. (B) EPR spectrum of DOPA-P3' alone (blue) and after
reaction of DOPA-P3P' with a2 (red) at final concentrations of 15 pM each. The radical content was
0.37 per DOPA-P3' in these experiments.
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equilibration of the DOPA-PP'/a2 complex is rapid relative to the conformational change, which
limits the rate of DOPA* formation. Thus, binding of ac2 to DOPA-Pp' is pulled to the right due
to irreversible DOPA* formation in the timescale of this experiment.
Kinetic simulations. To test this model, kinetic simulations using KinSim were carried
out. The outcome of these kinetic simulations is shown in Figure 3-10. The simulations capture
the trend of the experimental data, when rapid equilibration between a2 and DOPA-PP' was
modeled. Under these conditions, regardless of the starting concentration of a2 and DOPA-PP',
the extent of DOPA* formation was similar and its rate constant was approximated by that for
the rate-limiting physical step that triggers radical migration. The simulations presented here are
in excellent agreement with the experimental data. At DOPA-PP' and ca2 concentrations of 8
plM each, where 33 % of total DOPA-PP'/a2 is initially complexed, the simulations yield a kobs
of 0.9 s- 1 for DOPA* formation. The experimental data under these conditions show DOPA*
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Figure 3-9. DOPA356* formation as a function of initial [DOPA-00'/a2]. EPR spectra of DOPA* in
the presence of CDP/ATP at DOPA-001'/2 complex concentrations of 3 AiM (A), 5 PiM (B), 10 PiM
(C), 25 pM (D) and 40 pM (E); the yield of DOPA* was 25 %, 27 %, 26 %, 28 % and 30 %,
respectively.
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formation with a rate constants of 1.3 ± 0.2 s- 1 (data not shown). Similarly, at DOPA-j313' and
a2 concentrations of 25 gM, where 52 % of total DOPA-3PP'/a2 is initially complexed, the
simulations yield a kobs of 0.9 s- 1 for DOPA* formation. The experimental data under these
conditions give a rate constant of 1.0 ± 0.2 s- 1 (Figure 3-6). The data along with their simulation
highlight the importance of the rate-determining conformational change that controls the
kinetics of DOPA* formation as well as the importance of rapid and reversible binding between
a2 and DOPA-3|', which ensures that the extent of DOPA* formation is not limited by the weak
affinity between these subunits.
SF UV-vis analysis of DOPA* formation with other substrate/effector pairs. DOPA
has proven to be a conformational probe that allows an examination of the physical changes that
occur upon binding of substrate and/or effector. To characterize these conformational changes
with heterodimeric 32, we analyzed the reaction of DOPA-j3P' with a2 as a function of
substrate/effector pairs using SF UV-vis and EPR spectroscopies. These experiments also test
the generality of the observation of asymmetry in the a2/P32 complex.
The kinetics of DOPA* formation with various substrate/effector pairs is presented in
Figures 3-11 through 3-13 and Table 3-1. In case of CDP/ATP, DOPA* formation occurred
with mono-exponential kinetics and a kobs of 1.0 ± 0.2 s- 1, which is indicative of the slow
physical step prior to radical transfer (Figure 3-6). With the UDP/ATP pair (Figure 3-11), the
results mirror those with CDP/ATP: mono-exponential formation of DOPA* with a kobs Of 1.1 ±
0.1 s- 1. Furthermore, with CDP/ATP and UDP/ATP, 24 + 1 % and 28 + 2 % of the initial Y1220
was trapped as a DOPA*, respectively. With GDP/TTP (Figure 3-12), 33 % of the initial Y122°
is trapped as a DOPA* in a biphasic fashion, with rate constants of 6.1 s-5 (25 %) and 1.0 s- 1
(8 %). In contrast with the results from CDP/ATP and UDP/ATP, an additional conformational
change is detected. The ADP/dGTP pair displays the most unusual kinetics of DOPAo
generation among the four pairs tested (Figure 3-13). While with the other three
substrate/effector pairs, decay of the Y122* is directly correlated with formation of DOPA*, with
ADP/dGTP, there is no connection between these two events in the first 250 ms of the kinetic
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Figure 3-10. Kinetic Simulation of DOPA356* formation with DOPA-3'/7a2. Simulations were
carried out with initial DOPA-['/xa2 concentrations of 8 pM (A) and 25 pM (B), where 33 % and
52 % of total DOPA-Pp'/a2 has formed a complex, respectively. The simulation was performed
using the scheme above. A Kd Of 11 pM, fast equilibration, as well as a k2 of 1 s-' were used to model
the kinetics of DOPA* formation. The simulations yield rate constants of 0.9 s-' (A) and 1 s-' (B) for
DOPA* formation which agree well with experimentally determined rate constants of 1.3 s-' and 1 s-1,
respectively.
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Figure 3-11. Kinetics of DOPA356*-PP'/a2 formation with UDP/ATP. DOPA-13P' (55 pM) and
UDP (2.5 mM) in one syringe were mixed in a 1:1 ratio with pre-reduced a2 (55 pM) and ATP (6
mM) from another syringe. Black lines represent mono-exponential fits to the data with a kobs 1.1 s-1
A total of 6 traces were averaged at each wavelength.
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Figure 3-12. Kinetics of DOPA356.-*•P'/a2 formation with GDP/TTP. (A) DOPA-pP' (40 pM) and
GDP (2 mM) in one syringe were mixed in a 1:1 ratio with pre-reduced a2 (40 pM) and TTP (0.2
mM) from another syringe. Black lines are bi-exponential fits to the data with kobss of 6.1 and 1.0 s-1.
A total of 6 traces were averaged at each wavelength. (B) Point-by-point reconstruction of the
DOPA. UV-vis spectrum with GDP/TTP. Reaction conditions were identical to those in (A). At least
3 traces were averaged at each wavelength. The absorbance change associated with Y122* in this
spectral region has been subtracted. The radical content was 0.37 per DOPA-PP' in these experiments.
trace. DOPA* formation occurs in four distinct phases with rate constants of 146 s- 1 (12 % of
total AA 315 nm), 16 s- 1 (30 %), 2.2 s- 1 (27 %) and 0.13 s- 1 (32 %). At 410 nm, instead of decay of
the Y 122*, there is an initial biphasic burst with rate constants of 230 s- 1 (13 % of total AA410 nm)
and 17 s- 1 (34 %) followed by a slow decay of 0.12 s-1 (53 %).
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Figure 3-13. Kinetics of DOPA356*-PP'/a2 formation with ADP/dGTP. DOPA-PP' (55 pM) and
ADP (2.5 mM) in one syringe were mixed in a 1:1 ratio with pre-reduced a2 (55 pM) and dGTP (0.4
mM) from another syringe. (A) Observed time course monitoring formation of DOPA*. Insets show
kinetic fits to the data for the fast burst phase and the slow phase of DOPA* formation. (B) Observed
time course monitoring [Y122*]. Insets show kinetic fits to the data for the fast growth phase and the
slow decay phase. A total of 8 traces were averaged at each wavelength.
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The data at 410 nm show disappearance of 20 % of initial Y122* with a kobs of 0.12 s- 1.
This disappearance is kinetically linked to DOPAo formation which shows trapping of 14 % of
initial Y122* with a kobs of 0.13 s- 1. The fast kinetic phases for DOPAo formation, however, are
not linked to simultaneous fast disappearance of Y1220. Therefore, Y122* does not oxidize
DOPA356 in this fast kinetic segment, and a different moiety must be oxidizing DOPA to a
DOPA*. In an effort to identify this oxidizing agent,RFQ EPR experiments were carried out.
Table 3-1. Summary of kinetic parameters for DOPA356*-PP'/~a2 formation as a function of
substrate/effector pairs.
Substrate/ 1 Phasea  2 nd Phasea
Effector kobs (s-1), Amp (%)b kobs (s-1), Amp (%)b
None c
CDP/ATP 1 ± 0.2, 24 ± 1
GDP/TTP 6.1 + 1.2, 25 ± 1 1.0 ± 0.3, 8 ± 1
UDP/ATP 1.1 ± 0.1, 28 ± 2
ADP/dGTP 0.13 ± 0.01, 17 + 3d
a The rate constants reported are the average of those measured at 410 nm for Y122• loss and at 305 or 315 nm for
DOPAo formation. b Amp = amplitude; the amount of Y122- trapped in each kinetic phase is indicated as a % of
total initial Y122o- c No changes observed. d Note that the unusual kinetics with ADP/dGTP may be related to
high [ADP] used in this experiment.
RFQ EPR spectroscopy with ADP/dGTP. The kinetics with ADP/dGTP suggest that
DOPA* formation takes place prior to decay of Y122*. Similar results have been obtained before
with the mechanism-based inhibitor 2'-azido-2'-deoxyUDP (N3UDP), which, upon reaction
with a2/02 gives rise to a stable N-centered radical (No). Salowe et al. observed that
inactivation of RNR occurred prior to loss of Y122*.9 In this case, a tight non-covalent complex
was postulated to drive inhibition of RNR activity, followed by slow loss of Y122*. This proposal
has recently been confirmed using size exclusion chromatographic methods, which show tight
complex formation in the presence of N3UDP/ATP.22 In addition, Ekberg et al. observed a
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2-fold faster rate of No formation than Y122* loss during inhibition of D237E-P2/a2 activity with
N3CDP using flow EPR methods.23 This result is similar to the kinetics observed with
DOPA-PP'/a2 and ADP/dGTP in that an oxidant other than Y122* appears to be giving rise to the
new radical (No or DOPA*).
To investigate what this new oxidant may be, RFQ-EPR experiments were carried out
with DOPA-P3'/a2 and the ADP/dGTP pair. The experiment was carried out under identical
conditions as in Figure 3-13. The reaction was quenched at 111 ms, 214 ms and 324 ms, where
the SF UV-vis experiments indicated formation of DOPA* independent of Y122 ° loss (Figure
3-13B, inset), and the EPR spectrum subsequently recorded. The results are shown in Figure
3-14. Between 0 and 323 ms, only the Y122* is observed. No new signal is seen with wider
sweep widths (1000 G to 5000 G) or at lower temperatures (15 K, data not shown). Spin
quantitation indicates that no Y122o has been lost or gained at these short time points suggesting
that the increase at 410 nm is not associated with Y1220, but with another species. In addition, at
the end of the experiment, the contents of the two syringes were mixed, transferred to an EPR
tube and hand-quenched after 20 s. In this case an EPR composite spectrum consisting of
DOPAo and Y122* signals was observed, similar to those in Figure 3-8A, indicating that the
sample was competent in DOPA* formation on the second time scale.
The data from the SF UV-vis and RFQ-EPR experiments appear to be at odds, since
kinetics obtained from the former shows that at the 324 ms time point, DOPA* should have
formed. The RFQ-EPR studies, however, reveal no DOPAo. This apparent inconsistency may
be reconciled by considering that the fast spectral changes may not be related to changes in the
concentration of DOPA* or Y122*, i.e. the absorbance changes are not related to redox reactions.
Similar observations have previously been made with NO2Y-02 (Yee and Stubbe, unpublished
results). It is unclear what these absorption changes correspond to and additional experiments
are required to determine their relevance to radical initiation.
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Figure 3-14. RFQ EPR Spectroscopy with DOPA-P'/7a2 in the presence of ADP/dGTP. DOPA-
f3' and ADP were rapidly mixed with pre-reduced a2 and dGTP to give final concentrations of 35
pM DOPA-PP'/a2, 1.75 mM ADP and 0.25 mM dGTP. The reaction was quenched at the times
indicated and the EPR spectrum subsequently recorded at 77 K. Acquisition with wider sweep width
and lower T (15 K) revealed no additional features. The dead-time of the instrument (16 ms) has been
accounted for in the quench times above.
EPR analysis of DOPA* formation with other substrate/effector pairs. The SF
UV-vis data above show differences in the kinetics of DOPAo formation as a function of the
substrate/effector pair bound in the active site of a2. To examine whether the conformation of
the DOPA* in the a2/DOPA-PP' depends on the nucleotides in a2, as in the case of DOPA-02,
reactions with other substrate/effectors were monitored by EPR spectroscopy. The resulting
spectra at 9.4 GHz (X-band) are shown in Figure 3-15. As with DOPA-P2, small differences in
the line width and g value may be discerned as a function of the regulatory state of a2. These
parameters are summarized in Table 3-2 and are markedly similar to those determined with
DOPA-P2/a2 with the same substrate/effector pairs. Comparison of these spectra with those
obtained with DOPA-02/a2, shows that the substrate/effector pairs generate, by the criteria of
EPR spectroscopy, a DOPA* in an environment similar to that in DOPA-P2, despite the absence
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Figure 3-15. Comparison of DOPA 356*-fp'/a2 as a function of substrate/effector pairs. Spectra have
been normalized for number scans.
of a second C-terminal tail known to be responsible for subunit interactions (Figure 3-16, Table
3-2). This indicates that truncation in the P'-protomer does not abolish communication between
the x2 subunit and the P-protomer of DOPA-P•'. Thus, the C-terminal 22 residues missing
from the P'-protomer are not involved in radical migration or allosteric communication within
the a•/P pair, an observation that has important implications for the nature of the a2/P2 complex.
Further support for an asymmetric a2/P2 complex is obtained by comparing the extents
of DOPA* formation with DOPA-02 and DOPA-Pp'. These data are summarized in Table 3-3
for various substrate/effector pairs and show that with the former, 48 ± 4 % of total initial Y122*
is trapped as a DOPA*, whereas with the latter 27 ± 5 % of initial Y1 2 2* forms a DOPA*.
Therefore, DOPA-P2 forms more DOPA* by a factor of 1.8 ± 0.2. A model to explain these
results will be presented below.
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Comparison of X-band EPR parameters for DOPA356*-p2/a2 and DOPA356*-
P13'/Pa2 as a function of substrate/effector pairs.
Substrate/ DOPA-P2/a2 DOPA-|2/a2 DOPA-P|'l/a2 DOPA-|33'/a2
Effector g value Line width (G) g value Line width (G)
GDP/TTP 2.0045 14 2.0045 14
CDP/ATP 2.0044 13 2.0044 13
UDP/ATP 2.0044 12 2.0044 13
ADP/dGTP 2.0045 13 2.0045 13
Table 3-3. Comparison of the extent of DOPA356* formation with DOPA-02/a2 and
DOPA-03f3'/a2 as a function of substrate/effector pairs.
NDP/(d)NTP DOPA-j2/a2a DOPA-PP•/a2a
SF UV-vis
CDP/ATP 47 24
GDP/TTP 54 33
UDP/ATP 45 28
ADP/dGTP 51 20
EPR
CDP/ATP 49 28
GDP/TTP 47 35
UDP/ATP 48 25
ADP/dGTP 40 26
a The amount of Y122* trapped in SF UV-vis and EPR experiments is indicated as % of total initial Y122o.
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Table 3-2.
2.02 2.01 2 1.99 2.02 2.01 2 1.99
g value g value
2.02 2.01 2 1.99 2.02 2.01 2 1.99
g value g value
Figure 3-16. Comparison of the EPR spectrum of DOPA356* in DOPA-P2/a2 vs. DOPA-PP'/a2 as a
function of NDP/(d)NTP. DOPA*-f2/a2 (red traces) overlaid on top of DOPA.-PP'/a2 (blue traces)
in the presence of CDP/ATP (A), GDP/TTP (B), UDP/ATP (C) and ADP/dGTP (D).
PELDOR spectroscopy to determine the distance between DOPAo and Y122* in
DOPA-PP'/a2. PELDOR studies with DOPA-12 demonstrated that hole migration takes place
along only one of the two symmetrically related radical transfer pathways in the a2/I2 complex.
Trapping of a DOPA* during this process allowed the first distance constraints to be made for
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Figure 3-17. X-band PELDOR spectroscopy of Y122*-DOPA356* with DOPA-PP'/a2. (A) EPR
absorption spectrum of DOPA*-PP'/a2 with GDP/TTP. The observed spectrum (red trace) is a
composite of 0.26 equiv of DOPA356* (blue trace) and 0.73 equiv of unreacted Y122* (green trace).
Pump and detect microwave frequencies used for PELDOR spectra are indicated by arrows. Note that
the detection ) (blue arrow) is at a higher field than the perturbation or 'pump' u (green arrow). (B)
Dipolar oscillation observed for Y122*-DOPA356* with various NDP/(d)NTP pairs. In all cases the
distance extracted from fitting the data (red line) is 30.6 ± 0.5 A. The modulation amplitude, is a
function of the number of Y122o-DOPA* detected in the sample.
residue Y356, which is part of the conformationally flexible C-terminal tail and hence invisible in
all P2 structures solved to date. The distance measured between Y 122* and the DOPA*
diagonally across the dimer interface was 30.6 ± 0.5 A. Similar experiments were performed
with DOPA-p3' with all substrate/effector pairs and are presented in Figure 3-17. As with
DOPA-02, PELDOR measurements and data analysis with DOPA-pp' were performed by Prof.
Marina Bennati. 24,25 DOPA-P•'•l2 were mixed with various substrate/effector pairs at room
temperature to yield a final complex concentration of 0.28 mM. The sample was transferred to
an EPR tube and hand-quenched in liquid N2 after 45-60 s of reaction time. The X-band EPR
absorption spectrum for the CDP/ATP pair recorded at 6 K is shown in Figure 3-17A along with
'pump' and 'detect' frequencies used to excite the Y122* and detect the echo modulations from
the DOPA*-Pp'. The echo modulation as a function of substrate/effector pairs is shown in
Figure 3-17B along with the modulation amplitude, X, which is dependent on the number of
Y122*-DOPA* pairs in the sample. Simulation of this data indicates that, similar to DOPA-P2,
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the distance between Y1229-DOPA* is 30.6 ± 0.5 A, irrespective of the substrate/effector pair
bound in the a2 subunit. Therefore, truncation of the C-terminal 22 residues in the P'-protomer
does not affect the distance between DOPA* on the 1-protomer and the Y122* in the P'-monomer
of DOPA-P3'. The implications of this result will be discussed in the light of an asymmetric
a2/P2 model below.
The fate of DOPA.-P'/oa2. Having characterized the kinetics and stoichiometry of
DOPA* formation as well as elucidated subtle structural features of the DOPA* at the subunit
interface, its fate was examined next. Two aspects of the trapped DOPA*-PP' were investigated:
First, its accessibility to small molecules in solution, and, second, its stability within the
DOPA-PP'/a2 complex. It was hoped that these studies would begin to delineate factors that
stabilize a radical within the RNR complex as well as the reactions involved in its reduction.
Reaction of DOPA*-0'/la2 with hydroxyurea. We first examined the accessibility
and reactivity of DOPA356* with hydroxyurea (HU). The mechanism of HU-mediated inhibition
of RNR activity is not understood.26' 27 In solution, a 2 nd order kobs of 1.9x106 M- 1 S- 1 has been
determined for reduction of a pulse-generated Ye by HU.28 With RNRs, reaction with HU yields
different products based on the origin of 02. While HU reduces the Y122* in E. coli 12,27 in
mouse 12, it can reduce the Y* as well as the diferric center yielding 2 Fen per iron center; the
ferrous irons subsequently dissociate from the protein leaving behind apo-1P2. 29 The difference
in products is likely related to the distinct reduction potentials of the FemFe"l-FeLFem couples in
E. coli and mouse 12, which have been estimated at -0.2 V and +10-115 mV, respectively. 19,30
An important set of experiments has been carried out by Sjiberg and coworkers with E.
coli 12: When HU was reacted with 12 alone, a 2nd order kobs of 0.5 M- 1 s- 1 was determined.31
However, in the presence of a2, substrate and effector, i.e. in the regulatory state, HU-mediated
reduction was 8-fold faster. It is unclear whether this is due to an altered reactivity of the diiron
Y122* center, as indicated by results from Stankovich et al.,32 or whether HU can directly interact
with transient amino acid radicals during hole migration between a2 and 12. Studies by
Grlislund and Thelander on mouse 12 led them to favor the former model.33 Determination of
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Figure 3-18. Sequential-mix SF UV-vis spectroscopy monitoring reduction of DOPA3 56 * by HU.
DOPA-pf' and GDP in one syringe were rapidly mixed with pre-reduced a2 and TTP from another
syringe and the mixture aged for 5 s in an aging loop. The mixture was then combined with HU at
final concentrations of (A) 1.5 mM or (B) 75 mM. Insets in each plot show a magnified view of the
initial rapid absorbance changes. Tri-phasic decay of the DOPA* is observed in both cases; the rate
constants and amplitudes are summarized in Table 3-8.
HU-mediated reduction of the Y* with various pathway mutants yielded similar rate constants.
Thus, they suggested that reduction by HU did not require an intact radical transfer pathway.
However, their conclusion may not apply to E. coli P2 as the properties of its diferric Y122• are
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different from those in mouse 12. In addition, these experiments were carried out in the absence
of a2, substrate and effector.
DOPA-02 offers an ideal probe for examining the interaction of HU with the radical
transfer pathway at residue 356. To investigate whether HU can reduce DOPA356*, sequential
mix SF UV-vis experiments were carried out. In these experiments, DOPA-33' and GDP were
mixed with pre-reduced a2 and TTP and the mixture aged for 5 s, where DOPA*-00' formation
was complete but no decay had occurred, in an aging loop. After this period, the mixture was
rapidly mixed with HU to yield final concentrations of 1.5 mM or 75 mM. The results of these
experiments are presented in Figure 3-18. When DOPA-PP3'/a2 in complex with GDP/TTP is
combined with assay buffer containing no HU, no decay of DOPA* is observed (data not shown).
With 1.5 mM HU (Figure 3-18A), rapid decay of 95 % of the initially formed DOPA* is
observed, while with 75 mM HU (Figure 3-18B) the DOPA* is completely reduced. Rapid
disappearance of DOPA* in the presence of HU strongly suggests that it can directly access and
react with residue 356 in the radical transfer pathway.
The kinetics of HU-mediated DOPAo reduction relative to those with Y356• could be
informative. The caveat is that DOPA* is harder to reduce than Y356° (assuming the reduction
potential is not perturbed in the pathway) and that the [DOPAo] is at least -20-fold higher than
[Y 356*] during radical transfer. With 1.5 and 75 mM HU, the kinetic data can be fit to three
exponentials. The kinetic parameters are summarized in Table 3-4. With 1.5 mM HU, 77 % of
the total change occurs with an apparent 2nd order kobs of 14 M- 1 s- 1. Similary, with 75 mM HU,
78 % of the total reaction occurs with a kobs of 12 M- 1 s-1. Therefore, reduction of DOPA*
appears to be dominated by this kinetic phase (with kobs of -12-14 M-'s-l), which is not
saturated at 75 mM HU, as these rate constants are similar. At 1.5 mM HU, 15 % of the total
change occurs with a fast rate constant of 4940 M-is- 1; the remaining 7 % disappear with a kobs
of 84 M-'s - 1 (Table 3-4). With 75 mM HU, the remaining kinetic phases differ from those at
1.5 mM. In this case, 16 % of the total change occurs with a 2 nd order rate constant of 0.6 M-'s - 1,
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similar to that reported by Sjoberg for the reduction of Y 122'. 3 1 The remaining 7 % disappear at
550 M-i's- (Table 3-4).
The data above suggest that HU can interact with the radical transfer pathway. The fast
rate constant at both HU concentration, may represent direct reaction with DOPA*, whereas the
slow rate constants, and certainly the 0.6 M-is - 1 observed before, may be conformationally gated.
Accounting for the difference in reduction potentials between Y* and DOPA*, which by solution
measurements is 260 mV, the 2 nd order rate constants for reaction with Y356* would be 1.2 x 108
and 2 x 106 M-is - ' with 1.5 and 75 mM, respectively. The latter is in the range of rate constant
observed for reaction of HU with pulse-generated Yo in solution. This may be interpreted as
indicating that reaction of HU with Y356 during radical transfer is feasible.
Table 3-4. Summary of kinetic parameters in the reaction of DOPA356 -pp'1 with HU
obtained using sequential SF UV-vis spectroscopy.
1st Phasea 2 nd Phasea 3 rd Phasea[Hydroxyurea] kobs (M- 1 s-'), kobs (M - 1 S-), kobs (M - 1 S-l)
Amp (%)b Amp (%) Amp (%)b
0c
1.5 4940 + 300, 15 + 1 84 + 8, 7 + 1 14 + 1, 78 ± 1
75 550 ± 47, 7.0 ± 0.3 12 + 1, 77 + 1 0.63 + 0.01, 16 ± 1
a 2 nd order rate constants are reported. bAmp = amplitude; the amount of DOPA356* reduced in each kinetic phase
is indicated as a % of total initial DOPA356*. c No changes observed.
The disparate kinetics of DOPA* loss in the presence of different concentrations of
hydroxyurea has interesting implications for the interaction between HU and residue 356. With
DOPA-PP'/cx2 and GDP/TTP, 2 distinct, non-interconverting conformations result in DOPAo
formation. In the current experiment, tri-phasic reduction kinetics is observed indicting three
distinct conformations. The fact that one of these conformations is similar between the reactions
with 1.5 mM and 75 mM HU, whereas the other two are different, may indicate that HU itself is
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affecting the conformational flexibility in DOPA-PP'. This needs to be examined using a similar
reaction with DOPA-PP' and DOPA-02 at multiple [HU].
To assess whether an intact radical transfer pathway is required for reaction of HU with
Y122*, wt 02 and Y356F-P2 were reacted with HU and the reduction rate constant determined by
UV-vis spectroscopy using the dropline method. The results are shown in Figure 3-19 and yield
2nd order rate constants or 0.41 ± 0.02 M-'s - 1 and 0.47 ± 0.02 M-is - 1 for Y356F- and wt 02,
respectively. Thus, an intact pathway is not required, that is, HU does not reduce Y122* by
injecting reducing equivalents through the pathway used for radical propagation during turnover.
In conclusion, the working model that emerges from the experiments and analyses above
is that HU can react with DOPA356* and Y356* during radical transfer, though the rate constant
strongly depends on the [Y356*] during this process. The reaction of HU with Y122* does not
require Y356. The 8-fold increase that is observed in the regulatory state of RNR is likely due to
an altered accessibility and/or reactivity of Y122*. Nevertheless, the pathway radical at residue
356 is more exposed than Y122*, as demonstrated by the faster reduction kinetics with DOPA356*,
despite its lower reduction potential. During turnover with wt RNR, reaction of HU with Y356* is
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Figure 3-19. Kinetics of HU-mediated reduction of Y122* with wt and Y356F-02. The reaction
contained 10 jpM of (A) wt 32 (1.3 Y122*/dimer) or (B) Y356F-f2 (1.0 Y122*/dimer) and 1 mM HU in
assay buffer at 25 0C. Black lines represent mono-exponential fits to the data and yield 2nd order kobws
of 0.47 ± 0.02 M-1 s-1 (A) and 0.41 ± 0.02 M-' s- 1 (B).
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avoided by ensuring that a build-up does not occur. Additional experiments, specifically,
studies in the regulatory state with Y356F-12, or with ca2 pathway mutants are necessary to
further refine this model.
The fate of DOPA-PP43'/AI2 studied by EPR spectroscopy. The studies above
demonstrate that HU does interact with DOPA* suggesting that it is sufficiently exposed for
small molecules to gain access. To study the properties of DOPA356* further, its stability within
the complex with c2 was examined as a function of substrate/effector pairs. DOPA-PP' and
CDP were mixed with pre-reduced a2 and ATP. At defined time points, an aliquot was
removed from the reaction mixture, transferred to an EPR tube and freeze-quenched by hand in
liquid N2. Subsequently, the total spin and its distribution between Y 122* and DOPAo were
determined by EPR methods. Time-dependent EPR spectra of DOPA*-PP'/Ia2 generated by
incubation with CDP/ATP are shown in Figure 3-20. The DOPA* decays with a time constant,
T, of -7 min and a half-life, T1/ 2, of 4.8 min. At the 1 min time point, 24 % of the total radical is
present as DOPA* and 76 % as Y122*. By 8 min, -6 % DOPAo remains but the amount of Y 122°
unexpectedly increased by >10 %. This result was reproduced in a second similar experiment,
where an increase of -12 % in [Y122°] was observed. The experiment was repeated to determine
whether an increase in [Y122"] would occur with GDP/TTP. The result is summarized in Table
3-5 and shows that the DOPA* is more stable in the presence of GDP/TTP. An endpoint was
not reached in this experiment, that is loss of DOPA* may not be complete at the last time point
recorded. It is estimated that in the presence of a2 and GDP/TTP, the DOPA* decays with I >8.5
min and T1/2 >6 min. Importantly, the total spin lost in this experiment can all be accounted for
by loss of DOPA*. Therefore, in contrast to the CDP/ATP case, no increase in [Y122 0] is
observed. Finally, a similar experiment was performed with CDP alone revealing DOPA* decay
kinetics with I of 4.8 min and T1/2 of 3.4 min (Table 3-6). As with GDP/TTP, no increase in
[Y122°] was observed.
The data show that with the CDP/ATP pair, an increase in [Y1220] takes place at the
expense of DOPA*. The loss of DOPA* and increase in Y12 2* occur with similar kinetics
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0 2 4 6 8 10
Time (min)
[Spin] [Y122*] [DOPA*]
Time (min) (pM) % Y122* % DOPA* (pM) (pM)
0 11 100 11
0.08 10.8 73 27 7.8 2.9
1 10.3 76 24 7.8 2.5
2.5 10.4 82 18 8.5 1.9
5 9.5 89 11 8.5 1.0
8 9.2 95 5 8.7 0.5
Figure 3-20. Decay Kinetics of DOPA356 *-PP'/a2 with CDP/ATP. (A) DOPA-pP' and CDP were
mixed with pre-reduced a2 and ATP. At defined time points, an aliquot was removed, transferred to
an EPR tube and frozen in liquid N2. The quench times are 0 min (purple), 1 min (red), 2.5 min (blue),
5 min (green), 8 min (black). The 0.08 min spectrum is similar to that in Figure 3-8A and has been
omitted. (B) DOPA* decay kinetics can be fit to a mono-exponential function with a tr2 of 4.8 min.
(C) The total spin and its distribution between Y122* and DOPA* were determined by EPR quantitation
methods and are summarized in this table.
suggesting that a fraction of the DOPA* is able to re-oxidize Y122. However, because of the low
Y 1 22 " content of DOPA-pp', which is typical for all semisynthetic P2s made thus far, the
increase in [Y1220] observed, is close to the lower limit of detection that can be quantitated
(-0.5-1 pM). To increase the sensitivity of this experiment and obtain compelling evidence for
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re-oxidation of Y122 by DOPA*, a new method is required to enhance the radical content of
semisynthetic P2s.
Enhancing the radical content of DOPA-P3'. A number of different protocols were
attempted to increase the radical content of DOPA-P3'. The method of Atkin et al. was
attempted using the procedure described in Chapter 2. 34 However, as with DOPA-P2, the
chelation/reconstitution procedure leads to destruction of the DOPA probe. Therefore,
increasing the radical content of DOPA-PP' requires reconstitution of the Y122° on
Mesna-activated P2, prior to ligation to DOPA-22mer peptide. The procedure developed to
generate high radical content DOPA-P3' is shown in Figure 3-21. In this method,
Mesna-activated 32, generated by intein chemistry, is subjected to reductive chelation followed
by treatment with the ferroine chelator, ferrozine, to yield apo, Mesna-activated 12. This protein
is then reconstituted by the usual procedure generating Mesna-activated 12 with a high Y122*
content, which is then ligated to DOPA-22mer peptide at 40 C for 40 h. Incomplete ligation
results in homodimeric, truncated and full-length 32, and heterodimeric P2s, which are separated
by Mono Q anion exchange chromatography. The elution profile is shown in Figure 3-22A.
The UV-vis spectrum of DOPA-PP' generated in this fashion is shown in Figure 3-22B.
Dropline quantitation yields 1.2 Y1 22* per DOPA-Pp'. Using this method, 0.6-0.8 mg of pure
DOPA-PP' were isolated per g of wet cell paste. Note that the yields for DOPA-f2 containing a
radical content 1.2 Y 122 */dimer are much lower due hydrolysis of the Mesna-thioester which
occurs throughout the procedure above.
Oxidation of Y 122 by DOPA*. The experiments to examine the fate of the DOPA* were
repeated with DOPA-P3P' containing 1.2 Y 122* per dimer. The results are shown in Table 3-7 for
the CDP/ATP pair. At 0.5 min, 27 % of the total radical is present as DOPA*, and 73 % as Y122o,
By 10 min, <3 % DOPA* remains, but the amount of Y122* has increased by >14 % relative to
the 0.5 min signal. These results clearly indicate re-formation of Y1220 at the expense of the
DOPA*. Importantly, the increase in [Y122*] by >2.4 jiM, is well above the lower limit of
detection of 0.5-1 [tM by EPR methods. The experiment was replicated five times to determine
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the error associated with this measurement. From these studies, 36 ± 4 % of the initially formed
DOPA* is capable of reoxidizing Y122. The remaining 64 % is quenched by alternative
mechanisms.
To examine the generality of this observation, additional experiments were performed
with UDP/ATP (data not shown) and with DOPA-132 with CDP/ATP (Table 3-8) and CDP
alone (data not shown). While in all experiments DOPA* is observed, no increase in [Y1220]
occurred on quenching of DOPA*. Thus, the conformation of a2/DOPA-[133' in the presence of
CDP/ATP is unique relative to all other combinations of protein, substrate and effector tested.
Low diferric Ym
Mesna-activated,
truncated 32
High diferric Y122
3- Mesna-activated,
truncated 32
Diferrous Ym
a Mesna-activated,
truncated [32
I
Apo
q E, F Mesna-activated,
truncated 32
High diferric Y122
DOPA-33'
Figure 3-21. Summary of procedures used to generate DOPA-PP' with a radical content 1.2 Y122* per
heterodimer. (A) Expression of 32-intein-CBD and purification by chitin chromatography yields
truncated 02 with low Y122* content. (B) Transthioesterification with Mesna followed by desalting on
a Sephadex G-25 column. (C) Anaerobic reduction of the diiron Y122* center with Na2S20 4 and
methyl viologen. (D) Removal of diferrous iron with ferrozine followed by Sephadex G-25
chromatography to generate apo, Mesna-activated truncated 02. (E) Reconstitution of the diferric
Y122* cofactor with anaerobic addition of Fen followed by addition of 02 yields Mesna-activated,
truncated 32 with a high Y122* content. (F) Removal of adventitiously-bound ferric iron by incubation
with sodium ascorbate, followed by desalting on a Sephadex G-25 column. (G) Anaerobic ligation to
DOPA-22mer peptide. (H) Removal of excess peptide and MonoQ chromatography (see Figure
3-22A) gives DOPA-00' with a Y1220 content similar to wt 02 prepared by recombinant expression.
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High diferric Ym*
DOPA-[2 / DOPA-33'
and DOPA-0'2
A, B02(1-353)-Intein-CBD a
Table 3-5. Determination of [DOPA*] and [Y122*] in the reaction
a2/TTP on the minute time scale.
of DOPA-PP'/GDP with
[Spin] [Y122*] [DOPA.]
Time (min)a (IM)b % Y122"c  % DOPA*e (atM) (FIM)
1 10.1 65 35 6.6 3.5
3 9.4 71 29 6.7 2.7
4.5 9.5 71 29 6.7 2.8
6.5 8.6 77 23 6.7 2.0
9 8.3 82 19 6.8 1.6
aReaction time. bEPR spin quantitation was performed using Cun as standard. cSpectral point-by-point subtractions
were performed using Y122*-DOPA-03' as reference. The % of Y122* and DOPA* out of total spin at each time point
is shown.
Table 3-6. Determination of [DOPA*] and [Y1220] in the reaction of DOPA-PP'/CDP with a2
on the minute time scale.
Time [Spin] [Y1220] [DOPA.]
(min)a (tM)b % Y122.' % DOPA*c  (WIM) (tM)
0 9.1 100 9.1
1 9.3 73 27 6.8 2.5
2.5 8.6 78 22 6.7 2.0
4 7.8 87 13 6.8 1.0
5.5 7.5 89 11 6.7 0.8
7 7.1 96 4 6.8 0.3
9.5 6.9 100 6.9 0
aReaction time. bEPR spin quantitation was performed using Cu" as standard. CSpectral point-by-point subtractions
were performed using Y122*-DOPA-013Y as reference. The % of Y122- and DOPA* out of total spin at each time point
is shown.
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Figure 3-22. Purification of DOPA-PP' with 1.2 Y12 2* per heterodimer. (A) MonoQ elution profile
of the ligation mixture of DOPA-22mer peptide with high radical content, Mesna-activated 32. The
lengthy procedure required for chelation and reconstitution of the diferric Y122* results in major
hydrolysis of the Mesna-activated thioester complex and thus low ligation yields: (1) P'2, (2) DOPA-
pp' and (3) DOPA-02. (B) UV-vis spectrum of DOPA-PP' with 1.2 Y122* / heterodimer. The inset is
a magnified view of the spectral region related to the diferric Y122* center.
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Table 3-7. Determination of [DOPA*] and [Y122*] in the reaction of DOPA-pp'/CDP with
a2/ATP on the minute time scale. In this experiment DOPA-PP' contained 1.2 Y122*/dimer.
Time [Spin] [Y122*] [DOPA*]
(min)a (PLM)b % Y 12 2*c % DOPA*c  (PIM) (plM)
0 22.3 100 22.3
0.08 22.0 72 28 15.8 6.2
0.5 21.8 73 27 15.9 5.9
2 19.8 83 17 16.4 3.4
5 19.6 87 12 17.1 2.3
10 18.8 > 97 < 3 > 18.2 < 0.5
aReaction time. bEPR spin quantitation was performed using Cun as standard. cSpectral point-by-point subtractions
were performed using Y122*-DOPA-P3 ' as reference. The % of Y122* and DOPA* out of total spin at each time point
is shown.
Table 3-8. Determination of [DOPA*] and [Y1220] in the reaction of DOPA-p2/CDP with
a2/ATP on the minute time scale.
Time [Spin] [Y1220] [DOPAo]
(min)a (ttM)b % Y 1220c % DOPAOc (iM) (iM)
0 7.8 100 7.8
5 sec 7.7 52 48 4 3.7
2.5 7.4 55 45 4.1 3.5
10 4.8 86 15 4.1 0.7
aReaction time. bEPR spin quantitation was performed using Cun as standard. cSpectral point-by-point subtractions
were performed using Y122*-DOPA-13 ' as reference. The % of Y122- and DOPA* out of total spin at each time point
is shown.
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DISCUSSION
The results presented in this chapter have important implications for the initial events that
occur in nucleotide reduction. A model is presented below, which attempts to incorporate these
along with previous results with mechanims-based inhibitors, and structural and mechanistic
studies.
An asymmetric model for a2/32 interaction. The model proposed based on current
RNR knowledge is shown in Figure 3-23. First, the features of the model will be described, then
the evidence for each step will be elaborated and evaluated using available data below.
In the first step of the model (Kd, Figure 3-23), there is an initial asymmetric interaction
between a2 and 02, such that two complexes are formed: one in which the Y122* is in the active
ap pair (Etive), and one in which there is no Y 122* in the active ap pair (Eiactive). After complex
formation, radical initiation results in C439* formation (kc) in Eactive. This thiyl radical initiates
nucleotide reduction to yield dCDP (kn). A step involved in this chemistry, perhaps disulfide
formation, results in hole propagation from C439* in one active site into the adjacent C439 (kx).
This second radical transfer step does not require a slow conformational change, but occurs
rapidly. In addition, an event involved in this chemistry, perhaps release of dCDP, results in
interconversion of complex Einactive into an active complex (kint). This interconversion is fast
relative to the conformational change that precedes radical transfer. Conversion of CDP into
product in the second a active site results in a disulfide. Upon reverse radical propagation (kr),
the subunits dissociate and ca2 must be re-reduced before another catalytic cycle can take place.
This model has three main features: First, the initial interaction in the a2/P2 complex is
asymmetric (see below for a definition) leading to hole propagation along only one of two
radical transfer pathways, which in the structural model of Uhlin and Eklund are related by
C2-symmetry.1 Second, dCDP production is cooperative, that is, after formation of the first
dCDP, a signal allows rapid generation of the second dCDP and a slow conformational trigger,
which was required for the first radical transfer event, is not necessary. 14 And finally, different
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conformational states of a2/I2 are in equilibrium and rapidly interconverting under turnover
conditions, but not with mutants that do not form deoxynucleotides (see below).21
Evidence for the model will be presented below and it will be evaluated using data
obtained from studies of different steps in the nucleotide reduction process. These studies
include benzophenone-maleimide-labeled P2, mechanism-based inhibitors, such as 2'-azido-
2'-deoxyUDP (N3UDP), 2',2'-difluoro-CDP (F2CDP) and 2'-fluoromethylene-CDP (FM-CDP),
semisynthetic P2 variants, and pre-steady state experiments monitoring dCDP formation with wt
RNR in the first turnover. Each of these approaches interferes with different steps of the radical
initiation event and provides snapshots at different stages of this process. Y356C-Bpa-P2
(Bpa356-[2) is incompetent in turnover and allows investigation of the initial binding mode to a2.
DOPA-P2 and DOPA-PP' pass the initial binding step but block formation of a thiyl radical in
a2 by trapping an intermediate on the pathway. With suicide inhibitors binding of a2 to P2 and
radical generation are not perturbed, however, intermediates in the nucleotide reduction process
partition in unexpected ways and deoxynucleotides are not formed. Finally, in pre-steady state
experiments, binding, radical initiation and active site chemistry are not perturbed. However,
turnover may be rapidly quenched before onset of the steady state.
Sources of asymmetry in the ao2/12 complex. A main feature of the model is that the
initial interaction between a2 and 12 is asymmetric. There are several sources of asymmetry in
RNR and before discussing the model in Figure 3-23, it is important to define what is meant by
'asymmetry' in the current context. Here, asymmetry is defined as a complex, in which the
interaction between one ap pair is different from that between the other ap pair. That is, the two
ap pairs within the complex are not related by C2-symmetry, unlike the picture described by the
docking model. Asymmetry may also be provided by the distribution of Y122* Or by the missing
C-terminal tail in 12 (Figure 3-24). However, in the discussion that follows, it is not referring
to these types of asymmetry, but to the lack of symmetry between the two ap pairs in the ca2/P2
complex. Recently, Uppsten et al. were able to crystallize the a2/02 complex of S. typhimurium
with an unusual oligomeric state and solve the structure to 4 A resolution.35 The structure that
192
has emerged is a good presentation of our definition of asymmetry. It shows that the interaction
between one ap pair in the complex is different from that of the other ap pair. In this structure,
one ap pair appears to be ready to engage in radical transfer, it is structurally similar to the
model of Uhlin and Eklund. The other ap pair, however, is not interacting at all. Consequently,
the distance between the Yo and C* in one ap pair is 44 A, in the other, however, it is >60 A
(Figure 3-25).
Eactive
DIC % ,
-Y E'C
kr
CDP
kn dCDP
Einactivek.
dCDP C
CDP
Figure 3-23. Asymmetric model for RNR turnover. The asymmetry shown here is generated upon
complex formation (Kd) in the a2 subunit. The square monomeric units are inactive, as a result of an
asymmetric interaction, the circle monomeric units are active. Therefore, after complex formation,
only half of total Y122* participates in radical migration (k). Subsequent to formation of the first
dCDP (kn), a signal acitavates the second subunit, allowing for thiyl radical generation (kx) and
another turnover of CDP. The inactive complex from the initial interaction also equilibrates into an
active form. The complex can catalyze a maximum of two nucleotide reduction events before the
active site cystines must be re-reduced (kr), which is, at least, partially rate limiting in the steady state.
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Figure 3-24. Sources of asymmetry in E. coli RNR. Asymmetry may be generated by distribution of
the Y122* cofactor (A), by removal of the C-terminal tail (B), or by an asymmetric interaction that
renders one of the monomeric units inactive (C). Note that in our model, (C) occurs upon ca2/P2
complex formation as shown in Figure 3-23.
Figure 3-25. Diagram of the asymmetric a2/12 complex structure from S. typhimurium determined
by Uppsten et al at 4 A resolution. The distances shown were determined in Pymol (pdb code 2BQ1)
from the phenolic oxygen atom of Y105 (E. coli equiv of Y122) to the sulfur atom of C388 (E.coli equiv
C439).
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Y 1 22* distribution and aggregation state. Before discussing and evaluating the features
of the model, two important issues need to be addressed. The distribution of Y12 2*s and the
aggregation state of the a2/32 complex as a function of concentration and nucleotides are two
major unresolved issues in all class I RNRs. For the discussion below, we will assume a 1:1
complex of a2/p2, regardless of the initial subunit concentrations, and a random distribution of
Y122*S within P2. These are further elaborated below in this section.
Three different scenarios regarding the Y122* distribution are possible. Sj6berg and
colleagues have previously assumed a "one or none" Y122*/P2 scenario, that is each P2 contains
either one Y122 */dimer or none.13 The maximal Y122* content is 1/32. This distribution was
assumed because their wt 32 preparation routinely yielded one Y122*/dimer. Mutants that had a
lower radical content were thought to contain a certain population that carried zero Y122*s/dimer.
While this simplifies analysis of biochemical experiments, it does not explain the normal
stoichiometry of -1.2 Y122*/32 obtained as expression and purification methods have been
optimized over the years. It also is inconsistent with recent PELDOR results, which detect the
weak dipolar coupling between two Y122*s in P2.24 Quantitative PELDOR analysis, would be the
ideal method for measuring the distribution of Y122*s; however, such methods have yet to be
established.
An alternative scenario for Y122* distribution would be an 'all or none case', i.e. each P2
contains either 2 Y122*s/P2 or none. The relative proportion of each of these populations would
then determine the ensemble average Y122* content. Biochemically, such a distribution may
come about if there exists stringent cooperativity between the two Y122* sites in 32, that is each
time one 0 is loaded with Y122*, cofactor assembly in its adjacent momomer is much more likely
than in another 12. This model is in accord with recent reconstitution experiments with YfaE, an
important enzyme in the assembly and maintenance of the diiron Y122* cofactor in vivo, which
yield -2 Y122*s/02.36'37 This scenario also explains the observation of PELDOR signals between
the two Y122*s even at low 12 concentrations. However, there is also evidence that may argue
against such a distribution. First, studies by Pierce et al. using Mnn as a probe indicate negative
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cooperativity between two monomers of 12; that is, after cofactor assembly in one monomer,
assembly in the adjacent monomer is less likely than in another 12.38 Pierce et al. also argue that
the substoichiometric Fe content is a result of this negative cooperativity. However, the
relevance of these studies to our 12s, which in most cases are assembled in vivo, is unclear.
Further, the 'all or none' scenario may be inconsistent with pre-steady state experiments, which
have revealed 1.5 ± 0.3 dCDP per Y122* in a single kinetic phase (see below). However, the
scatter in the pre-steady state kinetic data does not allow this scenario to be eliminated.14
As noted above, this discussion will assume that the Y122* is statistically distributed
among 32, that is, in each 02 preparation, there are populations that contain 0, 1 or 2
Y122*s/dimer. The relative proportions of these are statistically determined. The observation of a
PELDOR signal requires a certain population with 2 Y122*s per 32. The observation of 1.5 ± 0.3
dCDP per Y122* requires a certain population of 1 Y122* per 12. Therefore, a random distribution
of Y122*S is a compromise between the two extreme scenarios discussed above and reconciles
results from PELDOR studies, the stoichiometry of 1.2 Y122*/P 2 as well as results by Ge et al.14
The consequences of a statistical distribution of Y122* are shown in Figure 3-26 for
DOPA-02, DOPA-P' and wt 12. Using a radical content of 0.3 for DOPA-02, each monomer
has (0.3/2) a 15 % chance of containing a Y1220. Therefore, 2.25 % (0.152) of total protein will
have two Y122* per DOPA-02, 25.5 % (2 x 0.15 x 0.85) will have 1 Y122* per DOPA-02 and the
remaining 72.25 % (0.852) will contain no Y122*. This indicates there are (25.5/2.25) -11 times
more DOPA-02 with 1 Y122* per dimer than with 2 Y122*s per dimer, i.e. the vast majority of
radical containing protein has 1 Y122* per DOPA-f2. Therefore, the contribution form the
2.25 % may be ignored. The same analysis may be applied to DOPA-00', demonstrating that
3.4 %, 30.2 % and 66.4 % of total protein contains 2, 1 and 0 Y122*s per DOPA-PP', respectively.
Figure 3-26 also shows the distribution of Y122* in wt 12.
A second problem is that the quarternary structure of the active complex as a function of
concentration and bound nucleotides is not understood. E. coli a2 alone can be a monomer or a
dimer. When the active site Cys residues are oxidized, it is primarily monomeric.3 9 E. coli P2 is
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always dimeric, when its diiron Y122* cofactor is assembled. In the apo form, it is also dimeric,
however, the monomers can exchange. At low concentrations, the a2/42 complex consists of a
1:1 dimer of each subunit. Experiments previously performed in our lab indicate that the rate
determining step in turnover shifts from a conformational change at low complex concentrations,
to the re-reduction step, at high concentrations, perhaps indicative of changes in the quarternary
structure of a2/132 as a function of concentration. 14 To simplify the discussion below, a 1:1
complex between a2 and f32 is assumed under all experimental conditions.
Initial asymmetric interaction in DOPA-32/a2 and DOPA-3f3'/ac2. The first step of
the model consists of an initial asymmetric interaction. A strong case can be made for this step
with DOPA-32 and DOPA-030'. Part of this evidence was presented in Chapter 2, where only
48 + 4 % of initial Y122* generated a DOPA356*; the other -52 % of the Y122* remained unreacted
(Table 3-3). This proposal was assessed by PELDOR experiments, where an interaction was
observed only between Y122o-DOPA*, but not between DOPA*-DOPA* pairs. The quarternary
structure is not known at concentrations of 0.25-0.3 mM, which was used for PELDOR
experiments; but, as noted above we will assume a 1:1 complex. In addition, a lower limit of
detection in PELDOR experiments has yet to be established. Nevertheless, our interpretation of
the lack of detectable interaction between DOPA*-DOPA* in the PELDOR studies is that in the
first turnover, radical initiation occurs along only one of two possible pathways (Figures 2-23 &
2-26), that is radical migration is not synonymous or synchronous across both pathways.
Several observations, presented in this Chapter, further support an initial asymmetric
interaction: SF UV-vis and EPR experiments demonstrate that only 27 ± 5 % of total initial
Y1220 is trapped as DOPA* (Table 3-3). Compared with DOPA-f32, this corresponds to an
approximately 2-fold (1.8 ± 0.2) lower yield in DOPA* formation. One element of asymmetry is
provided by the subunit interaction, leading to -50 % of DOPA* formation with DOPA-32.
With DOPA-03' additional asymmetry is provided by removal of the last 22 residues in the
1'-monomer. Therefore, the observed stoichiometry of DOPA* formation is rationalized as
shown in Figure 3-27 and is consistent with initial asymmetry in the complex.
197
00(O0000O
72.25 %
25.5 %
2.25 %
DOPA-302
00(*0000O
66.4 %
30.2 %
3.4%
DOPA-P'
00(e0000e
DOPA-PP'
Figure 3-26. Statistical distribution of Y122* in DOPA-02, DOPA-PP' and wt 02. The radical
contents were 0.3, 0.37 and 1.2 per DOPA-P2, DOPA-P3' and wt 02 respectively. The % of total
protein containing 0, 1 or 2 Y122*s per dimer is indicated.
C D E
Figure 3-27. Current working hypothesis to explain yields of DOPA356* with DOPA-P3' and
DOPA-P2. DOPA amino acid has been omitted from the diagram for clarity. In this model, a2 has
been omitted for clarity and the asymmetry is shown in the P subunits. Here, only one of the
monomers in the DOPA-P2 dimer is active (circle), whereas the other is inactive (square) as a result
of an asymmetric interaction. Thus, conformer (A) of full-length DOPA-P2 traps a DOPA*, while
conformer (B) remains inactive, resulting in 50 % DOPA* formation. In DOPA-PP', only (C) leads to
generation of a DOPA., whereas (D), (E) and (F) are inactive due to absence of the C-terminal tail or
of the essential Y122*; hence 25 % of total Y122* is trapped.
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In addition, X-band EPR and SF UV-vis analysis presented in this chapter show that the
DOPAo*-•' resides in a local environment which is very similar to that of DOPAo*-2 (Figures
3-7 & 3-16). Moreover, DOPA-PP' preserves the essential conformational changes which
allow for kinetically competent DOPA* formation in a local environment which maintains
communication with the a2 subunit. It was shown in Chapter 2, that binding of different
substrate/effector pairs influences the conformation of DOPA-132. The experiments here show
that substrate/effector pairs in the DOPA-PP'/a2 complex have a similar effect on DOPA*-p3'
as evidenced by the EPR spectrum of DOPA*-13', which is very similar to that of DOPAo-02
regardless of the substrate/effector pair bound in a2. Accordingly, allosteric changes caused by
binding of substrate and effector are transmitted to the subunit interface by contacts between an
ap pair in the complex, rather than diagonally across the subunit interface.
PELDOR measurements in the presence of all four substrate/effector pairs yield a
distance of 30.6 ± 0.5 A, very similar to the distance measured in DOPA-02 (Figure 3-28). This
suggests that the 1'-monomer in DOPA*-Pp' maintains a structure similar to the second
1-monomer in DOPA*-032. Thus, despite the presence of the C-terminal tail in DOPA-32, the
position of the second 1-monomer appears to be similar to the P'-monomer, which cannot
interact with a2. This suggests that radical transfer along on ap pair commences as soon as 32
binds a2 and before interaction in the other ap pair is established. In addition, deletion of the
C-terminal tail in DOPA-PP' does not affect the stability of the DOPAo as the half-life for
DOPA*-PP' is 6.5 min and 5 min in the presence of GDP/TTP and CDP/ATP, respectively,
similar to that determined for DOPA*-12.
In summary, the observations in the previous and in this chapter regarding the
stoichiometry of DOPA* formation, environment of the DOPA* in DOPA-02 and DOPA-P3',
the stability of the DOPA* and PELDOR studies are all consistent with an initial asymmetric
interaction with a2.
Structural source of initial asymmetric interaction. What might be the cause of this
initial asymmetry in a2/02 complex formation? Structural studies with holo and apo 12 suggest
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that it contains C2-symmetry along the dimer interface.3' 40 In these structures, the C-terminal
tail is never resolved due to thermal instability, suggesting that it is disordered, rather than a
source of asymmetry. Structural studies with a2 also suggest that it contains C2-symmetry
along the dimer interface. 1'4 Binding studies with substrate, product and allosteric effector by
show that it contains -2 binding sites per dimer, suggesting that both monomers are capable of
binding substrate and effector.41' 42'43 These binding studies are normally carried out with a2
alone. An interesting experiment was performed by Ehrenberg. They used [5-F]-dCDP to
examine binding to a2 by NMR methods.10 They found that ca2 contained 2 binding sites for this
product analogue; however, the number of sites was halved, to 0.9 + 0.1, when P2 was added. A
similar result was obtained with dCDP. Bases on these results, we propose that the asymmetry
arises upon complex formation between ax2 and 02, similar to the two-step binding model
suggested by SjOberg et al, which was described in the Introduction. However, the nature of this
asymmetry remains unresolved.
Evidence for asymmetry from other experiments. An initial asymmetric interaction
has been tested with Bpa 356-02 experiments. The caveat in these studies is that there are several
different conformations, that are in equilibrium, that the interaction between a2 and Bpa 356-42 is
not stable, that crosslinking is inefficient and that separation of the different species is difficult
by anion exchange chromatogrphay. However, in these experiments, SDS PAGE reveals a major
band that corresponds to an a-x crosslinked product. The a2-32 crosslinked product is below
the lower limit of detection (-0.1 gg) by this method. Careful fractionation of the reaction has
yielded a product which contains one ap crosslink and is further accompanied by one equivalent
of non-crosslinked a and P. These observations may be interpreted as an initial asymmetric
interaction resulting in one crosslinking event per a2/02 complex.
Results with the mechanism-based inhibitors N3UDP may be used to test the model in
Figure 3-23. An important caveat with N3UDP is that mechanistic models for this reaction do
not involve active site disulfide formation. 9' 44' 45 Therefore, with N3UDP, radical propagation and
active site chemistry within only one oap pair should be observed. PELDOR studies with N3UDP
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failed to reveal No-No dipolar coupling, though as noted above, a lower limit of detection has not
been established.2 5 Nevertheless, the Y122*-N* interaction is dominant in these studies. With
N3UDP, inactivation is due to loss of Y 122* and ax2 activity, where 50 % of the initial Y122° is lost
rapidly resulting in No formation. The No then decomposes slowly releasing 3-ketodeoxy-
nucleotide along with slow loss of the remaining 50 % Y 122*. With [5'- 3H]-N 3UDP, 0.9-1.1
sugar labels per a2, as well as loss of 0.9 uracil and 0.9 N2 per a2 is observed.9 It is possible
that the slow decay of No is associated with active site disulfide formation, thus enabling the
remaining Y 122* to participate in C439* formation. However, more mechanistic experiments
regarding the slow chemistry of No loss are required to assess this hypothesis. While the slow
loss of -50 % Y122° is not understood, studies with N3UDP are indicative of half-sites reactivity
as only one active site of a2 appears to be involved. In our model this results from an
asymmetric interaction.
Similar studies have been carried out with F2CDP and [1'- 3H]-F 2CDP. In this case 1.0
sugar labels per a2 is observed concomitant with loss of 1.0 cytosine per ca2. These observations
are consistent with asymmetry demonstrating that only 1 active site in a2 is active in the initial
turnover.8 Presumably, the signal that activates the second active site has not occurred in the
chemistry with F2CDP, though this has yet to be determined. In this case 100 % of a2 activity is
lost in multi-phasic fashion and the kinetics of this loss is not understood. Further assessment of
the reactions that ensue with F2CDP requires the detailed mechanism of inactivation, which to
date has not been elucidated.
Observations with FM-CDP may be more difficult to reconcile. In this case, with 1 and
2 equivalent of inhibitor per a2, 65 % and 80 % loss of Y122*, and 20 % and 100 % loss of oa2
activity is observed in multi-phasic fashion, respectively. 7 With [5'-3H]-FM-CDP and [6-14C]-
FM-CDP, 1.2-1.4 and 1.0 labels per a2 is observed, respectively. In addition, 1.4 and 0.5
equivalents of fluoride and cytosine are lost, respectively. FM-CDP inhibition has been
proposed to involve partitioning between multiple pathways. Some of these involve active site
disulfide radical formation, whereas others do not. Given that multiple pathways are involved,
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however, and that the partitioning ratio between these pathways is unknown, it is difficult to
assess our model using results with this inhibitor.
Cooperativity in dCDP formation. The second main feature of the model is
cooperative formation of dCDP. Here, with cooperative, we mean that the second equivalent of
dCDP per a2 does not require a slow conformational change. Evidence for cooperativity in
dCDP formation comes mainly from pre-steady state analysis of the wt ca2/52 reaction and the
requirement for an initially asymmetrical interaction. Ge et al. demonstrated that 1.8 ± 0.4
(1.4-2.2) dCDPs are produced per a2 in a single kinetic phase. Because a similar result was
obtained with C754/C759S-a2, both active sites in a2 must be operative. 14 The evidence discussed
above shows that both radical transfer pathways do not propagate at the same time. Therefore,
for 1.8 equiv. of dCDP to be produced in the same kinetic phase, the additional hole migration
event, required for the second dCDP in the first turnover, must occur without a rate-determining
conformational change. Moreover, the observation of 1.5 dCDP per Y122* requires transport of
the radical to both a2 active sites, even in populations of 02 that contain only 1 Y122*/dimer. As
discussed before by Ge et al., this may occur at W48, which are 17 A apart in the docking model.
Alternatively, this may occur at Y356, the position of which has not been defined.
Following from the arguments above, there must be a signal that transports the oxidizing
equivalent into the second active site of a2 (for 02 with 1 Y122*) or initiates radical transfer
within the second pathway (for 02 with 2 Y122*). Several candidate events may be considered:
release of product from the first radical migration/active site chemistry event, reverse hole
migration and reformation of Y122*, or disulfide bond formation in the active site between C225
and C462. Interestingly, comparison of oxidized and reduced structures of a2 shows that C462
moves 7 A upon oxidation, which leads to other changes in 0 sheet interactions at C462, as well as
to movements in neighboring strands.4 Therefore, we favor disulfide formation in the active site
of a2 as the signal that promotes radical transfer diagonally across the interface of the two cpP
pairs. However, the lack of data and difficulty in studying this physical switch prevents a more
thorough assessment of the other two options.
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Multiple conformations and fast interconversion. The third main feature of the model
is the interconversion of conformational states during turnover (kint). Initial studies by Brown,
Reichard and Thelander demonstrated multiple aggregation states of a2 and a2/P2 in the
presence of various nucleotides and as a function of active site Cys oxidation state.46'39 The SF
UV-vis data presented in Chapter 2 have highlighted the propensity of RNR to exist in various
conformational states. Furthermore, EPR data of DOPA*-02 and DOPA*.P' have shown that
nucleotides have a discernible effect on the structure and local environment of the ca2/P2
interface. Conformational flexibility is a hallmark of RNRs, as they must coordinate the
allosteric regulation by several (d)NTPs to reduction of four NDPs. Multiple non-
interconverting conformations have been observed with DOPA-02, DOPA-PP' (in the presence
of GDP/TTP) and even with the mechanism-based inhibitors, where partitioning of reaction
intermediates may be linked to conformations of the complex. However, the requirement for 1.8
dCDPs per a2 suggests that in the first turnover, and subsequently under multiple turnover
conditions, these various conformational states converge to produce dCDP in a cooperative
manner in the wt reaction. Therefore, after an initial asymmetric interaction, where half of the
complex population does not participate in radical initiation, these 'inactive' complexes must
rapidly interconvert into conformations which are competent in turnover (kint, Figure 3-23).
This interconversion is a direct consequence of the asymmetrical interaction and observation of
1.8 dCDP per a2. In fact, the latter can only occur if all populations that contain 2 Y122*/P2
produce 2 dCDP molecules (2 x 0.36 - see Fig. 3-26) and all populations containing 1 Y122*/P2
also produce 2 dCDP molecules per a2 (2 x 0.48 - see Fig. 3-26) leading to (0.72 + 0.96 =) 1.7
dCDP per a2.
Direct observation of a fast interconversion, relative to the rate-determining physical step
that gates hole propagation, was made with DOPA-PP' (Figures 3-9 & 3-10). A weak
interaction between DOPA-P3' and a2 dictates that the majority of DOPA-0i' is initially not
complexed. However, SF UV-vis and EPR experiments demonstrate that all possible DOPA*,
as described in Figure 3-27, is trapped in a single kinetic phase. Therefore, association of
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DOPA-PP' with a2 and active complex formation must be much faster than the rate-limiting
conformational change. Kinetic simulations, where fast equilibration of free DOPA-P3' and ca2
was assumed, were consistent with this model (Figure 3-10).
Testing the asymmetry model. In summary, a model has been proposed that attempts to
reconcile observations from decades of research using various approaches. Evidence with
DOPA-P2, DOPA-P3', pre-steady state experiments and studies with mechanism-based
inhibitors are consistent with this model. Additional experiments are required to test and refine
the model in Figure 3-23. Fluorescence binding studies with pp' may further test cooperative
binding and asymmetric interaction. In these studies, we would expect the Kd of heterodimeric
32 to be similar to that of a peptide containing the last 30 residues of P2. Single turnover
experiments with heterodimeric P2, i.e. Y356F/wt P3', would be informative in testing kx and kint
in Figure 3-23, as would pre-steady state analysis of PP', where the P'-monomer is truncated,
In the former case, the results would show whether radical transfer diagonally across the ap pairs
occurs at Y356; in the latter case, we would expect to see 1/2 of dCDP per a2 in one kinetic phase
relative to the wt reaction. In addition, studies with P2, where one monomer contains protonated
Y and the other contains deuterated Y may allow direct observation of radical transfer diagonally
across the ac pair interface after a single turnover (kx, Figure 3-24).
Reverse radical migration in DOPA*-PP'/a2. In this chapter, we also presented
further characterization of the DOPA*. Specifically, the fate of the DOPA* was monitored upon
incubation at 250C or upon rapid mixing with HU. Results in the former experiment
demonstrate, for the first time, that 36 % of the DOPA* engages in reverse hole propagation
highlighting the reversible nature of the radical initiation pathway. Experiments with HU show
that it can directly interfere with the radical propagation event, as previously proposed by
Karlsson et al.
Initial experiments monitoring the fate of DOPA. showed an unexpected increase in the
[Y12 2*] in the presence of CDP/ATP. However, due to the low radical content of DOPA-PP'
(0.37), the increase was close to the lower limit of quantitation by EPR methods. Efforts to
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increase the population of the ox2/DOPA*-PP' complex participating in reverse radical transfer
failed. Therefore, a new protocol was necessary which would allow us to increase the Y122•
content of DOPA-p3' in order to obtain better evidence for reverse hole migration. This has
been difficult because the standard protocol reported by Atkin et al. leads to destruction of the
DOPA probe. 34
We devised a method based on reductive chelation of the diiron center, which was
previously developed by Perez et al. In this procedure, the Y122* is reduced with hydroxylamine
and the diiron center is reduced and removed using Na 2S204/methyl viologen and the ferrous
chelator ferrozine, respectively. Reconstitution of Y122* on trunctated Mesna-activated P2,
before DOPA-22mer ligation, ensures that DOPA does not interfere with the redox reactions
involved in Y122* assembly.
With DOPA-pp', containing 1.2 Y1 22*, clear evidence for reverse hole migration was
obtained. The generality of this observation was tested by performing reactions with CDP alone,
GDP/TTP, GDP alone or UDP/ATP. With all NDP/(d)NTP pairs, a DOPA* was observed with
distinct half-lives, indicative of nucleotide-mediated structural changes at the subunit interface.
However, reverse hole migration was not observed. Our interpretation of these results is that 36
± 4 % of the complex with CDP/ATP exists in a specific conformation which results in reverse
radical transfer. Steenken and Neta, as discussed in Chapter 2, demonstrated that a
benzosemiquinone, and by inference an o-semiquinone, cannot oxidize phenol in a bimolecular
reaction. 47 Thus, the results with CDP/ATP may suggest that in the conformation that undergoes
reverse hole migration, the reduction potential of Y122* and/or DOPA356* are perturbed. While a
rate constant for reverse radical transfer was not determined, the data indicates that this process
is slow. Temperature-dependent studies may reveal whether this is due to the unfavorable
thermodynamics of the reaction, i.e. an ET/PCET-limited reaction, or gated by conformational
changes. 2,48
205
Figure 3-28. Pictorial presentation of PELDOR measurements with DOPA356*-02/a2 (left) and
DOPA356 -PP13'/a2 (right). In both cases, a distance of 30.6 ± 0.5 A was determined regardless of the
substrate/effector pair bound.
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CHAPTER 4:
Site-Specific Insertion of 3-Aminotyrosine into Subunit a2
of E. coli Ribonucleotide Reductase: Direct Evidence for
Involvement of Y730 and Y731 in Radical Propagation
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INTRODUCTION
In all organisms, ribonucleotide reductases (RNRs) catalyze the conversion of
nucleotides to 2'-deoxynucleotides, providing the precursors required for DNA biosynthesis and
repair. 1-3 The mechanism of nucleotide reduction is conserved in all RNRs and requires
formation of a transient active site thiyl radical (C439.). 4' 5 However, the mechanism of active site
thiyl radical generation, the radical initiation event, is not conserved and provides the basis for
distinction between four classes of RNRs. 6-9 A major unresolved mechanistic issue is that of thiyl
radical formation in class I RNRs, and presumably in the recently identified class IV RNR. In
this Chapter, we report site-specific incorporation of 3-aminotyrosine (NH2Y) into one of the
subunits of E. coli RNR and present the insights provided by these mutants into the mechanism
of radical initiation.
The E. coli class I RNR consists of two homodimeric subunits, a2 and 02, which form an
active 1:1 complex during turnover.10-12 a2 is the business end of the complex. It contains the
active site where thiyl radical-mediated nucleotide reduction occurs, as well as multiple
allosteric effector binding sites which modulate substrate specificity and turnover rate. 13 P2
houses the stable diferric tyrosyl radical (Y122') 14-16 cofactor which is required for formation of
the transient C439* in the active site of a2.4 -6 The structure of a26' 17 and j218'19 have been solved
and a structure containing both subunits has also been reported.20 A structure of the active a2/02
complex, however, has remained elusive. From the individual structures of a2 and P2, Uhlin
and Eklund have generated a docking model of the a2/02 complex based on shape and charge
complementarities and conserved residues.6 This model suggests that the Y122* in 32 is located
>35 A away from C439 in a2 (Figure 4-1).21-23 Hole propagation over this long distance requires
the involvement of transient amino acid radical intermediates.24 26 The residues proposed to
participate in this pathway are universally conserved in all class I RNRs.
Evidence in support of the long distance between Y122* and C439 has recently been
obtained from pulsed electron-electron double resonance spectroscopic measurements 27 with a
210
mechanism based inhibitor.28-32 The distance obtained from this study is consistent with the
docking model and establishes that a large conformational change, that positions Y122* in 32
adjacent to C439 in a2, does not occur. 32
To examine the validity of the proposed pathway, site-directed mutagenesis 33' 34 and
complementation studies35 have been carried out. These studies demonstrate that each residue in
Figure 4-1 plays an important role in RNR function. However, the absence of activity in these
mutants precludes mechanistic investigations. 3
3
'
34
At present, evidence for the involvement of only one of the proposed pathway residues,
Y356 , is substantial. Demonstration of the involvement of this residue is particularly important as
it resides within a disordered region of |32 and hence its distance to W48 in f32 and to Y 73 1 in a2 is
long and not known (Figure 4-1). We have recently been able incorporate unnatural amino acids
at residue 356 using expressed protein ligation methods, to generate mechanistically informative
mutants.36 ,37 In one variant, Y356 was replaced with the radical trap 3,4-dihydroxyphenylalanine
(DOPA).38 Studies with DOPA356-02 and a2 in the presence of substrate and/or effector showed
formation of a DOPA radical (DOPA*) in a kinetically competent fashion directly demonstrating
that residue 356 is redox-active (Chapter 2).38 We have also employed a DOPA heterodimer,
DOPA-f33' (where the t'-monomer lacks the C-terminal 22 residues), to show reverse hole
migration from residue 356 to Y122 (Chapter 3).39 The most compelling evidence, however, for
the redox-active role of Y356 has come from a series of FnY 356-02s (n=2, 3, or 4).40-43 These
FnY356-f32 derivatives have allowed systematic modulation of the reduction potential and pKa of
this residue, key to unraveling the role of proton-coupled electron transfer within the pathway
(see Chapter 6).21,40 Activity assays of FnY 356-p2s showed that radical initiation, and thus
nucleotide reduction, is turned on or off based on the reduction potential difference between the
FnY and y.43 In addition, modulation of the pKa in FnY-I2s, allowed us to show that there was
no obligate coupling between the electron and proton at this residue during radical transport (see
Chapter 7).43 Studies using semi-synthetic P2s have thus defined the function and mechanism of
residue 356 in radical propagation.
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In contrast, the roles of a2 residues Y73o and Y731 in radical propagation are still
ill-defined. Mutagenesis studies have demonstrated their importance in RNR function.34,44,45
However, as with residue Y356 in 32, the inactivity of these mutants (Y730F-a2 and Y731F-a2)
precluded mechanistic interrogation of the role of Y730 and Y731 in radical propagation,
Furthermore, incorporation of unnatural amino acids into a2 is not feasible by expressed protein
ligation given the location of these residues. We have thus sought an alternative method to site-
specifically incorporate unnatural amino acids.
We now report evolution of an NH2Y-specific Methanococcus jannaschii aminoacyl-
tRNA synthetase (NH2Y-RS) and its use in vivo with the appropriate M. jannaschii amber
suppressor tRNA, to incorporate NH2Y at residues Y730 and Y731 of the a2 subunit.46 50 NH2Y
was chosen as a probe because its reduction potential (0.64 V at pH 7.0, Scheme 4-1)51 is 0.19 V
lower than that of Y, indicating that it might act as a radical trap, similar to DOPA, and directly
report on participation of residues Y730 and Y731 in hole migration (Figure 4-1). Furthermore
NH2Y is more stable to oxidation than DOPA, making it a more practical target.51'52 Using this
methodology, 100 mg quantities of each NH2Y-a2 has been generated. Incubation of
Y730NH 2Y-a2 (or Y731NH2Y-x2) with P2, substrate and allosteric effector, results in formation
of an NH2Y radical (NH2Y*) in a kinetically competent fashion as demonstrated by
stopped-flow (SF) UV-vis and EPR spectroscopy. Unexpectedly, the NH2Y-a2s retain the
ability to make deoxynucleotides, suggesting that the NH2Y* observed, occurs during radical
propagation in a complex that is competent in nucleotide reduction. These results suggest that
direct hydrogen atom transfer is the operative mechanism for hole migration within a2.
212
Y122
W48
4.(
1
0
Fe2
D237
A S ?A E441
Y131
Figure 4-1. The putative radical initiation pathway generated from the docking model of a2 and 12.6
Y356 is not visible in any structures because it lies on the disordered C-terminal tail of 32. Therefore,
the distances from Y356 to P2-W 48 and to a2-Y 731 are not known. Distances on the a2 side are from
the structure determined by Uhlin and Eklund,6 those on the 12 side are from the high-resolution
structure of oxidized 12.19
Scheme 4-1. One electron oxidation of NH2Y.51
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MATERIALS AND METHODS
Materials. Luria Bertani (LB) medium, BactoAgar, 2YT medium, and small and large
diameter (100 and 150 mm) Petri dish plates were obtained from Becton-Dickinson. NH 2Y, M9
salts, tetracycline (Tet), kanamycin (Kan), ampicillin (Amp), L-arabinose (L-Ara),
chloramphenicol (Cm), L-leucine (Leu), D-biotin, thiamine HC1, ATP, cytidine-5'-diphosphate
(CDP), NADPH, ethylenediamine tetraacetic acid (EDTA), glycerol, Bradford Reagent,
Sephadex G-25, phenylmethanesulfonyl fluoride (PMSF), streptomycin sulfate, hydroxyurea,
2'-deoxycytidine and 2'-deoxyguanidine-5'-triphosphate (dGTP) were purchased from
Sigma-Aldrich. Isopropyl-p-D-thiogalactopyranoside (IPTG), DL-dithiothreitol (DTT) and T4
DNA ligase were from Promega. DH10B competent cells and oligonucleotides were from
Invitrogen. Site-directed mutagenesis was carried out with the Quickchange Kit from
Stratagene. Calf-intestine alkaline phosphatase (CAP, 20 U/JtL) was from Roche. KpnI and
Xbol restriction enzymes were from NEB. The pTrc vector was a generous gift of Prof. Sinskey
(Department of Biology, M. I. T.). The purification of E. coli thioredoxin53 (TR, 40 units/mg), E.
coli thioredoxin reductase 54 (TRR, 1400 units/mg), and wt P3255 (6200-7200 nmol/minomg, 1-1.2
radicals per dimer) have been described. The concentrations of a2, Y730NH 2Y-a2 and
Y731NH2Y-a2 were determined using &280 nm = 189 mM-lcmn'. Glycerol minimal media leucine
(GMML) contains final concentrations of 1 % (v/v) glycerol, lx M9 salts, 0.05 % (w/v) NaCl, 1
mM MgSO 4, 0.1 mM CaCl 2 and 0.3 mM L-leucine. RNR assay buffer consists of 50 mM Hepes,
15 mM MgSO 4, 1 mM EDTA, pH 7.6.
Qualitative assay for cellular uptake of NH2Y by LC-MS. The uptake assay was
performed as previously described with minor modifications. 48 DH10OB E. coli cells were grown
to saturation at 370C in GMML in the presence of 1 mM NH 2Y and 0.1 mM DTT and
subsequently harvested and lysed as outlined previously. Chromatography of the crude extract
was performed on a Zorbax SB-C18 (5 glm, 4.6 x 150 mm) column with a linear gradient from
5 % to 25 % MeCN in 0.1 % TFA solution over 8 min at 0.5 mULmin. Under these conditions,
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NH2Y elutes at -13 % MeCN. For HPLC-ESI-MS analysis, NH2Y standard solutions were
prepared in water.
Directed evolution of NH 2Y-RS in E. coli. Positive and negative selection cycles were
carried out as detailed previously.48 Briefly, plasmid pBK-JYRS encodes a library of M.
jannaschii TyrRS variants, which are randomized at 6 residues within 6.5 A of the Tyr binding
cleft, under the control of the E. coli GlnRS promoter and contains a KanR marker.46 Plasmid
pREP/YC-J17 was used for positive selections;56 it encodes a chloramphenicol acetyl transferase
(CAT) gene with a nonessential amber mutation, Aspi12TAG, and a T7 RNA polymerase (T7
RNAP) gene with two nonessential amber mutations, Met1TAG and Glnl 07TAG. It also contains
a gene for the cognate mutant tRNACUA (mutRNAcuA) that is charged by the library of TyrRSs, a
GFPuv gene, the expression of which is driven by T7 RNAP and a TetR marker. Plasmid
pLWJ17B3 was used for negative selections; 57,58 it encodes a toxic barnase gene with three
nonessential amber mutations, Gln2TAG, Asp44TAG and Gly65TAG, under the control of an Ara
promoter. It also contains the mutRNACUA gene and an AmpR marker (Table 4-1).
In each positive selection round, the pBK-JYRS plasmid library, containing the library of
mutant TyrRSs, was transformed into E. coli DH10OB competent cells containing plasmid
pREP/YC-J17 by electroporation.48 The cells were recovered in SOC medium and grown at 37
"C for 1 h. They were then washed twice with GMML and plated onto 6-8 GMML agar plates
(150 mm) containing 12 gg/mL Tet, 25 ptg/mL Kan, 60 gg/mL chloramphenicol (Cm), 1 mM
NH 2Y and 100 pLM DTT. DTT was included in all solutions or plates that contained NH2Y in
order to maintain a reducing environment. Plates were incubated at 37 "C for 72 h. Surviving
cells were scraped from the plates and pooled into GMML liquid medium. The cells were then
subjected to plasmid isolation using the Qiagen Miniprep Kit. The pBK-JYRS library (-3 kb)
was separated from pREP/YC-J17 (-10 kb) by agarose gel electrophoresis and extracted from
the gel with the Qiagen Gel Extraction Kit. Plasmid DNA was quantitated using OD260 nm-
To perform a negative selection, plasmid DNA isolated from the positive selection was
transformed by electroporation into E. coli DH10OB competent cells containing pLWJ17B3. 48 The
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cells were recovered in SOC medium, shaken at 37 "C for 1 h and plated onto LB agar plates
containing 100 gg/mL Amp, 50 gg/mL Kan and 0.2 % L-Ara. The plates were incubated at 37
OC for 10-12 h. Surviving cells were recovered and plasmid isolation was performed as
described above.
After a total of 6 rounds (3 positive and 3 negative selections), the 4t positive selection
was performed by spreading cells onto two sets of plates. One set contained NH 2Y/DTT as
described for the positive rounds, the other contained only DTT. The two sets of plates were
examined for differences in green fluorescence stemming from GFPuv, the expression of which
is driven by T7 RNAP on the positive selection plasmid (Table 4-1). A total of 48 single
colonies were selected from the plates which contained NH 2Y/DTIT and inoculated into 100 gL
GMML in a 96 well plate. One [tL from each resulting cell suspension was plated onto two sets
of GMML agar plates containing 0, 20, 40, 60, 80 and 110 [tg/mL Cm and 0.1 mM DTT in the
presence and absence of 1 mM NH2Y. Plates were incubated at 37 "C for 72-120 h. Candidate
clones are able to survive on plates with NH 2Y/DTT and high concentrations of Cm (-100
glg/mL) and emit green fluorescence under UV light, but die on plates without NH 2Y at low
concentration of Cm (20 pgg/mL). Candidate clones were inoculated into 5 mL 2YT medium
containing 24 gg/mL Tet and 50 gg/mL Kan and grown to saturation. Plasmid DNA was then
isolated as described above and analyzed by DNA sequencing. The plasmid containing the
NH2Y-RS gene, which was selected by the procedures above, is pBK-NH 2Y-RS.
Expression of K7NH 2Y-Z-domain. The efficiency of NH2Y incorporation using
pBK-NH 2Y-RS was tested using the C-terminally His-tagged Z-domain of protein A
(Z-domain), as previously described. 4 8 pLEIZ, 57 '59 which encodes the Z-domain with an amber
stop codon at residue 7 and mutRNACUA, and pBK-NH 2Y-RS were cotransformed into
BL21(DE3) competent cells. All growths were carried out in the presence of Kan (50 ptg/mL)
and Cm (35 gLg/mL) at 37"C. A single colony was inoculated into a 5 mL 2YT medium and
grown to saturation (-13 h). One mL of this saturated culture was diluted into 25 mL 2YT
medium and grown to saturation overnight (-11 h). Ten mL of this culture were then diluted
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into each of 2 x 250 mL GMML medium. When the OD6 0 nm reached 0.65 (9 h), one of the
cultures was supplemented with NH2Y and DTT (final concentrations of 1 mM and 0.1 mM,
respectively); the other culture was supplemented only with DTT (0.1 mM). Fifteen min after
addition of NH2Y/DTT (or DTT), IPTG was added to each culture to a final concentration of 1
mM. After 5 h, cells were harvested by centrifugation. Z-domain grown in the presence and
absence of NH2Y was then purified by Ni2÷ affinity chromatography, as previously described,
and subjected to SDS PAGE and MALDI-TOF MS analysis. 48 For MALDI-TOF MS analysis,
the Z-domain was exchanged into water by dialysis and mass spectra were subsequently
obtained under positive ionization mode at the Scripps Center for Mass Spectrometry.
Table 4-1. Vectors used in this study.
Plasmid Description Reference
pBK-JYRS M. jannaschii TyrRS library, KanR 46
pREP/YC-J17 Positive selection plasmid: CAT (Asp 112TAG), T7 RNAP 56
(MetITAG, Glnio7TAG), mutRNACuA, GFPuv, TetR
pLWJ17B3 Negative selection plasmid: barnase (Gln2TAG, 57, 58
Asp44TAG, Gly65TAG), mutRNACUA, AmpR
pBK-NH 2Y-RS NH2Y-RS, KanR This study
pLEIZ Z-Domain, CmR 57, 59
pTrc-nrdA nrdA expression vector: nrdA (Tyr7 3oTAG or Tyr7 31TAG) This study
with trc promoter, AmpR
pAC-NH 2Y-RS NH2Y-RS, 6 x mutRNACUA, TetR This study
pMJ1-nrdA nrdA expression vector: nrdA with T7 promoter, AmpR  This study
pBAD-nrdA nrdA expression vector: nrdA with L-Ara promoter, This study
mutRNACUA, TetR
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Cloning of pTrc-nrdA. To generate vector pTrc-nrdA, the nrdA gene was amplified
with primers 1 (5'-AT AAT TGG TAC CCA AAA ACA GGT ACG ACA TAC ATG AAT C-
3') and 2 (5'-GCT GCA GGT CGA CTC TAG AGG ATC CCC CCT TCT TAT C-3') using Pfu
Turbo polymerase. The primers contain KpnI and XboI cut sites at the 5' and 3' ends of the gene
(underlined), respectively. The fragment was purified using the PCR Purification Kit from
Qiagen. The isolated DNA was then incubated with KpnI and XboI, the resulting products
separated on an agarose gel, and extracted with the Qiagen Gel Extraction Kit. The gene
fragment was ligated into pTrc, which had been cut with the same restriction enzymes.
Incubation of the insert-vector in a ratio of 3:1 and ligation with T4 DNA ligase at 160C for 30
min resulted in pTrc-nrdA. Generation of pTrc-nrdA was performed by Clement Chan.
Expression of wt a2 from vector pTrc-nrdA was performed in BL21(DE3) cells as
previously described for expression from plasmid pMJ1-nrdA and yielded 3 g of wet cell paste
per L culture.55 '6 Purification of a2 (see below) yielded 10 mg of a2 per g of wet cell paste with
>95 % purity and a specific activity of 2500 nmol/minmg as measured by the
spectrophotometric RNR assay (see below). Expression of wt a2 from pTrc-nrdA was
performed by Clement Chan.
Generation of pTrc-nrdA7 3oTAG and pTrc-nrdA731TAG. The TAG codon was
inserted into position 730 or 731 of the nrdA gene in vector pMJ1-nrdA using the Stratagene
Quickchange Kit. Primers 3 (5'-G GTC AAA ACA CTG TAG TAT CAG AAC ACC CG-3')
and 4 (5'-CG GGT GTT CTG ATA CTA CAG TGT TIT GAC C- 3') were used for
incorporation of TAG into position 730 of a2. Primers 5 (5'-G GTC AAA ACA CTG TAT
TAG CAG AAC ACC CG-3') and 6 (5'-CG GGT GTT CTG CTA ATA CAG TGT TTT GAC
C-3') were used for incorporation of TAG into position 731 of a2. The mutations were
confirmed by sequencing the entire gene at the MIT Biopolymers Laboratory. The nrdA730oTAG
and nrdA731TAG genes were then amplified with primers 1 and 2 and ligated into vector pTrc as
described above for wt nrdA.
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Cloning of pAC-NH 2Y-RS. The pAC vector is analogous to vector pSup, which has
been described, except that it contains the TetR selection marker rather than the CmR marker. 61 In
addition, pAC-NH 2Y-RS contains the NH2Y-RS gene under control of glnS' promoter and rrnB
terminator and six copies of the mutRNACUA gene under control of a proK promoter and
terminator. To generate pAC-NH 2Y-RS, the NH2Y-RS gene was subcloned into the pAC
vector from pBK-NH2Y-RS using the PstI and NdeI restriction sites, which are 3' and 5' of the
NH2Y-RS gene, respectively. Cloning of pAC-NH2Y-RS was carried out by Youngha Ryu and
Roshan Perrera in the Schultz Lab.
Attempts at expression of Y730NH 2Y--a2. In an effort to maximize production of a2
containing NH2Y, without generation of NH 2Y*, growth conditions were examined at different
temperatures, under aerobic and anaerobic conditions and with hydroxyurea in the media to
reduce the Y122* in wt 02.
In each case, a single colony of DH10OB or BL21(DE3) E. coli cells was used to inoculate
a 5 mL 2YT small culture. After saturation, this culture was diluted 100-fold into 2 x 100 mL
GMML media. When OD 600nm was -0.6-0.8, and after the variations detailed below, one flask
was supplemented with NH2Y and DTT to final concentrations of 1 mM and 0.1 mM. The other
growth served as the control. After 15 min, expression of NH2Y-a2 was induced by addition of
IPTG to both 100 mL cultures (or 0.2 % (w/v) L-arabinose with expression system (1) - see
below). Small aliquots were removed from each flask after a defined time period (5-12 h) and
expression of a2 assessed by SDS PAGE analysis in the presence and absence of NH 2Y/DTT.
When the effect of temperature on expression of Y730NH2Y-a2 was tested, growth
conditions for the small culture were identical to those above. When OD600 nm was -0.6-0.8, the
temperature setting was changed to 25 or 300C. After 15 min, NH2Y and DTT were added and
the growth was continued as described above.
When the effect of Y122--02 on expression of Y73oNH 2Y-a2 was tested, growth
conditions for the small culture were identical to those described above. When OD6oo nm was
0.6-0.8, hydroxyurea was added to a final concentration of 65 mM. After 15 min, NH 2Y and
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DTr were added to final concentrations of 1 mM and 0.1 mM, respectively. After an additional
15 min, induction was carried out as above. Each hour after induction, the culture was
supplemented with an additional 15 mM hydroxyurea.
When the effect of 02 On expression of Y730NH2Y-a2 was tested, growth conditions for
the small culture were identical to those described above. When the small culture was saturated,
it was diluted 100-fold into a 250 mL 2YT medium containing the appropriate antibiotics in a 1
L Erlenmeyer flask. At saturation, the culture was diluted 50-fold into 5-7 L GMML medium
in a fermenter flask with appropriate antibiotics. When OD600 nm was 0.6-0.8, the air was
replaced with N2(g). After 15 min, NH2Y and DTT were added to final concentrations of 1 mM
and 0.1 mM, respectively, and the growth continued as described above.
Several expression systems were tested: (1) the pBK-NH2Y-RS/pBAD-a2, in which
pBK-NH 2Y-RS carries the NH 2Y-RS gene under control of the constitutive E. coli Gln-RS
promoter and terminator and a KanR marker, and vector pBAD-X2 carries the a2 gene with the
appropriate amber codon under control of an L-Ara-inducible promoter and a rrnB terminator as
well as the mutRNACUA gene under control of a 1pp promoter and rrnC terminator and a TetR
marker; (2) The pBK-NH2Y-RS/pMJI-nrdA vector combination, in which vector pMJl-nrdA
carries the nrdA gene with the amber codon under control of T7 promoter and terminator and a
AmpR marker. (3) The pAC-NH 2Y-RS/pMJ1-nrdA system, where pAC-NH2Y-RS carries the
NH2Y-RS gene under control of glnS' promoter and rrnB terminator, six copies of the
mutRNACUA gene under control of a proK promoter and terminator and a TetR marker (Table
4-1).
Successful expression of Y73oNH 2Y-a2 and Y731NH2Y-a2. Successful expression of
Y730NH2Y-a2 was achieved with the pTrc-nrdA730TAG/pAC-NH2Y-RS expression system,
where vector pTrc-nrdA73oTAG contains the nrdA gene with an amber codon at position 730
under control of the trp/lac (trc) promoter and rrnB terminator and an AmpR marker. E. coli
DH10OB cells were transformed with vectors pTrc-nrdA73oTAG and pAC-NH 2Y-RS, and grown
at 370 C on LB/Agar plates containing Amp (100 jig/mL) and Tet (25 gg/mL) for two days. All
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liquid culture growths contained Amp (100 pLg/mL) and Tet (25 gLg/mL) and were carried out in a
shaker/incubator at 370 C and 200 rpm. A single colony from the plate was inoculated into 5 mL
of 2YT medium and grown to saturation (-2 days). The 5 mL saturated culture was then diluted
into 180 mL of 2YT medium and grown to saturation (-1 day). Twenty five mL of this culture
were then inoculated into each of 6 x 6 L Erlenmeyer flasks, each containing 1 L of GMML
medium supplemented with D-biotin (1 [Lg/mL), thiamine (1 tg/mL) and a lx heavy metal stock
solution. A 1000x heavy metal stock solution contains the following per L as described:62 500
mg MoNa204*2H 20, 250 mg CoC12, 175 mg CuSO 4*5H20, 1 g MnSO4oH20, 8.75 g
MgSO4*7H20, 1.25 g ZnSO 4*7H20, 1.25 g FeC12*4H 20, 2.5 g CaCl 2o2H 20, 1 g H3BO3 and 1 M
HC1. When OD600 nm reached 0.6 (12-18 h), NH2Y and DTT were added to final concentrations
of 1 mM and 0.1 mM, respectively. After 15 min, IPTG was added to a final concentration of 1
mM and the growth continued for 4.5 h, at which point the cells were harvested by centrifugation,
frozen in liquid N2 and stored at -800C. Typically, 1.5 g of wet cell paste were obtained per L
culture. Expression of Y731NH 2Y-a2 was carried out in identical fashion using vectors
pTrc-nrdA73 1TAG and pAC-NH 2Y-RS. Expression of Y730NH2Y-a2 and Y731NH2Y-ca2 was
performed by Clement Chan.
Purification of Y730NH2Y-a2 and Y731NH 2Y-a2. NH2Y-a2s were typically purified
from 10 g of wet cell paste. All purification steps were performed at 40C. Each g of wet cell
paste was resuspended in 5 mL of a2 Buffer (50 mM Tris, 1 mM EDTA, pH 7.6) supplemented
with 1 mM PMSF and 5 mM DTT. The cells were lysed by passage through a French Pressure
cell operating at 14,000 psi. After removal of cell debris by centrifugation (15,000 x g, 35 min,
40C), DNA was precipitated by dropwise addition of 0.2 volumes of a2 Buffer containing 8 %
(w/v) streptomycin sulfate. The mixture was stirred for an additional 15 min and the precipitated
DNA was removed by centrifugation (15,000 x g, 35 min, 4"C). Then, 3.9 g of solid (NH4)2SO4
was added per 10 mL of supernatant over 15 min (66 % saturation). The solution was stirred for
an additional 30 min and the precipitated protein isolated by centrifugation (15,000 x g, 45 min,
40C). The pellet was re-dissolved in a minimal volume of a2 Buffer and desalted using a
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Sephadex G-25 column (1.5 x 25 cm, 45 mL). The desalted protein was loaded at a flow rate of
0.5 m~lmin directly onto a dATP column (1.5 x 4 cm, 6 mL), which had been equilibrated in a2
Buffer. The column was washed with 10 column volumes of a2 Buffer. NH2Y-a2 was then
eluted in 3-4 column volumes of a2 Buffer containing 10 mM ATP, 15 mM MgSO 4 and 10 mM
DTT. ATP was subsequently removed by Sephadex G-25 chromatography. The protein was
flash-frozen in small aliquots in liquid N2 and stored at -800C. Typically 4-6 mg of pure
NH 2Y-a2 were obtained per g of wet cell paste.
Reaction of NH 2Y-a2 with P2, CDP, and ATP monitored by EPR spectroscopy.
Pre-reduced wt-a2 or NH2Y-a2s were generated by incubating each variant (40 gM) with 35
mM DTT at room temperature for 40 min. Hydroxyurea and additional DTT were added to final
concentrations of 15 mM, and the incubation continued at room temperature for an additional 20
min. Each protein was then desalted on a Sephadex G-25 column (1.5 x 25 cm, 45 mL), which
had been equilibrated in assay buffer (see Materials).
Pre-reduced NH2Y-a2 and ATP were mixed with wt P2 and CDP in assay buffer to give
final concentrations 20-24 gM, 3 mM, 20-24 pLM and 1 mM, respectively. The reaction was
hand-quenched in liquid N2 from 10 s to 12 min. EPR spectra were recorded at 77 K in the
Department of Chemistry Instrumentation Facility on a Bruker ESP-300 X-band spectrometer
equipped with a quartz finger dewar filled with liquid N2. EPR parameters were as follows:
microwave frequency = 9.34 GHz, power = 30 gW, modulation amplitude = 1.5 G, modulation
frequency = 100 kHz, time constant = 5.12 ms, scan time = 41.9 s. Analysis of the resulting
spectra was carried out using WinEPR (Bruker) and an in-house written program in Excel.
These programs facilitate fractional subtraction of the unreacted Y122* Signal from the recorded
spectrum, yielding the spectrum of NH 2Y*-a2. The ratio Y122* and NH 2Y* signals was assessed
by comparing the double integral intensity of each trace. EPR spin quantitation was carried out
using Cu" as standard.63
Kinetics of NH 2Y*-a2 formation with 32, CDP and ATP by stopped-flow (SF)
UV-vis spectroscopy. SF kinetics was performed on an Applied Photophysics DX. 17MV
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instrument equipped with the Pro-Data upgrade using PMT detection at Xs indicated in figure
legends. The temperature was maintained at 25"C with a Lauda RE106 circulating water bath.
Pre-reduced Y73oNH 2Y-a2 (or Y731NH2Y-a2) and ATP in one syringe were mixed in a 1:1
ratio with wt P2 and CDP from a second syringe to yield final concentrations of 8-10 pM, 3 mM,
8-10 VM and 1 mM, respectively, in assay buffer. Data was collected in split time-base mode.
Time courses shown are the average of at least 6 individual traces. For point-by-point
reconstruction of the Y730NH2Y*-a2 and Y731NH2Y*-a2 absorption profiles, 2-4 traces were
averaged between 305 and 365 nm in 5 nm intervals. The absorption change was corrected for
the absorption of Y122* in this region, based on the published E at these Xs,64 -66 and then plotted
against X. Calculation of the E for Y730NH2Y*-a2 (10500 M-'cm -1) and Y731NH2Y*-oa2 (11000
M-'cm-1) were performed using the S of Y122* (6410 nm = 3700 M-lcm-1)6 6 and assuming that
consumption of each mole of Y122* leads to formation of one mole of NH2Y* in a2. Curve
fitting was performed with OriginPro or KaleidaGraph Software.
Spectrophotometric and radioactive activity assays for RNR. The spectrophoto-
metric and radioactive RNR assays were performed as described before.36'43 The concentration
of NH2Y-a2 was 0.2, 1 or 3 pM; 132 was present at a 5-fold molar excess. [5- 3H]-CDP (1190
cpm/nmol) was used in the radioactive assay. Radioactive assays were performed by Clement
Chan.
Reaction of NH 2Y-a2 with 12, N3ADP and dGTP monitored by EPR spectroscopy.
2'-Azido-2'-deoxyadenosine-5'-diphosphate (N3ADP) was previously prepared by Scott
Salowe.6° Pre-reduced Y730NH 2Y-a2 (Y731NH2Y-a2 or wt a2) and dGTP were mixed with wt
12 and N3ADP in assay buffer to yield final concentrations of 20 pM, 1 mM, 20 pM and 250 pM,
respectively. The reaction was hand-quenched in liquid N2 after 20 s. EPR data acquisition and
spin quantitation with Cu" were performed as described above. The resulting spectra were
analyzed using WinEPR (Bruker) and an in-house written Excel program. Deconvolution of the
three signals observed in these experiments was performed by first subtracting the No signal
which has been reported and was reproduced here with the wt a2/02 reaction. Then, unreacted
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Y12 2* was subtracted from this spectrum, yielding the NH2Yo-a2 spectrum. The ratio of the
three signals was assessed by comparing the double integral intensity of each trace.
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RESULTS
Toxicity and uptake of NH2Y. Evolution of an NH2Y-specific aminoacyl-tRNA
synthetase (RS) requires that NH2Y is taken up by E. coli, that it is not toxic, and that it is not
incorporated into proteins by any endogenous RSs. All three requirements were met by NH 2Y.
When DH10OB E. coli cells were grown in liquid GMML medium in the presence of NH2Y (1
mM) or NH2Y and DTT (1 mM and 0.1 mM, respectively), NH2Y was observed in all cell
extracts as judged by HPLC and ESI-MS (data not shown).48 Toxicity of NH 2Y was assessed by
growing DH10B E. coli cells in liquid GMML medium and on Agar plates in the presence of
NH2Y or NH2Y/DTT. Growth rates were not significantly affected by the presence of NH 2Y.
The presence of DTT however, caused cells to grow at a rate 25-35 % more slowly than those in
the presence of only NH2Y or absence of NH 2Y/DTI (data not shown).
Evolution of an NH2Y-specific RS. The Schultz lab has developed a robust in vivo
method for incorporation of unnatural amino acids into any target protein. 46 -50 In this method, the
RS is selected from a library of M. jannaschii TyrRS mutants. A cognate amber suppressor M.
jannaschii tRNA, mutRNACUA, does not require modification as the region of interaction
between mutRNAcUA and the RSs in the library is not varied.67 Iterative rounds of positive and
negative selections are carried out on the RS library which has been randomized at six residues
in and around the Y binding cleft: Tyr32, Leu65, Phel08, Glnl09, Aspl58 and Leu162. The
positive selection is based on suppression of an amber stop codon at a permissive site in the CAT
gene in the presence of NH 2Y/DTT and the cognate tRNA (Table 4-1).46 Surviving clones carry
RSs that are functional with the host cell translation machinery and incorporate NH2Y or other
amino acids in response to the amber stop codon. The negative selection is based on lack of
suppression of three amber codons in the toxic barnase gene in the absence of NH 2Y (Table
4-1).68 Surviving clones carry RSs that do not incorporate any natural amino acids in response to
the amber stop codon.
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After seven selection cycles, 48 colonies were examined for their ability to suppress the
amber stop codon. Single colonies containing pBK-NH 2Y-RS and pREP/YC-J17 were picked
from the last positive selection (7t round) and plated on GMML agar containing variable
concentrations of Cm (0-110 gLg/mL) in the presence or absence of NH 2Y. Ability to grow with
NH 2Y/DTT indicates that the amber codon in the CAT gene is suppressed by incorporation of
NH2Y. Further, the amber codons in the T7 RNAP gene are suppressed in a similar fashion and
drive expression of GFPuv, resulting in emission of green fluorescence, when the cells are
irradiated with UV light. The desired colonies are those that grow in high concentrations of Cm
(-100 gg/mL) and NH2Y/DTT and emit green fluorescence upon irradiation, but die at low Cm
concentrations (-20 jgg/mL) in the absence of NH 2Y. Of the 48 colonies tested, 2 met these
criteria and were pursued further.
DNA sequencing of the plasmids from these colonies revealed identical RSs with the
following residues at the randomized positions: Gln32, Glu65, Glyl08, Leul09, Ser158 and
Tyr162. Interestingly, residue 32, a Tyr in wt M. jannaschii TyrRS and positioned within 2 A of
the C-atom ortho to the hydroxyl group of bound Tyr ligand, is a Gln in the selected RS.6 9,70 The
crystal structure of wt M. jannaschii TyrRS suggests that the Gln allows accommodation of the
o-NH 2 group and perhaps provides favorable hydrogen bonding interactions. The RS identified
from these clones was used for all subsequent experiments.
Expression of K7NH2Y-Z-domain. To test the efficiency and fidelity of NH2Y
incorporation with the selected RS, the C-terminally His-tagged Z-domain protein (Z-domain),
with an amber stop codon at the permissive Lys7 residue, served as a model.57 ' 71 Expression in
the presence of NH 2Y/DTT in GMML medium, yielded 5 mg of Z-domain per L culture after
purification. SDS PAGE analysis (Figure 4-2, inset) demonstrated that in the absence of NH2Y,
the amount of Z-domain protein expressed was below the level of detection. The purified
protein was subjected to MALDI-TOF MS analysis. Previous studies have shown that the
Z-domain is post-translationally modified by removal of the N-terminal Met followed by
acetylation of the resulting N-terminal amino acid. 57 Accordingly, MALDI-TOF MS analysis of
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Z-domain expressed in the presence of NH2Y/DTT revealed four peaks with MW = 7812, 7854,
7943 and 7985 Da (Figure 4-2). These features correspond to K7NH2Y-Z-domain minus the
first Met (MWexp= 7813 Da), its acetylated form (MWexp= 7855 Da), full length
K7NH2Y-Z-domain (MWexp= 7944 Da) and its acetylated form (MWexp= 7986 Da), respectively.
Importantly, no K7Y-Z-domain was detected (MWexp= 7929 Da for the full length form).
Together, the studies with the Z-domain demonstrate that the evolved RS is specific for NH2Y
and is efficient at its incorporation into this target protein.
Expression and purification of NH2Y-a2s. Having evolved an NH2Y-specific RS and
confirmed the efficiency and fidelity of NH 2Y insertion, we next sought an overexpression
system for ca2 that is compatible with the plasmid/host requirements for NH2Y incorporation.
Several different growth conditions and expression systems were investigated in an effort to
maximize a2 production and NH2Y insertion at residue 730. Growth under anaerobic conditions
or in the presence of hydroxyurea was investigated to minimize the reaction of wt P2 with
NH 2Y-a2, which could lead to premature trapping of an NH 2Y* and destruction of the probe. In
the former case, the anaerobic class III RNR is operative in E. coli and therefore wt class I 2 is
not expressed.1,72 In the latter case, presence of hydroxyurea leads to reduction of the essential
Y122. in class I 2 so that it cannot react with NH 2Y-a2. 73,74 Temperature manipulation was also
investigated to minimize formation of inclusion bodies.
Three different expression systems were investigated (see Methods for details): (1)
pBK-NH2Y-RS/pBAD-nrdA, (2) pBK-NH 2Y-RS/pMJ -nrdA and (3) pAC-NH 2Y-RS/
pMJl-nrdA (see Table 4-1). With system (1), expression of full-length a2 at levels 1.5-fold
above endogenous a2 were observed. With system (2), only truncated oc2 was observed and
with system (3) overproduction of truncated a2 was accompanied by expression of full-length
a2 that was similar to endogenous levels of a2 (data not shown). The failed or low levels of
expression may be due to limiting mutRNACUA inside the cell and/or the low levels of expression
of ca2 from the pBAD-nrdA and the pMJ1-nrdA.
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Figure 4-2. MALDI-TOF MS and SDS PAGE analysis of K7NH2Y-Z-domain. MALDI-TOF MS
of purified K7NH2Y-Z-domain obtained under positive ionization mode. The m/z [M+H] + are
indicated for the main peaks in the spectrum. They correspond to N-terminally cleaved Met form of
K7NH2Y-Z-Domain (exp. 7814) and its acetylated form (exp 7856), full-length
K7NH2Y-His-Z-Domain (exp. 7945) and its acetylated form (exp 7987). Inset: SDS gel of purified
Z-domain after expression in the absence (lane 2) or presence (lane 3) of NH2Y. The arrow
designates the K7NH2Y-Z-domain band. Protein ladder and corresponding MW are shown in lane 1.
The recent report of successful expression and incorporation of unnatural amino acids
into E. coli nitroreductase using pTrc, 75 prompted us to investigate the pAC-NH2Y-RS/
pTrc-nrdA expression system. The pTrc-nrdA vector carries the a2 gene under control of the
trp/lac (trc) promoter with the amber stop codon at the desired residue.76 Importantly,
pAC-NH2Y carries six copies of mutRNACUA increasing the concentration of the cognate tRNA
inside the cell.6 1
Expression of wt a2 from pTrc-nrdA was examined first. Overproduction and
subsequent purification, gave 10 mg of pure a2 per g of wet cell paste. This expression level is
2-4x greater than the expression of a2 from pMJ1, which has been routinely used in our lab to
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express a2 and a2 mutants (data not shown). In addition, the specific activity of a2 was similar
to that produced from pMJ1-nrdA (2500 nmol/minomg).
Expression of Y731NH2Y-a2 in DH10B cells doubly transformed with pAC-NH2Y-RS
and pTrc-nrdA is shown in Figure 4-3. In the presence of the IPTG inducer and NH 2Y/DTT,
the amber stop codon is suppressed and NH 2Y-a2 is overexpressed. In the absence of NH2Y,
overproduction of only truncated ca2 is observed. Finally, in the absence of inducer IPTG and
NH2Y, no overexpression of a2 occurs. A similar profile is obtained for the expression of
Y730NH2Y-a2 (Figure 4-4). Purification of NH2Y-a2 using dATP affinity chromatography
gives 4-6 mg of the target protein per L culture in >90 % homogeneity (Figures 4-5 & 4-6).55 ,60
The mutant proteins behaved similarly to wt a2 during the purification procedure.
Reaction of NH 2Y-a2s with wt 02, CDP and ATP monitored by EPR spectroscopy.
The availability of NH2Y-a2s has allowed us to assess the participation of Y7 30 and Y731 in
radical propagation across the 032-a2 interface. The experimental design is based on the radical
trapping method previously established with DOPA-j32.38 '39 In this method, a stable radical is
trapped with an unnatural Y analog that is more easily oxidized than Y. If the trapping requires
the presence of f32, substrate, and allosteric effector, then it provides direct evidence for redox
activity of that residue during radical propagation. Lack of radical formation may indicate that
the residue is not redox-active or that the oxidized product is unstable. We proposed that the
ease of oxidation of NH2Y (E' is 190 mV lower than Y at pH 7) would lead to generation of an
NH 2Y* allowing its detection by UV-vis and EPR methods.51 Unfortunately, spectroscopic
characterization of NH 2Y* has not been previously reported.
Based on our studies DOPA-02,38 we anticipated that the NH2Y* might be stabilized to
some extent by the protein environment. With DOPA-f32, maximal amounts of DOPA* were
generated by 5 s, which was stable for 2.5 min.38' 39 Thus, Y730NH2Y-a2 (or Y731NH2Y-a2) was
mixed with wt f32, substrate (CDP) and effector (ATP), incubated at 250 C for variable periods of
time (10 s to 12 min) and quenched manually in liquid N2. EPR spectra of these reactions
revealed a new signal that was present in maximal amounts at the 10 s time point (Figure 4-7).
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Figure 4-3. Expression of Y731NH2Y-a2. Cells were grown in the presence or absence of IPTG and
NH2Y/DTT as indicated and the level of expression assessed by SDS PAGE. The position of protein
bands for full-length a and truncated a are denoted by arrows.
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Figure 4-4. Expression of Y730NH2Y-a2. Cells were grown in the presence or absence of IPTG and
NH2Y/DTT and at 250 or 37 'C, as indicated, and the level of expression assessed on a SDS PAGE
gel. The position of protein bands for full-length a and truncated a are denoted by arrows.
A control in the absence of CDP and ATP, revealed only Y 122* (Figure 4-7, inset). Thus
formation of the new signal is controlled by the presence of substrate and effector as previously
observed with similar studies on DOPA-f32.3 8
The observed spectrum is a composite of at least two species: unreacted Y 1220 and the
putative NH2Y 730 *. To reveal the features of the new radical(s), the spectrum of the Y 122.( 14) with
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distinct, well characterized low field features, was subtracted from the composite signal. The
resulting nearly isotropic signal (Figure 4-7, red trace) has an apparent gay of 2.0043 and a
peak-to-trough width of 24 G.77 We ascribe this new signal to NH 2Y 730o.
Spin quantitation at the 10 s time point revealed that 8 % of total initial spin (relative to
starting Y122*) had been lost. Of the remaining spin, 47 % is associated with Y122* and 53 % with
the new signal. To further characterize this signal, power saturation studies were carried out.
The Y122* is adjacent to the diferric cluster, which dramatically alters its relaxation properties. If
the new radical is in fact located within a2, >35 A removed from the diferric cluster as indicated
by the docking model, then its P1,2 would be markedly reduced. The results of power
dependence experiments are shown in Figure 4-8. The data were fit to Eq. 4-1,78 where K is a
sample and instrument dependent scaling factor, P is the microwave power, b is indicative of
homogeneous (b=3) or inhomogeneous (b=l) spectral broadening and PI/2 is the microwave
power at half saturation of the EPR signal.78'79 For the Y12 2*, a P1/2 of 28 + 4 mW was determined,
similar to previous measurements. 79,80 The saturation profile of the new signal gave a P1/2 of 0.42
± 0.08 mW consistent with a radical distant from the diiron center.
K x ('IP)
Signal Amplitude = [1 +(P/P2).5 (4-1)
Similar experiments have also been carried out with Y731NH2Y-a2. A new signal, the
putative NH2Y731o, is also observed only in the presence of CDP/ATP (Figure 4-9). Subtraction
of the Y122* spectrum, reveals a spectrum that is similar, but not identical, to that of NH 2Y730o
(Figures 4-9 & 4-10). The nearly isotropic signal associated with NH2Y731* consists of a g,v of
2.0044 and a peak-to-trough width of 22 G. At the 10 s time point, 14 % of total initial spin has
been lost. Of the remaining spin, 45 % is associated with NH 2Y731* and 55 % with Y122s.
Kinetics of NH 2Y*-a2 formation monitored by SF UV-vis spectroscopy. Pre-steady
state experiments were carried out to assess whether NH2Y*-a2 formation occurs with a rate
constant fast enough to be competent in nucleotide reduction in wt RNR. Previous steady state
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Figure 4-5. SDS PAGE analysis of purified Y730NH2Y-a2. (1) and (4) MW markers; MWs are
indicated. (2) Purified Y730NH2Y-a2 (1.5 jLg). (3) Purified wt a2 (1.5 jlg).
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Figure 4-6. SDS PAGE analysis of purified Y731NH2Y-a2. (1) MW markers; MWs are indicated.
(2) Purified Y731NH2Y-a2 (1.5 jig).
and pre-steady state kinetic analysis of E. coli RNR monitoring nucleotide reduction have shown
that radical propagation is preceded by a slow conformation change. 81 This slow physical step
masks intermediates that form in the propagation process. In the presence of CDP/ATP, and at
concentrations of a2 and 02 used in the present study, the rate constant for this conformational
change varies from -4-17 s-.81 The steady state rate constant for dCDP formation is on the
order of 2 s-' and is thought to be limited by re-reduction of the active site disulfide that
accompanies dCDP formation, or by a conformational change associated with this re-reduction.
In previous studies with DOPA-P2, a2 and CDP/ATP, DOPA* formation occurred in two fast
kinetic phases (38.0 and 6.8 s-1) and a slow phase (0.7 s-1). Thus, the two fast phases in the
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Figure 4-7. Reaction of Y730NH2Y-a2/ATP with wt 32/CDP monitored by EPR spectroscopy. The
reaction components were mixed at 250C to yield final concentrations of 20 pM Y730NH 2Y-a2/02, 1
mM CDP and 3 mM ATP. After 10 s, the reaction was quenched in liquid N2 and the EPR spectrum
(black) subsequently recorded at 77 K. Unreacted Y122* (blue, 47 % of total spin), was subtracted to
reveal the spectrum of NH2Y730* (red, 53 % of total spin). Inset: Reaction of Y730NH2Y-ax2 with wt
32 in the absence of CDP/ATP.
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Figure 4-8. Microwave power dependence of Y122* and NH2Y730* signal intensities. The EPR
spectrum of Y122* and NH2Y 730* was recorded as a function of microwave power and the integrated
intensity of each signal plotted against the square root of power. Black lines represent fits to the data
using Eq. 4-178 and yield P1/ 2 of 28 ± 4 mW (b=1.3 + 0.2) and 0.42 ± 0.08 mW (b=1.2 + 0.2) for Y122°(blue) and NH2Y730* (red), respectively.
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Figure 4-9. Reaction of Y731NH2Y-a2/ATP with wt 32/CDP monitored by EPR spectroscopy. The
reaction components were mixed at 250C to yield final concentrations of 20 pM Y731NH2Y-a2/42
complex, 1 mM CDP and 3 mM ATP. After 20 s, the reaction was quenched by hand-freezing in
liquid N2 and the EPR spectrum subsequently recorded (black trace) with at 77 K as described in the
Methods section. Unreacted Y122* (blue, 55 % of total spin), was subtracted to reveal the spectrum of
NH2Y730* (red, 45 % of total spin). Inset: Reaction of Y730NH2Y-a2 with wt 02 in the absence of
CDP/ATP.
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Figure 4-10.
from Fig. 4-9.
Comparison between NH2Y730* (blue trace) from Fig. 4-7 and NH 2Y 73 1* (red trace)
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DOPA-32 experiments, and potentially the third phase,82 were kinetically competent with
respect to the conformational change, which limits dCDP formation in the first turnover.81
To monitor changes in the concentration of NH2Y*, its spectrum and extinction
coefficient must be determined. Our initial assumption was that its UV-vis spectrum would be
similar to that of DOPA* (max at 315 nm and E -12000 M-'cm1).3 8 ,83 The extinction coefficients
associated with Y122* between 310 and 365 nm are low (E - 500-1900 M-1cm - 1) and can be used
in spectral deconvolution. 64' 65 Thus, using SF spectroscopy, we carried out a point-by-point
analysis of the UV-vis properties of the new radical. Y730NH2Y-a2 (or Y731NH2Y-a2) and
ATP in one syringe was mixed with wt 32 and CDP from a second syringe and the absorbance
monitored from 305-365 nm in 5 nm intervals. The absorbance change at 1.5 s at each X,
corrected for the absorption by the Y122*,64' 65 was then plotted against the X. The results are
shown in Figure 4-11 and indicate that NH2Y730* and NH 2Y731* have similar, but distinct
absorption profiles. The UV-vis spectrum of NH 2Y730* consists of a broad feature with a ma at
325 ± 1 nm (E -10500 ± 500 M- ' cm-). The NH 2Y731* spectrum exhibits a max at 320 ± 1 nm
(E - 11000 ± 500 M-1 cm') and a more defined shoulder at 350 nm. The extinction coefficients
for NH2Y*-a2s were determined using E for Y122* at 410 nm66 and the assumption that loss of
each mole of Y122* leads to formation of one mole of NH2Y*.
SF UV-vis experiments carried out to monitor the kinetics of loss of Y122* (410 nm) and
formation of NH2Y* (325 nm) are shown in Figure 4-12A for Y73oNH2Y-a2. At 410 nm,
bi-exponential kinetics with rate constants of 12.0 ± 0.1 s- 1 and 2.4 ± 0.1 s- 1 were observed,
similar to rate constants obtained for formation of NH 2Y* at 325 nm (13.6 ± 0.1 s- 1 and 2.5 ± 0.1
s-1). Analogous experiments carried out with Y731NH2Y-a2 showed that loss of Y122* occurred
bi-exponentially (17.3 ± 0.2 and 2.3 ± 0.1 s- 1) concomitant with formation of NH 2Y731* (21.0 ±
0.1 s- 1 and 3 ± 0.1 s- 1, Figure 4-12B). The rate constants and amplitudes for both reactions are
summarized in Table 4-2. A control experiment was carried out in the absence of substrate and
effector with Y730NH2Y-a2 (or Y731NH 2Y-ca2) and P2. As indicated by EPR experiments, no
loss of Y122* or formation of NH2Y* occurred under identical conditions (data not shown).
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Figure 4-11. Point-by-point reconstruction of the UV-vis spectrum of NH2Y 730* (blue dots) and
NH2Y731* (red dots). Pre-reduced Y730NH2Y-xa2 and ATP in one syringe were mixed with wt P2 and
CDP from another syringe, yielding final concentrations of 10 PM, 3 mM, 10 1tM and 1 mM,
respectively. With Y731NH2Y-a2, the reaction was carried out at final concentrations of 9 pM
Y731NH2Y-a2f2, 1 mM CDP and 3 mM ATP. The absorption change was monitored in 5 nm
intervals; at each X, 2-4 time courses were averaged and corrected for the absorption of Y122* using
previously determined E in this spectral range. 64 ,65 The corrected AOD was converted to 8,66 which was
then plotted against X.
As noted above, the fast rate constants observed with the NH2Y-a2s are kinetically
competent in RNR turnover. Thus studies with these mutants provide the first direct evidence
for their involvement in radical propagation. The slow rate constant, also observed in the
DOPA-P2 experiments, is similar to the steady state rate constant for RNR turnover. A possible
explanation for this slow phase is discussed below.
Finally, analysis of the amounts of each radical at 2 s shows that with Y730NH 2Y-a2 and
Y731NH 2Y-a2, 39 % and 35 % of total initial Y122* is consumed, respectively. In contrast with
the DOPA-02, the NH2Y* is less stable. The instability needs to be assessed in detail and
requires kinetic analysis using rapid-freeze quench methods to unravel its mechanistic
implications.
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Figure 4-12. Kinetics of formation for NH 2Y 730* and NH2Y731* . (A) Pre-reduced Y730NH 2Y-O2 (20
pM) and CDP (2 mM) in one syringe were mixed in a 1:1 ratio with P2 (20 pM) and ATP (3 mM)
from another syringe. A total of 7 traces were averaged at each X. (B) Pre-reduced Y731NH2Y-a2 (18
pM) and CDP (2 mM) in one syringe were mixed in a 1:1 ratio with 32 (18 pM) and ATP (3 mM)
from another syringe. A total of 6 traces were averaged at each X.
Kinetics of NH 2Y*-ac2 decay monitored by EPR spectroscopy. We previously
examined the stability of the DOPA356*-42 at the subunit interface of a2/DOPA-02, which
revealed a T1/2 of -5 min in the presence of CDP/ATP (Chapter 3). The loss of spin was
associated with loss of DOPA* and no new DOPA* formed. At the end of the reaction, -50 % of
the total initial spin, which had given rise to DOPA*, was lost. The remaining 50 % of total
initial spin was unreacted Y122*. Similar time-dependent EPR experiments were carried out with
NH 2Y-(x2s to monitor the fate of NH2Y*-ca2 after its generation. For each reaction, EPR spectra
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were recorded at several time points over the minute time scale. At each time point, the EPR
spectrum was analyzed as described above (Figures 4-7 & 4-9). The [spin]total, [Y122*] and
[NH2Y.] was determined at each time point, after formation of the NH2Y*.
Table 4-2. Summary of kinetic data for formation of NH2Y*-a2.
1st Phase 2"d Phase
RNR Subunits CDP/ATP kobs (s'-1), Ampl (%) kobs (S-)a, Ampl (%)
Y7 30NH 2Y-a2p2 NO _c _ c
Y730NH 2Y-a2P2 YES 12.8 ± 0.8, 20 + 1 2.5 + 0.1, 19 ± 1
Y731NH2Y-a2p2 NO _c _c
Y731NH2Y-a2P2 YES 19.2 + 1.8, 24 ± 1 2.7 + 0.4, 11 ± 1
a The rate constants reported are the averages of those measured at 410 nm (for Y122* loss) and at 320 nm (for
NH2Y731* formation) or 325 nm (for NH2Y730* formation). The error corresponds to the standard deviation
between these two measurements. b Ampl, amplitude; the amount of Y122. trapped in each kinetic phase is
indicated as a % of total initial Y122*. Because the determination of 9 for NH2Y* was based on that of Y122*, the
amplitudes at 410 nm and 320 or 325 nm are nearly identical. c No changes observed.
The decay data is shown in Figure 4-13 for the Y730NH2Y-a2 reaction and Figure 4-14
for the Y731NH2Y-a2 reaction. The data with Y730NH2Y-a2 are similar to those with
DOPA-P2. After 11 min -50 % of total initial Y122* was lost. The decay data can be fit to a
mono-exponential function with rate constants of 0.27 ± 0.06, 0.24 ± 0.05 and 0.26 ± 0.09 min-1,
for [spin]total, [Y122*] and [NH2Y 730*], respectively (Figure 4-13). Accordingly, the decay rate
constants of these species are commensurate within error, yielding an average value of 0.26 ±
0.07 min- ', suggesting that a single pathway is responsible for loss of spin, Y122* and NH2Y-.
Loss of spin with Y731NH2Y-u2 was faster than with Y730NH2Y-a2 (Figure 4-14).
Decay of [spin]total, [Y1220] and [NH 2Y731*] occurred with rate constants of 0.43 ± 0.07, 0.34 +
0.08 and 0.31 ± 0.1 min'- , respectively (Figures 4-14 B, C, D). The results are similar to the
Y730NH 2Y-a2 case, in that all three rate constants are commensurate. In contrast to the
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Figure 4-13. Stability of NH2Y730* probed by EPR spectroscopy. (A) Y730NH2Y-a2 and ATP were
mixed with wt 12 (1.0 Y122* / 12) and CDP at 250C to give final concentrations of 20 pM, 3 mM, 20
pM and 1 mM, respectively. At defined time points, an aliquot was removed, transferred to an EPR
tube, frozen in liquid N2 and its EPR spectrum recorded. The [spin]toa (black dots), and its
distribution between Y122* (blue dots) and NH2Y730* (red dots) was determined, after the initial rapid
formation of NH2Y*, and plotted vs. time. Time courses for [Y122*] (B), [NH 2Y730*] (C), and [spin]toa
(D) are shown with mono-exponenetail fits to the data indicated by red lines. See text for rate
constants.
Y730NH 2Y-a2 reaction, however, 85 % of initial spin is lost by the -10 min time point. The
disappearance of Y 122* was also monitored by UV-vis spectroscopy by recording
time-dependent UV-vis spectra after initiation of the reaction and quantitating [Y122*] using the
dropline method (Figure 4-14E). This analysis yields a decay rate constant of 0.39 ± 0.03 min - ',
in agreement with the EPR measurements. Together, these experiments indicate an average
decay rate constant of 0.37 ± 0.07 min - 1. These studies report on the stability of NH2Y730* VS.
NH2Y 731* as further discussed below.
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Figure 4-14. Stability of NH2Y 731* probed by EPR and UV-vis spectroscopy. (A) Y731NH2Y-a2 and
ATP were mixed with wt 12 (1.2 Y122* / 32) and CDP at 250C to give final concentrations of 20 PM,
3 mM, 20 pM and 1 mM, respectively. At defined time points, an aliquot was removed, transferred to
an EPR tube, frozen in liquid N2 and the EPR spectrum recorded. The [spin]tot (black dots) and its
distribution between Y122* (blue squares) and NH 2Y 7 31* (red triangles) was determined, after the initial
rapid formation of NH2Y*, and plotted vs. time. Time courses for [Y122*] (B), [NH2Y731*] (C), and
[spin]tow (D) are shown with mono-exponenetail fits to the data indicated by black lines. (E) Time
course of Y 122* decay measured by UV-vis spectroscopy. The reaction was carried out at 250C and
contained final concentrations of 18 pM Y731NH2Y-oa2/02 (1.2 Y122* / 32), 1 mM CDP and 3 mM
ATP. At defined time points a UV-vis spectrum was recorded and the [Y122*] (blue dots) computed
using the dropline method. The black line is a mono-exponential fit to the data. See text for kobsS.
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Activities of NH 2Y-a2s. Recently, using a series of FnY 356-p2s, we found a correlation
between nucleotide reduction activity and the reduction potential of residue 356, when its
potential was 80 to 200 mV higher than that of tyrosine.40,'43 The reduction potential of DOPA is
260 mV lower than that of Y (pH 7) and with DOPA-f2,38 deoxynucleotide formation was
below our lower limit of detection. With NH2Y-a2, the potential of NH2Y is 190 mV lower
than that of Y (pH 7). To test whether this energy barrier would be large enough to shut down
radical transfer to C439, and therefore nucleotide reduction, activity assays were performed on
NH2Y-a2s.
Activity was determined by monitoring dCDP formation indirectly (spectrophotometric
assay) or directly (radioactive assay). The activities determined using these assays are
summarized in Table 4-3. The results show nucleotide reduction activity for Y730NH2Y-a2 and
Y731NH2Y-ca2 that is 4 % and 7 % that of wt a2, respectively. The observed activity may be
inherent to NH2Y-a2s; on the other hand, it may be ascribed to co-purifying endogenous wt a2
or to wt a2 generated by the host cell as a result of amber codon suppression with Tyr-loaded
mutRNAcuA in place of NH 2Y-loaded tRNACUA.
Table 4-3. Monitoring the activity of NH2Y-a2s by measuring deoxynucleotide and N*
formation.
N3ADP Assay
a2 Variant Spectrophotometric Radioactive RNR (% No at 20 s,b % N*
RNR Assay (% wt)r Assay (% wt)a vs. initial Y1 22*C)
wt a2 100a 100a  52
Y73oNH 2Y-a2 4 ± 0.3 4 + 0.5 19 ± 2 ,b 15 + 2c
Y731NH2Y-a2 7 ± 1 7 + 0.5 2 0 + 2 ,b 15 + 2c
a The activity is reported as % of wt activity, which was 2500 nmol/min.mg. The error is the standard deviation
from 3 independent measurements for the spectrophotometric assay and 2 independent measurements for the
radioactive assay. b The amount of No is indicated as % of total spin at 20 s; the error is associated with EPR spin
quantitation methods. c The amount of N* is indicated as % of total initial Y122*; the error is associated with EPR
spin quantitation methods.
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To distinguish between these two options, assays with N3ADP were carried out. N3ADP
is a mechanism-based inhibitor of class I RNRs which generates a moderately stable N-centered
nucleotide radical (N*) covalently bound to the nucleotide and a cysteine in the active site of
a2.28 -31'84 This radical may be used as a reporter of the ability of NH2Y* to generate a C 43 9* and
initiate chemistry on the nucleotide. Previous studies of the inactivation of wt a2/02 by
N3ADP/dGTP suggest that on a 20 s time scale, 50-60 % of the initial Y122* is lost leading to
formation of an equivalent amount of No.30,60 Therefore, if the activity observed with NH2Y-a2s
is indicative of wt a2, -2 % and -3.5 % of total initial Y122* would be expected to form a N.
with Y730NH 2Y-a2 and Y731NH 2Y-a2, respectively.
Assays with N3ADP were carried out by mixing each NH2Y-a2 (or wt a2) and dGTP
with wt P2 and N3ADP. After 20 s the reaction was hand-quenched in liquid N2. The EPR
spectrum obtained for Y730NH2Y-a2 is shown in Figure 4-15. The observed spectrum is a
combination of at least three radicals: Y122*, NH2Y730*, and N.. The spectrum can be
deconvoluted using the differences in spectral widths and the unique spectral features within
these regions (Figure 4-16). Thus, the data were analyzed by first subtracting the No spectrum,
which contains the broadest of the three signals. The resulting spectrum was then subjected to
fractional subtraction of the Y12 2* component, yielding the NH2Y730* signal. The concentration
of each of the radicals was determined using standard EPR quantitation methods.63
The results from this quantitative analysis are shown in Table 4-4. They show that 18 %
of the total spin has been lost at the 20 s time point. Of the remaining spin, 19 ± 2 % is
associated with N*; 43% is Y122* and 39% is NH2Y 730*. Accounting for the lost spin after 20 s,
15 ± 2 % of total initial Y122* (i.e. at t=O) leads to N. formation. With Y731NH2Y-a2 (Figure
4-17 & Table 4-4), 25 % of the total spin is lost after 20 s with 20 + 2 % present as No, 41 % as
Y12 2 * and 39 % as NH2Y 73 1*. Accounting for the lost spin after 20 s, 15 ± 2 % of total initial
Y122* leads to formation of No. Therefore, with both mutants, the amount of N* observed
exceeds the 2 % or 3.5 % No (for Y730NH2Y-a2 and Y731NH2Y-a2, respectively), expected if
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the steady state activity was due to contaminating wt a2. These results strongly suggest that
NH2Y-a2s are competent in C439* formation and thus nucleotide reduction.
Kinetics of NH 2Y731* decay in the presence of N3UDP/ATP monitored by EPR
spectroscopy. As noted above, and summarized in Figures 4-15 and 4-17, at the 20 s time
point in the reaction of NH2Y-a2s with N3ADP, 18-25 % of the total spin is lost. To examine
the kinetics of this decay, time-dependent EPR spectra were recoreded with Y731NH2Y-a2/02
and N3UDP/ATP. At each time point, the spectrum was deconvoluted, as exemplified above,
and the [spin]tota, [Y122*], [NH2Y731*] and [N.] were determined. The results of this analysis are
shown in Figure 4-18. The disappearance of [spin]total and [Y122*] can be fit to a single
exponential decay function yielding rate constants of 0.67 ± 0.15 min- 1' and 1.07 ± 0.11 min- ',
respectively. These decay rate constants are significantly greater than those measured in the
presence on CDP/ATP. Therefore, the NH 2Y731*-a2 is less stable when complexed with
N3ADP/dGTP relative to CDP/ATP. The implications of this result will be discussed below.
243
I I I I I
2.04 2.03 2.02 2.01 2
g value
I I I I I I 1
1.99 1.98 1.97 2.04 2.03 2.02 2.01 2
g value
I 1 1
1.99 1.98 1.97
Figure 4-15. N3ADP assay for Y730NH2Y-a2. The reaction contained final concentrations of 20 pM
Y730NH 2Y-a2/02 (1.2 Y122* / 32), 1 mM N3ADP and 0.25 mM dGTP. After 20 s, it was freeze-
quenched in liquid N2 and its EPR spectrum recorded. (A) Subtraction of No (aqua, 19 % of total spin)
from the observed spectrum (lavender) yields the black trace, which contains the Y122* and NH2Y730"
signals. (B) Subtraction of Y122* (blue, 43 % of total) from the resulting spectrum in (A) reveals the
spectrum of NH2Y 730* (red, 39 % of total spin). See Table 4-4 for quantitation of the concentration of
each radical species.
2.04 2.03 2.02 2.01 2 1.99 1.98 1.97
g value
Figure 4-16. EPR spectral comparison of N* (black), Y122* (blue)
features of No and Y1220, on the low field side of the spectrum,
complex spectra in Figures 4-7, 4-9, 4-15 and 4-17.
and NH2Y 730* (red). The distinct
facilitate in deconvolution of the
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Figure 4-17. N3ADP Assay for Y731NH2Y-a2. The reaction contained final concentrations of 20 ipM
Y731NH2Y-a(2/02 (1.2 Y122* / P2), 1 mM N3ADP and 0.25 pM dGTP. After 20 s, it was
freeze-quenched by hand in liquid N2 and its EPR spectrum recorded. (A) Subtraction of No (aqua,
20 % of total spin) from the observed spectrum (lavender trace) yields the black trace, which contains
Y122* and NH 2Y731* signals. (B) Subtraction of Y122* (blue, 41 % of total) from the resulting spectrum
in (A) reveals the spectrum of NH2Y 730* (red, 39 % of total spin). See Table 4-4 for concentration of
each of the three component radicals. Note that at the 20 s time point, 18.1 pM spin out of the initial
24 pM remained.
Table 4-4. Analysis of the reaction of wt a2 or NH 2Y-a2s with 32 and N3ADP/dGTP after
20 s.a
[NH 2Y*]
a2 Variant [Spin]T (pM)b [N*] (tiM) [Y122°] (jiM) (PLM)
wt a2 22.9 11.9 11.0 -
Y730NH 2Y-a2 19.5 3.7 8.4 7.6
Y731NH2Y-a2 18.1 3.6 7.5 7.1
a The error associated with EPR quantitation was -10 %. b In each case, the initial [Y122o] was 24 gM.
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Figure 4-18. Stability of NH2Y731* in the presence of N3UDP/ATP probed by EPR spectroscopy.
Y731NH2Y-cx2 and ATP were mixed with wt 02 (1.2 Y122* / 32) and N3UDP at 250 C to give final
concentrations of 24 pM, 1 mM, 24 pM and 3 mM, respectively. At defined time points, an aliquot
was removed, transferred to an EPR tube, frozen in liquid N2 and the EPR spectrum recorded. The
[spin]to, (black dots) as well as its distribution between N* (aqua dots), Y122* (blue dots) and NH2Y731*(red dots) was determined, after the initial rapid formation of NH2Y*, and plotted vs. time. The black
and blue lines indicate mono-exponential fits to [spin]toa decay and [Y1220] decay, respectively. See
text for rate constants.
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DISCUSSION
Generation of Y73oNH 2Y-a2 and Y7 31NH 2Y-o2. In this study, we have evaluated the
proposed roles for residues Y730 and Y731 in radical propagation, by site-specifically replacing
them with NH 2Y (Scheme 4-1). We employed the in vivo suppressor tRNA/RS method, which
has been pioneered46 and developed47-50 by the Schultz lab and promises to have an immense
impact on protein biochemistry. Using this technology, we evolved the desired tRNA/RS pair,
which allowed us to generate Y730NH2Y-a2 and Y731NH 2Y-a2 in yields of 4-6 mg per g of wet
cell paste. The large size of a2 (172 kDa) and the small size difference between NH2Y and Y
have precluded quantitative assessment of NH 2Y incorporation into a2 by direct ESI or MALDI
TOF mass spectrometric methods. Analytical methods using LC/MS of tryptic digests of this
172 kDa protein, to evaluate levels of NH2Y relative to Y in NH2Y-a2s, are currently being
developed. Nevertheless, our studies with the model Z-domain protein indicate that
incorporation of NH 2Y is efficient and specific. In addition, evaluation of our NH 2Y-a2
preparations, using N3ADP and dCDP assays, also suggest presence of low levels of wt a2.
The ability to incorporate NH2Y site-specifically into proteins will be of general use.
Our characterization of the UV-vis and EPR spectroscopic properties of the NH2Y* should allow
NH2Y to serve as a probe for enzymes that are thought to employ transient Y*s in catalysis or in
electron transfer between metal centers. In addition, Francis and colleagues have recently shown
that NH2Y may be derivatized with fluorescent dyes.85,86 Thus, NH2Y may also be utilized as a
tool for site-specifically appending probes of interest to the target protein.
Structural assignment of the new radical. When NH2Y-a2s are reacted with j32, in the
presence of CDP/ATP, a new EPR-active signal is observed. As noted above, however, neither
UV-vis, nor EPR spectral properties of the NH2Y* had previously been reported. The
assignment of our new signal to NH2Y* is based on SF UV-vis and EPR spectroscopic
measurements in conjunction with knowledge of the properties of DOPA, catechol, and
o-aminophenol radicals. 87' 88 First, point-by-point reconstruction of the new radical's UV-vis
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spectrum by SF methods reveals an absorption spectrum similar to DOPAo, which is expected
based on the structural similarity between these two amino acids. Second, subtraction of the
Y122* EPR spectrum from the observed EPR signal, yields a spectrum with a gay of 2.0043 ±
0.0001 which is typical of organic radicals. The small hyperfine couplings (<10 G) from the ring
protons and from the amine nitrogen are similar to those previously reported for o-aminophenol
radicals. 87 Third, information about the location of the new radical relative to the diferric cluster
has been obtained by power saturation studies. These studies show that Y122* saturates with a
P1/2 of 28 mW due to its vicinity to the diferric cluster (4.6 A to the nearest iron in the cluster). 19
Mechanism based inhibitors that covalently label the active site of a2, >35 A from the cluster,
have P1/ 2 values of 0.16 mW.80 The new radical has a P,12 of 0.42 ± 0.08 mW consistent with a
species distant from the diiron center. These data together strongly suggest that the new radical
is NH2Y* (Scheme 4-1).89 High field EPR and ENDOR experiments, isotopic labeling studies
with 15N and 2H in conjunction with computational studies will be presented in Chapter 5 to
further support this assignment.
Kinetics of NH 2Y*-a2 formation. SF kinetic studies give NH2Y* formation rate
constants of 12.8 and 2.5 s-' for Y730NH2Y-a2, and 19.2 and 2.7 s1 for Y731NH 2Y-a2. The fast
rate constant is indicative of a rate-determining conformational change, which has previously
been found to precede radical propagation in wt P2, under single turnover conditions.81 Thus,
formation of NH2Y* occurs in a kinetically competent fashion at the expense of the Y122 ..38
Further, as with DOPA, NH2Y acts as a conformational probe and allows direct detection of this
physical step, reporting on the regulatory state of the NH 2Y-a2/p2 complex. The slow rate
constant observed in these kinetic studies has also been observed when monitoring DOPA3560
formation (0.4 to 0.8 s-1 with different substrate/effector pairs).38, 82 These rate constants are all in
the same range, similar to the turnover number of RNR at the protein concentrations used in
these experiments. Our previous studies have suggested that in the steady state, re-reduction of
the disulfide or a conformational change associated with this process is rate-limiting. If the
latter is the case, then this rate constant of 2-3 s-1, might be indicative of the slow conversion of
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one form of RNR into the more active form. Alternatively, incorporation of NH 2Y could result
in a2 with two conformations of the tyrosine analogue that do not interconvert rapidly or two
different conformations of the a2 itself. The separate kinetic phases for NH2Y* formation
indicate that these two conformations do not interconvert on the time scale of the SF experiment.
Additional kinetic analysis is required to further assign the nature of the slow rate constant
observed.
Activity Assays of NH2Y-a2s. Steady state turnover measurements show the ability of
both mutant proteins to produce dNDPs. As noted above, this activity could be associated with
endogenous wt a2, which co-purifies with NH 2Y-a2s, or with wt a2 which is generated by
suppression of the amber codon with Tyr-loaded tRNACUA in place of NH2Y. Alternatively, the
activity may be inherent to NH2Y-a2s.
To distinguish between these options, experiments with the mechanism-based inhibitor
N3ADP were carried out. The results indicate 15 ± 2 % N* formation with Y730NH 2Y-a2 and
Y731NH 2Y-x2. These values exceed the expected 2 % and 3.5 %, respectively, if the steady
state turnover were due to background levels of wt a2. Thus, the results suggest that NH2Y-a2s
are competent in nucleotide production. This implies that the putative NH2Y* is an intermediate
during active radical transport. Detailed kinetic analysis on the ms time scale will further test
this proposition. If true, then these observations would mark the first detection of an amino acid
radical during long-range hole migration in an RNR variant that is competent in dNDP
formation.
Rate of decay of NH2Y*-a2. Further evidence for activity of NH2Y-a2s requires a
detailed kinetic analysis of the decay of NH2Y*, Y122* and total spin during the normal reaction
(CDP/ATP) and with the mechanism-based inhibitor (N3CDP/ATP). Due to lack of availability
of N3CDP, the radical decay kinetics with N3UDP/ATP was examined instead and compared to
that in the presence of CDP/ATP. In these studies, the concentration of each radical species was
examined as a function of time after the rapid formation of NH2Y* and loss of Y122*.
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With Y730NH2Y-a2 in the presence of CDP/ATP, the rate constants for decay of Y12 2*,
NH2Y* and total spin were similar (0.26 ± 0.07 mini- ) indicating that a single pathway is
responsible for loss of each species. The Y122* is known to have long life time. Therefore, the
data indicate that loss of radical occurs through NH2Y*. Our model for radical decay is shown in
Figure 4-19. In this model, kl and k4 are the radical initiation and nucleotide reduction events
with values of -12 s-1 and 500 s- 1, respectively.81 Values of k2, k3 , k5, k6 and k7 have not been
experimentally determined. The observed decay rate constant is a function of k2 and k6 and
further depends on the ratios of k2/k3 and k6/k7 (Eq. 4-2). Note that k2=k6, if product dCDP is
released from the NH2Y-a2/02 complex after its formation.
NH2Y* Decay Rate = k2 x [2] + k6 x [6] (4-2)
With Y731NH2Y-a2, radical decay also occurs through NH2Y* with a kobs of 0.37 ± 0.07
min' as monitored by a combination of EPR and UV-vis spectroscopies. Therefore, NH2Y730*
has a life time that is 40 % longer than that of NH2Y73 1*. This may be due to the position of Y73 1
at the subunit interface, which appears to be more exposed and accessible to solution. It is also
consistent with the different EPR spectra of NH2Y 730* and NH2Y731* which demonstrate that each
residue is surrounded by a distinct protein environment.
Radical decay kinetics were also determined in the presence of N3UDP/ATP. Our
working model for this reaction is shown in Figure 4-20. This scheme is simplified relative to
that with CDP/ATP (Figure 4-19) as radical propagation is unidirectional. It can be shown that
kobs is a function of kA, kB and kc as indicated in Eq. 4-3. Importantly, the decay rate constants
in this case were 1.07 ± 0.11 min-' and 0.67 ± 0.15 min-1 for NH2Y731* and Y1220, respectively.
Faster radical decay with N3UDP/ATP may be due to greater stability conferred by CDP/ATP
than by N3UDP/ATP. With DOPA-P2, we have previously observed different DOPA* life times
as a function of nucleotides bound in the a2 subunit. Alternatively, faster radical decay with
N3UDP/ATP relative to the CDP/ATP case may be indicative of C439* formation by NH2Y*: it
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may be argued, if NH2Y-a2 did not generate a C439*, then the radical decay constant in the
presence of CDP/ATP should be similar to that in the presence of N3UDP/ATP, as both
processes would not proceed past kl and k2 (Figure 4-19) or kA and kB (Figure 4-20). At present,
we favor the former explanation. However, our working model is that NH 2Y-c2s are competent
in nucleotide reduction. Definitive evidence will come from rapid-freeze quench EPR studies
which would directly show generation of N* by NH2Y*, if NH2Y-a2s are in fact active. The
results in this Chapter further suggest that detailed pre-steady state kinetic analysis of the
reactions with N3CDP/ATP and CDP/ATP in conjunction with kinetic modeling are likely to
uncover additional rate constants in Figures 4-19 & 4-20. Important in this regard will be the
rate constant of for steps k3/k5 and kc in Figures 4-19 & 4-20, respectively. Perhaps the most
interesting rate constant is k3. This step (k3) is thermodynamically unfavorable and may be rate
limiting in Figure 4-19.
kobs = kAkB (4-3)kB + kc
Implications for mechanism of oxidation. The results above strongly suggest that
NH2Y-a2s are active. Competence in nucleotide reduction has interesting mechanistic
implications for radical propagation within Y730NH2Y-a2. Three mechanisms may be
envisioned for oxidation of C439 by NH2Y 730*: This reaction may occur by (1) a stepwise process,
i.e. electron transfer (ET) followed by proton transfer (PT), (2) an orthogonal proton-coupled
electron transfer (PCET) or (3) a co-linear PCET (i.e. hydrogen atom transfer - Figure 4-21).90-
92 The option of the stepwise process may be eliminated due to thermochemical bias against
formation of high energy charged intermediates in the non-polar a2 active site as well as the
insurmountable energy barrier for formation of a cysteine cation radical by the NH2Y*/NH2Y-
couple (Figure 4-21A).91 Orthogonal PCET requires oxidation of C439, which has a solution
reduction potential of 1.33 V at pH 7, by a NH 2Y* which has E' of 0.64 V at pH 7 (Figure
4-21B).1,51 Therefore, the second option would require a thermodynamically uphill process that
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is unfavorable by 16 kcal/mol. The hydrogen atom transfer mechanism, however, is
thermodynamically more accessible (Figure 4-21C). Its feasibility is based on knowledge of the
homolytic bond dissociation energies of R-SH (88-91 kcal/mol) and o-aminophenol, calculated
to be 78-83 kcal/mol.1,93-95 Therefore, oxidation of C4 39 by NH2Y730 * by a hydrogen atom
transfer mechanism, assuming no perturbations in the protein milieu, is uphill by 'only' 5-13
kcal/mol. Thus, nucleotide reduction activity in Y730NH2Y-a2 would thermodynamically favor
a hydrogen atom transfer mechanism for C439* formation by NH2Y730*.
Interestingly, the bond dissociation energy of catechol (82-83 kcal/mol) is similar to that
of o-aminophenol. 93 However, DOPA356-P2 is inactive in nucleotide reduction. In case of
DOPA-02 orthogonal PCET, the functional mechanism of oxidation at this residue (i.e. similar
to Fig. 4-21B), requires matching redox potentials for efficient radical propagation and
nucleotide reduction. With, Y730NH2Y-a2, competence in nucleotide reduction, despite
unmatched redox potentials (-0.69 V difference), appears to be reconciled due to a different
mechanism of oxidation via hydrogen atom transfer, which appears to operate at this residue in
the pathway.
In conclusion, we report evolution of a suppressor tRNA/RS pair that is specific for the
unnatural amino acid NH 2Y. Site-specific insertion of NH2Y will be useful for other systems
that use Y*s in catalysis and for attaching probes of interest to a target protein. Using this
technology we generated Y730NH2Y-a2 and Y731NH2Y-a2 and tested involvement of these
residues in long-range radical propagation. The results demonstrate kinetically competent
radical transfer from the Y122* in P2 across the subunit interface and trapping of NH2Y 730* or
NH2Y 731*. This event is triggered by binding of substrate and effector. Steady state activity
assays in conjunction with reactions with the suicide inhibitor N3ADP indicate that
Y730NH2Y-a2 and Y731NH 2Y-a2 are competent in nucleotide reduction. This implicates a
hydrogen atom transfer mechanism for oxidation of C439 by NH2Y730*. Definitive evidence for
activity of NH2Y-a2s requires a detailed kinetic analysis of the decay of NH2Y* and formation
of No with the mechanism-based inhibitor N3NDP.
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Figure 4-19. Working model for loss of spin during reaction of NH2Y-a2s with CDP/ATP. Steps
kl, radical initiation, and k4, nucleotide reduction, occur with rate constants of 2 s-1 and 500 s- 1,
respectively. Reactions k2 and k6 lead to loss of radical by consumption of NH2Yo. Rate constants for
the oxidation of C439 by NH2Y* (k3) or the reverse reaction (k5) have not been determined. Reverse
radical migration is indicated by k7.
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Figure 4-20. Working model for loss of spin during reaction of NH2Y- 2s with N3ADP/dGTP.
After radical initiation and NH2Y* formation (kA), partitioning occurs between C439* formation and
subsequent No formation (kc) or quenching by yet unknown mechanisms (kB).
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Figure 4-21. Mechanistic options for oxidation of C439 by NH2Y 730*. (A) Stepwise ET/PT. The
initial ET event generates a distinct intermediate which contains a thiyl cation radical and an
3-aminotyrosinate (NH2Y730-). Subsequent PT yields a neutral thiyl radical and NH 2Y730 . This
reaction is highly disfavored (see text). (B) Orthogonal PCET - ET and PT are coupled but the
electron and proton have different destinations. The proton of C439 is transferred orthogonally to a
basic residue, its electron is transferred to NH2Y 730*, thus generating a C439* and NH2Y730. (C)
Co-linear PCET - Hydrogen atom transfer from C439 to NH 2Y 730*. Proton and electron originate from
and arrive at the same moiety.
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CHAPTER 5:
Detailed Kinetic and Spectroscopic Examination of NH 2Y*
Formation with NH 2Y-a2s
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INTRODUCTION
Ribonucleotide reductases (RNRs) catalyze the conversion of nucleotides to
deoxynucleotides, thereby providing the monomeric units required for DNA replication and
repair. 1' 2 The class Ia RNR from E. coli is the best studied RNR to date. It consists of a 1:1
complex of two homodimeric subunits: a2 and [2.3,4 a2 is the site of nucleotide reduction. It
contains the active site as well as binding sites for allosteric regulators, which control the rate
and specificity of nucleotide reduction. 02 houses a diiron tyrosyl radical (Y122*) cofactor
essential for nucleotide reduction.5 Each turnover requires radical transfer from Y122* in 12 to
C439 in a2. The mechanism of this event, the radical initiation, is a major unresolved issue.6'7
A structure of the active RNR complex has not been solved. However, based on docking
of individual structures of a2 and 32, Uhlin and Eklund made the unusual proposal that a
pathway consisting of aromatic amino acids would transport the radical from Y122* in 32 over 35
A to the active site of a2 (Figure 5-1).8'9 This was a bold proposition for several reasons. In no
other systems are amino acids known to transport radicals over a long distance. All other long
range electron transfer pathways contain metal cofactors, which are absent from the proposed
pathway in RNR. Additionally, in contrast to the majority of electron transfer pathways, which
are irreversible, the radical generation pathway in RNR is reversible.
Nevertheless, evidence from various approaches has accumulated ultimately making a
strong case that long range radical transfer mediated by aromatic amino acids is the mechanism
of C439* generation in the E. coli RNR (see Chapters 2, 3 & 4). Important in this regard were the
seminal experiments by Reichard and Ehrenberg, demonstrating that the Y122* participates in
catalysis, 5 as well as studies by Stubbe and coworkers, which unraveled a radical nucleotide
reduction mechanism and revealed nucleotide radical formation at the expense of Y122* with
mechanism-based inhibitors. 10-13
Initial evidence for the pathway in Figure 5-1 came from site-directed mutagenesis
studies, which showed that mutation of any residue in the pathway abrogates nucleotide
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Y122 W48
25A
>. GDP
3.4 ASL
Y356(?)
Figure 5-1. The proposed radical initiation pathway within an cp pair. Residues in grey have been
shown to be redox-active using DOPA-02 and NH 2Y-a(2s, respectively. Note that the position of
Y356 iS unknown.
reduction activity. 14' 15 Complementation studies subsequently showed that these residues were
required in vivo as well as in vitro. 16 These studies implicated involvement of the residues in
Figure 5-1 in radical propagation, however, a large conformational change that would reduce the
distance between Y122* and C439 remained a possibility.
Compelling evidence against such a conformational change and for the docking model
has recently been obtained using pulsed electron-electron double resonance (PELDOR)
spectroscopy and double quantum coherence (DQC) spectroscopy, which can measure the
distance between two paramagnetic species separated by 15-80 A.' 7, 8  Studies using the
mechanism-based inhibitor 2'-azido-2'-deoxyUDP (N3UDP), which gives rise to a stable
N-centered radical (No) in the active site of a2, allow the 'diagonal' distance between the Y122°
in one ap pair and the No in the other ap pair to be measured. The distance obtained was similar
to that calculated from the docking model.19
The pathway consists of P2-W 48 and three tyrosine residues (Y356 in P2, Y730/Y731 in a2).
Evidence for redox activity of residue W48 has been obtained from examination of in vitro
reconstitution of the diiron Y122* cofactor in apo 32, even before the proposal of long-range
radical propagation.20-22 In these experiments UV-vis, EPR and Mdssbauer spectroscopic
methods revealed formation of a W4 8H*+ adjacent to a FeI'-FeIv cluster. Further, under Fe
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limiting conditions, oxidation of Y122 by W48H*+ directly established communication between
these residues. These observations have been complemented with Y-W dipeptide model studies,
which demonstrate that reversible oxidation of Y by W* is chemically feasible depending on the
protonation state of each residue.23 These results provide chemical precedence for the reversible
communication proposed between Y122* and W48.
The involvement of residue Y356 in radical propagation has been interrogated by
semisynthetic construction of p2.24,25 The construction method involved intein-mediated
site-specific incorporation of unnatural amino acids. The analogues incorporated sterically
resemble Tyr, but have altered reduction potentials and pKas. Incorporation of 3,4-
dihydroxyphenylalanine (DOPA), which has a lower reduction potential than Tyr (260 mV lower
at pH 7), led to trapping of a DOPA 356*, its formation requiring binding of substrate and/or
effector. Formation of DOPA* occurred concomitantly with disappearance of Y122* in a
kinetically competent fashion (see Chapters 2 & 3). Thus these experiments demonstrated direct
communication between residues 356 and 122. In a variant of DOPA-02, DOPA-PP' (where
the P'-monomer lacks the C-terminal 22 residues), this communication was observed in both
directions: after formation of DOPA356*, reformation of Y122* was accompanied by loss of
DOPA356*. Incorporation of a series of fluorotyrosine analogues (FnYs) has provided additional
convincing evidence for a redox active role of residue 356 in radical generation and shed light on
the mechanism of oxidation of this residue.
26-28
To investigate the roles of residues Y730/Y731 in radical propagation, we recently used the
suppressor tRNAlsynthetase method, pioneered by Schultz and coworkers, to site-specifically
replace each of these residues with the Tyr analogue 3-aminotyrosine (NH2Y - see Chapter
4).29,30 This analogue is 190 mV easier to oxidize than Tyr.3 1 Examination of NH 2Y-a2 variants
demonstrated kinetically competent radical propagation into the a2 subunit and formation of a
new radical species, which we proposed was a NH 2Y* based on UV-vis and EPR
characterization. In this chapter, we further investigate the structure of the putative NH2Y. using
15N and 2H isotopic substitution, 9 GHz and 180 GHz EPR spectroscopies, EPR spectral
264
simulation and density functional theory (DFT) calculations. Our results unambiguously
demonstrate that the new signal is associated with the NH2Y probe, provide insight into the
conformation of the NH2Y* within a2, and yield spin densities for the major nuclei interacting
with the unpaired spin. This is the first detailed characterization of an NH2Y* within an enzyme.
The position of the NH 2Y* within the a2/02 complex is examined using PELDOR spectroscopy.
The results give distances between the newly formed NH 2Y*, at residue 730 or 731, in one •p
pair and the remaining Y122* in the other ap pair, which are consistent with the distances
predicted by the docking model. In addition, studies with Y356F-02 show that formation of
NH2Y730 * and NH2Y 731* is pathway-dependent. Alternative pathways circumventing Y356 do not
exist. Finally, X-band EPR and SF UV-vis spectroscopic methods with various
substrate/effector combinations reveal a new role for the allosteric effector in catalysis.
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MATERIALS AND METHODS
Materials. L-Tyrosine, 15N-HNO 3 (conc: -10 N, 98 % '5N enrichment), Palladium
catalyst on carbon (10 wt % loading), 1,10-phenanthroline, hydroxyurea, Sephadex G-25 and all
nucleotides (CDP, GDP, UDP, ADP, ATP, TTP, dGTP) were obtained from Sigma-Aldrich.
D20 (99.8 atom % in D) and Ni-NTA were from VWR and Qiagen, respectively. 1H and "3C
NMR spectra were recorded on a Varian 300 MHz NMR spectrometer at the MIT Department of
Chemistry Instrumentation Facility (DCIF). Aqueous samples for 'H NMR and 13C
(1H-decoupled) NMR were carried out in D20 with 3-(trimethylsilyl)-propionic acid-d4 (TSP)
and tetramethylsilane as an external standards, respectively. His6-Y356F-32 was previously
prepared by Dr. Cyril Yee and contained 1.0 Y122* per dimer (specific activity <1/10 that of wt
P2). Steady-state absorption spectra were recorded on an Agilent 8453 Diode Array
Spectrophotometer.
Synthesis of 3-[ 15 N]-nitrotyrosine, [15N]-NO2Y. ['5N]-HNO 3 (10 N) contained 98 %
15N as determined by mass spectrometry. Synthesis of ['5N]-NO2Y was carried out as
previously described with minor modifications. 32 Prior to the synthesis, 15N-HNO 3 was diluted
to 7.5 N with water. L-Tyr (7.0 mmol) was added to a 25 mL pear-shaped flask, equipped with
a stir bar, and dissolved in 5 mL H20 at room temperature. The mixture was supplemented with
1.55 mL of [15N]-HNO 3 (11.6 mmol) by dropwise addition over 1 min and stirred for 30 min at
room temperature to fully dissolve L-Tyr. The mixture was then cooled by stirring for 15 min in
an ice-water bath. Then 4 mL of ["SN]-HNO 3 (30 mmol) were added dropwise to the mixture at
4'C over 2 h (8 x 0.5 mL additions of [15N]-HNO 3 in 15 min intervals). The solution was then
stirred for an additional 5 h at 40C and refridgerated overnight, which caused precipitation of
[15N]-NO2Y. The precipitate was isolated and dried by vacuum filtration on a coarse Buchner
funnel providing product in 80 % yield (5.6 mmol). The product was analyzed by 1H and 13C
NMR and by UV-vis spectroscopies.
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To determine the extinction coefficients, 20-30 mg of the product were weighed out and
dissolved in a defined volume of water. UV spectra were acquired on a Cary3 UV-vis Spectro-
photometer. Extinction coefficients were then calculated using Beer's Law. A similar procedure
was carried out with 'authentic' NO 2Y obtained from Sigma-Aldrich.
1H NMR (300 MHz, D20, 25 oC) 8= 3.18 (dd, 1H, CO-H 1, 7.4 Hz, 14.8 Hz), 3.30 (dd, 1H,
Cp-H 2, 5.8 Hz, 14.8 Hz), 4.24 (dd, 1H, Ca-H, 5.8 Hz, 7.4 Hz), 7.14 (dd, 1H, arom. C-H, 1.1 Hz,
8.7 Hz), 7.54 (dd, 1H, arom. C-H, 2.2 Hz, 8.7 Hz), 8.01 (t, 1H, arom. C-H, 2.2 Hz). 13C NMR
(300 MHz, D20, 25 OC) 6= 34.7 (s, Cp), 54.2 (s, Ca), 120.4 (d, arom. C2, 2.1 Hz), 126.1 (d, arom.
C1, 1.6 Hz), 126.8 (d, arom. C4, 2.4 Hz), 134.2 (d, arom. C3, 15.2 Hz), 138.2 (s, arom. C6), 153.1
(d, arom. C5, 1.2 Hz), 172.1 (s, COOH). UV-vis (H2O/HC1, pH 2) hx -277 nm (8 -5500
M-'cmn'), 2m -358 nm (8 -2600 M-'cm-'); (H20/NaOH, pH 12) mx -286 nm (E -4100
M-'cm-1), ý, -431 nm ( ~-4100 M-'cm-1).
Synthesis of 3-[iSN]-aminotyrosine, [1SN]-NH2Y. [15N]-NO 2Y (5.2 mmol) was
combined with 18 mL H20 and 70 mL MeOH in a 250 mL round bottom flask, equipped with a
stir bar, at room temperature. The solution was supplemented with 0.52 mmol (550 mg) of Pd/C
catalyst. The mixture was evacuated gently and filled with H2(g) several times. It was then
stirred for 2 h under H2 atmosphere using a double H2(g) balloon. After the incubation, the
catalyst was removed by filtration using a fine Buchner funnel. The solvent was removed in
vacuo providing product in quantitative yield. The product was dissolved in a small volume of
water, lyophilized to dryness and assessed by 'H, 13C NMR and UV-vis spectroscopic methods.
It was >95 % pure as determined by NMR spectroscopy. Extinction coefficients for the product
and 'authentic' NH2Y (Sigma-Aldrich) were determined as described above for NO 2Y.
1H NMR (300 MHz, D20, 25 OC) 8= 3.12 (m, 2H, Cp-Hs), 3.90 (t, 1H, Ca-H, 6.3 Hz),
6.99 (m, 1H, arom. C-H), 7.19 (m, 2H, arom. C-H). 13C NMR (300 MHz, D20, 25 OC) 8= 35.2
(s, Cp), 55.5 (s, Ca), 116.9 (s, arom. C1), 118.2 (d, arom. C3, 9.4 Hz), 124.8 (d, arom. C2, 1.7 Hz),
126.9 (d, arom. C4, 1.9 Hz), 131.4 (s, arom. C6), 149.5 (s, arom. C5), 173.3 (s, COOH). UV-vis
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(H20/HC1, pH 1) X -275 nm (8 -1900 M-lcm 1); (H20, pH 7) X -289 nm (E -3200
M-cmr-1); (H20/NaOH, pH 12) X ~ -303 nm (E -4700 M-'cm-).
Growth, expression and purification of [15N]-NH2Y730-a2. All procedures were
carried out as detailed in Chapter 4 without modifications and gave 6 mg of pure
[15N]-NH2Y730-a2 per g of wet cell paste.
Activity assays. The activity of [15N]-NH 2Y730-a2 was determined by the spectrometric
assay (Chapter 4).
Reaction of Y73oNH 2Y-a2 with 12, NDP/(d)NTP monitored by EPR spectroscopy.
The reaction of pre-reduced Y730NH2Y-a2 with P2 (1.0 Y122*/dimer, 6200 nmol/minomg) was
carried out with all four substrate effector pairs in parallel. Y730NH2Y-a2 and effector were
mixed with 32 and substrate in a final volume of 250 gpL to yield final concentrations of 24 jPM
Y730NH 2Y-a2/02, CDP/ATP (1 mM, 3 mM), GDP/TTP (1 mM, 0.25 mM), UDP/ATP (1.5 mM,
3 mM) or ADP/dGTP (1 mM, 0.12 mM). All four reactions were quenched after 20 s by
hand-freezing in liquid N2. EPR spectroscopy and data processing was carried out as detailed in
Chapter 4.
Reaction of [15N]-Y 730NH 2Y-a2 with 02 and NDP/(d)NTP monitored by EPR
spectroscopy. [15N]-NH2Y730-a2 was pre-reduced as described in Chapter 4. The reaction of
pre-reduced [15N]-Y 730NH2Y-a2 with 02 (1.2 Y122*/dimer) was carried out with all four
substrate/effector pairs in parallel under conditions identical to those described for
Y730NH2Y-a2 above.
Reaction of Y730NH 2Y-a2 or [15N]-Y 730NH 2Y-a2 with 12, NDP/(d)NTP in
deuterated buffer monitored by EPR spectroscopy. Assay buffer (50 mM Hepes, 15 mM
MgSO 4, 1 mM EDTA) was prepared in D20 and its pD adjusted to 8.0. Nucleotides stock
solutions were prepared in deuterated assay buffer. Y730NH 2Y-a2, [15N]-Y 730NH2Y-a2 and P2
were exchanged into deuterated buffer by multiple concentration/dilution cycles at 40C using a
centriprep concentration device and a YM-30 membrane until the solution consisted >99 % of
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deuterated buffer. The reaction of Y73oNH 2Y-a2/02 (or [15N]-Y 730NH 2Y-a2) in deuterated
buffer with various substrate/effector pairs was carried out as described above.
Preparation of high-field EPR and PELDOR samples. Pre-reduced Y730NH2Y-a2
(or Y731NH2Y-a2) and [32 were combined in an equimolar ratio and concentrated at 40C in a
minicon concentration device (YM-30 membrane) to a final complex concentration of 70-100
PM (9 280nm(oW2+ 2 ) = 320 mM-lcm-1). The concentrated sample was divided into 100 pL aliquots
and placed in 1.5 mL Eppendorf tubes, flash-frozen in liquid N2 and shipped on dry ice along
with substrate/effector solutions and glycerol-containing buffer to Prof. Marina Bennati at the
University of Frankfurt (Germany). High-field EPR and PELDOR samples were prepared by
Prof. Marina Bennati by thawing each aliquot on ice and adding 5 pL of a substrate/effector mix
to yield final concentrations of CDP/ATP (1 mM, 3 mM) or GDP/TTP (1 mM, 0.25 mM). Each
reaction was allowed to proceed for 30 s at room temperature, at which point 15 pL of glycerol
buffer (100 mM Hepes, 30 mM MgSO 4, 2 mM EDTA, 50 % glycerol, pH 7.6) was added to
yield a final glycerol concentration of -6 %. The reaction was quenched immediately after
addition of glycerol buffer by hand-freezing in liquid N2. High-field (180 GHz) EPR and
X-band PELDOR spectra were recorded and analyzed by Dr. Vasyl Denysenkov and Prof.
Marina Bennati.
Simulation of X-band EPR spectra. The EPR powder spectra of NH2Y*-a2 in the
presence of CDP/ATP were analyzed using SimFonia software (Briker) for simulation of
anisotropic g- and hyperfine tensors. The g values used were determined by 180 GHz EPR
spectroscopy. For all simulations, a Lorentzian/Gaussian ratio of 0.3 was used. Only hyperfine
couplings from I=1/2 and I=1 (for [14N]-NH2Y*) were varied to yield the best fit to the
experimental data. For simulation of NH2Y*-a2 spectra in protonated and deuteratd buffer an
isotropic line width parameter of 15.4 and 8.4 MHz were used, respectively. To assess the
quality of the simulation, the experimental and simulated spectra were normalized to unit area.
)2 was then computed using Eq. 5-1, where yi and y'i are the data for the experimental and the
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simulated spectrum, respectively. 33 Iterative rounds of simulation and calculation of X2 were
performred until X2 was optimized.
2 = (yi -y'i)2 (5-1)
Computational studies. DFT calculations were performed by Dr. Jbrg Fritscher and
Prof. Marina Bennati at the University of Frankfurt. The simulation in Figure 5-8C was carried
out by Dr. Debora Martino using an in-house program written in MatLab.
Reaction of Y731NH 2Y-oa2 with 132, NDP/(d)NTP monitored by EPR spectroscopy,
The reaction of pre-reduced Y731NH2Y-a2 with 132 (1.2 Y122*, 7800 nmol/min-mg) was carried
out with all four substrate effector pairs in parallel. Y731NH 2Y-a2 and effector were mixed with
132 and substrate to yield final concentrations of 20 pM Y731NH2Y-a2/032, CDP/ATP (1 mM, 3
mM), GDP/T1P (1 mM, 0.25 mM), UDP/ATP (1.5 mM, 3 mM) and ADP/dGTP (1 mM, 0.12
mM). All four reactions were quenched after 20 s by hand-freezing in liquid N2. EPR
spectroscopy and data processing was carried out as detailed in Chapter 4.
Reaction of Y730NH2Y-a2 (or Y731NH 2Y-a2) with His6-Y356F--32 monitored by
EPR spectroscopy. Pre-reduced Y730NH2Y-a2 (or Y731NH 2Y-a2) and ATP were mixed with
His6-Y 356F-32 and CDP to yield final concentrations of 15 .tM, 3 mM, 15 pLM and 1 mM,
respectively. The reaction was quenched at 20 s or 2 min by hand-freezing in liquid N2. A
similar reaction under identical conditions was carried out with GPD/TTP with final
concentrations of 1 mM and 0.2 mM, repsectively. For a direct comparison, a reaction was also
carried out with wt 132 in the presence of CDP/ATP in parallel. Acquisition of EPR spectra and
spin quantitation were described in Chapter 4. Note that the pre-reduction procedure removes
the Y122* Of copurifying wt 132 in the NH2Y-a2 preparations.
SF UV-vis spectroscopy of NH2Y-ac2/12 with various NDP/(d)NTP pairs. All
reactions were carried out in assay buffer (50 mM Hepes, 15 mM MgSO 4, 1 mM EDTA, pH 7.6).
In all cases Y730NH2Y-a2 (or Y731NH2Y-a2) and effector (if present) in one syringe were
combined with 132 and substrate (if present) from a second syringe to yield 5 pM NH2Y-a2/132.
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The following substrate and/or effector combinations (final concentrations) were studied:
CDP/ATP (1 mM, 3 mM), GDP/TTP (1 mM, 0.2 mM), UDP/ATP (1 mM, 3 mM), ADP/dGTP
(1 mM, 0.2 mM), CDP (1 mM), GDP (1 mM), UDP (1 mM), ADP (1 mM), ATP (3 mM), TTP
(0.2 mM) and dGTP (0.2 mM). The reactions were monitored at 325 nm for Y730NH2Y*-a2, (E
-10500 M-'cmn- ) and 320 nm for Y731NH2Y*-a2 (E ~11000 M-lcmn'). In each experiment, 5-7
were traces were averaged and kinetic parameters obtained by curve fitting using OriginPro or
KaleidaGraph Software. Iterative rounds of fitting and calculation of a residual plot and the R2
correlation value were carried out until both were optimized. All the fits shown had satisfactory
residuals throughout the time course, i.e. randomized scatter at Abs-~0, and R2 values Ž0.99.
Temperature-dependent SF UV-vis spectroscopy of Y73oNH2Y-0a2/32 with
CDP/ATP. Temperature-dependent SF UV-vis experiments were carrid out between 23oC and
360 C. The final concentrations were 4 pM Y730NH2Y-a2/I2, 1 mM CDP, 3 mM ATP in assay
buffer (50 mM Hepes, 15 mM MgSO4, 1 mM EDTA, pH 7.6). The instrument was equilibrated
at each temperature (23, 25, 28, 34, 360 C) for 10-15 min before acquisition of kinetic traces.
The internal instrument temperature reading was within 0.4-0.80 C of the temperature setting
used on the circulating water bath. At each temperature, formation of NH2Y 730* was monitored
by averaging 5-7 individual traces at 325 nm. Kinetic parameters were obtained by fitting to
double-exponential curves using OriginPro Software. To obtain thermodynamic parameters,
Eyring analysis was performed by plotting ln(kobs/T) vs. 1/T and fit to Eq. 5-2, where kobs is the
observed fast or slow rate constant for NH2Y* formation, T is the tempterature (from the
circulating water bath), kB is the Boltzman constant, h is Planck' s constant, R is the universal gas
constant, AH+ is the enthalpy of activation and AS+ is the entropy of activation. Using the AH+
and AS+ values obtained from this analysis, the free energy of activation for the reaction (AG+)
at 25 0C was computed using Eq. 5-3.
DH1 DS'ln(kobs/T) = ln(kw/h) + DH + S (5-2)RT RT
AG 4 = AH - TxAS 4 (5-3)
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RESULTS
Isotope labeling of NH2Y to examine the new signal with NH2Y-a2s by EPR
spectroscopy. To assess the involvement of residues Y730 and Y731 in radical propagation, we
recently reported efficient site-specific incorporation of NH2Y into a2 using the amber
suppressor tRNA/ aminoacyl-tRNA synthetase method developed by the Schultz lab. We
demonstrated formation of a putative NH 2Y* based on UV-vis, EPR and EPR power saturation
studies, only in the presence of CDP/ATP. Further assignment of the new EPR spectrum
requires isotopic substitution studies coupled with EPR and ENDOR spectroscpies, simulation of
the spectra and computational methods.
To support our assignment and obtain information about the orientation of the P-protons,
spin density distribution and H-bonding interactions, isotopic substitution studies have been
carried out. As noted in Chapter 4, no EPR spectrum of NH2Y* has been reported. However, the
o-aminophenol radical, an excellent surrogate for NH2Y*, has been examined in detail. These
studies have shown that the o-aminophenol radical has significant hyperfine coupling to the 14N
nucleus (I=1) and the exchangeable amine protons (1=1/2), although spin densities have not been
reported. A summary of the EPR parameters obtained for the o-aminophenol radical generated
by numerous laboratories using different oxidants is summarized in Table 5-1.34-39 The
variability of data in Table 5-1 is due to different oxidants or solvents in which the radical was
generated. In case of metal oxidants, such as Ce" or Co11 the structure of the radical was not
described. The o-aminophenol radical may be coordinated to the metal oxidant making
comparison with our NH2Yo inappropriate (Table 5-1, entries 2, 8, 9). In case of the organotin
oxidant, the structure of the resulting radical was analyzed. The o-aminophenol radical was
found to be coordinated to Sn; a Sn hyperfine constant of 160 MHz was reported (Table 5-1,
entry 7). In entry 4, a complicated oxidation mechanism involving hydrogen azide was used, but
the pH of the reaction was not reported. In entry 3, Dixon et al. have suggested a reassignment
of the data by Neta et al. (entry 1) based on analysis of their own spectra in entry 4 (Table 5-1).
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However, this reassignment is not consistent with earlier work by Dixon et al. (Table 5-1, entry
2) or with parameters provided by other groups (Table 5-1, entries 5-9). The data in entries 5
and 6 were acquired in CH2Cl2/THF and MeOH at -61 0 C and -75 0 C, respectively. These low
dielectric solvents may better simulate the environment in the protein interior, although the
dielectric at residues Y730 and Y731 is not known. It appears the data in entries 1, 5, and 6
provide the best models for comparison with our NH 2Y* as the radicals were generated by
standard radiolysis or photolysis methods and are not complicated by the presence of metal
oxidants.
According to these entries in Table 5-1, substitution of [14N]-NH 2Y with ['15N]-NH 2Y
would be expected to change its EPR spectrum by removing the triplet pattern produced by '4N
(I=1) and replacing it with a doublet pattern arising from the 1=1/2 nucleus of '5N. Due to the
similar gyromagnetic raios of 1'4N and ' 5N (15N/1 4N=1.4), the strengths of hyperfine coupling is
not expected to change significantly.
The results in Table 5-1 also show that the exchangeable aromatic amine protons of
NH2Y have significant hyperfine interaction with the unpaired spin. Thus, replacement of these
protons may be used to interrogate the identity of the new signal. Replacement of 1H (1=1/2)
with 2H (I=1) would be expected to change its EPR spectrum based on the change in the nuclear
spin quantum number. However, due to the smaller gyromagnetic ratio of 2H compared to 'H
('H/2H=6.5), the splitting by 2H would be too small to be resolved in our frozen solution spectra.
Thus, replacement of 2H with 1H would effectively eliminate hyperfine splitting from the
exchangeable amine protons in deuterated buffer. It would also eliminate weakly coupled matrix
protons or H-bond interactions that may be present and result in a trace with a narrower spectral
width.
The data in Table 5-1 also indicate a significant hyperfine splitting from the C4-proton
(Figure 5-1). This indicates a substantial spin density at C4. Consequently, we would expect a
significant hyperfine interaction from the P-protons in NH2Y* via a hyperconjugation
mechanism, the basis of which has previously been described.
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Table 5-1. Summary of EPR parameters (in MHz)a previously reported for an o-amino-
phenol radical.b
Entry Reference g factor bA3H bA4H bA5H bA6H bAN bAN'H
1 Neta et al.c 2.00372 <0.28 12.1 2.8 8.2 13.3 14.8 (2)m
2 Dixon et al.d nr' -2.52 18.5 4.2 7.3 18.5 22.8
3 Dixon et al.e nr 0 12.1 8.2 2.8 13.3 14.8 (2)m
4 Dixon et alf nrI  1.4 11.9 7.1 2.9 14.1 17.0
5 Loth et al.g  nrd 1.29 6.5 1.5 6.1 12.4 21.3/16.2
6 Loth et al. h nrl  0.28 8.4 3.9 7.0 12.6 19.3/15.4
7 Sur et al.' 2.0025 4.82 9.6 4.8 <0.28 14.4 19.3
8 Simandi et al. 2.0041 2.13 11.8 2.1 5.9 12.7 18.2 (2)m
9 Simandi et al.k 2.0047 2.13 11.8 2.1 5.9 12.7 2.8 (2)m
2.0037 - 0- 6.5 - 1.5 - <0.28 12.4 - 14.8 -
2.0047 4.82 18.5 8.2 - 8.2 18.5 22.8
a Hyperfine coupling constants were reported in Gauss, they have been converted to MHz as per 1 G=2.8 MHz. b
See Figure 5-2 for numbering scheme of o-aminophenol radical. AH is the hyperfine coupling constant from the
proton attached to C, of the o-aminophenol radical. AN is the coupling from the N-nucleus, ANH is the coupling
from the amine protons. c Generated by in situ radiolysis/EPRspectroscopy in water at room temperature (Ref. 34).
d Generated by reaction of o-aminophenol in water with Ce and monitored by flow EPR at RT (Ref. 36). e
Suggested assignment by Dixon et al of the data in Neta et al (Ref. 35). f Auto-oxidation in water in the presence of
hydrogen azide and p-benzoquinone at RT. g Spectra obtained in CH2C12/THF at -61 0C (Ref. 39). h Spectra obtained
in CH30H at -75 0C (Ref. 39). i Data are for a 4-t-butyl-2-aminophenoxyl radical complexed to triphenyltin -
generated by in situ irradiation at RT (Ref. 38). i Oxidation mediated by Co1n in CH3OH, monitored at 250C (Ref.
37). k Oxidation mediated by Con in CD30D, monitored at 250C (Ref. 37). i nr, not reported. m Two protons with
identical hyperfine splitting constants.
0*
6 d3NH 2
5 3
4
Figure 5-2. Numbering scheme for o-aminophenol radical data in Table 5-1. Accordingly, A 3H in
Table 5-1 corresponds to the hyperfine coupling constant from the proton attached to C3.
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Preparation of [15 N]-NH 2Y. To test these predictions, [' 5N]-NH2Y was prepared
according to the synthetic route in Scheme 5-1 in 80 % yield with 98 % ['5N] isotopic
enrichment (see Materials). As expected, the nuclear coupling from '5N to 13C was observed in
'H-decoupled 13C NMR and in 'H NMR spectra of [15N]-NH 2Y. Interestingly, in case of
[S5N]-NO 2Y, 1J, 2J and 3j couplings were observed in the 13 C NMR spectrum on the order of
15.2 Hz, 2.3 Hz and 1.4 Hz, respectively (Figure 5-3). With [15N]-NH 2Y, only the 'J and 2j
couplings are present in the 13C NMR spectrum at 9.4 Hz and 1.8 Hz, respectively (Figure 5-3).
Previous NMR studies with aniline have shown 'J, 2J and 3 15 N-_13C couplings on the order of
13.9-14.8, 2-4 and 0-1.5 Hz, respectively, depending on the solvent and concentration.40
'
5NH:
OH
H2N C••OOH
H15NO3 Pd-C
H2(9)
H2N H2N
Scheme 5-1. Synthetic scheme used for preparation of 'SN-NH 2Y. See Methods for details.
2 j, 2.4 Hz OH 21J, 15.2 Hz
3J, 1.2 Hz 2j, 2.1 Hz
H2N 3J, 1.6 Hz
COOH
2J, 1.9 1 1J, 9.4 Hz
2
2 J, 1.7 Hz
COOH
Figure 5-3. '5N-' 3C J-couplings observed with [15N]-NO 2Y (left) and [15N]-NH 2Y (right). The
strength of 'J, 2J and 3J couplings from the 'H-decoupled '3C NMR spectrum are shown.
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To further confirm the identity of the product, pH-dependent UV-vis spectra were
acquired. The /max and 6 for 3-ammoniumtyrosine, 3-aminotyrosine and 3-aminotyrosinate
were determined with authentic NH 2Y (from Sigma-Aldrich) at low, neutral and high pH,
respectively (Scheme 5-2). This data is summarized in Table 5-2. Measurement of these values
for our synthetic [15N]-NH 2Y showed a very similar trend (Table 5-2). Thus, the 1H, 13C and
UV-vis analyses confirm that the product is in fact [15N]-NH 2Y.
OH OH O
pNH2 .NH 2
pKa,-4.9 pKa10O.1
~I n L2LC
Scheme 5-2. Different protonation states and pKas of NH2Y. Species A, B, and C have absorption
maxima at 275, 289, and 303 nm, respectively. The pKas for conversion of A to B and B to C are from
Refs. 31 and 32.
Table 5-2. UV spectral properties of authentic 14N-NH 2Ya and synthetic ' 5N-NH2Y
determined in H20 at 25 0 C.
Authentic NH 2Y Synthetic '5N-NH 2YProtonation Form
max (nm)b, E (M-lcml)-1 c ax (nm), E (M'lcm-l)c
H3N+-Y 275 ± 1, 2150 + 150 275 ± 1, 1900 + 130
H2N-Y 289 ±1, 3200 ± 220 289 ± 1, 3200 + 220
H2N-Y- 303 ± 1, 5100 + 360 303 + 1, 4700 ± 330
a "Authentic" 14N-NH2Y was obtained from Sigma-Aldrich. b Estimated error based on accuracy of
spectrophotometer. C Estimated error based on accuracy of spectrophotometer and microbalance weight
measurements.
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Preparation of [1SN]-NH 2Y-a2. [15N]-NH 2Y was incorporated into a2 as described
for [14N]-NH2Y. Purification by dATP chromatography gave 6 mg 15N-labeled Y730NH2Y-a2
with 98 % ' 5N enrichment per g of wet cell paste. The product was >95 % pure by SDS PAGE.
Spectrophotometric assays revealed that nucleotide reduction occurred at 115 ± 12 nmol/minomg.
This is similar to the activity of 100 + 8 nmol/min.mg observed with Y73oNH2Y-a2 (Chapter 4).
Generation of [14N]-NH2Y 730o and [s1 N]-NH 2Y730. with various NDP/(d)NTP pairs.
The availability of [14N]- and [15N]-Y 730NH2Y-a2 allows us to examine the effect of [15N]
incorporation on the EPR spectra of NH2Y* and to test the generality of the effect of ['5N] by
carrying out the reaction with all substrate/effector paris, CDP/ATP, GDP/TTP, UDP/ATP and
ADP/dGTP. Pre-reduced [14N]-Y 730NH 2Y-a2 or [15N]-Y 730NH2Y-a2 and effector were
mixed with wt f32 and substrate. The reaction was hand-quenched after 20 s in liquid N2 and its
EPR spectrum recorded. This reaction time was chosen as the [NH2Y.] was found to be
maximal in the presence of CDP/ATP (Chapter 4). To investigate the effect of the exchangeable
amine protons on the EPR spectrum, the reaction of [14N]-Y 730NH 2Y-a2 and [15N]-Y 73oNH 2Y-
a2 with 02, substrate and effector were also performed in deuterated buffer (see Methods). Care
was taken to exchange both subunits into deuterated buffer by concentration/dilution cycles prior
to the reaction.
All spectra were composites of Y122* and NH 2Y* signals. The NH 2Y* were obtained by
subtracting the Y122* contribution as described in detail in Chapter 4. The results are presented in
Figure 5-4. Spectral widths, g values and the yield of NH2Y* for [14N]-Y 730NH 2Y-a2 in
protonated buffer are shown in Table 5-3. The spectra of [14N]-NH2Y 730* in protonated buffer
in the presence of CDP/ATP, GDP/TTP and UDP/ATP are similar, but different from that with
ADP/dGPT (Figure 5-4). The distinct features with ADP/dGTP may be explained by subtle
changes in the dihedral angle of one of the 13-protons, as we suggested in the case of DOPA-32
(Chapter 2). With CDP/ATP, GDP/TTP and UDP/ATP, 18-19 gM of total spin have remained
after 20 s reaction time. With ADP/dGTP, however, -60 % of the initial spin has been lost.
Therefore, the data in Table 5-3 suggest that the stability of the NH2Y* is dependent on the
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substrate and effector bound in the active site of a2. Observation of an EPR-active signal with
all four substrate/effector pairs is consistent with the proposed roles for Y730 as an intermediate
during radical initiation.
Spectra of [15N]-NH 2Y 730. in protonated buffer establish that 15N incorporation has an
effect on the EPR spectrum (Figure 5-4). However, the effect is difficult to describe because of
superposition of hyperfine splittings, presumably from the exchangeable amine protons and the
P-protons. Simulation of these spectra is necessary to uncover the effect of '5N incorporation
(see below).
The spectra of [14N]-NH 2Y730o and [15N]-NH 2Y730* in deuterated buffer, show a marked
perturbation relative to those in protonated buffer (Figure 5-4). Both spectra are sharper relative
to those in protonated buffer presumably due to elimination of hyperfine interaction from matrix
protons. The marked change from protonated to deuterated buffer indicates that the
exchangeable amine protons have significant hyperfine interaction with the unpaired spin. The
spectrum of [14N]-NH 2Y 730° appears as a doublet of doublets with a large and a small hyperfine
splitting constant. The spectrum of ['5N]-NH2Y730* has collapsed to an apparent anisotropic
triplet spectrum, clearly demonstrating the effect of 15N incorporation. Qualitatively, it appears
that the amine nitrogen displays anisotropic hyperfine interaction as the 15N hyperfine coupling
affects the spectrum only on the low field side. A more quantitative analysis of these traces
requires spectral simulations, which will be presented below. Together, these isotope-dependent
spectral shifts upon 15N incorporation or deuteration validate our hypothesis that the new signal
is associated with the NH 2Y probe.
As noted above, the features of the NH2Y 730* in protonated buffer in the presence of
ADP/dGTP are different from those of the remaining three pairs. In deuterated buffer, however,
this trend appears to have disappeared (Figure 5-4). This perhaps indicates that the different
features in protonated buffer arise from modulation of a hydrogen bond to the NH2Y 730 * as a
function of substrate/effector pairs in a2. Alternatively, the D20 environment may 'fix' the
dihedral angle of Cp-H, so that spectra in D20 are identical regardless of the substrate/effector
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bound in a2. At this point a distinction cannot be made. However, we have proposed that at this
junction in the radical transfer pathway proton and electron move together as an H atom.6 Thus,
detection of a hydrogen bond at NH2Y730• would have important implication for catalysis and the
role of proton-coupled electron transfer in hole migration. This requires detailed structural
analysis of the NH 2Y730* by various spectroscopic and computational methods as well as
experimental determination of the anisotropic g factors of NH2Y°.
Table 5-3. Yield of NH2Y* and total spin after reacting Y730NH 2Y-a2 with P2 and various
NDP/(d)NTP pairs for 20 s.
Spectral [NH2Y*]  Total SpinSubstrate/Effector g valuea Spectral [NHM) Remanl Sping(M)
width (G)b (ttM)C Remaining (pM)d
CDP/ATP 2.0043 24.0 ± 1 9.7 18.2
GDP/TTP 2.0044 25.0 + 1 10.1 19.4
UDP/ATP 2.0043 22.3 ± 1 9.3 18.2
ADP/dGTP 2.0041 22.1 ± 1 2.4 9.8
a The error in the g value measurements is ± 0.0001. b The peak-to-trough spectral widths are reported from a
single measurement. C [NH 2Y*] after 20 s reaction time. d Total spin remaining at 20 s relative to total spin at
t=0, which was 24 pM in these experiments.
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2.03 2.02 2.(01 2 1.99 1.98 2.03 2.02 2.01
g value g value
2 1.99 1.98
2.03 2.02 2.01 2 1.99 1.98
g value g value
Figure 5-4. Normalized EPR spectra of isotopically substituted NH2Y 730*. Spectra were acquired
with Y730NH 2Y-a2/132 containing [14 N]-NH2Y or ['5N]-NH2Y in protonated or deuterated buffer in
the presence of CDP/ATP (A), GDP/TTP (B), UDP/ATP (C) or ADP/dGTP (D). Note that spectra of
['4N]-NH 2Y 730* in deuterated buffer in the presence of UDP/ATP and ADP/dGTP have not been
collected. See Table 5-3 for further analysis of the spectra of ['4N]-NH 2Y 730* in protonated buffer.
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Analysis of NH 2Y7 30 * by 180 GHz EPR spectroscopy. To obtain the g anisotropy for
NH2Y 730 * necessary for spectral simulation and further characterization of the radical, high field
EPR spectra were acquired. Y730NH2Y-a2 and 02 were concentrated to 80 pM, and NH 2Y*
formation was initiated by addition of CDP/ATP. The reaction was hand-quenched in liquid N2
after 30-45 s. EPR spectra at 180 GHz and at 6 K or 70 K are shown in Figure 5-5. At 6 K, the
spectrum is a composite of Y122* and NH 2Y*. However, at 70 K, the signal associated with Y1229
adjacent to the diferric cluster is not observed and only the NH 2Y* is apparent. The g values
obtained from analysis of this spectrum reveal its anisotropy: gx=2.00520, gy=2.00420,
gz=2.00220 with an accuracy of ± 0.0001.
The value of gz is close to the free-electron g value (ge) of 2.002319. The g, and gy
values, however, significantly depart from ge. These results are consistent with the Stone g
matrix theory and will be further discussed below.41,42 The principal axes of the g matrix for
NH2Y* are defined in Figure 5-6A. Accordingly, g, is paralled to the C4-O bond, gz is
perpendicular to the aromatic plane and gy is perpendicular to g, and gz.
-300 -200 -100 0 100 200 300 64050 64100 64150 64200 64250
Field sweep (G) Field (G)
Figure 5-5. EPR spectra of NH2Y 730* at 180 GHz in the presence of CDP/ATP. (A) Spectrum at 6 K
containing 32/NH 2Y730*. This spectrum is a composite of Y122* and NH2Y* signals. (B) Spectrum at
70 K containing only the NH2Y730* signal with g values of gx=2.00520, gy=2.00420 and gz=2.00220.
The error in these measurements was + 0.0001.
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Figure 5-6. Numbering scheme, g tensor axis orientation and conformations of NH2Y*. (A)
Numbering scheme and axis orientations used for NH2Y* in DFT calculations and simulations (see
Tables 5-4, 5-5 & 5-6). Note that the z-axis is perpendicular to the molecular plane. (B) Dihedral
angle of Cg-protons used in the DFT calculation in Table 5-4. In this case, the calculations show a
strong hyperfine coupling constant to only one of the two Cr-protons. (C) Dihedral angle of
Cp-protons used in the DFT calculation in Table 5-5. In this case, the calculations show a strong
hyperfine coupling constant to both Cp-protons.
Spectral simulations. The availability of g values for NH2Y 730* facilitates simulation of
the EPR spectra in Figure 5-4. To guide in spectral assignment of our spectra, DFT calculations
were performed at the B3LYP level to predict the hyperfine coupling constants in the NH2Y*
system. These calculations were carried out on two conformations of NH2Y*, in which the
dihedral angels between the P-protons and the plane of the aromatic ring were different, to
assess their effect on the hyperfine interaction. The results are summarized in Tables 5-4 and
5-5. They show that in one conformation (Table 5-4 and Figure 5-6B), major hyperfine
coupling constants are expected from the ring proton ortho to the hydroxyl group (-11.08 MHz),
only one of the Cp-protons (15.94 MHz), the aromatic NH2 moiety (4.16 MHz with a major
z-component) and its exchangeable protons (-12.32 and -12.78 MHz). In another conformation
(Table 5-5 and Figure 5-6C), where the dihedral angle between the P-protons and the plane of
the aromatic ring has been changed by rotation about the Cp-CI bond, major hyperfine
interactions are expected from the ring-proton ortho to the hydroxyl group (-10.25 MHz), both
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Cp-protons (30.11 and 29 MHz), the aromatic NH2 group (4.22 MHz with a major z-component)
and its exchangeable protons (-12.54 and -13.01 MHz). Thus, depending on the conformation
of the NH 2Y730* within a2, one or both f-protons may show strong hyperfine interactions. The
strength of coupling will depend on the dihedral angle between the Cp-CpH bond and the plane
of the aromatic ring.
Table 5-4. Hyperfine coupling constants (in MHz) calculated
and 5-6B for numbering scheme and conformation of NH 2Y*.
Nucleus
N
N-H 1
N-H 2
P-H
P-H2
ring-H 2
ring-H 5
ring-H 6
Ax
-3.89
-17.64
23.34
14.16
1.65
1.95
-16.23
-2.9
A,
-3.53
-16.67
-15.57
14.42
1.8
4.22
-13.33
-2.17
Az
19.9
-21.99
0.56
19.21
5.88
8.21
-3.63
3.06
for NH2Y*. See Figures 5-6A
Aiso
4.16
-12.32
-12.78
15.94
3.11
4.8
-11.08
-0.67
Table 5-5. Hyperfine coupling constants (in MHz) calculated for NH2Y* in an alternative
conformation. See Figure
conformation of NH2Y*.
Nucleus
N
N-H 1
N-H 2
P-Hi
V-H2
ring-H 2
ring-H 5
ring-H 6
5-6A and 5-6C for numbering scheme and the alternative
Ax
-3.97
-18.03
-23.73
28.04
26.95
1.88
-15.05
-3.37
Ay
-3.6
-16.93
-15.83
28.94
27.81
4.16
-12.5
-2.84
Az
20.23
-2.65
0.54
33.34
32.24
8.27
-3.2
2.82
Aiso
4.22
-12.54
-13.01
30.11
29
4.77
-10.25
-1.13
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Simulation of EPR spectra of [s'N]-NH2Y730o* acquired in deuterated buffer was
attempted first. In this case, hyperfine coupling to the exchangeable deuterons is very small thus
facilitating the simulations by lowering the number of unknown hyperfine coupling constants.
Consequently, only the N-nucleus of the amine group, the ring proton ortho to the hydroxyl and
one or two Cp-protons need be included in the simulations. The g values determined by EPR
spectroscopy at 180 GHz were used in the simulations. Previous experiment and theoretical
studies with Y*s have shown that the hyperfine interaction with the ring proton is anisotropic.43'44
Thus, in case of the ring proton, an anisotropic hyperfine splitting was simulated. On the other
hand, Cp-proton hyperfine interactions have been shown to be isotropic or nearly isotropic in
several Ye-containing systems.45 There is not much precedence for simulation of an aromatic
N-nucleus containing amino acid radical within a protein. However, studies on a tryptophan
cation radical in cytochrome c peroxidase by Hoffman and colleagues46 and on a neutral
tryptophan radical in RNR by Lassman and coworkers47 demonstrate that the N-nucleus of an
aromatic amine group is axially coupled to the unpaired spin with a major z-component. These
studies are consistent with the DFT calculations in Tables 5-4 and 5-5, which show isotropic,
axial and anisotropic hyperfine interactions with the Cp-proton(s), the aromatic N-nucleus and
the ring proton ortho to the hydroxyl group, respectively. With these guidelines for the
symmetry of hyperfine interactions in mind, iterative rounds of simulation and calculation of x2
(see Methods) were performed until additional changes in the simulated parameters yielded no
further decrease in X2. Approximately 100 iterations were carried out with 5-12 unknown
hyperfine coupling constants from 3-4 nuclei (one or two Cp-protons, the N-nucleus and one
ring proton). The best solution consisted of an isotropic hyperfine splitting by the Cp-proton
(Ax=Ay=Az), axial hyperfine splitting by the N-nucleus (Ax=Ay 4 Az) and anisotropic hyperfine
interaction from the ring proton ortho to the hydroxyl group (Ax f Ay # Az). The axial
symmetry of the 14N hyperfine interacation shows that the axis of the largest 14N or 15N hyperfine
tensor, Az, is parallel to gz. As shown in Figure 5-6A, the gz-axis is perpendicular to the
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molecular plane. This orientation is found for most n radicals with planar It systems and is also
anticipated by theory. 46
The best simulation of the EPR spectrum of [15N]-NH2Y 730* in deuterated buffer is
shown in Figure 5-7A. The simulated parameters are summarized in Table 5-6. The data show
that a single Cp-proton is sufficient to yield a good simulation with a low X2 value. This sets a
constraint on the dihedral angle between each Cp proton and the plane of the aromatic ring.
BU 3300 3320 3340 
3360 0
Field (G) Field (G)
Figure 5-7. Simulation of [15N]-NH2Y730* EPR spectra in deuterated assay buffer. (A) Experimental
and simulated spectra of [15N]-NH2Y730* in the presence of CDP/ATP. (B) Experimental and
simulated spectra of [14N]-NH 2Y 730* in the presence of CDP/ATP. In this case the parameters were
identical to those in (A) except that the nuclear parameters for 15N were replaced with those of 14 N.
The parameters for these simulations are summarized in Tables 5-6.
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Table 5-6. Parameters (in MHz) used for simulation of [14N]-NH 2Y 730* and [15N]-NH2Y 730*
EPR spectra in protonated or deuterated buffer.a
Nucleus Ax A, Az Also
5NH2 Y - D20
CO-H
15N
ring-H 5 b
30.8
5.04
3.0
30.8
3.6
3.0
30.8
5.04
3.0
14.8
19.6
30.8
3.6
3.0
14.8
19.6
25.4
3.6
4.6
9.4
9.4
30.8
5.04
4.5
14NH2Y - D20
30.8
3.6
4.5
1 NH2Y - H 20
30.8
5.04
4.5
14.8
13.7
14NH2Y - H 20
30.8
3.6
4.5
14.8
13.7
14NH2Y - H20
25.4
3.6
4.6
9.4
9.4
30.8
11.4
-5.3
30.8
8.1
-5.3
30.8
44.2
8.5
30.8
31.5
8.5
30.8
44.2
8.5
19.0
4.2
30.8
31.5
8.5
19.0
4.2
33.0
26.8
8.0
3.6
3.6
27.9
6.5
-5.7
-7.5
-7.5
a See Figures 5-7 & 5-8
NH2Yo.
for simulations. b See Figure 5-6A for numbering scheme and the g tensor axis for
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30.8
11.4
-5.3
-16.2
-9.7
30.8
8.1
-5.3
-16.2
-9.7
Cp-H
Ring-H 5 b
Cp-H
15 N
Ring-H5 b
Cp-H
Ring-H5 b
Cp-H
Ring-Hs b
15"N-H1
The simulation of [14N]-NH 2Y 730* in deuterated buffer is shown in Figure 5-7B. The
parameters used in this simulation are summarized in Table 5-6. In this case, the simulated
spectrum is identical to that in Figure 5-7A, except that the N-nucleus hyperfine constants have
been divided by 1.4 - based on the difference in the gyromagnetic ratios of 14N and '5N - and the
nuclear parameter 1=1/2 for 15N is replaced with I=1 for 14N. The hyperfine constants for the
ring proton ortho to the hydroxyl and the Cp-proton have not been changed. The fact that a
simple substitution of the 15N simulation with 14N nuclear parameters generates an excellent fit to
the [14N]-NH 2Y 730* data provides further strong support that the new signal is associated with
NH2Y. Note that the quadrupolar coupling generated by the 14N nucleus has not been simulated
here. The quadrupole moment of the 14N nucleus is sufficiently small that it yields quadrupolar
coupling constants on the order of 1 G or 2.8 MHz. 47 This is within the line width of the X-band
EPR spectra. It may, however, contribute to spectral broadening of the 14NH2Y* signal.
The best simulation of the ['5N]-NH2Y 730o spectrum in protonated buffer is shown in
Figure 5-8A. In this case, the simulated and experimental spectra have been overlaid, rather
than offset as in Figure 5-7, because they do not completely overlap. The parameters obtained
from simulation of spectra in deuterated buffer were not changed and the simulations were
carried out by only considering the additional hyperfine interactions due to the exchangeable
aromatic amine protons (Table 5-6).
The best simulation for [14N]-NH2Y 730* in protonated buffer is shown in Figure 5-8B. In
simulating this spectrum, only the nuclear spin quantum number has been changed and the
hyperfine coupling constants divided by 1.4 relative to the parameters obtained for [15N]-
NH2Y 730* in protonated buffer.
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Figure 5-8. Simulation of NH 2Y730* EPR spectra in protonated assay buffer. (A) Experimental and
simulated spectra of ["5N]-NH2Y 730* in the presence of CDP/ATP. (B) Experimental and simulated
spectra of [14N]-NHEY730* in the presence of CDP/ATP. In this case the parameters were identical to
those in (A) except that the nuclear parameters for 15N were replaced with those of 14N (see Table
5-6). (C) Experimental and 'fit' spectra of [14N]-NH2Y 730* using a program in MatLab. In this case
the hyperfine constants for the two exchangeable amine protons were identical (see Table 5-6).
The poor simulations obtained with NH2Y 730* in protonated buffer may be due to an
internal H-bond within NH2Y* that is not captured in the simulations (Scheme 5-3). It is
important to uncover whether such an interaction exists, as it would have implications for
hydrogen atom transfer reactions of NH2Y 730* with residues Y731 and C439. Preliminary
288
32 80
computational studies by Loth et al. suggest that the H-bonded conformation is 1-6 kcal/mol
more stable than all other conformations without an internal H-bond (Scheme 5-3).39 For the
two conformation shown in Scheme 5-3, the H-bonded structure has been estimated to be 1.5-2
kcal/mol more stable than the other conformation. Detection of internal H-bonding in NH2Y730o
requires ENDOR spectroscopy in protonated and deuterated buffer with [14N]- and
[15N]-Y 73oNH 2Y-€x2/32.
O *.0111 H
-5.
Scheme 5-3. Rotation about the C3-N bond in NH2Y*. The nitrogen has been left out of the figure
for clarity. The N-orbital carrying the lone pair electrons is shown at the N-nucleus in both
conformations. When this N-orbital is coplanar with the aromatic ring, H-bonding is not optimal, as
shown in conformation (A). Rotation about the C3-N bond, indicated by the red arrow, results in a
conformation in which the lone pair orbital is perpendicular to the plane of the aromatic ring. In this
conformation, one of the amine protons is coplanar with the aromatic ring and in a H-bonding
orientation. The O-orbitals are not shown, but an ideal orientation results when one of the two
O-orbitals are also coplanar with the aromatic ring. The H-bond is indicated by the dashed line.
Alternatively, the poor simulation obtained with NH2 Y730* in protonated buffer, relative
to those in deuterated buffer, may be due to a small structural change as a result of changing the
environment from D20 to H20, or to poor simulation of the additional six parameters for the
exchangeable amine protons. In the former case, a better simulation would require re-assigning
the hyperfine coupling constants for Cp-H, the aromatic N-nucleus and the aromatic ring proton.
In the latter case, a better simulation would require fitting rather than reproducing the data. With
o-aminophenol radicals, previous investigators have used identical hyperfine coupling constants
for both amine protons when the radical was generated in H20 (Table 5-1). However, different
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coupling constants for the two amine protons were required for the simulations when the radical
was generated in CH30H or in CH 2C12. Extrapolating to NH2Y*s, the relative polarity of solvent
and protein residues surrounding the NH2Y* may induce conformational changes that can change
the hyperfine coupling constant from each of the two amine protons. In Figure 5-8B, the
simulations were performed assuming distinct hyperfine splitting for each amine proton. The
simulation in Figure 5-8C assume identical hyperfine interaction. In addition, the spectrum in
Figure 5-8C has been fit, rather than simulated, using an in-house written MatLab program.
Nevertheless, both attempts yield simulated spectra that do not capture all the features in the
observed spectra. Additional studies are required to obtain more satisfactory simulations of the
NH2Y 730 * spectra in protonated buffer.
It is important to note that the simulations do not provide the sign of the hyperfine
interaction matrix. ENDOR studies are required to measure the sign of these constants. In Table
5-6 the isotropic hyperfine constants have been calculated by adopting the signs from the
computational studies from Table 5-4. While DFT calculations are not powerful enough to
'predict' g values and hyperfine coupling constants, they can predict the symmetry and therefore
sign of hyperfine interactions with ease.
The spectra and simulations presented in this section yield isotropic hyperfine constants,
which allow calculation of spin densities at Ci, C5 and the aromatic N-nucleus and elucidation of
the dihedral angles between the Cp-protons and the aromatic ring. The calculations to obtain
this structural information will be presented below.
Formation of NH 2Y7 31 * with other substrate/effector pairs. In Chapter 4, we
presented the EPR spectrum of NH 2Y731* in the presence of CDP/ATP. This spectrum contained
features distinct from that of NH2Y 730*. To further characterize NH2Y731*, its spectrum has been
recorded in the presence of the other substrate/effector pairs. All spectra were composites of
Y 122* and NH 2Y*. Subtraction of the Y 122* component yields the spectra shown in Figure 5-9.
The peak-to-trough spectral widths, g values, total spin and yield of NH 2Y* at the 20 s time
point are summarized in Table 5-7.
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Figure 5-9. EPR spectra of NH2Y 731* in the presence of various NDP/(d)NTPs. Spectra subsequent
to subtraction of the Y122* are shown. See Table 5-7 for summary of spectral parameters.
Observation of an NH 2Y* with all four substrate/effector pairs is consistent with the
proposed redox-active role of Y731 in radical propagation, which we postulated on the basis of
results in Chapter 4. As with NH2Y 730*, the traces in the presence of CDP/ATP, GDP/TTP and
UDP/ATP are similar, but different from that in the presence of ADP/dGTP (Figure 5-9). This
may be due to a variation in the Cp-proton dihedral angles or a result of distinct H-bonding
interactions. In addition, the yield of total spin and NH2Y 731* at the 20 s time point are similar
for CDP/ATP, GDP/TTP and UDP/ATP, but different from that with ADP/dGTP. With
ADP/dGTP, NH2Y 731* is more stable and present in a lower yield compared with other
substrate/effector pairs (Table 5-7).
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Table 5-7. Yield of NH2Y* and total spin after reacting Y731NH2Y-a2 with 32 and various
NDP/(d)NTP pairs for 20 s.
Substrate/Effector g valuea Spectral [NH 2Y*] Total Spin
width (G)b (FtM)c Remaining (PM)d
CDP/ATP 2.0044 20.2 7.7 17.0
GDP/TrP 2.0044 19.4 7.4 18.0
UDP/ATP 2.0044 21.8 7.6 16.8
ADP/dGTP 2.0042 21.3 5.5 21.1
a Note that the error in the g value measurements is + 0.0001. b The peak-to-trough spectral widths are reported
from a single measurement. c [NH2Y.] after 20 s reaction time. d Total spin remaining at 20 s relative to total
spin at t=0, which was 24 pM in these experiments.
Comparison of the data in Table 5-3 for NH2Y 730* VS. those in Table 5-7 for NH 2Y731*
show that the spectra at residue 731 are narrower than those at 730, though the observed g values
are similar. The yield of the NH2Y* and its stability also depend on the position of the probe.
With CDP/ATP, GDP/TTP, and UDP/ATP, the NH2Y* is more stable and present at higher
concentrations at residue 730 than at 731 (Tables 5-3 & 5-7). This may be related to the
position of Y731 in the a2/P2 complex, which is more solvent-exposed than Y730. The
ADP/dGTP pair is an outlier in this regard, as the NH2Y* is more stable at residue 731 relative to
730.
The NH 2Y731* was also studied by 180 GHz EPR spectroscopy. Samples were prepared
and analyzed as described for NH2Y 730 *. The results are shown in Figure 5-10. Analysis of
these spectra reveals the anisotropy for NH2Y 731*: gx=2.0052, gy=2.0042, gz=2.0022. These are
identical to the g values measured for NH2Y730* as indicated by the g values measured by
X-band EPR spectroscopy (Tables 5-3 & 5-7). Incorporation of [15N]-NH 2Y into residue 731
and acquisition of EPR spectra in deuterated buffer, and their analysis, will be required to study
the structure NH 2Y731* in more detail.
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Figure 5-10. EPR spectra of NH 2Y 731* at 180 GHz. (A) Spectra at 6 K containing P2/NH2Y7319 in the
presence of CDP/ATP (black trace) or GDP/TTP (red trace). These spectra are composites of Y122'
and NH2Y* signals. (B) Spectra at 70 K containing only the signal from NH2Y731* in the presence
CDP/ATP (black) or GDP/TTP (red). Both spectra yield g values of gx=2.00520, gy=2.00420 and
gz=2.00220. The error in the g values was ± 0.0001.
Distance measurements using PELDOR spectroscopy with NH 2Y-a2s. Having
examined the structure of NH2Y*, we next sought to investigate its position within the ca2/P2
complex. While Y7 30 and Y73 1 have been proposed to participate in radical transfer, their
position within the pathway has remained undetermined. Direct spectroscopic analysis of these
residues has been hampered by the conformational change that masks radical initiation.48
However, the emergence of the NH2Y probe allows a direct measurement between the newly
formed NH2Y* in one dal/ pair of the radical transfer pathway with the remaining Y122* in the
other oca/ pair. The results of similar experiments were presented in Chapters 2 & 3 for
DOPA-02 and DOPA-P3', respectively, which provided the first distance constraints regarding
the position of residue 356 in the radical transfer pathway.
PELDOR samples were prepared by first concentrating pre-reduced NH2Y-a2 and 02
(1.2 Y 122*/dimer) to 80 ipM. Formation of NH2Y* was induced by addition of GDP/TTP
followed by hand-quenching each sample in liquid N2. The resulting spectra are shown in
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Figure 5-11. Figure 5-11A (black trace) shows the X-band spin-echo detected absorption
spectrum of this reaction for Y731NH2Y-a2 along with the pump and detect frequencies used in
the four-pulse DEER sequence.49 The spectrum is a composite of NH2Y73 1* and Y122* signals.
Subtraction of the Y122* component (blue, 59 %) yields the NH2Y731* (red, 41 %). Figure 5-1 1B
shows the echo modulation trace for NH 2Y731* recorded at the detection frequency after
subtraction of a mono-exponential signal decay function. The modulation frequency of this
spectrum is indicative of the distance between Y122*-NH2 Y731*, the modulation depth is a
function of the concentration of radical pairs. Analysis of this trace using the distance-domain
Tikhonov regularization procedure5o results in the distance distribution profile in Figure 5-11C
(red), which indicates a distance of 38.1 ± 1.2 A between Y122* and NH2Y73 1*. A small peak
corresponding to the Y 122*-Y 1 22* pair is also observed.'7
A similar analysis has been carried out with Y730NH 2Y-a2. In this case, the echo
modulation spectrum shown in Figure 5-11B (green) is obtained. Analysis of this trace yields a
distance of 38.7 ± 1.8 A along with a peak related to unreacted Y122*-Y1 22*. The basis for
residual Y122o-Y122* is related to differences in the formation rate constant and stability of
NH2Y* at residue 730 vs. 731 (see Chapter 4).
In the PELDOR spectra in Figure 5-11, a coupling between NH 2Yo-NH 2Y* distance is
not detected (though a lower limit has not been set). This is consistent with recent findings of
half-sites reactivity in the a2/02 complex, which contains two radical transfer pathways,
structurally related by C2-symmetry (Figure 5-12). In the first turnover, radical transfer occurs
within only one of these pathways. In case of NH2Y-a2s, radical transfer results in formation of
a new NH2Y* at the expense of Y122* in one o/P pair. The Y1220 within the other ac3 pair, where
radical initiation does not occur, is preserved thus allowing distance measurements diagonally
across the a2/02 complex between these two radicals. The measured distance by PELDOR
presented here and the distances predicted by the docking model are summarized in Figure 5-12,
The implications of these measurements will be discussed below.
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Figure 5-11. PELDOR spectroscopy with NH2Y-a2s. (A) Spin-echo detected EPR spectrum after
reaction of Y731NH2Y-a2/02 with GDP/TTP. The spectrum of unreacted Y122* (blue) has been
subtracted from the observed spectrum (black) yielding the NH2Y 731* spectrum (red). Pump (P) and
detect (D) frequencies are indicated by arrows. (B) Normalized four-pulse DEER at 6 K for
Y731NH2Y-a2/02 (red) and Y731NH 2Y-a2/P2 (green) with GDP/TTP. The black lines describe fits
using the Tikhonov regularization procedure. (C) Resulting distance distributions obtained from the
analysis in (B) are shown for each NH2Y-a2. The distances of 3.32 and 3.27 nm (black) are related to
the Y1220-Y1 220 pair.
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Figure 5-12. Distances between Y122* and other residues in the radical transfer pathway. Diagonal
and linear distances predicted by the docking model (black) and measured diagonal distances obtained
by PELDOR in this study (blue). The residues constituting a pathway in one ao/ pair are colored in
light grey (Fe shown in teal); residues in the second pathway are shown in green (Fe shown in orange).
For clarity, the residues and ligands in only one pathway (right) have been labeled. Distances from the
model (black) represent averages from both pathways in the complex and have been measured from
the aromatic C4 atom of each Tyr residue. The position of Y356 is unknown. The distance between
residue 356 and Y122* was obtained from PELDOR studies with DOPA-f2 (Chapter 2).
Reaction of NH 2Y-a2 with Y356F-02. Having identified the structure of the NH 2Y*
and established its position in the ax2/P2 complex using PELDOR spectroscopy, we next
addressed the pathway dependence of its formation. To do so, we used the His6-Y3 56F-32. In
this mutant, radical transfer into a2 does not occur because the pathway is blocked at residue 356.
Thus, if formation of NH2Y 730* or NH2Y7310 requires a redox-active Y356 residue, then no NH 2Y*
should be observed. If however, alternative pathways exist that can lead to NH 2Y 730* or
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NH 2Y731* formation, then an NH2Y* may be observed. The results of these experiments are
shown in Figure 5-13. The reaction was quenched at 20 s and at 2 min. The EPR spectra reveal
that no NH2Y* had been formed in either experiment; only the well-characterized Y122* signal is
observed. In addition, spin quantitation reveals no significant loss of spin at the 20 s or the 2 min
time points consistent with a requirement for Y356 in radical hopping into a2. In contrast, in a
parallel control experiment, when Y356F-P2 is replaced with wt P2, the composite spectrum
described in Chapter 4 is obtained with both NH2Y-a2s. Therefore, a redox-active Y356 is a
prerequisite for hole migration into subunit a2.
Recently, Clement Chan has performed an experiment with a double a2 mutant,
Y731F/Y73oNH 2Y-a2. As with the His6-Y 356F-P2 mutant, no NH 2Y* is observed in the presence
of substrate and effector and no loss of spin had occurred. These results suggest that formation
of an NH2Y730* requires a redox-active Y356 and Y731in the a2/P2 complex.
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Figure 5-13. Pathway dependence for NH2Y* formation. (A) EPR spectra of Y730NH2Y-ca2 in the
presence of CDP/ATP with wt 32 (red) or His6-Y3 56F-32 (blue) after a 20 s reaction time. (B) EPR
spectra of Y731NH2Y-a2 in the presence of CDP/ATP with wt P2 (red) or His6-Y3 56F-P2 (blue) after
a 20 s reaction time.
SF UV-vis spectroscopy of NH2Y-a2/432 with various NDP/(d)NTP combinations.
The kinetics of NH 2Y' formation with CDP/ATP was described in Chapter 4 for Y730NH 2Y-a2
and Y731NH2Y-a2. The results showed formation of an NH 2Y* in a kinetically competent
manner. However, a slow rate constant of -2-3 s- 1 was also observed, the physical nature of
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which is undetermined. To investigate the effect of nucleotides on the kinetics and extent of
radical transfer, additional reactions have been carried out with GDP/TTP, UDP/ATP,
ADP/dGTP, all four substrates alone (CDP, GDP, UDP, ADP) and three effectors alone (ATP,
TTP, dGTP). Representative data and fits for a reaction containing only GDP or TTP are shown
for Y730NH 2Y-a2 in Figure 5-14. The results for all substrate and effector combinations are
summarized in Table 5-8. Representative data and fits for the reaction of Y731NH2Y-a2 with
GDP or ADP alone, and with TTP or dGTP alone are shown in Figure 5-15, with the kinetic
parameters of the complete set summarized in Table 5-9. Analysis of kinetic data was carried
out by iterative rounds of fitting and calculation of the R2 correlation value and residual plot until
the R2 value was maximized and the residual plot was randomly scattered around zero.
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Figure 5-14. Kinetics of NH2Y 730* formation monitored by SF UV-vis spectroscopy. Kinetics of
NH 2Y* formation in the reaction of Y730NH2Y-a2/f2 in the presence of GDP alone (A) or TTP alone(B). Both experiments were carried out at a final complex concentration of 5 pM. Nucleotide
concentrations were 1 mM GDP or 0.2 mM TTP. Red lines describe fits to data. See Table 5-8 for
kinetic parameters. All fits had satisfactory residuals and R2 correlation values of 20.99.
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Summary of kinetic parameters for reaction of Y730NH2Y-a2 with 02 and
various substrate/effector combinations at 250 C.
1 st Phase 2 nd Phase 3 rd Phase
Nucleotides kobs ( - 1)  Amp kb ( - 1  Amp kobs ( - 1) Amp(% Y122*) (% Y122*) (% Y1220)
CDP 5.2 ± 0.5 9 + 1 0.8 + 0.1 19 + 2
CDP/ATP 12 + 1 20 + 2 2.4 ± 0.2 19 ± 2
ATP 27 3 2 1
UDP 1.4 ± 0.2 5 1 0.2 + 0.1 19 ± 2
UDP/ATP 4.5 + 0.2 20 + 2 0.64 + 0.03 15 + 2
GDP 2.5 + 0.1 12 ± 1 0.3 + 0.1 16 + 2
GDP/TTP 18 + 2 15 ± 2 2.3 + 0.2 16 + 2
TTP 120 ± 10 2 + 1 1.8 + 0.2 2 + 1 0.06 + 0.01 10 + 1
ADP 50 + 5 2 + 1 6.5 + 0.7 2 + 1 0.06 + 0.01 3 1
ADP/dGTP 39 + 2 8 + 1 3.7 ± 0.2 7 + 1
dGTP 48 ± 3 3 + 1 1.1 ± 0.1 3 ± 1 0.11 + 0.01 17 + 2
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Figure 5-15. Kinetics of NH2Y 731* formation monitored by SF UV-vis spectroscopy. Kinetics of
NH2Y* formation in the reaction of Y731NH2Y-a2/p32 in the presence of GDP alone (A), TTP alone
(B), ADP alone (C) or dGTP alone (D). All experiments were carried out at a final complex
concnentration of 5 pM. Nucleotide concentrations were 1 mM GDP, 0.2 mM TTP, 1 mM ADP, or
0.2 mM dGTP. Red lines describe fits to data. See Table 5-9 for kinetic parameters. All fits had
satisfactory residuals and R2 correlation values of 20.99.
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Table 5-9. Summary of kinetic parameters for reaction of Y731NH2Y-o(2 with 32 and
various substrate/effector combinations at 25 0C.
1 st Phase 2 nd Phase 3rd Phase
Nucleotides kobs s-1)  Amp kobs (S-1)  Amp kobs (S- 1) Amp(% Y122*) (% Y122*) (% Y122*)
CDP 10.8 ± 1.1 9 ± 1 1.3 + 0.1 16 + 2
CDP/ATP 18 ± 2 22 + 2 2.5 + 0.3 10 + 1
ATP 0.05 ± 0.01 8 + 1
UDP 4.4 ± 0.2 11 + 1 0.8 ± 0.1 15 ± 2
UDP/ATP 7.1 ± 0.6 16 ± 2 1.2 + 0.1 13 + 1
GDP 7.7 + 0.8 13 ± 1 1.4 ± 0.2 10 ± 1
GDP/TTP 28 + 3 22 + 2 2.3 + 0.3 9 1
TTP 20 + 1 3 ± 1 0.07 + 0.01 8 ± 1
ADP 70 + 4 3 ± 1 3 + 0.3 2 + 1 0.08 ± 0.01 8 + 1
ADP/dGTP 25 ± 2 13 + 1 2.3 + 0.2 5 ± 1
dGTP 35 ± 4 3 1 0.9 ±0.1 3 ±1 0.1 ± 0.01 19 ± 2
Inspection of the data in Table 5-8 reveals that NH 2Y* formation is fast and efficient
with CDP/ATP, GDP/TTP and UDP/ATP. In these cases biphasic kinetics are observed with a
fast phase of 4.5-18 s- 1, which is similar to the rate constant measured by pre-steady state
experiments monitoring dCDP formation (4-17 s-l), and a slow phase of 0.64-2.4 s- 1, which is
similar to the turnover number (-2 s-1). The yield of the reaction is also similar with these pairs,
ranging from 31-39 % (Table 5-8). With ADP/dGTP, trapping of NH 2Y* is fast and biphasic
with rate constants of 39 and 3.7 s- 1, but it is -2-fold less efficient than with the other three
NDP/(d)NTP pairs. This trend is similar to that observed in the EPR spectra of NH2Y*, where
spectra in the presence of CDP/ATP, GDP/TTP and UDP/ATP were qualitatively similar but
distinct from the spectrum obtained in the presence of ADP/dGTP.
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A similar conclusion is reached when examining the kinetics of NH 2Y* with
Y731NH2Y-ax2. Here, biphasic rate constants of 7.1-28 s-' and 1.2-2.5 s- 1 are observed with
CDP/ATP, GDP/TTP and UDP/ATP (Table 5-9). With ADP/dGTP, rate constants of NH2Y*
are within the range of those with the other NDP/(d)NTP pairs (25 s- 1 and 2.3 s-1), but the yield
of the reaction is -2-fold lower. Interestingly, the rate constants for NH2Y* formation with
Y731NH2Y-a2 are always faster than with Y730NH2Y-a2 in the presence of CDP/ATP,
GPD/TTP and UDP/ATP.
Comparison of the outcome of the reaction with substrate alone and effector alone may
suggest a role for each of these in radical transfer. In the case of Y730NH2Y-a2 with effector
alone, NH 2Y* formation does occur, albeit in an inefficient and slow fashion. With ATP and
TTP, only 2 and 14 % of initial Y122* give rise to an NH2Y*, respectively. In case of TTP, the
majority of the reaction (10 of 14 %) occurs with a rate constant of 0.06 s- 1, which clearly cannot
support turnover. With dGTP, 23 % of initial Y122* generates a NH 2Y*, however, the majority of
this reaction (17 of 23 %) occurs with a kobs Of 0.11 s-1. It should be noted that with effector
alone, the kobsS in other kinetic phases are significantly faster than that measured by Ge et al,
although the yield of NH 2Y* associated with these kinetic phases is low. With ATP, TTP and
dGTP alone, fast kobsS of 27, 120 and 48 s- ' with NH 2Y* yields of 2, 2, and 3 % of total initial
Y 122* are observed, respectively (Table 5-8). The nature of these fast conformational changes is
at present not understood.
A similar trend is obtained with Y731NH2Y-a2, that is, effectors are competent in NH 2Y*
production, however, the yield is lower than with substrate/effector or with substrate alone and
the rate constants for the majority of the total change are too slow to support turnover (Table
5-9). With ATP, TTP and dGTP, 8, 11, and 25 % of initial Y122* forms an NH 2Y*. With TTP
and dGTP, the majority of this change (8 of 11 % and 19 of 25 %) occurs with slow rate constant
of 0.07 and 0.1 s- ', respectively. In addition, with Y731NH2Y-a2, the kobss with (d)NTPs alone
are slower than those with Y73oNH 2Y-a2. NH2Y* formation with ATP is mono-phasic with kobs
of 0.05 s-' (compared to 27 s- 1 with Y730NH 2Y-a2). With TTP, a rate constant of 20 s-' is
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observed, which is similar to the rate constant for the rate-limiting physical change measured by
Ge et al, and slower than that measured with Y730NH2Y-a2 (120 s-1). With dGTP, a kobs of 35
s- 1 is detected, which is slower than that with Y730NH2Y-a2 (48 s-l).
With substrate alone, NH 2Y* formation is fast and efficient, however, less so than in the
presence of substrate and effector together. With Y730NH2Y-a2 and Y731NH 2Y-a2 in the
presence of CDP/ATP, GDP/TTP and UDP/TTP, it appears that substrate is providing the main
conformational trigger, as reactions with substrate alone trap nearly as much NH2Y* with a
similar rate constant to those with substrate and effector. However, the presence of effector does
increase both the rate constant for and extent of radical transfer. Importantly, the presence of
effector increases the extent of NH2Y* formation in the fast phase, while decreasing the extent of
NH 2Y* formation in the slow phase. Examining the reaction of Y730NH 2Y-a2/p2 with
CDP/ATP vs. CDP alone, shows that in the former case 20 % is trapped rapidly, with 19 %
trapped with a slow kobs. With substrate alone, only 9 % is trapped rapidly and 19 % is trapped
with a slow kobs. This trend is also seen with UDP/ATP vs. UDP alone. In the former case 20 %
and 15 % of total initial Y122* are trapped with a fast and a slow kobs, respectively. With UDP
alone, the yield of NH2Y* in the fast phase has decreased to 5 %, while that in the slow phase has
increased to 19 %. A similar analysis can be applied to reactions with GDP/TTP vs. GDP alone,
This shows that 18 % of initial Y 122* is trapped rapidly with GPD/TTP, whereas only 2 % is
trapped rapidly with GDP alone (Table 5-8).
This trend holds when examining the kinetics of NH 2Y* with Y731NH2Y-a2 and
NDP/(d)NTP vs. NDP alone. For example, with CDP/ATP, the extent of NH2Y* formation with
a fast and slow kobs are 22 % and 10 %. Removing ATP from this reaction, decreases the former
to 9 % and increases the latter to 16 % (Table 5-9). This trend also holds with UDP/ATP and
GDP/TTP. The kinetics in the presence of ADP/dGTP with Y730NH2Y-ca2 and Y731NH2Y-a2
are also consistent with this trend. In these cases, the reaction with ADP alone is triphasic,
whereas those with ADP/dGTP are biphsic. The additional phase with ADP alone occurs with a
kobs of 0.06 and 0.08 s- 1 with Y730NH2Y-(2 and Y73 1NH 2Y-a2, respectively. Therefore, in
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these cases, the absence of effector is responsible for appearance of a slow phase, which cannot
support turnover and accounts for a significant portion of the overall change.
To summarize, in almost all cases with substrate alone, more NH2Y* is formed with a
slow rate constant than with the fast rate constant. However, when the reaction is supplemented
with effector, more NH2Y* is formed with a fast rate constant, compatible with turnover, than
with a slow rate constant. Thus, the results seem to suggest that the role of the effector is to
redistribute a larger population of the complex into a conformation, which generates a NH2Y*
more rapidly. While substrate provides the main conformational trigger, it requires the presence
of effector to arrange the complex into a state that initiates radical transfer in a more rapid
fashion, compatible with turnover.
Temperature dependence in formation of NH 2Y730*. To further characterize the
conformational changes that gives rise to formation of the NH 2Y*, temperature-dependent SF
UV-vis studies were performed. A representative time course is shown in Figure 5-16A at 34°C.
Kinetics were recorded at five different temperatures and the data are summarized in Table 5-10.
At all temperatures, the kinetics were bi-phasic with a fast and a slow rate constant. The data
reveal that the extent of NH 2Y* formation is temperature-independent ranging from 22-29 %
and 11-16 % in the fast and slow kinetic phases, respectively (Table 5-10). This lack of
temperature dependence of the equilibrium constant for formation of NH2Y* suggests that the
AH 0-0 according to van't Hoff analysis (Eq. 5-4). This further suggests that In(K) may be used
to estimate an ASo for formation of NH 2Y* (Eq. 5-4). However, as noted in Chapter 4, due to
the set of reactions that ensue upon NH2Y. generation, it is unclear whether or not formation of
NH2Y. is at equilibrium within the time scale of the current experiment.
In(K) - + AS(5-4)RT R
Both rate constants for trapping the NH 2Y* vary with temperature according to the
Arrhenius model for temperature dependence of chemical reactions (Table 5-10). Comparing
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the kobs at 230C and at 36°C, shows a -2-fold and a 2.3-fold increase for the kobs in the fast and
slow kinetic phases, respectively. The data were analyzed using the Eyring equation (Eq. 5-2)
by plotting ln(kobs/T) for each phase vs. 1/T. This analysis for the fast and slow rate constant is
shown in Figure 5-16B & 5-16C, respectively. Accordingly, thermodynamic parameters of
AH+ = +13.1 kcallmol and AS+ = -9.5 kcal/mol were obtained for the fast conformational
change and H+ = +11.8 and AS+ = -17.5 kcallmol for the slow conformational change. Using
Eq. 5-3, these parameters yield a AG+298 K Of -15.9 kcal/mol and -17 kcal/mol, for the fast and
slow conformational change, respectively (Table 5-11).
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Figure 5-16. Temperature-dependence of NH2Y 730* formation. (A) Representative time course at
340 C in the reaction of Y730NH2Y-a22/12 with CDP/ATP. The red line describes a bi-exponential fit
to the data. See Table 5-9 for kinetic parameters at various temperatures. (B) Eyring plot and linear
fit according to Eq. 5-2 for the fast rate constant observed in NH2Y 730* formation. (C) Eyring plot and
linear fit according to Eq. 5-2 for the slow rate constant observed in NH2Y 730* formation.
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Summary of kinetic parameters for the reaction of Y73oNH 2Y-a2/02 with
CDP/ATP as a function of temperature.
1 st Phase 2 nd Phase
T (oC) kobs ( - 1  Amp kobs ( - 1) Amp(% Y1220) (% Y122*)
23.0 10.5 ± 1.1 26 ± 2 1.7 ±0.2 13 + 1
25.0 14.1 + 1.3 26 ± 2 2.4 + 0.2 14 1
28.0 14.3 ± 1.0 29 + 2 2.3 ± 0.2 11 + 1
34.0 23.3 + 1.3 22 ± 2 4.6 + 0.4 16 ± 1
36.0 20.3 + 2.7 24 ± 3 3.9 + 0.5 14 ± 2
Table 5-11. Summary of thermodynamic parameters for NH2Y* formation with Y730NH2Y-
a2 in the presence of CDP/ATP.
Rate AHl AS+  AG+298 K
Constant (kcallmol) (kcal/mol) (kcallmol)
Fast kobs 13.1 ± 2.3 -9.5 + 1.7 15.9 + 2.8
Slow kobs 11.8 ± 2.1 -17.5 3.1 17.0 ± 3.0
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Table 5-10.
DISCUSSION
In Chapter 4, we established the application of a suppressor tRNA/aminoacyl-tRNA
synthetase pair to site-specifically incorporate NH2Y into residues 730 and 731 of a2. Using
these constructs we demonstrated a new intermediate, NH2Y*, that we characterized by EPR and
UV-vis spectroscopies. We also showed that generation of NH 2Y* required the presence of
substrate and effector and described the kinetics of its formation and decay in the presence of
CDP/ATP. In this Chapter, additional studies have been carried out to address the structure of
the NH2Y*, its position in the a2/32 complex, the pathway-dependence of its formation and the
role of substrate and effector in its formation.
Examination of the structure of NH2Y7 3o*. To study the structure of the NH2Y°,
isotopic substitution with 15N and solvent 2H were carried out and the resulting radical examined
by 9 GHz and 180 GHz EPR spectroscopy, spectral simulation and DFT calculations.
Importantly, in these studies the g values were experimentally determined with ['4N]-NH2Y 730°
by EPR spectroscopy at 180 GHz. The g values of an aromatic radical can be informative in
regard to its local environment. According to the Stone model for g factor perturbation, 41,42'51 the
g component perpendicular to the aromatic nr radical plane, gz, is equal to the free-electron g
value, ge, whereas the g components within the aromatic plane, gx and gy, have higher g values
than ge. The g anisotropy in organic radicals, which have significant spin density on a
heteroatom, such as O or N, originates from a larger spin orbit coupling of these atoms, relative
to C, and from presence of electrons that occupy nonbonding orbitals. Therefore, hydrogen
bonds or the solvent dielectric or other near by residues which effect the electrostatic
environment, will change the g values. Recent DFT calculations by Un and coworkers on model
Yos in solution and on the Y122* in E. coli, have validated the work by Stone.5 2 They show that
the gx value is inversely proportional to hydrogen bonding and solvent dielectric, i.e. the
presence of a hydrogen bond will decrease the gx value and the higher the dielectric constant, the
lower g,x. In the class I RNRs, determination of g, and X-ray crystal structures of [32s from
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various organisms have shown that the g,x value is a diagnostic for the presence of a hydrogen
bond.45 Therefore, it is likely that the g values measured with NH 2Y730* and NH2Y731° will be
more informative in the near future, as more experiments are carried out with NH2Y*s in other
systems.
A key issue regarding the application of NH2Y to other systems will be its ability to form
an internal H-bond upon oxidation. As noted above and demonstrated in Scheme 5-3, the
amine group may adopt an orientation in which it is H-bonded to a lone pair on the O-atom,
Preliminary computational studies by Loth et al. in the 1960s with o-aminophenol radical
indicated that the H-bonded conformation is 1-7 kcal/mol more stable than other structures
without an internal H-bond.39 Specifically, for the two structures shown in Scheme 5-3, the
H-bonded conformation was found to be 1.5-2 kcal/mol more stable. Additional theoretical and
experimental studies using more advanced methods will be necessary to assess these predictions.
If an internal H-bond does form, it would interfere, although it is unclear to what extent, with the
chemistry of hydrogen atom transfer at that residue. Orthogonal proton-coupled electron
transfer reactions would be less affected. In a2, we have proposed that Y730 and Y731 are
involved in a hydrogen atom transfer network with C439. In Chapter 4, we postulated that the
NH2Y-a2s were competent in C439* generation. At this point it is unclear whether the ability to
generate C439* is due to a lack of an internal H-bond formation in NH 2Y*-a2s, or whether this
H-bond does form but does not interfere significantly with redox reactions at residues 730 and
731.
The isotopic replacement studies and spectral simulations in this Chapter have yielded
hyperfine coupling constants that may be used to obtain unpaired spin densities in NH 2Y.,
Proton hyperfine interactions consist of an isotropic term and an anisotropic term due to direct
dipolar coupling. For an a-proton, i.e. a proton, such as H5, that is directly bound to the
aromatic ring (see Table 5-6 & Figure 5-6A), the isotropic term is proportional to the spin
density at the carbon nucleus to which it is attached to. Quantitatively, this is described by the
McConnell relation (Eq. 5-5), where AH is the isotropic hyperfine constant, and QCH is related to
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the o-t electron interactions in a C-H bond and can be calculated with good accuracy from first
principles. 53'54 Empirically QCH varies between -56 and -84 MHz with a value of -69.7 MHz
being used by most investigators. 55 Finally, pc is the spin density at the C-nucleus to which the
proton is attached. Using this relation we obtain a spin density of 0.08 at C5 (Figure 5-6).
AH = QCH X PC (5-5)
Proton hyperfine coupling constants from a P-proton, i.e. a proton not directly connected
to the aromatic ring, are usually as strong as those from an a-proton. This interaction is in
general described by a hyperconjugation mechanism between the 3 proton and the p orbital of
the aromatic ring. The strength of this interaction is dependent on the dihedral angle, 0, between
the Cp-H bond and the Pz orbital at C1 of the aromatic ring.53 The total hyperfine interaction,
consisting of dipolar and isotropic components, is given by Eq. 5-6, where AT is the total
hyperfine interaction, AH is the isotropic component and Dc is the dipolar component between C1
and the P-proton, which does not correlate with the spin density at C1.
AT = AH + DC (5-6)
The isotropic component is defined by Eq. 5-7, where Bo is not associated with
hyperconjugation and is neglected because it is small relative to the second factor. 53, 56 B1
accounts for the contribution by hyperconjugation and has a value of 140-162 MHz.57 Using our
experimentally determined value of 30.8 MHz and 0 MHz for Cp-H 1 and Cp-H2, respectively,
B0 = 0, and 01 + 02 = 1200 we obtain a spin density of 0.25-0.29 at C1 and 0 angles of -30' and
900. A Newman projection that shows these 0 angles relative to the Pz of C1 is shown in Figure
5-17A. Note that a second Cp-H was not required for the simulations, therefore a coupling of 0
MHz was used for Cp-H 2.
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AH =(Bo X PC) + (Bi x pc x cos2 ()
Obtaining spin density at the N-atom of the amine substituent is not as straight forward
because theoretical and experimental studies on aromatic C-N systems have not been as
prevalent as those described above for a-protons and P-protons, or 13C and 170 hyperfine
interactions in aromatic radicals. Hoffman and coworkers used 13C, and 14N/15N ENDOR to
arrive at the spin density of the aromatic N-nucleus in a tryptophan cation radical of cytochrome
c peroxidase.46 Lassman and colleagues have determined the spin density of a W* in E. coli
Y122F-P2 using the anisotropic hyperfine constants, which they obtained by simulation of their
EPR spectra.47 In their studies, the N-nucleus hyperfine tensor was axially symmetric. Because,
ENDOR studies have not been carried out and because our simulations show axial symmetry for
the N-hyperfine tensor, N spin densities are derived based on the approach used by Lassman and
coworkers. Accordingly, Eq. 5-8 was used, where Ae is the effective hyperfine constant, Az is
the z-component of the hyperfine tensor, Aiso,, is the isotropic coupling constant (see Table 5-6)
and B has been empirically determined to be 47.8 MHz. This analysis yields a spin density of
([31.5 - 8.1]/2 / 47.8=) 0.24 at the Pz orbital of the N-nucleus.
Ae = Az - Aiso = 2B (5-8)
Alternatively, the isotropic 14N hyperfine splitting constant may be related to the spin
density at the N- and adjacent C-nucleus using Eqs. 5-9 and 5-10, which have been derived
semi-empirically using a series of aromatic N-heterocyclic radicals (such as pyridine, pyrazine,
methylpyridine, etc.). 58-62 Eq. 5-9 may be used to determine the spin density at the N-nucleus.
Here, AN is the isotropic 14N hyperfine coupling constant and QN has a value of 42 MHz. Use of
this equation, yields a spin density of (8.1/42=) 0.2 at the N-nucleus in NH2Y 730*. It has been
suggested that the theory for 13C or 170 hyperfine interaction can be applied to 14N as described
in Eq. 5-10. Here PN and pc represent the spin density at the N-nucleus and the neighboring
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(5-7)
pz axis O* 0.24
HP 0.08 NH2
S= 2 = 900 0.27
A B
Figure 5-17. Structure of the NH2Y 730*. (A) Dihedral angles from measurement of CO-H hyperfine
constants. The dihedral angles are shown relative to the Pz of C1, labeled as Pz axis. (B) Summary of
spin densities at C1 (0.27), N (0.24), and C5 (0.08) determined in this study. The remainder of spin
density is attributed to the O-nucleus of the hydroxyl group and the C3-nucleus of the aromatic ring.
C-nucleus, respectively, QNC represents the electron spin polarization in the s orbitals of 14 N due
to spin density in the p orbital of the N-atom, and QCN represents the polarization due to the spin
density at C3. In the literature, the values for QNC and QCN vary from 53.5 to 86.5 MHz, and
-4.8 to 19.6 MHz, respectively. 58-62 Nanda et al. have treated this topic most recently and have
determined QCN and QNC values of 53.5 and -4 MHz, respectively. 60 Using these values, and a
PN of 0.2, which was obtained from application of Eq. 5-9, a pc of 0.23 is obtained for C3. This
would yield a po of 0.22 for the hydroxyl oxygen in NH2Y 730*. However, we stress that these Q
values were obtained from sp2 hybridized N-heterocycles. As previously pointed out,58 Q values
can only be considered constants in a series of compounds in which the state of hypridization of
the C- and N-nuclei does not vary. In NH2Y, the amine moiety is clearly sp 3 hybridized.
Therefore, we prefer the determination of 14N spin densities using the anisotropic hyperfine
splitting constants as discussed above.
AN = QN x PN (5-9)
AN = (QNC X PN) + (QcN X PC) (5-10)
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From the discussion above, 0.57 to 0.61 of the total spin density is accounted for, leaving
0.43 - 0.39 (Fig. 5-17B). Based on previous studies, the majority of this will be associated with
the O-atom, the C3 and the C4 Of the aromatic ring, which in Y*s, have spin densities of 0.26,
0.23, and 0.05 respectively. In catechol, the spin density at each of the oxygens was determined
to be 0.16.63 In NH2Y*, the spin density of the hydroxyl group should be between 0.16 and 0.26,
but greater than that of the N-nucleus as O has a larger spin-orbit coupling constant, 76 cm - 1
and 151 cm- 1, respectively. Because C4 densities are typically small, we assign (O+C 3) with the
remainder of the density.
The isotopic substitution studies described herein have established that the new signal is a
NH2Y*, as we postulated in Chapter 4. Spectral simulation, 9 GHz and 180 GHz EPR
spectroscopy and DFT calculations have revealed the dihedral angels of the P-protons and spin
densities within the NH 2Y* at the N-nucleus and at C1 and C5 (Figure 5-17). Additional
ENDOR and EPR studies will be necessary to assess the presence of an internal H-bond in
NH 2Y*, which will have important implications for the mechanism of radical transfer at this
juncture in the pathway. 13C and 170 studies will be required to determine how the remainder of
the spin density is distributed between the O-nucleus of the hydroxyl group and C3.
Positions of NH 2Y7 30* and NH 2Y731" within the radical transfer pathway. To
examine the positions of residues 730 and 731 within the a2/P2 complex, PELDOR studies with
Y73oNH 2Y-a2 and Y731NH2Y-a2 in the presence of 32 and GDP/TTP were performed in this
Chapter. These studies have yielded diagonal distances of 38.7 A and 38.1 A between
Y730'-Y 1 22* and Y731*-Y1 22*, respectively. To analyze these distances, we consider the docking
model, generated from the individual structures of a2 and 02 based on shape and charge
complementarities and conserved residues (Figure 5-12). Based on this model, the diagonal
distance across the a2/P2 dimer interface for the Y122-Y 731 and Y122-Y730 pairs are 38.6 ± 1.3 A
and 40.1 ± 1.3 A, respectively. Within error, these distances are similar to the 38.1 and 38.7 A
that we have reported here. Accordingly, our studies establish the positions of the critical Tyr
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pathway residues in the a2/02 complex, as presaged by the docking model, and also support a
long-range radical transfer mechanism for C439* formation.
An important insight may be provided by the width of the distance distribution for the
Y122*-Y 731* and Y122 *-Y 730* pairs, shown in Figure 5-11C. PELDOR spectroscopy was
presented with DOPA-2/oa2 in the presence of all four substrate/effector pairs in Chapter 2. In
these cases, the half-peak width of the distance distribution was 0.5 A. The half-peak widths
measured with NH 2Y-a2s are considerably larger than those with DOPA-02, 1.2 A and 1.8 A,
for Y731NH 2Y-a2 and Y730NH 2Y-a2, respectively. DOPA-32 is unable to generate a C439 .,
whereas with NH 2Y-a2s we have proposed competence in nucleotide reduction. The larger
distribution with NH2Y-a2s may be due to a distribution of conformations of the P-monomer
that contains the Y122*. We hypothesize that this distribution is due to two populations of
NH2Y-a2: a population which has formed deoxynucleotide and generated NH2Y* upon reverse
radical transfer, and another population that has not formed deoxynucleotide and trapped NH2Yo
during forward radical transfer. As we proposed in Chapter 3, formation of deoxynucleotide
within one pathway results in a conformational change in the active site and promotes radical
transfer into the second a active site. Therefore, we suggest that the distribution represents
populations of NH 2Y-a2, which have undergone the conformational changes, as a result of
deoxynucleotide formation, and thus have a slightly different diagonal distance than the
population that traps NH2Y* in forward radical transfer. NH2Y* formation is biphasic in the
presence of CDP/ATP or GDP/TTP. Thus, the two populations may correspond to those that
generate NH2Y* with a fast kobs (-12 s- 1) and those that generate NH 2Y* with a slow kobs (~2 s-1)
This proposal is consistent with two lines of evidence. First, with DOPA-02 and
DOPA-PP' an identical distance and distance distribution is obtained in the presence of all four
substrate/effector pairs. Both constructs are inactive in nucleotide reduction. Therefore, the
conformational change associated with active site disulfide formation does not occur (Chapter 3)
and the distribution for the Y122*-DOPA356* distance is narrow relative to the distributions
observed with NH2Y-a2s. Second, with N3UDP, an N-centered radical (No) is formed in the
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active site, which is stable for several minutes. The mechanistic models for No formation do not
include active site disulfide generation. Based on our model, this would indicate a narrow
distance distribution. Consistent with this idea, experiments have provided the diagonal distance
between Y122*-N* with a distribution similar to that observed with DOPA-P2 or DOPA-3PP'.
In summary, PELDOR studies with NH2Y-a2s have established the position of Y730 and
Y73 1 in an active a2/j2 complex. The studies reported set the stage for further X-band
PELDOR experiments with other substrate/effector pairs and high field PELDOR experiments
which could be used to measure the angle between paramagnets and ultimately the important
distance from Y356 to Y731. Time-resolved PELDOR experiments with NH2Y-a2s, or PELDOR
experiments with j31j' and NH2Y-a2s will provide further insight into the model proposed above
to explain the conformational distribution observed herein.
Kinetics of NH2Y* formation with various NDP/(d)NTP combinations. In this
chapter, the kinetics of NH2Y730* and NH 2Y731* formation was examined as a function of
substrate/effector pairs bound in a2 using SF UV-vis spectroscopy. The results have provided
insight into the role of each nucleotide in triggering of radical initiation across the a2/32 subunit
interface.
In Chapter 2, we presented the kinetics of DOPAo formation as a function of substrate/
effector combination. Considering the reactions in the presence of the four NDP/(d)NTP pairs,
there are several main features that need be discussed when comparing the results in Chapter 2
with those in this chapter. First, with DOPA-32, tri-phasic kinetics is observed in the presence
of CDP/ATP, UDP/ATP and ADP/dGTP; with GDP/TTP the kinetics are biphasic. With
NH2Y-a2s, only biphasic kinetics is observed with all NDP/(d)NTP pairs. The nature of the
third kinetic phase in DOPA-~2 is at this point unclear. It is likely related to the additional
mutations (V353G/S354C) present in all semisynthetic 02s. In Chapter 8, we will show that these
mutations have a marked effect on the pre-steady state kinetics of dCDP formation.
Experiments with intein wt 032 and NH 2Y-a2s will be useful in demonstrating whether the
additional kinetic phase is in fact associated with the mutations in semisynthetic 32. Second, the
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rate constant for the fast kinetic phase depends on the position of the radical trap. The kobs
increases in the order Y730NH2Y-a2 < Y731NH2Y-a2 < Y356DOPA-32; e.g. with CDP/ATP, the
kobs for the fast phase is 12, 18 and 38 s- 1, respectively. This observation is surprising as in all
cases, radical trapping is limited by the conformational change that precedes radical initiation.
Thus, it is difficult to explain how the rate constant for NH2Y* or DOPA* formation can vary
with the position of the trap in the pathway. Additional experiments are needed to illuminate this
issue. Third, the yield of DOPA* formation is different from that of NH2Y*. With DOPA-132,
48 + 4 % of total initial Y122* generates a DOPA*. With Y730NH2Y-a2 and Y731NH2Y-a2, 30 ±
9 % and 28 ± 6 % of total initial Y122* is involved in NH2Y* formation, respectively. This
difference likely reflects the stability of NH2Y* and its ability to generate a C439*. With
DOPA-P2, nucleotide reduction, and thus C439* formation, does not occur.
Comparison of DOPA* formation kinetics in Chapter 2 led us to conclude that substrate
binding provided the main conformational determinants for triggering radical propagation, that
effector alone was capable of triggering radical propagation, although in a slow and inefficient
manner, and that the yield of DOPA* formation was highest when both substrate and effector
were present. All these conclusions apply to the experiments with NH2Y-a2s presented here. In
these cases, substrate is the main signal for radical propagation across the subunit interface and
concomitant NH2Y* formation. Further, as with DOPA-132, NH2Y* is observed with NH2Y-a2s
in the presence of effector alone, although this process is slow and low-yielding. However, in
contrast to the studies with DOPA-P2, an additional important insight is provided by the studies
in this Chapter. Comparison of kinetics in the presence of substrate with those in the presence of
substrate and effector shows that in the latter case more NH 2Y* is formed with a fast kobs,
whereas in the former case, more NH 2Y* is formed with a slow kobs. Thus, the presence of
effector increases the yield of NH 2Y* in the fast phase, while decreasing it in the slow phase,
which is not kinetically competent based on results of Ge et al.47 This suggests that the role of
the effector is to redistribute a larger population of the complex into a conformation, which
generates a NH2Y* with a faster kobs that is competent in turnover. Accordingly, the effector
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plays an important role in changing the conformation of the complex from an inactive into an
active state. Steady state experiments show that in the presence of substrate alone, kcat is 2-10
fold lower than that in the presence of substrate and effector. The current results indicate that the
rate of nucleotide formation is similar in the presence of substrate and substrate/effector,
however, a smaller population is productive in product formation in the presence of substrate
alone vs. in the presence of substrate and effector together. This results in an apparent lower
specific activity in the presence of substrate alone.
In summary, the kinetics of NH2Y* formation have provided important insights regarding
the role of nucleotides in radical propagation. NH 2Y is an excellent probe for examining the
state of the a2/32 complex as a function of nucleotides and will be useful in re-investigating the
model of allosteric regulation proposed by Reichard and coworkers. One prediction that this
model makes, is that the combination of ATP/TTP results in an inactive complex.64 It could,
however, not be tested using activity assays, because the presence of substrate affects the
regulatory state of the complex. In addition, a role for dATP in activation and inhibition of RNR
has been suggested, which may be tested using NH2Y-a2s.
318
REFERENCES
(1) Stubbe, J.; van der Donk, W. A. Chem. Rev. 1998, 98, 705.
(2) Jordan, A.; Reichard, P. Annu. Rev. Biochem. 1998, 67, 71.
(3) Brown, N. C.; Canellakis, Z. N.; Lundin, B.; Reichard, P.; Thelander, L. Eur. J.
Biochem. 1969, 9, 561.
(4) Thelander, L. J. Biol. Chem. 1973, 248, 4591.
(5) Ehrenberg, A.; Reichard, P. J. Biol. Chem. 1972, 247, 3485.
(6) Stubbe, J.; Nocera, D. G.; Yee, C. S.; Chang, M. C. Y. Chem. Rev. 2003, 103, 2167.
(7) Stubbe, J.; Riggs-Gelasco, P. Trends Biochem. Sci. 1998, 23, 438.
(8) Uhlin, U.; Eklund, H. Nature 1994, 370, 533.
(9) Nordlund, P.; Sjoiberg, B.-M.; Eklund, H. Nature 1990, 345, 593.
(10) van der Donk, W. A.; Yu, G.; Perez, L.; Sanchez, R. J.; Stubbe, J. Biochemistry 1998, 37,
6419.
(11) van der Donk, W. A.; Yu, G.; Silva, D. J.; Stubbe, J. Biochemistry 1996, 35, 8381.
(12) Thelander, L.; Larsson, B.; Hobbs, J.; Eckstein, F. J. Biol. Chem. 1976,251, 1398.
(13) Salowe, S. P.; Ator, M. A.; Stubbe, J. Biochemistry 1987, 26, 3408.
(14) Climent, I.; Sjoiberg, B. M.; Huang, C. Y. Biochemistry 1992, 26, 4801.
(15) Ekberg, M.; Sahlin, M.; Eriksson, M.; Sjoberg, B.-M. J. Biol. Chem. 1996, 271, 20655.
(16) Ekberg, M.; Birgander, P.; Sjoberg, B.-M. J. Bacteriol. 2003, 185, 1167.
(17) Bennati, M.; Weber, A.; Antonic, J.; Perlstein, D. L.; Robblee, J.; Stubbe, J. J. Am. Chem.
Soc. 2003, 125, 14988.
(18) Schiemann, O.; Prisner, T. F. Q. Rev. Biophys. 2007, 40, 1.
(19) Bennati, M.; Robblee, J. H.; Mugnaini, V.; Stubbe, J.; Freed, J. H.; Borbat, P. J. Am.
Chem. Soc. 2005, 127, 15014.
(20) Bollinger, J. M., Jr.; Tong, W.-H.; Ravi, N.; Huynh, B.-H.; Edmonson, D. E.; Stubbe, J. J.
Am. Chem. Soc. 1994, 116, 8015.
(21) Bollinger Jr., J. M.; Tong, W. H.; Ravi, N.; Huynh, B. H.; Edmondson, D. E.; Stubbe, J. J.
Am. Chem. Soc. 1994, 116, 8024.
(22) Ravi, N.; Bollinger Jr., J. M.; Huynh, B. H.; Edmondson, D. E.; Stubbe, J. J. Am. Chem.
Soc. 1994, 116, 8007.
(23) Reece, S. Y.; Nocera, D. G.; Stubbe, J. Biochim. Biophys. Acta 2005, 1706, 232.
(24) Yee, C. S.; Chang, M. C. Y.; Ge, J.; Nocera, D. G.; Stubbe, J. J. Am. Chem. Soc. 2003,
125, 10506.
319
(25) Yee, C. S.; Seyedsayamdost, M. R.; Chang, M. C. Y.; Nocera, D. G.; Stubbe, J.
Biochemistry 2003, 42, 14541.
(26) Seyedsayamdost, M. R.; Reece, S. Y.; Nocera, D. G.; Stubbe, J. J. Am. Chem. Soc. 2006,
128, 1569.
(27) Seyedsayamdost, M. R.; Stubbe, J. J. Am. Chem. Soc. 2006, 128, 2522.
(28) Seyedsayamdost, M. R.; Yee, C. S.; Stubbe, J. Nat. Protoc. 2007, 2, 1225.
(29) Xie, J.; Schultz, P. G. Methods 2005, 36, 227.
(30) Xie, J.; Schultz, P. G. Nat. Rev. Mol. Cell Biol. 2006, 7, 775.
(31) DeFelippis, M. R.; Murthy, C. P.; Broitman, F.; Weinraub, D.; Faraggi, M.; Klapper, M.
H. J. Phys. Chem. 1991, 95, 3416.
(32) Skawinski, W.; Flisak, J.; Chung, A. C.; Jordan, F.; Mendelsohn, R. J. Labelled Comp.
Radiopharm. 1990, 28, 1179.
(33) van der Donk, W. A.; Gerfen, G. G.; Stubbe, J. J. Am. Chem. Soc. 1998, 120, 4252.
(34) Neta, P.; Fessenden, R. W. J. Phys. Chem. 1974, 78, 523.
(35) Dixon, W. T.; M., M.; Murphy, D. J. Chem. Soc. Faraday 11 1974, 70, 1713.
(36) Dixon, W. T.; Hoyle, P. M.; Murphy, D. J. Chem. Soc. Faraday 11 1978, 74, 2027.
(37) Simandi, L. I.; Barna, T. M.; Korecz, L.; Rockenbauer, A. Tetrahedron Lett. 1993, 34,
717.
(38) Sur, S. K.; Colpa, J. P. Organometallics 1989, 8, 2749.
(39) Loth, K.; Graf, F. Helvetica. Chim. Acta 1981, 64, 1910.
(40) Wasylishen, R. E. Can. J. Chem. 1976, 54, 833.
(41) Stone, A. J. Proc. R. Soc. Chem. 1963, A271, 424.
(42) Stone, A. J. Mol. Phys. 1963, 6, 509.
(43) McConnell, H. M.; Heller, C.; Cole, T.; Fessenden, R. W. J. Am. Chem. Soc. 1960, 82,
766.
(44) Kwiram, A. L. J. Phys. Chem. 1968, 49, 2860.
(45) Pesavento, R. P.; van der Donk, W. A. Adv. Prot. Chem. 2001, 58, 317.
(46) Huyett, J. E.; Doan, P. E.; Gurbiel, R.; Houseman, A. L. P.; Sivaraja, M.; Goodin, D. B.;
Hoffman, B. M. J. Am. Chem. Soc. 1995, 117, 9033.
(47) Lendzian, F. e. a. J. Am. Chem. Soc. 1996, 118, 8111.
(48) Ge, J.; Yu, G.; Ator, M. A.; Stubbe, J. Biochemistry 2003, 42, 10071.
(49) Jeschke, G.; Bender, A.; Paulsen, H.; Zimmermann, H.; Godt, A. J. Magn. Reson. 2004,
169, 1.
(50) Chiang, J. W.; Borbat, P. P.; Freed, J. H. J. Magn. Reson. 2005, 172, 279.
(51) Un, S.; Gerez, C.; Elleingand, E.; Fontecave, M. J. Am. Chem. Soc. 2001, 123, 3048.
320
(52) Un, S. Magn. Reson. Chem. 2005, 43, S229.
(53) McConnell, H. M. J. Chem. Phys. 1956, 24, 764.
(54) McConnell, H. M.; Chestnut, D. B. J. Chem. Phys. 1958, 28, 107.
(55) Bender, C. J.; Sahlin, M.; Babcock, G. T.; Barry, B. A.; Chandrashekar, T. K.; Salowe, S.
P.; Stubbe, J.; Lindstrom, B.; Petersson, L.; Ehrenberg, A.; Sjtberg, B.-M. J. Am. Chem.
Soc. 1989, 111, 8076.
(56) Heller, C.; McConnell, H. M. J. Chem. Phys. 1960, 32, 1535.
(57) Fessenden, R. W.; Schuler, R. H. J. Chem. Phys. 1963, 39, 2147.
(58) Henning, J. C. M. J. Chem. Phys. 1966, 44, 2139.
(59) Talcott, C. L.; Myers, R. J. Mol. Phys. 1967, 12, 549.
(60) Nanda, D. N.; Narasimhan, P. T. Theoret. Chim. Acta 1974, 32, 321.
(61) Ward, R. L. J. Am. Chem. Soc. 1962, 84, 332.
(62) Geske, D. H.; Padmanabhan, G. R. J. Am. Chem. Soc. 1965, 87, 1651.
(63) Felix, C. C.; Sealy, R. C. J. Am. Chem. Soc. 1982, 104, 1555.
(64) Brown, N. C.; Reichard, P. J. Mol. Biol. 1969, 46, 39.
321

CHAPTER 6:
Mono-, Di-, Tri-, and Tetra-Substituted Fluorotyrosines: New
Probes for Enzymes that Use Tyrosyl Radicals in Catalysis
Adapted from: Seyedsayamdost, M. R.; Reece, S. Y.; Nocera, D. G.; Stubbe, J. J. Am. Chem.
Soc. 2006, 128, 1569.
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INTRODUCTION
Electron transfer (ET) has been the focus of most studies of charge transport in biology.
Proteins modified with redox active donors and acceptors, 1-5 protein partners, 6-10 and DNA
bioconjugates 11-14 reveal that electrons transfer over long distances according to Marcus' theory
of ET,15i s augmented by considerations for electron tunneling. 16,17 In functioning enzymes,
however, the occurrence of isolated ET is uncommon. Many primary metabolic steps involving
charge transport rely on amino acid radicals in which ET is coupled to proton transfer (PT).18-21
For such charge transport reactions, the problem is intrinsically more complicated because both
the electron and proton tunnel and these tunneling events can be coupled to one another.22' 23 As
the electron moves, the pKa of the oxidized cofactor will change; but to predict kinetics,
knowledge of the driving forces for the ET and PT reactions is insufficient. The reorganization
energy will be affected by the charge redistribution resulting from electron and proton motion.24-
27 In addition, the electronic coupling will change parametrically with the proton coordinate.
Of the amino acid radicals participating in biological charge transfer processes, the
tyrosyl radical (Ye) is pre-eminent.20, 21,28 This one-electron, protein-based oxidant has been
identified as both a stable cofactor in deoxynucleotide biosynthesis29 and as a transient
intermediate with directed reactivity in photosynthetic 02 evolution, 30 prostaglandin
biosynthesis, 31 and disproportionation of hydrogen peroxide.32 Despite extensive knowledge
about the structure of the Y*s in these systems and the ever increasing number of Y*s identified
in other proteins,33-35 the precise mechanism of their formation and reactivity at a functional
biological level has for the most part remained unknown. However, at a mechanistic level, it is
well established that oxidation of tyrosine under physiological conditions requires the loss of
both a proton and an electron, implicating proton-coupled electron transfer (PCET) in the radical
forming mechanism. 18,30' 36 Therefore, the study of Y*s in the initiation and propagation of charge
in biology will necessarily demand that new tools are needed to control both the electron and
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proton for Y* formation within the enzyme. This is especially pertinent to our studies of class I
ribonucleotide reductase (RNR) where reversible radical transfer is proposed to occur between a
stable Y122 radical (Y122*) on the P2 subunit and C439 on the a2 subunit.'1837 Radical migration
over this unprecedented distance has been suggested to involve a radical hopping pathway
spanning both subunits with three other tyrosine residues, Y356 (P2), 731 (a2) and 730 (a2),
leading into the a2 active site. Moreover, the mechanism of formation of the stable Y122*, which
involves a putative di-iron, FerI/Few intermediate as the oxidant, also remains unknown.38-42
Substitution of tyrosine with other redox active amino acids can provide insight into the
mechanism of charge transport in enzymes. However, only the natural amino acids of tryptophan
and cysteine have reduction potentials close to that of tyrosine and they are poor structural
substitutes. For this reason, we have turned our attention to unnatural amino acids, specifically,
fluorotyrosines because they offer minimal structural perturbations compared to tyrosine. They
are isosteric with tyrosine and the van der Waals radius of fluorine is only 0.15 A larger than that
of hydrogen, thus representing the most conservative substitution barring isotopic replacement.
Fluorination at various points on the phenol ring affects a large range of pKa values for the
unprotected amino acid (FnYs).4 3 A similar variation in the tyrosyl radical reduction potentials
upon fluorine substitution would provide a systematic variation in AGOET and AGopT, the factors
that control the thermodynamics of PCET reactions.
In this paper we report the synthesis and physical characterization of the N- and C-
protected fluorotyrosines, Ac-FnY-NH 2s, shown in Scheme 6-1. We also develop the
methodologies for determining the AGOET and AGopr for the half of the PCET reaction involving
fluorotyrosine oxidation by measuring the reduction potentials for the radical and the pKa of the
phenolic protons for Ac-FnY-NH 2s, the latter of which is shown to vary by >4 pKa units.
Furthermore, we report the spectroscopic properties of the FnY*s, both EPR spectra and UV/Vis
absorbance spectra using transient laser absorption spectroscopy. To demonstrate the efficacy of
the fluorotyrosine method in unraveling charge transport in biological systems of complexity, we
325
report the global substitution of tyrosine by 3-fluorotyrosine (3-FY) in 032, and present the EPR
spectrum of the 3-FY122*, along with its simulation.
Scheme 6-1. Fluorotyrosine analogues prepared in this study.
CONH9
Ac 
N
H
n = 0: Ac-Y-NH2
n = 1: Ac-3-FY-NH 2
2 n = 2: Ac-2,3-F2Y-NH 2, Ac-3,5-F2Y-NH2
n = 3: Ac-2,3,5-F3Y-NH 2, Ac-2,3,6-F 3 Y-NH 2
n = 4: Ac-2,3,5,6-F4Y-NH 2
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MATERIALS AND METHODS
Materials. All fluorinated phenols, pyruvic acid, pyridoxal-5'-phosphate (PLP), N-
acetyl-L-tryosinamide, 3-fluoro-L-tyrosine, trifluoroacetic acid (TFA), thionyl chloride, acetic
anhydride, triethylamine, gaseous ammonia, 1-(3-dimethylamino-propyl)-3-ethylcarbodiimide
hydrochloride (WSC*HC1) and N-methylmorpholine (NMM) were purchased from Sigma-
Aldrich. L-Tyrosine methyl ester hydrochloride (Y-OMe*HC1) and 4-benzoyl-N-[(1,1-
dimethylethoxy) carbonyl]-L-phenylalanine (Boc-BPA-OH) were from Advanced ChemTech.
1-Hydroxybenzotriazole (HOBt) was obtained from NovaBiochem. All chemicals were used as
received.
Synthesis of FnYs. The plasmid, pTZTPL, encoding the enzyme tyrosine phenol lyase
(TPL), was a generous gift of Prof. Robert Phillips. TPL purifications were carried out as
described.44 FnYs were synthesized by stirring a 1 L solution of 30 mM ammonium acetate, pH
8.0, 10 mM of the appropriate fluorophenol, 60 mM sodium pyruvate, 5 mM P-mercaptoethanol,
40 gM PLP and 30 U of TPL at room temperature for 3 - 4 days in the dark. Synthesis of
2,3,5,6-tetrafluorotyrosine required 300 U of TPL and a 3 - 4 week incubation period, with
additional 20 U TPL and 1 mM tetrafluorophenol added every week. It was important to keep the
phenol concentration at 10 mM or lower, as higher concentrations resulted in enzyme
denaturation. After the incubation period, the mixture was acidified to pH = 3.0 with conc. HC1.
The precipitated protein was removed by filtering the mixture through a 2 - 3 cm thick Celite
pad. The filtrate was extracted once with 0.5 volumes of ethyl acetate. The aqueous layer was
loaded onto a 200 mL (4 x 17 cm) AG50W-X8 (50 - 100 mesh) cation exchange resin in the
protonated state. After loading, the column was washed with 10 volumes water. The FnY
analogue was then eluted with a 10% ammonium hydroxide solution. Fractions that gave positive
ninhydrin tests (purple stain after heating, see below) were pooled, concentrated in vacuo,
lyophilized to dryness and stored at 4 'C. Yields ranged from 50 - 80% based on the phenol as
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the limiting reagent. The ninhydrin solution consisted of 0.19% w/v ninhydrin, 95% v/v ri-
butanol, 0.5% v/v acetic acid and 4.5% v/v water.
3,5-F 2Y: 'H NMR (300 MHz, D20) 8= 3.0 (dd, 1H, Ci-HI, 8.2 Hz, 14.7 Hz) 3.18 (dd,
1H, Cp-H 2, 5.1 Hz, 14.6 Hz) 3.93 (dd, 1H, C,-H, 5 Hz, 8 Hz), 6.88 (m, 2H, arom. C-H). 19F
NMR (300 MHz, D20) 8= 26.9 (d, 2F, 8.3 Hz).
2,3-F 2Y: 'H NMR (300 MHz, D20) 8= 2.74 (dd, 1H, Cp-H1, 7.7 Hz, 13.8 Hz), 2.92 (dd,
1H, Cp-H 2, 5.8 Hz, 13.8 Hz), 3.43 (dd, 1H, Ca-H, 5.8 Hz, 7.7 Hz), 6.46 (m, 1H, arom. C-H), 6.71
(m, 1H, arom. C-H). ' 9F NMR (300 MHz, D20) 8= -3.50 (dd, IF, 8.3 Hz, 19 Hz) 16.8 (dd, IF,
8.3 Hz, 19.8 Hz).
2,3,5-F 3Y: 1H NMR (300 MHz, D20) 8= 2.73 (dd, 1H, Cp-H1, 7.5 Hz, 13.9 Hz), 2.89
(dd, 1H, Cp-H 2, 5.9 Hz, 13.9 Hz), 3.43 (dd, 1H, C,-H, 5.8 Hz, 7.4 Hz), 6.66 (m, 1H, arom. C-H).
19F NMR (300 MHz, D20) 8= 0.28 (dd, IF, 16.6 Hz, 19.4 Hz) 12.55 (m, IF) 19.7 (m, IF).
2,3,6-F 3Y: 'H NMR (300 MHz, D20) 8= 3.08 (dd, 1H, Cp-H1, 8.2 Hz, 15 Hz), 3.24 (dd,
1H, Cp-H 2, 5.7 Hz, 9.2 Hz) 3.9 (dd, 1H, C,-H, 5.7 Hz, 8.1 Hz) 6.42 (m, 1H, arom. C-H). 19F
NMR (300 MHz, D20) 8= -7 (m, IF), 19.07 (d, IF, 22.2 Hz), 38.13 (t, 1F, 11.1 Hz).
2,3,5,6-F 4Y: 'H NMR (300 MHz, D20) 8= 3.12 (dd, 1H, CO-H1, 8.3 Hz, 14.9 Hz) 3.27
(dd, 1H, Cp-H 2, 5.4 Hz, 14.9 Hz) 3.9 (dd, 1H, C,-H, 5.5 Hz, 8 Hz). ' 9F NMR (300 MHz, D20) 8
=-5.14 (dd, 2F, 11.1 Hz, 27.8 Hz) 11.81 (dd, 2F, 11.1 Hz, 27.7 Hz).
Synthesis of Fn-tyrosine methyl ester hydrochloride (FnY-OMe*HCl). In a typical
synthesis, the diammonium salt of the FnY (0.597 mmol) was combined with 20 mL of methanol
in a 50 mL round bottom flask. Thionyl chloride (400 gL) was added dropwise and the solution
was stirred for three days at room temperature. The solvent was removed in vacuo and the
resulting white solid was dissolved in a minimal amount of methanol. The undissolved NH4C!
was removed by filtration and ether was added dropwise to the filtrate to induce crystallization.
After cooling to -20 0 C, the white crystals were isolated by filtration and dried in vacuo providing
product in 70 - 88% yield.
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3-FY-OMe*HCI: 1H NMR (300 MHz, (CD3)2SO, 25 OC) 8= 3.02 (m, 2H, Cp-H), 3.68 (s,
3H, -OCH3), 4.22 (m, 1H, Ca-H), 6.80 (m, 1H, arom. C-H), 6.90 (m, 1H, arom. C-H), 7.02 (m,
1H, arom. C-H), 8.56 (b.s., 3H, -NH3), 9.88 (b.s., 1H, PhO-H). 19F NMR (300 MHz, (CD 3)2SO,
25 OC) 8= 27.3 (t, 1F, 11.1 Hz).
3,5-F 2Y-OMe*HCI: 'H NMR (300 MHz, (CD 3)2SO, 25 OC) 8= 3.05 (m, 2H, Cp-H), 3.70
(s, 3H, -OCH3), 4.27 (m, 1H, Ca-H), 6.94 (d, 2H, arom. C-H, 8.8 Hz), 8.63 (b.s., 3H, -NH3),
10.15 (s, 1H, PhO-H). 19F NMR (300 MHz, (CD 3)2SO, 25 OC) 8= 32.1 (d, 2F,11.1 Hz).
2,3-F 2Y-OMe*HCI: 'H NMR (300 MHz, (CD3)2SO, 25 OC) 8= 3.09 (m, 2H, Cp-H), 3.65
(s, 3H, -OCH3), 4.14 (m, 1H, Ca-H), 6.78 (m, 1H, arom. C-H), 6.89 (m, 1H, arom. C-H), 8.64
(b.s., 3H, -NH3), 10.51 (s, 1H, PhO-H). 19F NMR (300 MHz, (CD3)2SO, 25 OC) 8= -0.5 (d, 1F,
22.2 Hz), 8= 19.5 (d, IF, 22.2 Hz).
2,3,5-F 3Y*HCI: 'H NMR (300 MHz, (CD3)2SO, 25 oC) 6= 3.12 (m, 2H, Cp-H), 3.69 (s,
3H, -OCH3), 4.22 (m, 1H, Ca-H), 7.10 (m, 1H, arom. C-H), 8.70 (b.s., 3H, -NH3), 10.83 (b.s.,
1H, PhO-H). 19F NMR (300 MHz, (CD3)2SO, 25 OC) 6= 5.5 (d, 1F, 16.7 Hz), 15.8, (s, 1F), 24.5
(s, 1F).
2,3,6-F 3Y*HCI: 'H NMR (300 MHz, (CD3)2SO, 25 oC) 6= 3.07 (m, 2H, Cp-H), 3.64 (s,
3H, -OCH3), 4.07 (m, 1H, Ca-H), 6.73 (m, 1H, arom. C-H), 8.70 (b.s., 3H, -NH3), 11.13 (s, 1H,
PhO-H). '9F NMR (300 MHz, (CD3)2SO, 25 oC) 8= -4.8 (s, 1F), 22.3, (d, IF, 22.2 Hz), 40.9 (m,
1F).
2,3,5,6-F 4Y*HCl: 1H NMR (300 MHz, (CD3)2SO, 25 oC) 8= 3.16 (m, 2H, Cp-H), 3.66 (s,
3H, -OCH3), 4.14 (m, 1H, Ca-H), 8.75 (b.s., 3H, -NH3), 11.56 (b.s., 1H, PhO-H). '9F NMR (300
MHz, (CD 3)2SO, 25 oC) 8 = -0.6 (d, 2F, 16.7 Hz), 16.2, (d, IF, 22.2 Hz), 8= 40.9 (m, 1F)
Synthesis of N-acetyl-Fn-tyrosinamide (Ac-FnY-NH 2). In a typical synthesis, 460
gimol of FnY-OMe in 5.2 mL MeCN were stirred with 4 equiv. of triethylamine and 3 equiv. of
acetic anhydride. The reaction was monitored by TLC (20:1 CHC13/MeOH). After 2 h, the
solvent was removed in vacuo. The product was redissolved in MeOH followed by removal of
MeOH in vacuo (2x). The N-acetylated, methyl ester derivative was converted to the amide by
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stirring the compound at a concentration of 100 mM in NH3(gy-saturated MeOH. The reaction
was complete after 3 days. The solvent was removed in vacuo and the product purified by silica
gel chromatography with 15:1 CH2C12/MeOH as the eluant. The product was characterized by 1H
and 19F NMR as well as by LR-ESI-MS. Yields of 80 - 95% were obtained for all analogues.
Ac-3-FY-NH2: 'H-NMR (300 MHz, CD30D) 6= (s, 3H, Ac), (dd, 1H, Cp-HI, 8.8 Hz,
14.0 Hz), (dd, 1H, Cp-H2, 5.8 Hz, 14.0 Hz), (dd, 1H, C,-H, 5.8 Hz, 8.8 Hz), (m, 1H, arom. C-H),
19F NMR (300 MHz, CD 30D) 8= (dd, 1F, 8.3 Hz, 19.4 Hz) (dd, 1F, 8.3 Hz, 19.4 Hz). LR-ESI-
MS: m/z (-H) calc. 239.0, obs. 238.9.
Ac-3,5-F 2Y-NH 2: 1H-NMR (300 MHz, CD 30D) 8= 1.92 (s, 3H, Ac), 2.75 (dd, 1H, Co.
H1, 9.2 Hz, 13.9 Hz), 3.03 (dd, 1H, Cp-H 2, 5.5 Hz, 13.9 Hz), 4.55 (dd, 1H, C,-H, 5.7 Hz, 9.2
Hz), 6.83 (m, 2H, arom. C-H). 19F NMR (300 MHz, CD30D) 8= 25.2 (d, 2F, 8.3 Hz). LR-ESI-
MS: m/z (-H) calc. 257.0, obs. 256.9.
Ac-2,3-F 2Y-NH2: 1H-NMR (300 MHz, CD30D) 8= 1.90 (s, 3H, Ac), 2.85 (dd, 1H, Cp-
H1, 8.8 Hz, 14.0 Hz), 3.12 (dd, 1H, Cp-H 2, 5.8 Hz, 14.0 Hz), 4.61 (dd, 1H, Ca-H, 5.8 Hz, 8.8
Hz), 6.83 (m, 1H, arom. C-H). '9F NMR (300 MHz, CD30D) 8= -3.12 (dd, 1F, 8.3 Hz, 19.4 Hz)
17.3 (dd, 1F, 8.3 Hz, 19.4 Hz). LR-ESI-MS: m/z (-H) calc. 257.0, obs. 256.9.
Ac-2,3,5-F 3 Y-NH2: 1H-NMR (300 MHz, CD30D) 6= 1.93 (s, 3H, Ac), 2.78 (dd, 1H,
Cp-H 1, 8.4 Hz, 14.1 Hz), 3.03 (dd, 1H, Cp-H 2, 6 Hz, 14.3 Hz), 4.53 (dd, 1H, Ca-H, 5.7 Hz, 8.2
Hz), 6.56 (m, 1H, arom. C-H). '9F NMR (300 MHz, CD30D) 8= -0.95 (t, IF, 19.4 Hz) 10.48
(m, 1F) 19.05 (dd, 1F, 11.1 Hz, 27.7 Hz). LR-ESI-MS: m/z (-H) calc. 275, obs. 274.9.
Ac-2,3,6-F3Y-NH2: 1H -NMR (300 MHz, CD30D) 8= 1.94 (s, 3H, Ac), 2.93 (dd, 1H,
CI-H 1, 8.8 Hz, 14 Hz), 3.17 (dd, 1H, Cp-H 2, 5.5 Hz, 13.8 Hz), 4.65 (dd, 1H, Ca-H, 5.7 Hz, 13.8
Hz), 6.51 (m, 1H, arom. C-H). 19F NMR (300 MHz, CD30D) 8= -10.4 (m, 1F) 17.4 (d, 1F, 21
Hz) 36.2 (t, 1F, 12 Hz). LR-ESI-MS: m/z (-H) calc. 275, obs. 274.9.
Ac-2,3,5,6-F 4Y-NH2: 1H-NMR (300 MHz, CD30D) 8= 1.92 (s, 3H, Ac), 2.96 (dd, 1H,
C3-H1, 8.4 Hz, 14.4 Hz), 3.2 (dd, 1H, Cp-H 2, 6 Hz, 14.4 Hz), 4.64 (dd, 1H, C,-H, 6 Hz, 8.4 Hz),
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LR-ESI-MS: calc 293, obs 293. 9F NMR (300 MHz, CD30D) 8= -5.0 (dd, 2F, 6 Hz, 22.5 Hz)
12.6 (dd, 2F, 6 Hz, 22.5 Hz). LR-ESI-MS: m/z (-H) calc. 293, obs. 292.9.
Synthesis of 4-Benzoyl-L-phenylalanyl-FnY methyl ester trifluoroacetic acid (BPA-
FnY-OMe*CF 3COOH). FaY-OMe (0.432 mmol, 1.0 eq), BPA-OH (160 mg, 0.432 mmol, 1.0
eq), N-ethyl-N'-(3-dimethylaminopropyl)carbodiimide hydrochloride (WSC*HC1) (91 mg,
0.475 mmol, 1.1 eq), and 1-hydroxybenzotriazole (HOBt) (64 mg, 0.475 mg, 1.1 eq) were
combined in a 50 mL round bottom flask with 20 mL of methylene chloride. N-
methylmorpholine (NMM) (175 gL, 1.73 mmol, 4 eq) was added and the solution was stirred
overnight at room temperature. The solution was diluted to 75 mL with methylene chloride and
washed with 2 x 30 mL of 10% citric acid solution. The organic layer was dried over MgSO4 and
the solvent removed in vacuo. The resulting clear oil was dissolved in a few mLs of methylene
chloride and loaded onto a 1 mm thick silica gel Chromatotron plate. The product was eluted
with 3% methanol/methylene chloride and the solvent was removed in vacuo. The resulting clear
oil was dissolved in 1:1 TFA:CH2C12 and stirred for 20 min at room temperature. The solvents
were then evaporated under a stream of N2(g) and the resulting clear oil was dried under high
vacuum. Trituration with CH2C12 followed by the dropwise addition of ether resulted in the
formation of white crystals, which were cooled to -20 'C and isolated by filtration. Synthesis of
these dipeptides was carried out by Steven Reece.
BPA-Y-OMe*CF3COOH: 'H NMR (300 MHz, (CD 3)2CO, 25 oC) 8 = 2.88-3.18 (m, 2H,
Cp-H), 3.37 (m, 2H, C 3-H), 3.68 (s, 3H, -OCH3), 4.62 (m, 1H, Ca-H), 4.88 (m, 1H, Ca-H), 6.78
(m, 2H, phenol-H), 7.15 (m, 2H, phenol-H), 7.30 (d, 2H, C6H4 0C 6H5, 7.7 Hz), 7.55 (m, 2H,
C6H40C 6H5), 7.67 (m, 3H, C6H40C6H5), 7.76 (m, 2H, C6H40C6H5).
BPA-3-FY-OMe*CF 3COOH: 'H NMR (300 MHz, (CD 3)2CO, 25 oC) 8 = 2.90 - 3.20
(m, 2H, Cp-H), 3.32-3.48 (m, 2H, Cp-H), 3.69 (s, 3H, -OCH3), 4.63 (m, 1H, Ca-H), 4.96 (m, 1H,
Ca-H), 6.85 - 7.04 (m, 2H, phenol-H), 7.14 (m, 1H, phenol-H), 7.32 (m, 2H, C6H40C 6H5 ), 7.50
- 7.82 (m, 7H, C6H40C 6H5) 19F NMR (300 MHz, (CD 3)2CO, 25 OC) 8 = 27.17 (m, 1F), 89.76 (s,
3F).
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BPA-3,5-F2 Y-OMe*CF 3COOH: 'H NMR (300 MHz, (CD3 )2CO, 25 OC) 8 = 2.89-3.25
(m, 2H, Cp-H), 3.38 (m, 2H, Cp-H), 3.70 (s, 3H, -OCH 3), 4.65 (m, 1H, C,-H), 4.95 (m, 1H, C,-
H), 7.03 (m, 2H, phenol-H), 7.33 (d, 2H, C6H4 0C6 H5, 8.3 Hz), 7.56 (m, 2H, C6H40C6H5), 7.62-
7.85 (m, 5H, C6H40C 6H5). 19F NMR (300 MHz, (CD 3)2CO, 25 OC) 8 = 26.6 (s, 2F), 85.6 (s, 3F).
BPA-2,3-F2 Y-OMe*CF 3COOH: 'H NMR (300 MHz, (CD3 )2CO, 25 oC) 8 = 2.93 - 3.49
(m, 4H, Cp-H), 3.69 (s, 3H, -OCH 3), 4.68 (m, 1H, C,-H), 4.95 (m, 1H, Ca-H), 6.80 (m, 1H,
phenol-H), 7.01 (m, 1H, phenol-H), 7.39 (d, 2H, C6H4 0C 6H5, 7.7 Hz), 7.56 (m, 2H,
C6H40C 6H5 ), 7.63 - 7.86 (m, 5H, C6H4 0C 6H5). 19F NMR (300 MHz, (CD 3)2CO, 25 OC) 8 = -1.7
(m, 1F), 18.3 (m, IF), 85.6 (s, 3F).
BPA-2,3,5-F 3Y-OMe*CF 3COOH: 'H NMR (300 MHz, (CD3)2CO, 25 OC) 8 = 2.93-3.51
(m, 4H, Cp-H), 3.70 (s, 3H, -OCH3), 4.68 (m, 1H, Ca-H, 5.04 (m, 1H, Ca-H), 7.11 (m, 1H,
phenol-H), 7.41 (d, 2H, C6 H4 0C 6H5, 7.7 Hz), 7.55 (m, 2H, C6H4 0C 6H5 ), 7.62 - 7.85 (m, 5H,
C6H40C 6H5). 19F NMR (300 MHz, (CD 3)2CO, 25 OC) 8 = 7.93 (d, 1F, 22.2 Hz), 18.56 (m, 1F),
26.1 (s, IF), 89.9 (s, 3F).
BPA-2,3,6-F 3Y-OMe*CF 3COOH: 1H NMR (300 MHz, (CD 3)2CO, 25 OC) 8 = 3.00-3.26
(m, 2H, Cp-H), 3.44 (m, 2H, Cp-H), 3.67 (s, 3H, -OCH3), 4.66 (m, 1H, Ca-H), 5.12 (m, 1H, Ca-
H), 6.76 (m, 1H, phenol-H), 7.41-7.85 (m, 9H, C6H40C 6H5). 19F NMR (300 MHz, (CD 3)2CO, 25
OC) 8 = -1.86 (m, IF), 25.2 (d, IF, 22.2 Hz), 44.1 (m, IF), 90.0 (s, 3F).
BPA-2,3,5,6-F 4Y-OMe*CF 3COOH: 'H NMR (300 MHz, (CD3 )2 CO, 25 OC) 8 = 3.10 -
3.52 (m, 4H, Cp-H), 3.68 (s, 3H, -OCH3), 4.65 (m, 1H, C,-H), 5.05 (m, 1H, Ca-H), 7.46 - 7.85
(m, 9H, C6H40C 6H5 ). 19F NMR (300 MHz, (CD3)2CO, 25 OC) 8 = -2.42 (d, 2F, 22.2 Hz), 14.6
(d, 2F, 22.2 Hz), 85.6 (s, 3F).
Physical measurements. 1H and 19F NMR spectra were recorded on a Varian 300 MHz
NMR at the MIT Department of Chemistry Instrumentation Facility (DCIF). Aqueous samples
for 1H NMR and 19F NMR were carried out in D20 with 3-(trimethylsilyl)-propionic acid-d 4
(TSP) as an internal standard and CFC13 as an external standard, respectively. Nonaqueous 1H
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and 19F NMR were externally referenced to tetramethylsilane and CFC13, respectively. Steady-
state absorption spectra were recorded on an Agilent 8453 Diode Array Spectrophotometer.
pKa determination of Ac-FnY-NH 2 analogues using UV spectroscopy and 19F NMR
spectroscopy. The pHs of several buffer solutions (10 mM Potassium phosphate, 200 mM KC1)
were adjusted using either KOH or HCI spanning a pH range of 2 - 13 at 0.3 - 0.5 pH unit
intervals. The blocked FnY was diluted into each buffer and the pH remeasured before and after
acquisition of the UV spectrum. The absorption at a(Y-), the wavelength of maximum
absorption for the deprotonated phenolate form, was plotted vs. pH and the data fit Eq. 6-1:
A(pH) - A(pH= 2) 10 (pH -pKa)
= fy = (6-1)
A(pH=13) - A(pH=2) 1 + 1 0 (pH -pKa)
where A is absorbance at mx(Ac-Y--NH2) and fy represents the fraction of the amino acid in
the phenolate form.
To determine the pKa of free 2,3-F 2Y by 19F NMR, the samples were prepared in a
similar fashion as described above for the pKa determinations by UV spectroscopy. After
preparation of the sample in an Eppendorf tube, the pH was measured again and the sample
transferred to an NMR tube. Spectra were externally referenced to CFC13 and 19F NMR recorded
at different pH values. The change in chemical shift of each fluorine nucleus was plotted against
pH and fit to Eq. 6-2:
6(pH) - 8(pH= 5.3) 10 (pH -pKa)
= fy = (6-2)
8(pH=9.4) - 6(pH=5.3) 1 + 10 (pH -pKa)
Differential pulse voltammetry (DPV). The buffer used for pKa measurements (10 mM
Potassium phosphate, 200 mM KC1) was also used for electrochemical experiments. DPV was
performed on the N-acetyl, C-amide-protected amino acids, using a CV-50W instrument from
Bioanalytical Systems as previously described.4 Briefly, measurements were performed in a
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three-electrode glass cell, with a glassy carbon working electrode, a platinum wire counter-
electrode and a Ag/AgCl/3M NaCl reference electrode. The glassy carbon electrode was polished
with a water/alumina slurry and sonicated for -1 min prior to each measurement. Typically, the
solution contained 150 - 200 jiM protected Ac-FnY-NH2 analogue in 10 mM potassium
phosphate buffer with 200 mM KCl as the supporting electrolyte. The pH of several buffer
solutions was adjusted with 1 M HC1 or 1 M KOH prior to addition of the analyte and spanned a
range of 1 - 13 at 0.3 - 0.5 pH unit intervals. After addition of the analyte to the solution and
immediately before each measurement, the pH was measured with a pH meter, and the solution
degassed by Ar sparging for 2 min. Measurements were made with the ferricyanide/ferrocyanide
couple as an internal standard (0.436 V vs. NHE). DPV parameters were as follows: scan rate, 10
mV/s; sample width, 17 ms; pulse amplitude, 50 mV; pulse width, 50 ms; pulse period, 200 ms;
quiet time, 4 s; sensitivity, 100 gA/V; temperature, 25 'C.
Generation of oxidized FnYs and EPR measurements. A 10 - 15 mM solution of each
free FnY was prepared and the pH adjusted to 11 with NaOH. The sample was transferred to an
EPR tube and the solution bubbled with Ar for 15 min. The tube was then sealed under Ar
pressure and quick-frozen in liquid N2. The tube was immersed in liquid N2 in a quartz finger
dewar and irradiated for 5 min using the unfiltered light from a 1000 W high pressure Xe arc
lamp. The photolyzed product was never allowed to warm above 77 K and the EPR spectra were
subsequently recorded on a Bruker ESP-300 X-band (9.4 GHz) spectrometer equipped with an
Oxford liquid He cryostat at 77 K. The EPR parameters were as follows: power = 0.2 mW;
modulation frequency = 100 kHz; modulation amplitude = 1.5 G, time constant = 5.12 ms and
conversion time = 20.48 ms. The resulting EPR spectra remained unchanged after storage of the
photolysed product for one month at 77 K in the dark. The EPR spectra of 3-FY-P2 and wt 32
(vide infra) were obtained at 25 K using the same parameters listed above, except with a
modulation amplitude = 2 G. The 3-FY-32 spectrum was simulated by Dr. Stoyan Smoukov and
Prof. Brian Hoffman using SIMPIP and QPOW obtained from the Illinois EPR Research Center.
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Transient absorption (TA) spectroscopy. Pump light for TA measurements was
provided by an Infinity Nd:YAG laser (Coherent) running at 20 Hz. The set-up of the instrument
was slightly modified from that previously described.46 The third harmonic (355 nm, 200 mJ per
pulse) was used to pump a Type II XPO (Coherent). The 600 nm signal beam was isolated and
frequency doubled in a XPO-UV frequency doubling crystal (Coherent) to produce a slightly
divergent 300 nm beam with a -5 ns pulse width and a pulse energy of -500 pJ. This beam was
then passed through a slow focusing lense and through the sample at a ~ 1600, producing a beam
spot of 2 mm diameter on the sample. A 75 W Xe arc lamp (unpulsed, PTI) provided the probe
light, which was focused onto the sample, overlapped with the pump beam, recollimated after the
sample, and focused onto the entrance slit of a Triax 320 spectrometer. The probe beam was
dispersed by a 300 x 500 blazed grating and collected with either an intensified gated CCD
camera (ICCD, Andor Technology, 1024 x 256 pixels, 26 Pim 2) for TA spectra or a
photomultiplier tube (PMT) for TA kinetics at a single wavelength. PMT outputs were collected
and averaged with a 1 GHz oscilloscope (LeCroy 9384CM). To produce a TA spectrum, a series
of four spectra were taken: IF (pump on/probe off), I (pump on/probe on), IB (pump off/probe
off), and Io (pump off/probe on). Uniblitz shutters driven by delay generators (DG535, Stanford
Research Systems) and T132 Uniblitz shutter drivers were used to block the pump and probe
light in this sequence using a TTL trigger from the Q-switch of the laser. Transient spectra were
corrected for fluorescence and background light using these spectra and the equation: AOD =
log[(Io - IB)/(I - IF)]. Spectra reported are the average of 1250 of the four-spectra sequences. The
instrument control and data analysis were performed by software written in LabView. Aqueous
BPA-FnY-OMe samples were prepared at 200-500 gLM concentrations in deionized water
buffered to pH 4 with 20 mM succinic acid. All TA measurements were performed in a 2 mm
quartz optical cell. For BPA-3-FY-OMe, 266 nm pump light was used as described
previously,47 and the sample was flowed through a 2 mm cell to ensure fresh sample for each
laser shot. T. A. spectroscopy was carried out by Steven Reece.
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Computational methods. Density functional theory calculations (DFT) were performed
using the Amsterdam Density Functional (ADF2002.02) program 48'49 a home-built Linux cluster
comprising 60 Intel processors organized in groups of 12 running in parallel. The generalized
gradient approximation was used as implemented in ADF by the Becke-88 functional for
exchange,50 and the Perdew-Wang-91functional for correlation.51 A basis set of triple-ýSlater-
type functions augmented by a polarization set (TZP) was used for all atoms; spin restriction was
lifted for all Ac-FnY*-NH 2 radicals. Energies reported are gas-phase internal energies at 0 K,
without zero-point vibrational energy, of the geometry optimized structure. Each structure was
optimized from the same amino acid backbone configuration, which was kept nearly constant
throughout the calculation. Orbital energies, Cartesian coordinates and atom numbering schemes
for each of the protonated, deprotonated and radical Ac-FnY-NH 2s are provided in the
Supporting Information. Computational studies were carried out by Steven Reece.
Global incorporation of 3-FY into 32. Competent BL21(DE3) cells were transformed
with pTB2, an 32 overexpression plasmid, and grown on an LB agar plate containing 100 mg/L
ampicillin. A single colony from the plate was used to seed a 200 mL culture containing 100
mg/L ampicillin. The culture was grown overnight and then centrifuged at 10,000 g for 10 min.
The cell pellet was resuspended in 50 mL of minimal medium containing no L-tyrosine and 100
mg/L ampicillin (details of the medium have been reported).52 The doubling time of the cells was
typically -40 min and at A600 nm of 0.6, 1 g/L of 3-FY was added to the culture. IPTG (0.5 mM)
was added to the culture 15 min after the addition of 3-FY. The cells were grown to A600 nm of
1.4 - 1.6 and harvested -4 h after induction. The yield was 5 g/L, similar to yields obtained for
wt 32 culture growths. 3-FY-02 was purified using published procedures. 53
Extent of incorporation of 3-FY into 02. The 3-FY content of 02 was analyzed by the
MIT Biopolymer Laboratory using the following procedure: The purified 3-FY-P2 (200 - 2000
pmol) was lyophilized to dryness in a Speedvac and hydrolyzed in 200 pL of 6 N HCl (Pierce
Sequence Grade) at 150 oC for 1 h or 110 oC for 22 h under N2 with norleucine (1000 pmol)
added as an internal standard. The samples were then dried in vacuo, treated with 2%
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borane/diisopropyl ethylamide complex solution (40 gL) to reduce methionine oxidation and
allowed to air-dry for 2 h. The samples were then dissolved in 0.3 M sodium acetate buffer (pH
5.5) containing 0.025 % w/v potassium EDTA, mixed rigorously, and centrifuged at 15,000 rpm
on a tabletop centrifuge for 5 min to remove particulate matter. Aliquots (30 gtL) were then
loaded onto an Applied Biosystem Model 420A Derivatizer using phenyl isothiocyanate as the
derivatizing agent, followed by automatic injection onto an Applied Biosystem 130A Separation
System, which uses a Spheri-5 PTC 5 micron, 220 x 2.1 mm column from Perkin-Elmer
Brownlee. A series of pure amino acid standards including 3-FY (500 pmol) were also
derivatized and analyzed to determine the retention time of each amino acid and for quantitation
purposes. The data was collected and analyzed using a Perkin-Elmer Applied Biosystem 610A
Data Analysis program. Global incorporation of 3-FY and determination of its extent were
performed by Dr. Hiep-Hoa Nguyen.
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RESULTS AND DISCUSSION
pKa determination of FnYs by UV and 19F NMR spectroscopy. A slightly modified
method from that of Kim and Cole43 and Phillips and coworkers54 yields the free FnYs in good
yields and high purity. The amine and acid functionalities of the free amino acids were protected
by acetylation and amidation to avoid complications arising from different protonation states of
these groups. Figure 6-1 presents the absorption spectra of phenol and phenolate forms of the
Ac-FnY-NH2 amino acids presented in Scheme 6-1. Substitution of the aromatic protons of
tyrosine with fluorine results in a blue-shift of the Xmax associated with the i --, R* transition
(Figure 6A), which red shifts upon deprotonation (Figure 6B). This observed bathochromic shift
with deprotonation of the phenol group allows for the measurement of pKa by UV spectroscopy.
The typical absorbance changes for Ac-FnY-NH2s induced by changes in pH are shown
in Figure 6-2 for the Ac-2,3-F 2Y-NH2 derivative. The pKa values were determined by plotting
fy- as a function of pH, and fitting the data to Eq. 6-1 (see inset). The pKa values listed in Table
6-1 for the protected Ac-FnY-NH 2 amino acids differ significantly from those previously
determined for the unprotected FnY analogues.43 N-acetyl and C-amide protected derivatives
allow us to monitor acid/base equilibria resulting only from the fluorophenol moiety; therefore
the pKa values obtained on these blocked derivatives better approximate the pKa that these
residues would have in a solvent-exposed, simple polypeptide chain. The pKa values of FnY
derivatives may be independently determined by 19F NMR. Figure 6-3 shows the pH dependence
of the two fluorine signals of free (i.e. unprotected) 2,3-F 2Y; as the pH is decreased, these
signals shift downfield. When the chemical shift is plotted as a function of pH and fit to Eq. 6-2,
pKas of 7.53 (using the lower field 19F nucleus) and 7.59 (using the higher field 19F nucleus) are
obtained, in good agreement with that previously reported for the unprotected amino acid (pKa =
7.6).43 Within a protein environment, the determination of pKa values of FaY by the 19F NMR
method may be easier to implement since large UV absorptions from intra-protein Y and W
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residues will obscure the bathochromic shift of FnY residues incorporated into the protein.
Indeed, 19F NMR signals of non-natural FnY amino acids have been used in small proteins to
probe changes in the environment of specific residues upon domain movements.55
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Figure 6-1. UV spectra of phenol and phenolate forms of Ac-FnY-NH2Ys. The UV spectra of
phenol (A) and phenolate (B) forms are shown for (-) Ac-Y-NH2, (-) Ac-3-FY-NH 2, (-) Ac-
3,5-F 2Y-NH2, (-) Ac-2,3-F 2Y-NH2, (-) Ac-2,3,6-F 3Y-NH2, (-) Ac-2,3,5-F 3Y-NH2, and (-)
Ac-F 4Y-NH2.
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Figure 6-2. UV spectra of Ac-2,3-F 2Y-NH2 as a function of pH. Changes in the absorption profile
of Ac-2,3-F 2Y-NH2 at aqueous solution pH of 5.1 (-), 7.0, 7.7, 8.0, 8.3 and 9.1(-). Inset: Fraction
of Ac-2,3-F 2Y- -NH 2 vs. pH (o) and fit (-) as described by Eq. 6-1.
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Figure 6-3. Dependence of 19F NMR chemical shifts on pH. '9F NMR spectra of free 2,3-F 2Y at
various pH values (bottom) and fraction of 2,3-F 2Y- as a function pH fit to Eq. 6-2 (top inset). Blue
data points represent signal of the higher field 19F nucleus, red data points represent that of the lower
field 19F nucleus.
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Table 6-1. Physical data for tyrosine and fluorotyrosine derivatives.
hmax(FnY) /nm Lax(FnY-) / nm Lax(FnY*)/Derivative (pKFa pKab pKac Ep(Y/Y-)/I mVd 6(0-H)/ppme(F /M cm -) (E / M-1 cm 1) nm
Y 275 (1400) 293 (2420) 407 10 - 9.9 642 9.44
3-FY 272 (1530) 289 (2740) 400 8.4 8.4 8.4 705 9.88
3,5-F 2Y 263 (560) 275 (1830) 395 6.8 7.2 7.2 755 9.88
2,3-Fz2Y 265 (910) 279 (2060) 408 7.6 7.7 7.8 810 10.51
2,3,5-F 3Y 267 (570) 276 (1460) 400 6.1 6.4 6.4 853 10.83
2,3,6-F 3Y 266(1050) 277 (2360) 415 6.6 6.9 7.0 911 11.13
F4Y -257 (420) -273 (1660) 411 5.2 5.6 5.6 968 11.56
a FnY pKa as reported in ref. 43. b Ac-FnY-NH 2 pKa as determined by the UV-Vis absorption titration method. c Ac-FnY-NH 2 pKa asdetermined by the DPV method. d DPV peak potential vs. NHE for the Ac-FnY*-NH 2/Ac-FnY--NH 2 couple. e FnY-OMe 'H NMR in(CD3)2SO.
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pH Dependent oxidation of Ac-FnY-NH 2s. Oxidation of Y is an irreversible one-
electron event56 and thus only peak potentials, Ep, may be obtained, most accurately by DPV. 45
We have determined Eps for each FnY as a function of pH. A differential pulse volatmmogram
for the Ac-FaY-NH2Y/Ac-FaY*-NH 2 couple is shown in Figure 6-4 indicating that
fluorination of the phenol ring leads to an increase in Ep. Plots of Ep vs. pH for the Ac-FnY-NH 2
amino acids are shown in Figure 6-5. At pH values exceeding the pKa of each Ac-FnY-NH 2, a
pH-independent peak potential is observed, indicative of the Ac-FY*-NH2/Ac-FnY--NH 2
couple, and these values are listed in Table 6-1. As the pH is decreased below the pKa, the peak
potential increases at 59 mV per pH unit corresponding to the Ac-FnY*-NH2/Ac-FnY-NH 2
redox couple in which tyrosine oxidation is accompanied by proton loss. The pH dependence of
Ep is in accordance with the Nernst equation (Eq. 6-3),
E, = Ep(Ac-Y*-NH 2/Ac-Y-NH2) + 2.3 RT/nF log (1 + 10-PH/ 10 -pKa) (6-3)
where Ep(Ac-Y*-NH 2/Ac-Y--NH2) is the peak potential of the deprotonated tyrosinate and the
pKa accounts for the Ac-Y-NH2 --+ Ac-Y--NH 2 + H' reaction. A fit of the Ep vs. pH curves in
Figure 6-5 to Eq. 6-3 yields pKas for Ac-FnY-NH 2s that are in good agreement with those
obtained using the UV titration method already described (see Table 6-1). The pKa of the
oxidized [FnY*]+ radicals cannot be determined from Eq. 6-3 because the aqueous solution is
oxidized at potentials below that needed for the electrochemical generation of [FnY*]+ at low
pHs.
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Figure 6-4. Differential pulse voltammogram for Ac-FY--NH2/Ac-FnY*-NH 2s. Traces shown are
for: (-) Ac-Y-NH2, (-) Ac-3-FY-NH 2, (-) Ac-3,5-F 2Y-NH2, (-) Ac-2,3-F 2Y-NH2, (-) Ac-
2,3,5-F 3Y-NH2, (-) Ac-2,3,6-F 3Y-NH2and (-) Ac-F 4Y-NH2.
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Figure 6-5. Reduction potential vs. NHE as a function of pH for Ac-FY-NH2 derivatives. Data
points are for: (o) Ac-Y-NH2, (o) Ac-3-FY-NH2, (o) Ac-3,5-F 2Y-NH 2, (o) Ac-2,3-F 2Y-NH2, (0o)
Ac-2,3,5-F 3Y-NH2, (o) Ac-2,3,6-F 3Y-NH2 and ( ) Ac-F 4Y-NH 2. Lines describe fits according to
Eq. 6-3. See Table 6-1 for parameters obtained from these fits.
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Electronic structure calculations of Ac-FnY-NH 2s. The Ac-FY*'-NH 2/Ac-FnY--NH 2
redox couple was found to generally increase with the number of fluorine substituents on the
phenol ring. Within the series of di- and trifluorotyrosines, the couples follow a trend: Ac-2,3-
F2Y-NH2 > Ac-3,5-F 2Y-NH2 and Ac-2,3,6-F 3Y-NH 2 > Ac-2,3,5-F 3Y-NH2 that is captured
computationally. Geometry optimizations on Ac-FnY-NH 2, Ac-FnY*-NH 2, and Ac-FnY--NH 2
were performed while keeping the amino acid backbone in the same conformation. Figure 6-6
(top) compares the difference in total bonding energy between the Ac-FnY*-NH2 and Ac-FnY--
NH2 redox states as calculated by DFT to the experimentally determined Eps (Ac-FnY*-NH 2/Ac-
FnY--NH2). The linear correlation between observed and calculated results validates the quality
of the computation. The electronic structure calculation summarized in Figure 6-7 shows that
the observed trend in the reduction potential arises from primarily stabilization of the HOMO and
HOMO-1 orbitals of the phenolate with increasing fluorination of the aromatic ring of tyrosine.
This stabilization of HOMO and HOMO-1 levels is most pronounced for Ac-FnY--NH 2; these
levels exhibit only a modest shift for Ac-FnY*-NH 2 (and Ac-FnY-NH 2) (data not shown). The
Kohn-Sham representations of the frontier molecular orbitals, shown for tyrosinate in Figure 6-
7, reveals that the HOMO orbital carries significant n-electron density at the 3 and 5 positions of
the aromatic ring whereas the HOMO-1 has ai-electron density localized on the orbital of the
oxygen of the phenol, in an in-plane antibonding interaction with the aromatic ring. The
interaction of the HOMO and HOMO-1 ring orbitals with the pxn-orbitals of the fluorine atom
substituents allows subtle variations in the reduction potential among members of the phenolate
series to be understood. For instance, substitution of fluorine at the 2,3 vs 3,5 ring positions
results in a 65 mV increase in the reduction potential of the radical. The HOMO, which is
presented in the framed box of Figure 6-7, exhibits an antibonding interaction between the rx-
orbitals of the fluorine atoms and the 3,5-carbon pat orbitals of the aromatic ring. By moving a
fluorine from a 5- to a 2-position, this antibonding interaction is relaxed significantly, resulting
in stabilization of the HOMO. A similar effect is observed for 2,3,5- and 2,3,6-
trifluorotyrosines.
346
A parallel calculation was performed to assess the difference between the observed ln(Ka)
and the total bonding energy difference of protonated and deprotonated Ac-FnY-NH2s. The
calculation predicts the general trend that increasing the number of fluorine substituents
decreases the pKa of the phenolic proton (Figure 6-6, bottom), however a poorer correlation is
observed as compared to that for the reduction potentials. The anomaly is most obvious for Ac-
2,3-F 2Y-NH2 and Ac-3,5-F 2Y-NH2, which are calculated to have similar pKas despite an
observed difference of 0.6 pKa units. We believe that such deviations arise from the deficiency of
gas phase DFT calculations in modeling specific hydrogen bonding interactions that are
important in determining the overall pKa of the fluorotyrosines.5 759
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Figure 6-6. DFT calculations for Eps and pKas of Ac-FnY-NH 2Ys. (Top) Plot of Ep(Ac-FnY.-
NH2/Ac-FnY--NH 2) vs. E(Ac-FnY*-NH 2) - E(Ac-FnY--NH 2), the total bonding energy difference
between Ac-FnY*-NH2 and Ac-FnY--NH 2 as calculated by DFT, with linear fit (-). (Bottom) Plot of
-In(Ka) vs. E(Ac-FnY--NH 2) - E(Ac-FnY-NH 2), the total bonding energy difference between Ac-
FnY--NH2 and Ac-FnY-NH 2 as calculated by DFT, with linear fit (-). Color coded points
correspond to data for (o) Ac-Y-NH2, (o) Ac-3-FY-NH2, (*) Ac-3,5-F 2Y-NH 2, (*) Ac-2,3-F 2Y-
NH2, (e) Ac-2,3,5-F 3Y-NH2, (e) Ac-2,3,6-F 3Y-NH2, (*) Ac-F 4Y-NH2.
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Figure 6-7. Energy level diagram for frontier molecular orbitals of the phenolates of Ac-FnY-NH 2s.
Shown are (-) Ac-Y--NH2, (-) Ac-3-FY--NH2, (-) Ac-3,5-F 2Y--NH2, (-) Ac-2,3-F 2Y--NH 2,(-) Ac-2,3,5-F 3Y--NH2, (-) Ac-2,3,6-F 3Y--NH2 and (-) Ac-F 4Y--NH2. Selected Kohn-Sham
representations of orbitals for the tyrosine analogue are shown at the 95% probability level. The
Kohn-Sham representation of the HOMO orbital for Ac-3,5-F 2Y--NH 2 is presented in the frame.
Spectroscopic characterization of FnY*s. Having determined the pKa and Ep for each
Ac-FnY-NH2, we next assessed the EPR and UV-vis properties of their oxidized forms. For
EPR studies, the oxidized species were generated by the method of Hulsebosch et al.60 using UV
photolysis at 77 K. The spectra obtained are shown in Figure 6-8; the signal was stable for at
least 1 month at 77 K. All FnY*s display broader signals than Y*; lower modulation amplitudes
and larger sweep widths did not uncover any additional hyperfine interactions. Qualitatively, the
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spectra of 2,3,5-F 3Y*, 2,3,6-F 3Y* and 2,3,5,6-F 4Y* are similar, whereas those of 3-FY*, 2,3-
F2Y* and 3,5-F 2Y* are distinctly different.
Attempts to simulate the EPR spectra displayed in Figure 6-8 by several methods were
unsuccessful. Both standard programs as well as DFT-based simulations were unsatisfactory, as
has been previously observed with 3-FY* (David Britt, personal communication). These results
suggest that frozen glasses of FaY* contain a wide distribution of dihedral angles of the P-
methylene hydrogen atoms. In Ye, one of these hydrogen atoms is responsible for the strongest
hyperfine coupling to the unpaired electron. 60 Since the strength of this interaction varies as
cos 20, where 0 is the dihedral angle between the plane of the aromatic ring and the P-methylene
hydrogen, a distribution over these angles can broaden the spectra. Nevertheless, these spectra
show that FnY*s have distinct EPR properties useful for the study of proteins with multiple Y*s.
Further, incorporation of these analogues into enzymes will fix the 0 dihedral angle for the
Cp-protons and reveal more resolved spectra.
The absorption spectra of the FnY* were obtained using the flash photolysis technique
with benzophenone as the photo-oxidant of Y. The triplet excited state of benzophenone has
been shown to be a competent, bimolecular oxidant of tyrosine with an excited state reduction
potential of 1.69 V vs. NHE and bimolecular rate constant for reaction with Y of 2.6 ± 0.2 x 109
M-Is-. 61 Moreover, the absorption spectrum of the benzophenone ketyl radical, produced upon
Y photo-oxidation, does not significantly overlap with that of the FaY*.
The photosensitized oxidation of tyrosine by benzophenone was accomplished by
designing a unimolecular ET within the dipeptide pair formed from the catenation of the
unnatural amino acid, 4-benzoyl-L-phenylalanine, BPA, to the FnY-OMe amino acids.
Excitation of a solution of BPA-Y-OMe dipeptide at pH 4.0 with a 300 nm nanosecond laser
pulse produces a species with the transient absorption spectrum shown in Figure 6-9 at 100 ns.
The strong, sharp peak with max = 334 nm and broad peak at max = 547 nm with a shoulder to
the blue are the spectral signatures of the reduced benzophenone ketyl radical 62 (655o nm(BPK*) =
3300 ±+ 700 M-'cm- in cyclohexane),63 whereas the absorption bands at imax = 390 and 407 nm
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are characteristic of Ye (c410(Ye) = 2750 + 200 ).64 The Yo peaks are slightly blue-shifted from
that of free Y* owing to their overlap with the tailing absorption of the 334 nm band of the ketyl
radical of BPA (BPA*). The subsequent gray traces recorded at 400 ns and 1 Rs show that the
overall profile shape does not change with time. The transient signals decayed concomitantly
with a rate constant of 5.6 x 106 s-1; single X kinetics data recorded at 547 nm is shown in the
inset of Figure 6-9. This unimolecular decay is consistent with charge recombination between
BPA* and Ye. The kinetics were unaffected by the presence or absence of oxygen in solution. A
minor residual absorbance (<10%), which persists for tens of microseconds, is likely due to a
small fraction of ET product formed in the bimolecular reaction between 3BPA-Y-OMe and
ground state BPA-Y-OMe. This reaction is favored at the high concentrations of dipeptide
required for the TA experiment.
Figure 6-10 shows the TA spectra obtained 100 ns after 300 nm excitation of each of the
BPA-FnY-OMe dipeptides. The amount of BPA*-FnY*-OMe produced in each experiment
varies due to changes in pump-probe beam overlap and sample concentration. Therefore, to
allow for comparison of the fluorotyrosyl radical absorption maxima between experiments, the
spectra in Figure 6-10 are normalized to the 547 nm peak of the BPA*. The absorbance
maximum of the BPA* species is invariant for each of the dipeptides whereas the absorption
band of the FnY* species varies in its maximum between 395 and 415 nm. The values of max for
each of the FnY*s are listed in Table 6-1. An interesting comparison can be made between the
FnY*s and Ye absorbance features. The 2,3-F 2Y*, 2,3,6-F 3Y* and F4Y* all have the familiar
double hump absorbance feature of Ye, though they are slightly broader and red-shifted. The
spectrum of 3-FY* also contains the double hump feature, though its max is now blue-shifted by
7 nm. Of particular note are the single peaks at 395 and 400 nm for 3,5-F 2Y* and 2,3,5-F 3Y*,
respectively, which are significantly blue-shifted from the larger 407 nm absorbance peak of Yo.
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g value
Figure 6-8. Normalized EPR spectra of F,Y*s. The oxidized product was formed by UV photolysis
of a pH 11 solution of each FnY at 77 K (see Methods).
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Figure 6-9. TA spectroscopy with BPA-Y-OMe. Spectra shown were recorded at (-) 100 ns, (-)
400 ns, and ( ) 1 gs following a 300 nm, 5 ns excitation of a 500 pM solution of BPA-Y-OMe
buffered to pH 4.0 with 20 mM succinic acid. Inset: Single 1 kinetics of the 547 nm absorption (o)
and a mono-exponential decay fit (-) to the data.
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Figure 6-10. UV-vis spectra of BPA-F,Y*-OMe derivatives. Spectra have been normalized to the
547 nm peak of BPA* 100 ns after excitation of each BPA-FnY-OMe.
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Incorporation of 3-FY into 32. To demonstrate the ability of FnYs as spectroscopic
probes of Y sites in biological systems, we replaced all Ys in 12 with 3-FY using global
incorporation methods. The successful procedure required growth of the bacteria in minimal
media from which L-tyrosine was omitted and replaced by 3-FY. Under these conditions the
doubling time of the bacteria was 40 min. SDS-PAGE analysis of whole cells subsequent to
induction with IPTG suggests that expression level of the 3-FY-12 is quite similar to that
observed for wt 12, which has a monomeric MW of - 43 kDa (Figure 6-11, lane 1). 3-FY-P2
was isolated using the standard isolation procedure for wt 12. Visual inspection of the gel of
purified 3-FY-12 (Figure 6-11, lane 4) shows that the isolated protein is -95 % homogeneous
and amino acid analysis of purified 3-FY-02 indicates -90 % incorporation of 3-FY. The
excellent yield of labeled protein and the similarities in its purification relative to wt 12, suggest
that the 3-FY-02 is folded. The amount of radical per 3-FY-32 was established by EPR
integration using wt E. coli 12 as a standard.65 The 3-FY-P2 was determined to contain 0.6 - 0.8
Y122*s/dimer as isolated. The absorption spectrum of the 3-FY122* (data not shown) shows that
.ax blue-shifts to 402 nm (wt Y122* has a m.a of 411 nm), consistent with the results from the
TA experiments described above.
The EPR spectrum of wt 12 from E. coli has previously been characterized at 9, 35, 140,
195, 245, 280 GHz and has anisotropic g values of gx = 2.00912 - 2.00868, gy = 2.00457 -
2.0043 and gz = 2.00225 - 2.00208.28 The X-band EPR spectrum of wt 12 is dominated by the
well-resolved, nearly isotropic, coupling to one of its 3-Hs (Ax = 61.2, Ay = Az = 53.7 MHz). 66
The second 1-H coupling is much smaller and is usually lost in the EPR linewidth. This study
presents the first observation of the magnetic properties of a 3-FY* in a protein. The X-band
EPR spectrum of this radical, along with the simulation, is shown in Figure 6-12. Table 6-2
presents the A-tensors of the nuclei with significant hyperfine couplings to the unpaired electron.
The splitting due to coupling to the P-H is similar to that observed for the Y122" in wt 12.
However, a strongly split doublet of doublets, demarcated by brackets in Figure 6-12, is apparent
at the extremes of the spectrum due to coupling to the fluorine nucleus. Together the results
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above show that 3-FY can be incorporated at high efficiency into 32, yielding 3-FY-02 with
high radical content and activity. Further, the EPR spectrum shows that the 3-FY 122* has well-
resolved hyperfine interactions that can be simulated, supporting our contention that the FnY*
EPR spectra of Figure 6-8 are broad due to a distribution in the dihedral angles of P-methylene
hydrogens.
RNR activity is preserved with global substitution of the 14 Y residues of P2. The activity
of the 3-FY-p2/oc2 complex was measured by a coupled spectrophotometric assay using
TR/TRR/NADPH as the reductant. 65 The specific activity obtained was -65 % that of wt 02,
suggesting that substitution of the 14 Y residues in 32 with 3-FY minimally perturbs the tertiary
structure of 3-FY-P2.
1 2
205 kDa
116 kDa
97 kDa
84 kDa
66 kDa
55 kDa
45 kDa
36 kDa
3 4
66 kDa
45 kDa
36 kDa
29 kDa
24 kDa
Figure 6-11. SDS PAGE analysis of 3-FY--P2. (1) overexpression of 3-FY-02, (2) high range
molecular weight marker, (3) low range molecular weight marker, (4) purified 3-FY-P2.
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Figure 6-12. EPR spectrum and simulation of 3-FY122*-j2. (Top) EPR spectrum (solid line) and
simulation (dotted line) of 3-FY122*-p2 at 25 K. The values used for the simulation are listed in Table
6-2. (Bottom) EPR spectrum of wt-f2 under the same conditions.
Table 6-2. A-tensors of nuclei with significant hyperfine interaction in 3-FY122*-32.
Nucleus Ax (MHz) Ay (MHz) Az (MHz) Oa
3-F -15 (6) -3 (4) 180 (2) 0
-H1I 48 (6) 54 (4) 50 (2) 0
5-H -25 (1) -8 (1) -17(1) 25
2,6-H 3 9 6 65
a 0 angles describe
hyperfine tensors.
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rotation about the axis normal to the plane of the phenol ring between the g tensor and
2
CONCLUSIONS
The mechanistic complexity arising from the coupling of electron and proton transfers in
charge transport processes involving amino acid radicals requires the development of new tools
and methods for their study. We show here that FnYs will be useful in the study of biological
charge transport mechanisms involving tyrosine for the following reasons. (1) They provide a
range of pKa for the phenolic proton and Ep for the Y*/Y couple, which allows for tuning of the
AGopr and AGoET for the PCET reaction. UV-Vis and 19F NMR spectroscopic studies in
conjunction with DPV illustrate that the Ac-FnY-NH 2s offer a range of almost 5 units in pKa and
320 mV in redox potential within the pH range of 6-9 where proteins are usually stable. (2) The
oxidized forms of FnY*s possess unique spectral signals allowing a distinction between Ye and
FnY* in the same system. The EPR spectra of FnY*s and time-resolved UV-vis spectra of BPA-
FnY-OMe dipeptides show that the EPR properties are altered and the kx. for FnY* absorption
can be shifted by -10 nm relative to Ye. (3) In addition to glutathione transferase67'68 and other
proteins,69-74 3-FY can be incorporated into RNR with relatively minimal structural perturbation,
as demonstrated by the preserved activity of the P2 subunit of class I E. coli RNR in which 14 Y
residues were globally replaced by 3-FY.
The FnYs will be useful for a variety of mechanistic studies in biology, in which tyrosine
is integral to radical initiation and transport. We demonstrate one example of this utility in the
next Chapter in which Y35 6 of 2 is site-specifically replaced with the FIYs presented in this
study. A study of the pH dependent activity of each of these new semi-synthetic enzymes cast
with the backdrop of the Ac-FnY-NH 2s pKa and Ac-FnY*-NH 2s reduction potential data
reported herein, allow for mechanistic details of the PCET reactivity at this site to be unveiled.
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CHAPTER 7:
pH Rate Profiles of FnY356s-2s (n = 2, 3, 4) in E. coli Ribonucleotide
Reductase: Further Evidence that Y356 is a Redox-Active
Amino Acid Along the Radical Propatation
Pathway and Elucidation of its
Mechanism of Oxidation
Adapted from: Seyedsayamdost, M. R.; Yee, C. S.; Reece, S. Y.; Nocera, D. G.; Stubbe, J. J.
Am. Chem. Soc, 2006, 128, 1562.
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INTRODUCTION
Class I E. coli ribonucleotide reductase (RNR) plays a crucial role in DNA replication
and repair by catalyzing the reduction of nucleoside diphosphates (NDPs) to deoxynucleoside
diphosphates (dNDPs).1,2 It is composed of two homodimeric subunits designated a2 and 02. A
complex between a2 and P2 is required for activity. 3 a2 houses the NDP binding sites and the
binding sites for the effectors that control the specificity and rate of nucleotide reduction. 3-5 P2
harbors the diferric tyrosyl radical (Y122o) cofactor proposed to initiate nucleotide reduction by
generating a transient thiyl radical (C439*) in the active site of a2. 6 The crystal structures of both
a2 and P2 have been solved independently.7-9 A docking model of the two proteins has been
generated using these structures based on their shape complementarity and on knowledge of
conserved residues. This model, a 1:1 complex of the a2 and 02 homodimers, places the Y* on
32 at a distance >35 A away from the terminal site of oxidation on a2, the C439 residue. Electron
tunneling between these residues based on Marcus theory (kET = 106 s- 1 for fl= 1.2 A-' under
activationless conditions) is too slow to account for a kcat of -2-10 s-1.10 Thus, the radical
generation process has been proposed to occur via a hopping mechanism involving aromatic
amino acid radical intermediates as shown in Figure 7-1.7"' As we showed in Chapters 2 & 3,
mounting evidence is calling into question the symmetry of the docking model. 12'13 However, a
strong case can be made for involvement of the residues on this pathway, specifically Y356 on 02
and Y731 and Y730 on a2. They are the only absolutely conserved residues that are not involved in
assembly of the di-iron cofactor or in the nucleotide reduction process.13, 14
Efforts to examine this pathway model experimentally and identify the mechanism(s) for
radical propagation have heretofore relied on site-directed mutagenesis of each amino acid
within the pathway on both the E. coli and mouse RNRs. 15-'8 More recently, in vivo
complementation studies in E. coli using pathway mutants to investigate radical migration have
been reported. 19 These studies demonstrate the requirement for these residues (Figure 7-1) in
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nucleotide reduction. However, they are not amenable to addressing the mechanism of the
radical propagation process or the intermediacy of amino acid radicals as the proteins are
"inactive". Investigation of the radical propagation process is further complicated by results from
steady-state and pre-steady state kinetic analyses of E. coli RNR that suggest that radical
propagation and nucleotide reduction are preceded by a slow physical step and that binding of
substrate and effector trigger this physical step. 13 This conformational gating makes the electron
transfer (ET) step kinetically invisible and thus impossible to study. One way to gain insight into
the propagation reaction therefore is to change the rate-limiting step from this physical step to
ET by altering the reduction potential of a residue within the pathway.
The limited repertoire of natural amino acids does not allow an informative perturbation
to be made and thus we have recently turned to site-specific insertions of unnatural amino acids
into 02 at Y356 using protein ligation methods. 20 A 3-N0 2Y356-P2 construct has allowed us to
measure the pKa of a single amino acid residue in a putative 260 kDa ax2/02 complex.21 A 2,3-
F2Y356-- 2 provided the first clues that the phenolic proton at 356 in 02 is not required for
conformational gating of turnover. 22 Results from studying the aniline amino acid, Y356PheNH2-
02 construct,23 suggested that the rate of radical transfer through position 356 is affected mainly
by the reduction potential of the residue at that position and not controlled by hydrogen-bonding
or proton transfer. In addition, studies with DOPA-P2 and NH2Y-a2s in Chapters 2-5 have
provided compelling evidence for a redox-active role of these residues in radical propagation
and have suggested a hydrogen atom transfer mechanism between Y730 and C439-
To assess the interplay between the electron and proton transfer events requires the
systematic variation of the radical reduction potential and phenolic pKa at Y356, the proposed gate
keeper for radical transport between the a2 and 32 subunits. In Chapter 6,24 we reported the
synthesis and characterization of a number of unnatural, N-acetyl and C-amide protected
fluorotyrosine analogues, Ac-FnY-NH2 (Table 7-1). These derivatives have radical peak
reduction potentials that vary from -50 to +270 mV relative to Ac-Ye-NH2 in the pH region in
which RNR activity can be measured and pKas that range from 5.6 to 7.8. We suggested that
365
these analogues would be useful in probing the mechanism(s) of proton-coupled electron
transfer (PCET) in systems that involve redox active tyrosines.
We now present the semisynthesis of P32 in which Y356 has been replaced with fluorinated
tyrosine derivatives of Table 7-1. These 132 analogues have allowed us to study the role of Y356
in the radical propagation process of E. coli RNR. The results suggest that an increase in the
peak reduction potential of the FY analogue relative to Y by 80 mV results in a change in the
rate-limiting step from a conformational change to the radical propagation process. These
studies support the proposal that the protonation state of the phenol of this residue is not
important in conformational gating, that the proton can be lost from this pathway without
affecting the overall enzymatic activity, and that Y356 is a redox-active amino acid on the radical
propagation pathway. Additionally, the rigorous assessment of the enzymatic activity afforded
by the FnY356-12 series establishes that the energetics of radical hopping through Y356 is finely
tuned in wt class I RNR and can only operate within a -130 mV window for the Y*/Y redox
couple.
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Table 7-1. Fluorotyrosine derivatives used to substitute Y356 of 32 and their physical properties.
CONH 2
AcN
H 1
6 \2
5 3
Fn OH
Fluorotyrosine pKa Ep(Y*/Y-) / mV
Ac-Y-NH2  9.9 642
Ac-3,5-F 2Y-NH2  7.2 755
Ac-2,3-F 2Y-NH 2  7.8 810
Ac-2,3,5-F3Y-NH2  6.4 853
Ac-2,3,6-F3Y-NH2  7.0 911
Ac-F4Y-NH2 5.6 968
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Figure 7-1. Putative PCET pathway of E. coli RNR based on the docking model (Ref 7). Y356 is not
visible in the crystal structure of 12; it is proposed to propagate the radical between W48 on 12 and
Y731 on a2. Distances on the 12 side are taken from the crystal structure of oxidized 12 at 1.4 A
resolution (Ref. 9).
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MATERIALS AND METHODS
Materials. ATP, cytidine-5'-diphosphate (CDP), reduced fl-nicotinamide adenine
dinucleotide phosphate (NADPH), N-hydroxyurea, trifluoroacetic acid (TFA), 2-
mercaptoethanesulfonic acid (Mesna), Fmoc-succinimide, Sephadex G-25 resin, DNase I (10
U/tL) and Triton X-100 were purchased from Sigma-Aldrich. BL21 (DE3) RIL Codon+
competent cells were obtained from Stratagene. Calf-intestine alkaline phosphatase (20 U/gL)
was purchased from Roche. All amino acid derivatives were purchased from Novabiochem,
Fmoc-L-Leu-PEG-PS resin and all other chemicals required for peptide synthesis were obtained
from Applied Biosystems. [2-14C]-CDP was purchased from Moravek Biochemicals. E. coli
thioredoxin (TR, SA of 40 U/mg) and E. coli thioredoxin reductase (TRR, SA of 1800 U/mg )
were isolated as previously described. 13
Physical measurements. 1H NMR spectra were recorded on a Varian 300 MHz NMR
spectrometer at the MIT Department of Chemistry Instrumentation Facility. NMR samples were
internally referenced to tetramethylsilane. pH measurements were performed with an Orion
microelectrode. Absorption spectra were recorded on an Agilent 8453 Diode Array
Spectrophotometer. EPR spectra were recorded at 77 K on a Bruker ESP-300 X-band (9.4
GHz) spectrometer equipped with an Oxford liquid helium cryostat.
Synthesis of Fmoc-FnYs. Fmoc-FnYs were synthesized by the method of Lapatsanis et
al. with minor modifications. 25 The tyrosine analogue (700 jmol) was dissolved in 2.4 mL of
10% Na2CO 3 and mixed with Fmoc-succinimide (970 imol) in 2.5 mL of dioxane at 4 *C. The
reaction was warmed to room temperature and reacted for 20 min to 2 h (FnYs with higher
fluorine substitution required longer reaction times). The reaction was monitored via TLC using
10:1 CHC13/MeOH as the mobile phase. After completion, the reaction was quenched with 25
mL water and extracted twice with 10 mL of EtOAc to remove Fmoc-succinimide. The pH was
then lowered to 2-3 with 2 N HCl and the solution extracted with EtOAc (10x, 10 mL). The
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organic layer was washed with saturated NaCl (3x, 3 mL), water (2x, 3 mL) and finally dried
over MgSO 4. The solvent was removed in vacuo and the product purified by silica gel
chromatography (16 g, 1.5 x 28 cm) using isocratic elution. The solvent system, Rf, and yield for
each analogue have been reported (Table 7-2).26
Fmoc-L-3,5-F 2Y: 1H-NMR (300 MHz, CD 30D) 8= 2.85 (dd, 1H, CO-HI, 9.7 Hz, 14.3
Hz), 3.12 (dd, 1H, Cp-H 2, 5.7 Hz, 14.3 Hz), 4.2 (m, 3H, fluorenyl C-H and C-H2), 4.37 (dd, 1H,
Ca-H, 5.7 Hz, 10 Hz), 6.82 (m, 2H, PhOH C-H), 7.35 (dt, 4H, arom. fluorenyl C-H, 7.6 Hz, 26.7
Hz), 7.62 (d, 2H, arom. fluorenyl C-H, 7.5 Hz), 7.8 (d, 2H, arom. fluorenyl C-H, 7.1 Hz).
Fmoc-L-2,3-F 2Y: 'H-NMR (300 MHz, CD 30D) 8= 2.9 (dd, 1H, Cp-HI, 9.6 Hz, 14.6
Hz), 3.23 (dd, 1H, Cp-H2, 4.8 Hz, 14.2 Hz), 4.24 (m, 3H, fluorenyl C-H and C-H2), 4.4 (dd, 1H,
Ca-H, 5 Hz, 9.7 Hz), 6.61 (m, 1H, PhOH C-Hs), 6.82 (m, 1H, PhOH C-H6), 7.28 (m, 2H, arom.
fluorenyl C-H), 7.38 (t, 2H, arom. fluorenyl C-H, 7.4 Hz), 7.6 (d, 2H, arom. fluorenyl C-H, 7.4
Hz), 7.77 (d, 2H, arom. fluorenyl C-H, 7.4 Hz).
Fmoc-L-2,3,6-F 3Y: 'H-NMR (300 MHz, CD30D) 8= 3.02 (dd, 1H, CO-H 1, 9.3 Hz, 14
Hz), 6 = 3.2 (dd, 1H, Cp-H 2, 5.7 Hz, 13.9 Hz), 4.2 (m, 3H, fluorenyl C-H and C-H2), 4.41 (dd,
1H, Ca-H, 5.7 Hz, 9.4 Hz), 6.46 (m, 1H, PhOH C-H), 7.33 (dt, 4H, arom. fluorenyl C-H, 7.1 Hz,
26.7 Hz), 7.6 (d, 2H, arom. fluorenyl C-H, 7 Hz), 7.78 (d, 2H, arom. fluorenyl C-H, 9 Hz).
Fmoc-L-2,3,5-F 3Y: 1H-NMR (300 MHz, CD30D) 8= 2.9 (dd, 1H, Cp-H1, 9.6 Hz, 13.5
Hz), 3.25 (dd, 1H, CO-H 2, 4.2 Hz, 13.8 Hz), 4.25 (m, 3H, fluorenyl C-H and C-H2), 4.43 (dd, 1H,
Ca-H, 4.7 Hz, 9.2 Hz), 6.82 (m, 1H, PhOH C-H), 7.32 (dt, 4H, arom. fluorenyl C-H, 7.2 Hz, 26.7
Hz), 7.58 (d, 2H, arom. fluorenyl C-H, 7.2 Hz), 7.75 (d, 2H, arom. fluorenyl C-H, 7.2 Hz).
Fmoc-L-2,3,5,6-F 4Y: 'H-NMR (300 MHz, CD30D) 8= 3.06 (dd, 1H, Cb-H1, 9.2 Hz,
14.2 Hz), 8 = 3.26 (dd, 1H, Cb-H2, 5.4 Hz, 14.2 Hz), 6 = 4.23 (m, 3H, non-arom. fluorenyl-H), 8
= 4.38 (dd, 1H, Ca-H, 5.4 Hz, 9.3 Hz), 8 = 7.34 (dt, 4H, arom. fluorenyl-H, 7.7 Hz, 27 Hz), 6 =
7.61 (d, 2H, arom. fluorenyl-H, 7.2 Hz), 8 = 7.78 (d, 2H, arom. fluorenyl-H, 7.5 Hz).
Peptide synthesis. The P32 C-terminal peptide CSFnYLVGQIDSEVDTDDLSNFQL
was synthesized by a combination of standard solid phase and solution phase peptide synthesis
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methods as previously described.21 The first 19 residues were added using a Pioneer Peptide
Synthesizer from Applied Biosystems. The remaining three amino acids (positions 20-22 on the
peptide) were coupled manually. The manual coupling reaction of Fmoc-FnYs were carried out
for 1 h and a typical reaction contained 4 equiv of Fmoc-FaY, 3.6 equiv of 0-(7-
azabenzotriazole-1-yl)-N,N,N'N'-tetramethyluronium hexafluorophosphate (HATU) and 8
equiv of diisopropyl ethylamine (DIPEA) in DMF. The purified peptides were characterized by
RP-HPLC and MALDI-TOF MS. The results are summarized in Table 7-3.
Table 7-2. Purification and yield of Fmoc-FnY-COOH.
Solvent System for
FnY Analogue Rf Yield (%)
Silica Gel Purification
Fmoc-2,3-F 2Y 20:1 CHC13/MeOH 0.3 95
Fmoc-3,5-F 2Y 10:1 CHC13/MeOH 0.4 85
Fmoc-2,3,5-F 3Y 10:1 CHC13/MeOH 0.2 50
Fmoc-2,3,6-F 3Y 10:1 CHC13/MeOH 0.25 51
Fmoc-F 4Y 20:1 CHCl3/MeOH 0.2 82
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Semisynthesis of 132 and FnY356-j2s. Culture growth, ligation and protein purification
were carried out as previously described 2' with minor modifications. After Mesna-mediated
cleavage of P2(1-353) from the chitin resin, excess Mesna was removed using a Sephadex G-25
column (200 mL, 3 x 30 cm) equilibrated in cleavage buffer (50 mM Hepes, pH 7.6, 500 mM
NaC1). Furthermore, prior to purification by MonoQ anion exchange chromatography, unbound
peptide was removed by concentration/dilution cycles using a YM-30 membrane. MonoQ
purifications were performed under reducing conditions with 1.5 mM DTT. Each FnY 356-~2 was
judged to be >95% pure on the basis of SDS-PAGE analysis. Each P32 was further characterized
by ESI-MS, and the tyrosyl radical was quantitated by UV-Vis and EPR spectroscopic methods
(Table 7-4).
Table 7-3. RP-HPLC and MALDI-TOF MS characterization of FnY-22mersa.
MS of (tButhio)- MS of deprotected FHY-
F.Y-22mer RP-HPLC protected FnY-22mer 22merRt (min)
m/z [M-H]- calcd (obs) m/z [M-HI- calcd (obs)
Y-22mer 19 2548.6 (2548.2) 2460.6 (2460.1)
2,3-F 2Y-22mer 19 2584.6 (2585.2) 2496.6 (2495.6)
3,5-F 2Y-22mer 18.5 2584.6 (2584.0) 2496.6 (2495.8)
2,3,6-F 3Y-22mer 19 2602.6 (2601.9) 2552.6 (2551.6)c
2,3,5-F 3Y-22mer 21.5 2602.6 (2601.5) 2552.6 (2551.6)c
F4Y-22mer 18 2642.6 (2 6 4 1.4 )b 2570.6 (2570.3)c
+ Na]-. c [M - 2H + K]-
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a See ref 21 for detailed description of HPLC and MALDI-TOF methods. b [M - 2H
Table 7-4. Physical and biochemical characterization of FnY 356-P2s.
ESI-MS Radical Contentb Maximal Specific Km for a2
FnY 356-P2 Yield (mg)a m/z [M + H] +  Activity
calcd (obs) (nmol/min mg)c
Y-32 14.3 43360 (43360) 0.34 450 0.55 ± 0.18
2,3-F 2Y 356-P2 15 43396 (43399) 0.33 370 0.62 + 0.11
3,5-F 2Y 356-32 20 43396 (43392) 0.31 450 ndd
2,3,5-F3Y3 56-P2 13 43414 (43410) 0.42 365 0.65 ± 0.15
2,3,6-F3Y356-42 10.5 43414 (43413) 0.41 95 ndd
F4Y356-P2 10 43432 (43434) 0.42 30 0.59 ± 0.2
V353G/ S354C-p2e - 1.1 1420 0.55 + 0.21
a Amount recovered from incubation with 45 mg of Mesna-activated P2. b Measured by the dropline correction method and
quantitative EPR methods using recombinant wt-f2 as standard. c Activity of intein-generated FnY 356-p2s is normalized for
radical content of Y-P2. dnd = not determined. eMade by recombinant methods.
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Purification of a2 and removal of contaminating (2. a2 (S.A. 1900 nmol/min/mg)
was purified as previously described.27 To reduce a2 and the Yo of contaminating P2 which co-
purifies with a2, a2 (-40 gM) was incubated with 30 mM DTT for 25 min at room temperature.
Hydroxyurea, ATP, and CDP were then added to final concentrations of 30 mM, 3 mM and 1
mM, respectively, and the incubation was continued for an additional 20 min at room
temperature. a2 was then isolated using a Sephadex G-25 column (-35 mL, 1.5 x 23 cm), which
had been equilibrated in assay buffer (50 mM Hepes, 15 mM MgSO 4, 1 mM EDTA, pH 7.6).
Determination of pH rate profiles of FnY356-02s. 2-[N-morpholino]ethanesulfonic
acid (Mes), N-2-hydroxethylpiperazine-N'-2-ethanesulfonic acid (Hepes), N-[Tris(hydroxyl-
methyl)methyl]-3-aminopropanesulfonic acid (Taps) and 2-[cyclohexylamino]-ethanesulfonic
acid (Ches) were used for the pH rate profiles. Each buffer was adjusted to the desired pH with
either KOH or HC1. Each reaction contained in a volume of 230 gL: 50 mM Hepes (or Mes,
Taps, Ches), 15 mM MgSO 4, 1 mM EDTA, 3 mM ATP, 1 mM [2-1 4C]-CDP (6 x 106 - 1.5 x
107 cpm/pmol), 30 gtM TR, 0.5 gM TRR, 1 mM NADPH, 3 gM a2 and 3 RM FnY 356-02. For
each reaction, nucleotides, TR, TRR and a2 were incubated at 25 'C for -1.5 - 2 min. The
reaction was then initiated by addition of FnY 356-02 and NADPH. At defined time points, 40 gL
were withdrawn and quenched with 25 gL of 2 % perchloric acid. At the end of the time course,
the reactions were neutralized with 20 gL of 0.5 M KOH. Each sample was incubated at -20 oC
overnight to ensure complete precipitation of potassium perchlorate. The samples were then spun
down for 3 min in a tabletop centrifuge. Each supernatant was transferred to a 1.5 mL screw top
microfuge tube, to which was added 14 U of calf intestine alkaline phosphatase, 120 nmol of
carrier deoxycytidine (dC) and Tris-EDTA buffer (pH 8.5) to a final concentration of 75 mM
and 0.15 mM, respectively. The amount of dC was then quantitated by the method of Steeper and
Steuart.28
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RESULTS
Synthesis and characterization of FnY3s/V 3s3G/S3s4C-[2s. 032 is a homodimer
containing 375 amino acids per monomer, which can be prepared semisynthetically by intein
methods.21 Residues 1-353 of [2 with its C-terminus fused to the VmaI intein and a chitin-
binding domain were made via molecular biological methods. Residues 357 to 375 were
synthesized by automated solid phase peptide synthesis with residues 354, 355 and 356 being
added manually. 21-23 A number of minor changes have been made from our initially reported
procedure to enhance recoveries of [2 and in efforts to increase the amount of Y122* per [2. In
general, C354 of the C-terminal tail of [2 can form a disulfide with the excess peptide used in
the ligation reaction to generate full length 32. Removal of the peptide is essential for accurate
quantitation of RNR activity as the peptide is a competitive inhibitor of the nucleotide reduction
process. 29 The final purification steps therefore used concentration/dilution cycles to remove
non-covalently bound peptide as well as anion exchange chromatographay on a MonoQ column
with DTT in all the buffers to reduce the peptide-02 disulfide bond and remove the peptide.
While DTT has previously been shown to reduce the Y122* in 32,30 the minimal time required for
this purification step, ensures that this side reaction does not occur. A summary of the recovery
of semi-synthetic 32s, their characterization by ESI-MS, the amount of Y122* per 32, and the
maximum specific activity of each 32, are presented in Table 7-4. The amount of Y122* radical
was quantified by X-band EPR spectroscopy and by the dropline correction method using the
UV-vis spectrum.31,32
Over the past few years we have continually modified various aspects of the semi-
synthesis of [2 in order to improve yields and amounts of Y1220 recovered. We have performed
all of the ligation reactions described here, with the exception of the 2,3-F 2Y-peptide, on the
same batch of [2-thioester. As a control for all of our experiments, wt-[2 made by the intein
procedure (containing V353G/S 354C/Y 356 and from here on referred to as Y-P2) was generated
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from the same batch and is reported in Table 7-4. Its specific activity is identical to the double
mutant made by site directed mutagenesis after normalization for the amount of Yo.
Problems encountered in the RNR activity assay. Because we wished to set lower
limits of detection on the rates of deoxynucleotide formation with the mutant RNRs, we made
two changes to the standard assays.2 1 First, a2 (specific activity of 1.9 gmol/min/mg) as isolated,
always co-purifies with a small amount of 32 (estimated to be <1% by SDS PAGE). We
therefore inactivated this contaminating 32 by reduction of its Y122* with hydroxyurea in the
presence of DTT, ATP, and CDP and showed with control experiments in the absence of the 32
mutant, that no dNDP was detectable within the time frame of the assay (data not shown).
Second the peptide used to generate semi-synthetic 32 is a known competitive inhibitor of P2's
interaction with a2. An additional purification step for 32 mutants was thus added to the
protocol to ensure that all of the peptide (covalently and non-covalently bound to 32) was
removed. In each 32, there is now a cysteine at position 354 in place of the serine of the wt-02.
032 mutants containing this cysteine are inactivated in the presence of a2, CDP and ATP in a
slow, time-dependent, reaction.2 1 This inactivation presumably results from an uncoupling of the
radical propagation pathway, resulting in the reduction of Y122*. Control experiments showed
that this uncoupling did not occur to any significant extent under the conditions of the assays
(data not shown). Finally, to ensure that the single amino acid substitution does not effect the
interaction between the a2 and 132, the Km values for several of the mutants were determined and
found to be identical to Y-132 as listed in Table 7-4.
pH rate profiles for wt and FnY356-f32s. Kinetic assays for nucleotide reduction over
the RNR accessible pH range from 6.5 to 9 were carried out to determine if direct evidence for
the role of Y356 as a redox-active amino acid on a pathway between a2 and 132 could be
obtained. The results of our kinetic assays for the various FnY 356-132s are shown in Figure 7-2
and are quite dramatic. First, all of the FnY 356-p32s are active between pH 6.5 to 8.5 and the
activity is relatively high despite the complexity of the semisynthetic procedure for P32
generation (Table 7-4). Second, the activities of 2,3-F 2Y 356-32, 3,5-F 2Y 356-132 and 2,3,5-
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F3Y356-f2 are very close to that of Y-32 in the pH range from 6.5 to 7.6. On the alkaline side,
the activity drops off for all FnY derivatives with the drop-off beginning at a lower pH for the
2,3,5-F 3Y 356-, 2,3,6-F 3Y356- and 2,3,5,6-F 4Y 356-P2s. With 2,3,6-F3Y 356-j2 and 2,3,5,6-
F4 Y356-32 the activity relative to Y-12 is substantially reduced throughout the entire pH rate
profile. At pH values greater than 8.5, the activity is below the lower limit of detection of our
assay method.
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Figure 7-2. pH rate profiles of FnY356-42s. The top panel shows an overlay of the pH rate profiles of
Y-32 and FnY 356-32s used in this study. The bottom panel shows a blow-up of the profiles of 2,3,6-
F3Y35 6-- 2 and F4Y356-42. Each point represents an average of two independent measurements. The
error was within 15 % for all points: (*) Y356-f2, (o) 3,5-F 2Y356-f2, (o) 2,3-F 2Y356-P2, (o) 2,3,5-
F3Y356-f2, (e) 2,3,6-F3Y356-f2, and (#) F4Y356-42.
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DISCUSSION
The F.Ys in Table 7-1 were incorporated into [2 by the intein procedure. They were
chosen to perturb the protonation state and reduction potential of residue 356 in an effort to
examine its role in the radical propagation process. For each mutant 32 the ability to make
deoxynucleotides was measured over the accessible pH range for RNR (6.5 to 9). The results,
Figure 7-2, reveal that the FnYs markedly perturb the activity suggesting that these mutants will
be useful for examining radical propagation.
The observed drop in RNR activity of FnY-02 mutants relative to Y-02 may be related to
changes in their reduction potentials. Unfortunately, one cannot measure the reduction potentials
of these FnYs within 32. We can, however, measure the peak reduction potentials of Ac-FEY-
NH2 derivatives. These values were determined in the pH range in which RNR activity can be
measured (6.5 and 9, Figure 7-3) using differential pulse voltammetry (DPV, see Chapter 6),
Previous work has shown that the peak potential for the Ye as measured by DPV is very similar
to its reduction potential measured by cyclic voltammetry and pulse radiolysis.33 The data in
Figure 7-3 show that the fluorinated tyrosine derivatives have potentials that vary from -50 mV
to +270 mV relative to tyrosine.
To gain insight into the relationship between RNR activity and the reduction potential of
residue at 356, Figure 7-4 was generated. In this Figure, the activity data of each mutant relative
to that of Y-02 is plotted against the peak reduction potential difference between Ac-FnY-NH 2
and Ac-Y-NH 2. Analysis of the data in this fashion allows removal of the pH dependent activity
inherent to Y-P2 and assumes that all of the mutants have the same inherent pH dependence.
The basis of this pH dependence is not understood. The construction of Figure 7-4 also assumes
that the reduction potential of Y3 56* and FnY 356* varies 59 mV/pH unit, as with Ep(Ac-FnY*-
NH 2/Ac-FaY-NH 2) and requires proton loss to bulk solution concomitant with oxidation.
Furthermore, we assume that if the protein environment perturbs the reduction potential for Y in
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Y-02, it has the same relative effect on each FaY in the corresponding FnY 356-P2. We note that
the data in Figure 7-4 reveal some scatter, which we attribute in part to the difficulties with
making P2 semi-synthetically. Moreover, fluorine substitution may affect the conformation of
residue 356 and its interactions with its environment. Four fluorines certainly have altered steric
properties relative to four hydrogens, stemming from the slightly larger van der Waals radius of
F vs. H (1.2 A vs 1.35 A, respectively) and the longer C-F bond vs the C-H bond (1.38 A and
1.09 A, respectively). Finally, using the pKa of Ac-FY-NH2 as a benchmark for FnY 356, a
difference in charge of this residue may result owing to the pKa differences of each of these
fluorinated tyrosines. Given the incongruities that may be engendered by fluorine substitution,
the data in Figure 7-4 are quite striking.
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Figure 7-3. Peak reduction potential of Ac-FY*-NH2s as a function of pH. The Ep vs. pH for
reduction of (-) Ac-Y*-NH2, (-) Ac-3,5-F 2Y*-NH2, (-) Ac-2,3-F 2Y*-NH2, (-) Ac-2,3,5-F 3Y*-
NH2, (-) Ac-2,3,6-F 3Y*-NH2, and (-) Ac-F 4Y*-NH224 in the pH range accessible to RNR are
shown. The lines indicate peak reduction potential differences of ±40 mV (solid), 90 mV (short dash)
and 180 mV (long dash) relative to that for Ac-Y*-NH2.
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Figure 7-4. Redox potential regimes of RNR activity. Relative activities of FnY356-P2s vs. Y-12,
obtained from Figure 7-2, and plotted as a function of peak reduction potential difference between the
corresponding Ac-FnY*-NH 2 and Ac-Y*-NH 224: (e,o) 3,5-F2Y 356-f2, (9,o) 2,3-F 2Y356-j2, (0)
2,3,5-F 3Y 356-32, (*,o) 2,3,6-F3 Y356-j2, and (o) F4Y356-- 2. Filled circles represent data points where
pH < pKa of the corresponding FY; open circles represent data points where pH > pKa of the
corresponding FY. The three different regimes of RNR activity are highlighted as either gated by a
physical/conformational change (regime 1), rate-limited by radical transport (regime 2), or reduced to
background levels (regime 3) depending on the peak reduction potential difference between the
corresponding Ac-FnY*-NH 2 and Ac-Y*-NH2.
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Three distinct activity regimes emerge from Figure 7-4. When peak reduction potential
differences are -50 mV to 80 mV (regime 1), nucleotide reduction activity falls within the range
of that observed for Y-12; both 2,3-F2Y 356-32 and 3,5-F 2 Y356-j32 exhibit 90 to 120% of the
activity obtained for Y-32. As the difference in peak reduction potential increases from 80 to
200 mV (regime 2), the RNR activity drops off dramatically. At >200 mV difference (regime 3),
no detectable activity of RNR is observed. 2,3,5-F 3Y356-|32 spans the potential range from ~ 25
to 145 mV, whereas 2,3,6-F 3Y356-12 and F4Y356-P2 have very low activities and high peak
reduction potential differences at all pHs accessible to RNR.
Our interpretation of these data is summarized by the three activity regimes marked with
the dashed lines in Figure 7-4. When the reduction potential difference is within the range of -50
to 80 mV (regime 1), the rate of nucleotide reduction in the FnY 356-f32s is governed by the same
factors as nucleotide reduction by Y-32. Pre-steady state experiments have shown that the rate
limiting step in E. coli RNR is a physical step or steps prior to the radical propagation process
that is gated by binding of substrate and allosteric effector. 13 In the steady state, the rate-
determining step is proposed to be the same physical step or alternatively a step involved in re-
reduction of a2 or a conformational change associated with this re-reduction, subsequent to
dNDP formation and re-generation of the y*.2 1 In either case, the rate of nucleotide reduction
should be independent of Y356* reduction potential, leading us to assign regime 1 to the
physically/conformationally gated step. The peak reduction potential of Ac-3,5-F 2Y*-NH 2 falls
effectively in the conformationally gated regime over all pHs, whereas the potentials of Ac-2,3-
F2Y*-NH 2 and Ac-2,3,5-F 3Y*-NH2 falls within this regime for pH <-8.4 and pH <-7.5,
respectively. At a pH of 6.81 (solid line, Figure 7-3), the peak reduction potential difference
between Ac-3,5-F 2Y*-NH2 and Ac-Y*-NH 2 is -40 mV. Similarly, at pHs of 6.6 and 6.93 (solid
lines, Figure 7-3) the peak reduction potentials of Ac-2,3-F2Y*-NH2 and Ac-2,3,5-F 3Y*-NH2,
respectively, are ~ 40 mV higher than that of Ac-Y*-NH2. The relative activities are all identical
within error (108, 99 and 100 % of Y-32, respectively, for 3,5-F 2Y356-j32, 2,3-F2Y356-P32 and
2,3,5-F 3Y 356-f2).
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When the driving force for Y356 oxidation exceeds 80 mV but is less than 200 mV
relative to Y, the rate of nucleotide reduction correlates with the difference in peak reduction
potential, suggesting that there has been a change in the rate limiting step to one involving
radical transport through FnY 356. This point is demonstrated for 2,3-F2Y 356-02 and 2,3,5-
F3Y356-02. The short dashed lines in Figure 7-3 indicate two pH values (8.6 and 7.8) at which
the peak reduction potential difference between Ac-2,3-F 2Yo-NH2 and Ac-Ye-NH2, and
between Ac-2,3,5-F 3Y*-NH2 and Ac-Ye-NH 2 is - 90 mV. If activity is determined solely by
the reduction potential, then the relative activity of 2,3-F 2Y356-P2 at pH 8.5 should approximate
that of 2,3,5-F 3Y356-02 at pH 7.8. The relative activities observed are 85 % and 81 %,
respectively.
At potentials differences greater than 150 mV (regime 3), the rate of radical transfer
appears to become so slow that nucleotide reduction is minimal and for potential differences
>200 mV activity is abolished. Note that the relative activities of 2,3,6-F3Y356-f2 at pH 8.4 and
that of F4Y356-P2 at pH 7.4, where the peak reduction potential difference between these
corresponding Ac-FaY*-NH 2s and Ac-Y*-NH2 is 180 mV (long dashed lines, Figure 7-3), are
11% and 8%, respectively. The direct correlation between activity and peak reduction potential
strongly suggests that Y356 is a redox-active amino acid on the pathway.
We also examined whether the protonation state of the FnYs at position 356 affects RNR
activity. Our previous studies with NO2Y356-P221 showed that the pKa of this residue at the
a2/02 interface is unperturbed relative to that of Ac-NO2Y-NH2 in solution. Similar
measurements of the pKas of the FaYs within f2 cannot be made because these phenolates do not
absorb in the visible region of the spectrum as does 3-N0 2Y-. We have thus assumed that the
pKas of the Ac-FnY-NH2 are indicative of those within the a2/02 complex. We have
incorporated this information into Figure 7-4 in an effort to determine if the protonation state of
the FnY has any correlation with RNR activity: the filled circles in Figure 7-4 represent data
points where pH < pKa of the corresponding FEY; conversely open circles represent data points
where pH > pKa of the corresponding FEY. This analysis reveals that most of the FnYs used in
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this study are deprotonated or exhibit changes in protonation state, whereas Y because of its
higher pKa, remains protonated throughout the range where the activity of RNR can be
measured. In contrast with the peak potential data, no clear correlation exists between the
protonation state of the FnY 356 and the activity of the corresponding mutant.
Our results do not provide any insight about the destination of the proton from Y356 in Y-
[2 in the forward PCET event or its delivery in the back PCET event. Comparison of sequences
of the disordered C-terminal tails of over 160 P2s suggest that, while there are no absolutely
conserved residues, E350 is present in 129 of 162 02 sequences. 34 Thus, it is possible that this
residue functions as a proton acceptor in the forward PCET reaction and a proton donor in the
reverse reaction. The importance of this residue is supported by mutagenesis studies carried out
on many of the residues within the C-terminus of P2. Individual substitution of Y356 and E350
with alanine was found to affect activity. In the former case, P2 was inactive and in the latter
case the rate was reduced 250 fold.35
The mechanistic details for radical transport involving a tyrosyl radical at this position
are important to consider. Radical transport involving the deprotonated fluorotyrosines can
proceed by simple ET (Eq. 7-1). Conversely, a stepwise ET/PT reaction of a protonated tyrosine
confronts a large thermochemical bias because AG' for the initial ET or PT event is high.36-3 9
Accordingly, these thermodynamic constraints implicate proton-coupled electron transfer
(PCET) for radical propagation (Eq. 7-2).40-43
FnY* + e -+ FnYO- (7-1)
Y* + e- + H+ -- YOH (7-2)
In Y-32, therefore, the proton must be lost concomitant with Y356 oxidation via PCET.
Assuming the radical propagation pathway shown in Figure 7-1, our results with the
FnY 356-02s suggest that hole migration between the W48-P2-Y 356-P2 pair and the Y356-f2-
Y731-(x2 does not occur by an obligatory hydrogen atom transfer as phenolates of the FnY 356-p2s
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are active. Furthermore, this activity for the phenolates is inconsistent with the models based on
site-directed mutagenesis studies' 5 and theory" that W48, Y356, and Y731 are connected by way of
a hydrogen-bonding network that is required for conformational gating of the radical
propagation process. The turnover number of 2,3,5-F 3Y356-P2 at pH 7.6, for example, is
identical to that of Y-P2, where it is deprotonated if one assumes that the pKa is not perturbed
from that of Ac-2,3,5-F 3Y-NH2, as indicated by our studies on NO2Y356-P2. 21 W48 and Y731
must therefore communicate by ET involving the 2,3,5-F 3Y-/2,3,5-F 3 Y* couple. Insertion of a
negative charge at the a2/P2 interface apparently does not affect overall RNR activity. These
results, taken together with our preliminary studies, 22,23 lead us to conclude that the proton from
Y3 56 in the wild type enzyme is transferred (off pathway) to solvent, either directly or via a base
or bases in P2 or a2.
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CONCLUSION
A major unresolved issue in class I RNRs is the mechanism of radical propagation - how
does Y122* on P2, transiently and reversibly generate a C439. on 0a2 proposed to be >35 A away.
This problem is different from most ET reactions in biology studied to date, which typically
occur over a distances of 10-15 A by a tunneling mechanism and consequently do not involve
aromatic amino acid radical intermediates. 4557 The participation of tyrosine in the radical
initiation pathway of RNR steps beyond simple ET because management of proton and electron
inventories is required for charge transport involving the amino acid. In Chapter 6, we have
shown that fluorotyrosine derivatives have radical peak reduction potentials from -50 to +270
mV relative to Y and pKas that range from 5.6 to 7.8. By exploiting these properties for FnYs
substituted at Y356, our data strongly suggest that this residue in P2 is a redox-active amino acid
on the radical propagation pathway in the class I RNRs. This result is important, as Y356 is the
only residue on the pathway that is not observable structurally. Different activity regimes of
RNR may be accessed by tuning the reduction potential of FnY 356* such that radical transport
becomes rate limiting in nucleotide reduction. Future experiments using pre-steady state kinetic
analyses will focus on establishing that the radical propagation process does, in fact, become rate
limiting at peak reduction potential differences >80 mV as proposed based on our reported data,
as well as on detection of radical amino acid intermediates during turnover. Studies reported
herein, further strongly suggest that hole migration between the j2-W48-P2-Y 356 and the
f2-Y356-a2-Y 731 pairs does not occur by hydrogen atom transfer, as phenolates of the FnY 356-
02s are active. The obligation of protons to the pathway from Y122 to Y356 in 32 and from Y731
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into C439 at the active site of (x2 remains an open question and needs to be investigated, most
efficiently by direct kinetic analysis of the radical intermediates.
Y122
L E441
Y731 I I U
Figure 7-5. Mechanism of Y356 oxidation during radical transfer. Y356 is oxidized by an orthogonal
PCET methanism, where movement of the phenolic electron and proton are coupled. The proton is
transferred off-pathway perhaps to residue E350, the electron is transferred to residue 48 or 731
depending on the direction of radical transfer.
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CHAPTER 8:
Switching the Rate-Determining Step from a Conformational
Change to Radical Propagation with 2,3,5-F 3Y-032
of E. coli Ribonucleotide Reductase
391
INTRODUCTION
Inside the cell, ribonucleotide reductases (RNRs) are responsible for reduction of all four
nucleotides to 2'-deoxynucleotides, which are essential for DNA replication and repair.1-3 The E.
coli RNR is the best RNR studied to date and consists of two homodimeric protein subunits, a2
and P2. ca2 harbors the active site, in which thiyl radical-mediated (C439*) nucleotide reduction
occurs.4 It also contains binding sites for allosteric effectors, which control the rate and
specificity of catalysis. P2 is the radical initiator subunit and carries a diiron tyrosyl radical
(Y1220) cofactor. 5'6 Each turnover requires oxidation of C 439 in a2 by Y122* in 32. A mechanism
for this reaction, the radical propagation event, has only recently emerged.
A structure of the active a2/02 complex does not exist. However, Uhlin and Eklund have
generated a docking model for how these two subunits interact, using shape and charge
complementarity. 7-9 Based on this model, the radical transfer pathway shown in Figure 8-1 has
been proposed, in which the distance between Y122* and C439 is >35 A. This pathway is unusual
as it consists of only aromatic amino acid radicals which catalyze reversible long-range charge
transport between Y122* and C43 9 . Mutagenesis studies have shown that the residues in Figure
8-1 are essential for catalysis.10 However, all site-directed mutants of the aromatic
Figure 8-1. The proposed radical initiation pathway within an 4xp pair. Residues in grey have been
shown to be redox-active using DOPA-02 and NH2Y-a2s, respectively. Note that the position of
Y356 is unknown
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pathway-residues generated thus far are inactive in catalysis thus preventing mechanistic studies.
Consequently, examination of this pathway requires more subtle and direct perturbations. 1
1
,
12
To explore the pathway in Figure 8-1, we have taken a focused approach of
incorporating unnatural Y analogues into residues Y356 in P2 and Y731NY730 in a2 using various
approaches. The analogues that have been inserted are structural homologues of Y; however,
they have altered reduction potentials and/or pKas. These analogues have taught us a great deal
regarding the pathway and the mechanism attendant to long-range hole migration. In chapter 2,
we replaced residue Y356 with 3,4-dihydroxyphenylalanine (DOPA) using expressed protein
ligation methods. Characterization of DOPA-02 revealed kinetically competent formation of a
DOPA radical (DOPA*) which we examined by UV-vis and EPR spectroscopies. In chapter 3
we generated and characterized heterodimeric DOPA-P2, DOPA-Pp', in which the f'-monomer
was missing the C-terminal 22 residues. We presented kinetically competent DOPA* formation
and reformation of Y122* by DOPA*. The insights gained with DOPA-[2 and DOPA-PP' have
been important as residue 356 lies on the C-terminal tail of P2 and has not been resolved in any
structure of 12 solved to date. In addition, they have supported the model in Figure 8-1 by
demonstrating that residue 356 is redox-active and have established connectivity between Y122*
and residue 356 in both directions.
In chapter 4, we incorporated 3-aminoY (NH2Y) into residues Y730 and Y731 of a2 using
an evolved suppressor tRNA/aminoacyl-tRNA synthetase pair. Our studies using SF UV-vis
and EPR spectroscopies revealed kinetically competent NH2Y radical (NH2Y*) formation. They
also showed that both NH2Y-ca2s are active in nucleotide reduction, suggesting that the NH 2Y*S
observed are transient and competent radical intermediates during long-range hole propagation.
In chapter 5, we employed isotopic substitution of NH 2Y using '5N and 2H, multi-frequency
EPR spectroscopies, spectral simulations and theoretical studies to provide a detailed structure of
the NH2Y730o, to establish the positions of residues 730/731 in the a2/32 complex using
PELDOR spectroscopy and to demonstrate pathway dependence for NH2Y730* and NH 2Y 731•
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formation. Together the studies with DOPA and NH2Y traps have provided compelling evidence
for the redox-active roles of residues Y356, Y731 and Y730o in radical propagation.
To further examine the mechanism of Y oxidation at residue 356, we demonstrated the
usefulness of fluorotyrosines (FnYs) by presenting their synthesis and detailed physical
characterization in Chapters 6. Subsequently, we generated a series of FnY-p2s (n=2, 3, 4)
which we used to interrogate the mechanism of involvement of residue 356 in radical transfer
(Chapter 7).
The results in Chapter 7 suggest that substitution of Y356 with a series of FnYs (n=2, 3, or
4) has a marked affect on the pH rate profile for nucleotide reduction. Three activity regimes are
observed. In the first regime, where the reduction potential difference between FaY and Y is -50
to 80 mV, the rate-limiting step in turnover is a conformational change that precedes radical
transfer. In this regime the mutant RNRs have specific activities similar to that of intein wt RNR.
In the second regime, where the reduction potential difference is between 80 and 200 mV higher
than that of Y, we have proposed a shift in the rate-limiting step from a conformational change
to radical transfer. In this range, the specific activities of mutant RNRs decrease as a function of
the reduction potential difference between FnY and Y. Finally, in the third regime, where the
reduction potential difference exceeds 200 mV, radical transfer is completely shut down
resulting in absence of nucleotide reduction activity. Importantly, one analogue, 2,3,5-F 3Y,
spans almost the entire reduction potential difference range, from +25 mV at pH 6.5 to +145 mV
at pH -9. In this chapter, we experimentally assess whether radical transfer has in fact become
rate-determining with 2,3,5-F 3Y-02, as we proposed in Chapter 7, and suggest a kinetic model
for its turnover.
Kinetic models for the steady state and pre-steady state reactions of wt RNR have been
examined before in detail. 13 A main experimental observation in these studies, has been that
disappearance of Y122* is never observed under various conditions, i.e. in the temperature range
of 2-250 C, with various substrate or substrate/effector combinations, with 3'-[ 2H]-CDP, at
lower reaction pH (6.6) or in deuterated buffer. The results have also revealed a burst of dCDP
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suggesting that a step or steps subsequent to dCDP formation is rate-limiting in turnover. This
burst phase corresponds to a conformational change that precedes radical transfer and occurs
with a kobs of 4-16 s-1. The model that has emerged from these kinetic studies of wt RNR is
shown in Figure 8-2. The Kd for CDP14 and dCDP 15 have previously been measured.
Pre-steady state kinetics have determined a rate constant of 4-17 s-1 for a physical step that
precedes radical transfer, as noted above. This step has been labeled 2-10 s-1 in Figure 8-2.
The remainder of the rate constants in Figure 8-2 were obtained from kinetic modeling of the
catalytic cycle and have been chosen to recapitulate the lack of observable intermediates during
forward or reverse radical propagation. This has required fast C4399 formation (2200 s-1), fast
active site chemistry (500 s-1) and even faster reverse radical transfer (>1000 s-1). The kinetic
model in Figure 8-2 provides a frame work for the models that will be introduced in the current
Chapter.
If a step during radical transfer has in fact become rate-limiting, as a result of FnY
insertion in our FnY-32s (Chapter 7), then we may expect buildup of an intermediate during this
process, which could be examined by stopped flow (SF) UV-vis or rapid freeze quench (RFQ)
EPR spectroscopies. In addition, rapid chemical quench (RCQ) studies would be useful to show
step 1 step 2
NDP
(ESH ESH )-NDP E HE I-NDP
' Y* Kd- 250 pM 'Y1  (10081) Ye
R2 -Ye (100 s1) 2t200sl step 3
step 7 TRO yNADPH IE S-NDP
R2Y./ 0 5oosI step 4
E -SH1 Kd 0.9 mM [Eo .MSH] >l:1 S[E oSH
oxidized- yj -yxidized- y .dNDP I0oxidize H -dNDP
dNDP
step 6 step 5
Figure 8-2. Kinetic model for the reaction of wt RNR. The Kd for CDP (step 1) and dCDP (step 6),
the conformational change preceding radical transfer (step 2) and re-reduction of active site disulfides(step 7) have previously been measured. The rate constants for forward radical transfer (step 3), active
site chemistry (step 4) and reverse radical transfer (step 5) are modeled based on results by Ge et al.13
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whether the intermediate occurs during forward or reverse radical transfer. If it occurs during
forward radical transfer, then we may expect to see linear formation of dCDP, rather than a burst,
If, however, it occurs during reverse radical propagation, we would still expect to see a burst of
dCDP. A major complication of the kinetics with FnY-02s is that the expressed protein ligation
method used to generate the mutants requires 2 mutations in addition to the Y--FnY change:
V353G and S354 C. 16,17 Steady state assays have shown that the latter does not affect the specific
activity, however, the former results in a 3-4x lower activity. As will be shown, this affects the
rate constant for the conformational change that gates radical transfer and thus the likelihood of
an intermediate buildup during this process.
The results in this Chapter show that no intermediates are observed by SF UV-vis or
RFQ EPR spectroscopies in the reaction of 2,3,5-F 3Y-02 with wt a2, CDP and ATP at high pH,
where radical transfer is proposed to be rate-limiting. Kinetic simulations show that forward or
forward and reverse radical transfer may be slow in turnover without generating a build-up of
intermediates. RCQ experiments are in line with this model, in that no burst of dCDP is
observed, which is predicted by the simulations. Most convincingly, in experiments with
NH2Y-a2s and 2,3,5-F 3Y-02, the pre-steady state pH rate profile for NH 2Y* formation is
similar to the steady state pH rate profile of 2,3,5-F 3Y-02 for dCDP production (Chapter 7).
This holds for Y730NH2Y-a2 and Y731NH 2Y-a2. These results strongly suggest that our
interpretation of the results in Chapter 7 has been correct. Substitution of FnYs into the radical
transfer pathway provides the required change in reduction potential to slow hole migration.
However, the slow conformational change that precedes radical transfer and rapid reformation of
Y122* avoid build-up of any intermediates.
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MATERIALS AND METHODS
Materials. [2- 14C]-CDP (50 tiCi/mL) was purchased from Moravek, calf-intestine
alkaline phosphatase (20 U/gL) was obtained from Roche. E. coli thioredoxin (TR, 40 U/mg)
and TR reductase (TRR, 1800 U/mg) were isolated as previously described. 2-[N-
morpholino]-ethanesulphonic acid (Mes), N-2-hydroxethylpiperazine-N'-2-ethanesulphonic
acid (Hepes), N-[Tris(hydroxylmethyl)methyl]-3-aminopropanesulfonic acid (Taps) 2-
[cyclohexylamino]-ethanesulphonic acid (Ches) and Emusifier-Safe scintillation liquid were
obtained from EMD Bioscience.
Semisynthesis of FnY-02 and FnY-I3'. Growth and expression of [2-intein-CBD,
ligation to FnY-22mer and separation of FnY-32 from FnY-3f3' using MonoQ chromatography
were carried out as detailed in Chapter 7.
Growth, expression and purification of His6 -V 353G/S354C-P2. Growth and expression
of His 6-V 353G/S 354C-P2 was carried out on a 10 L scale as previously described (Chapter 2).
This procedure yields 3 g of wet cell paste per L culture. Purification using Ni-NTA
chromatography was carried out as reported yielding 20 mg of pure His 6-V 353G/S 354C-f2 with
1.1 Y122 * per dimer by the dropline procedure.
Monitoring dCDP formation by RCQ studies. RCQ studies were carried out on a
KinTek Model RQF-3 Chemical Quench Flow instrument equipped with a Lauda RM6
circulating water bath. All experiments were carried out at 25 'C by mixing pre-reduced a2, 32
variant and TRR in syringe A in a 1:1 ratio with TR, NADPH, ATP and [2-1 4C]-CDP (12600 or
14100 cpm/nmol) from syringe B. In all experiments, the final concentrations were 10 ptM a2,
10 ptM P2 variant, 1 mM [2-1 4C]-CDP, 3 mM ATP, 60 pgM TR, 1.2 p.M TRR and 3 mM
NADPH. Reactions were carried out at in assay buffer (50 mM Goods buffer, 15 mM MgSO 4, 1
mM EDTA) at pH 6.8 with Mes, pH 7.6 with Hepes or pH 8.4 with Taps (see Chapter 7). The
zero time point was generated by replacing the contents of syringe A with buffer. Triplicate runs
were performed for each time point in a randomized fashion. For each time point, 28 [tL from
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each syringe were mixed, allowed to react for a defined time period, ranging from 50 ms to 60 s,
and quenched by combining with 198 p.L of 2 % perchloric acid. After quenching, the sample
was briefly spun down in a centrifuge and the reaction mixture neutralized to pH 7.5 by addition
of 150 tL of 0.5 N KOH. Samples were maintained on ice until completion of the entire time
course. At that point, the samples were incubated at -20 0 C overnight to allow for complete
precipitation of potassium perchlorate. Each sample was then thawed on ice, spun down in a
table top centrifuge, transferred to a new eppendorf tube and combined with calf intestine
alkaline phosphatase (20 U) and carrier deoxycytidine (150 nmol) in 120 mM Tris, 0.24 mM
EDTA, pH 8.5. The mixture was incubated at 370 C for 2-2.5 h. For each sample, cytidine was
separted from deoxycytidine on a Dowex-1 borate column according to the procedure of Steeper
and Steuart. The amount of [14C]-deoxycytidine was then quantitated on a Beckman LS 6500
Scintillation Counter by mixing 1.8 mL of the 8 mL eluant (from the Dowex-l borate column)
with 10 mL of Emulsifier-Safe scintillation fluid.
Data analysis of RCQ experiments. Curve fitting to linear and lag phase functions was
carried out with KaleidaGraph Software. Observed lag phases were fit to Eq. 8-1 using DynaFit
or KaleidaGraph, where dCDPt is the nmol of product formed as a function of time, Vcat is the
steady state rate (nmol/s), t is time, and kiag is the lag phase rate constant (s-).18
1(-k
dCDPt = Vcat t x [1-expiag t (8-1)
Generation of apo Y-P2, 2,3,5-F 3Y-12 or 2,3,5-F 3Y-PP' with lithium 8-hydroxy-
quinoline-6-sulfonate. The apo 02 variant was generated as described in Chapter 2 according
to a modification of the procedure reported by Atkin et al.' 9 Briefly, a solution of 2.5 mL of 12
variant (-20 mg, 90 gM) was dialyzed against 500 mL of chelator solution consisiting of 1 M
imidazole, 30 mM NH20H, 50 mM 8-hydroxyquinoline-6-sulfonate (pH 7.0) in a 3 mL
Slide-a-lyzer cassette for 3 h. The chelator was then removed by dialysis against 4 L Hepes
buffer (50 mM Hepes, 5 % glycerol, pH 7.6) for 3 h and further by desalting on a Sephadex
398
G-25 column (1.5 x 23, 40 mL), which had been equilibrated in Hepes buffer. This procedure
delivers apo P2 in 80-95 % yield. The concentration of apo P2 or pp' variant was determined
using E280nm = 120 mM-'cm-' .
Reconstitution of apo FnY-p2. Apo [2 variants were reconstituted as described in
detail in Chapter 2. This procedure yields radical contents of -1.2 Y122*/f2 as determined by the
dropline procedure (see Chapter 2).
Spectrophotometric and radioactive RNR Assay. RNR activity assays were
performed as described in detail in Chapter 2. The final concentration of a2 and P32 variant in
these assays were 3 [pM each. The specific activity of [2- 14C]-CDP was 3800 cpm/nmol.
Single wavelength and diode array SF UV-vis spectroscopy. SF UV-vis experiments
were carried out at 250 C as described in detail in Chapter 2. Single wavelength kinetics
experiments utilized PMT detection at 410 nm (max of Y122* with E = 3700 M-lcm-), 510 nm
(Qmax of Wo with 8 = 2200 M- 1cm - 1) and 560 nm (?max of WH*° with 8 = 3000 M-lcm-1). 20
Typically, pre-reduced a2 (50-70 pM) and ATP (6 mM) in one syringe were mixed with
2,3,5-F 3Y-02 or 2,3,5-F 3Y-PP' (50-70 gM) and CDP (2 mM) in a 1:1 ratio in 50 mM Taps, 15
mM MgSO 4, 1 mM EDTA, pH 8.4. Time courses shown are the average of at least 5 individual
traces. Diode array SF UV-vis spectroscopy was carried out with an Applied Photophsysics
PDA.1 Photodiode Array detector. The concentration of reaction components were the same as
those monitored by single k kinetics. The reaction time before each rapid scan spectrum is listed
in the Figure legends. Note that the pre-reduction procedure removes the Y 122* of contaminating
wt 32, which is present in a2 preparations.
RFQ-EPR spectroscopy. The instrument for preparation of RFQ EPR samples was
described in detail in Chapter 3. Typically, pre-reduced ca2 (50-70 gM) and ATP (6 mM) in
one syringe were mixed in a 1:1 ratio with 2,3,5-F 3Y-32 or 2,3,5-F 3Y-PP' (50-70 gM) and
CDP (2 mM) from a second syringe in 50 mM Taps, 15 mM MgSO4, 1 mM EDTA, pH 8.4.
Assembly, operation and quenching of samples were performed as described in Chpater 3. EPR
spectra were recorded at the Department of Chemistry Instrumentation Facility on a Bruker
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ESP-300 X-band (9.4 GHz) spectrometer. Spectra at 77 K were recorded with a quartz finger
dewar filled with liquid N2; spectra at 15 or 20 K were acquired with an Oxford liquid helium
cryostat and an Oxford ITC 503 temperature controller. Unless noted otherwise, EPR
parameters were as follows: Power = 50 gpW, modulation amplitude = 1.5 G, modulation
frequency = 100 kHz, time constant = 5.12 ms and scan time = 41.9 s.
Kinetic simulations. Kinetc Simulations were carried out using KinSim, available free
of charge from the web (http://www.biochem.wustl.edu/cflab/message.html). The kinetic
schemes used for kinetic modeling are shown in Figures 8-14 to 8-18.
pH rate profile for NH 2Y* formation in the reaction of 2,3,5-F 3Y-032 with NH 2Y-
a2s and CDP/ATP monitored by SF UV-vis spectroscopy. NH 2Y-a2 was prepared and
pre-reduced as detailed in Chapter 4. In all experiments, pre-reduced NH 2Y-a2 and ATP were
mixed with 2,3,5-F 3Y-p2 and CDP to yield final concentrations of 4 jgM, 3 mM, 4 pM and 1
mM, respectively. Single wavelength kinetics were monitored using PMT detection at 320 nm
(max of NH2Y 731* with E = 11000 M-lcm- 1) or 325 nm (,x of NH2Y 730* with 6 = 10500
M-lcm-). The temperature was maintained at 250C with a Lauda RE106 circulating water bath.
Reactions were carried out in Mes (pH 6.5-7), Hepes (pH 7-8), Taps (pH 8-8.8) or Ches (pH
8.8-9.2) buffer, which consisted of 50 mM Goods Buffer, 15 mM MgSO 4, 1 mM EDTA
adjusted to the desired pH. Syringes and reaction lines were equilibrated in the desired buffer
prior to the experiment. At each pH, a minimum of 5 traces were averaged and analyzed using
OriginPro Software.
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RESULTS
Rationale for pre-steady state experiments. Kinetic investigations of the radical
initiation pathway have shown that the aromatic amino acid radicals, which carry the oxidizing
equivalents from the Y122* in 32 into the active site of a2, are masked by a conformational
change. Thus, examination of the mechanism of long-range hole propagation requires that the
rate constant for this process is diminished relative to the conformational step. The results in
Chapter 7 indicate that the FnYs inserted site-specifically at residue 356 may provide the
necessary change in the driving force by increasing the reduction potential to alter the
rate-determining step. However, direct experimental validation that radical propagation has
become rate-determining in turnover has been missing.
Previous pre-steady state examination of wt RNR has shown that production of dCDP in
the first turnover is limited by a conformational change that precedes radical transfer. Recently,
we have, for the first time, directly monitored this conformational change by measuring the rate
constant for DOPA* and NH2Y* formation in DOPA-12 and NH2Y-a2, respectively (Chapters 2
& 4). In wt RNR, at low concentrations (<3 gLM), the conformational step remains rate-limiting
during multiple turnovers. At high concentrations of RNR (-15 [iM), however, re-reduction or a
step associated with re-reduction has been proposed to become rate-limiting under multiple
turnover conditions. Importantly, at low and high concentrations of RNR, a burst of dCDP
formation is observed in the first turnover, with rate constants of 4.4-16.5 s- 1 and amplitudes of
1.4-2.2 dCDP per a2 or 1.2-1.8 dCDP per Y122*. 13
To test the prediction, that radical transfer becomes rate-determining with FnY-02s,
pre-steady state experiments have been carried out with 2,3,5-F 3Y-02 and F4Y-02. Radical
transfer could be rate-determining in the forward or reverse PCET processes. If reverse radical
transfer has become rate-limiting, then a burst of dCDP would be expected in the first turnover
with a rate constant similar to the conformational step and an amplitude similar to those with wt
RNR. If, however, forward radical transfer has become rate-determining, then kinetic
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simulations show that linear or lag kinetics in dCDP formation would be expected (see below).
This also holds for the case, in which forward and reverse radical transfer are rate-determining.
The mutations required for semisynthesis of 32, result in a 3-4x diminishment of kcat relative to
wt RNR. It is unclear which elementary step in the kinetics of RNR is affected by these
mutations.
Pre-steady state analysis of His6-V 35 3G/S35 4C-32 by RCQ. To examine the kinetics
of dCDP formation, RCQ experiments have been performed. As a control for RCQ experiments,
HiS6-V 353G/S354C-P2 was examined first. This variant is prepared by recombinant expression
and has a specific activity that is 3-4x lower than that of wt 12. A time course of dCDP
formation with this variant is shown in Figure 8-3 at pH 7.6 and 6.8. Surprisingly, the burst of
dCDP formation observed with wt RNR, is absent in this double mutant. Qualitatively, this
appears to be consistent with a slower rate constant for the conformational change that precedes
radical transfer. Thus, the mutations required for semisynthesis of P2 may in fact have
inadvertently decreased the likelihood of observing intermediates during radical transfer, as
formation of potential radical intermediates is now 3-4x fold slower than in wt RNR.
At pH 6.8, the data can be fit to a linear rate of dCDP formation indicating that the
conformational change is slow during multiple turnover, even at these high protein
concentrations (Figure 8-3A). This result contrasts with those obtained with wt RNR, where the
conformational step is slow during multiple turnover only at low [RNR] and re-reduction or a
process associated with re-reduction is likely rate-limiting at high [RNR]. A magnified view of
the first 3 s shows that a linear fit describes the data well (Figure 8-3B). The specific activity
obtained from this experiment, 380 nmol/minomg, agrees well with that from steady state
nucleotide reduction assays monitoring [14C]-dCDP. Wt RNR has a specific activity of -1600
nmol/min*mg at this pH.
At pH 7.6, a lag phase appears to precede dCDP formation in the first turnover (Figure
8-3C), which is more easily discerned in a blow-up of the initial 3 s of the reaction (Figure
8-3D). Analysis of this trace indicates that a single lag phase, with a rate constant of 0.21 s-1, is
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sufficient to describe the data. The nature of this lag phase is at present not understood. It may
be related to reorganization of a2, 32 or a2/12 into an active form. The lag phase is followed by
a steady state nucleotide reduction rate of 600 nmol/minomg, which is similar to activities
obtained by steady state assays. Wt RNR has a specific activity of 3500 nmol/minomg at this pH.
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Figure 8-3. RCQ analysis of [14C]-dCDP formation with HiS6-V 353G/S354C-~2 (1.1 Y122*/dimer).
Reactions were carried out at pH 6.8 (A, B) and pH 7.6 (C, D). The experimental set up and the final
concentration of each component were described in the Methods Section. (A) A background count of
180 cpm, which was determined from triplicate reactions of syringe B against buffer (see Methods),
was subtracted from each time point. The counts for the first three time points were an average of
-100 cpm above background. The red line describes a linear fit to the data giving a specific activity of
380 ± 60 nmol/min*mg. (B) Magnified view of the initial 3 s of the reaction at pH 6.8. (C) A
background of 250 cpm, determined in a similar fashion as in (A), was subtracted from each time
point. The counts for the first three time points were an average of -120 cpm above background. The
data have been fit to Eq. 8-1 (red line) giving a lag phase of 0.21 ± 0.04 s- 1 and linear rate of 600 +
120 nmol/min*mg. (D) Magnified view of the initial 3 s of the reaction at pH 7.6.
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Pre-steady state analysis of FnY-02s by RCQ. Next, we examined pre-steady state
dCDP formation with intein wt P2, Y-P2, which was made by the same procedure as FnY-02s
(Figure 8-4). This construct contains 0.3 Y122* per Y-02, similar to the radical content of
FnY-p2s. The data can be fit with a single lag phase of 0.2 s- 1 followed by a steady state
turnover of 173 nmol/minomg. It is important to note that a burst of dCDP would be observable,
even with the low radical content of semisynthetic 02s. With the specific activity of dCDP used
in these experiments, a burst of dCDP corresponding to 1.2 dCDP per Y 122* would yield a count
of 600 cpm, which is 3x above background levels of dCDP (-200 cpm).
Similar experiments were carried out with 2,3,5-F 3Y-p2 at pH 6.8 and 8.4, and with
F4Y-P2 at pH 6.8 and 7.6. In case of 2,3,5-F 3Y-j2, the change in pH from 6.8 to 8.4 is
proposed to correspond with a change in the rate-determining step in turnover. The pH rate
profiles in Chapter 7 indicate that at pH 6.8, the conformational change preceding radical transfer
is the slowest step in turnover, whereas at pH 8.4, radical transfer itself has become
6
5
4
a 30C
002o
LU
0
1.2
1.0
0.8
C 0.6
0 0.4
LU 0.2
0.0
0 5 10 15 20 25 0 1 2 3 4 5
Time (s) Time (s)
Figure 8-4. RCQ analysis of [14C]-dCDP formation with Y-132 (0.35 Y122*/dimer) at pH 6.8. (A)The experimental set up and the final concentration of each component were described in the Methods
Sections. A background count of 130 cpm which was determined from triplicate reactions of syringe
B against buffer (see Methods), was subtracted from each time point. The counts for the first three
time points were an average of -45 cpm above background. The red line describes a fit to Eq. 8-1
yielding a lag phase of 0.20 ± 0.03 s' followed by a linear phase at 173 ± 26 nmol/minomg. (B)
Magnified view of the initial 5 s.
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rate-determining. Y-P2 and 2,3,5-F 3Y-P2 have specific activities of 200 and 205
nmol/minomg at pH 6.8 and 390 and 150 nmol/minomg at pH 8.4, respectively (Chapter 7).
The pre-steady state formation of dCDP with 2,3,5-F 3Y-32 is shown in Figure 8-5. At
pH 6.8, linear dCDP formation is observed with a specific activity of 254 nmollminemg, similar
to activities measured in Chapter 7 (Figure 8-5A/B). At pH 8.4, a single lag phase, which is
clearly discernibly in a magnified view of the initial 5 s of the reaction, with a rate constant of
0.29 s- 1, precedes steady state formation of dCDP, which occurs at 221 nmol/minomg (Figure
8-5C/D). The specific activity of 2,3,5-F 3Y-02 at pH 8.4 is significantly higher than expected
based on results in Chapter 7. This may be due to small differences in the reaction pH. In the
pH range of 8.2-8.5, the activity of 2,3,5-F 3Y-32 is strongly dependent on the pH. The specific
activities at pH 8.2 and 8.5 are 270 and 40 nmol/minemg, indicating that even small changes in
the reaction pH could have a marked effect on activity.
With F4Y-02, a drastic drop of activity was observed relative to Y-P2, throughout the
pH range (Chapter 7). This is consistent with the large reduction potential difference of 130-270
mV between F4Y and Y between pH 6.5 and 9.0. Therefore, we proposed that radical transfer
was rate-determining throughout the pH range. Consequently, with F4Y-P2, similar pre-steady
state dCDP formation profiles are expected at pH 6.8 and 7.6. However, experiments with
F4Y-P2 are complicated by the very low activity of this construct. In chapter 7, specific
activities of 26 and 22 nmol/min*mg were measured for F4Y-12 at pH 6.8 and 7.6, respectively,
at final concentrations of 3 plM a2/F4Y-02. Pre-steady state formation of dCDP at pH 6.8 is
shown in Figure 8-6A. This data set suffers from a low signal/noise, because the data points up
to 4 s have similar counts as the zero time point, due to low specific activity of this variant. To
illustrate the low signal/noise, counts, rather than conversion of the data to equivalents of a2,
have been plotted. A linear fit seems to describe the data best, which is shown in Figure
8-6A/B and yields a specific activity of 16 nmol/min*mg. Fitting the data with one or two lag
phases leads to a lower R2 correlation value between the data and the fit. Additional experiments,
with higher radical content in F4Y-32 are required to illuminate the pre-steady state kinetics
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with this mutant. At pH 7.6, the background (i.e. t=O) counts were low and lag phase kinetics are
observed (Figure 8-6C/D). The fit to Eq. 8-1 yields a lag phase rate constant of 1.6 s- 1 and a
specific activity of 24 nmol/minomg, similar to the activity measured in chapter 7.
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Figure 8-5. RCQ analysis of [14C]-dCDP formation with 2,3,5-F 3Y-132 (0.4 Y122*/dimer). Reactions
were carried out at pH 6.8 (A, B) and 8.4 (C, D). The experimental set up and the final concentration
of each component were described in the Methods Sections. (A) A background count of 75 cpm,
which was determined from triplicate reactions of syringe B against buffer (see Methods), was
subtracted from each time point. The counts for the first three time points were an average of -70 cpm
above background. The red line describes a linear fit to the data giving a specific activity of 254 ± 23
nmol/minomg. (B) Magnified view of the initial 3 s of the reaction at pH 6.8. (C) A background of
310 cpm, determined in a similar fashion as in (A), was subtracted from each time point. The counts
for the first three time points were an average of -80 cpm above background. The red line is a fit to
Eq. 8-1 yielding a lag phase of 0.29 ± 0.06 s-' and a linear phase of 221 ± 44 nmol/min*mg. (D)
Magnified views of the initial 5 s at pH 8.4.
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Figure 8-6. RCQ analysis of [14C]-dCDP formation with F4Y-32 (0.37 Y122*/dimer). Reactions
were carried out at pH 6.8 (A, B) and 7.6 (C, D). The experimental set up and the final concentration
of each component were described in the Methods Sections. (A) A background count of 170 cpm,
which was determined from triplicate reactions of syringe B against buffer (see Methods), was
subtracted from each time point. The counts for the first three time points were an average of -100
cpm above background. The red line described a linear fit to the data giving a specific activity of 16 +
5 nmol/minomg. (B) Magnified view of the initial 8 s of the time course at pH 6.8. (C) A background
of 200 cpm, determined in a similar fashion as in (A), was subtracted from each time point. The
counts for the first three time points were an average of -25 cpm above background. The red line is a
fit to the data, according to Eq. 8-1, and yields a lag phase of 1.6 ± 0.4 s- 1 and a linear phase of 24 ± 6
nmol/minomg. (D) Magnified view of the initial 10 s of the reaction at pH 7.6.
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The data from RCQ experiments with the various [32 analogues are summarized in Table
8-1. Importantly, no burst of dCDP is observed in any of these cases. In all cases linear or lag
kinetics in dCDP production are observed, which is consistent with a slower conformational step
prior to radical transfer. In the case of His-V 353G/S 354C-f32 and Y-[32, we conclude that the
3-4x lower activities observed are due to a 3-4x slower conformational gating step. This in turn,
lowers the likelihood of intermediate buildup during radical transport. In the case of
2,3,5-F 3Y-P[2 and F4Y-32, we propose that reverse radical transfer cannot be solely
rate-limiting in turnover, as this would have resulted in a burst of dCDP, although kinetic
simulations are required to assess this proposition (see below). Additional experiments with
FnY-[32 containing greater Y122* contents at different pHs are necessary to fully examine the
pre-steady state kinetics of F.Y-[32s. Nevertheless, any kinetic model must reproduce the linear
or lag phase kinetics in the pre-steady state formation of dCDP with 2,3,5-F 3Y-[32 or F4Y-132.
Kinetic models for the catalytic cycle of 2,3,5-F 3Y-032 will be discussed below.
Table 8-1. Summary of kinetic parameters
formation.
from RCQ experiments monitoring [14C]-dCDP
Lag Phase Linear Phase
2 Variant pH (s) (nmoi/min*mg)
V353G/S 354C-[2 6.8 - 380 + 80
V353G/S 354C-[2 7.6 0.21 ± 0.04 600 ± 120
Y-[2 6.8 0.20 ± 0.03 173 ± 26
2,3,5-F 3 Y356-32 6.8 - 254 ± 23
2,3,5-F 3Y 356-[32 8.4 0.29 + 0.06 221 + 44
F4Y-[32 6.8 - 16 ± 5
F4Y-j32 7.6 1.6 ± 0.4 24 ± 6
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Increasing the radical content of semisynthetic FnY-032s. To further test the proposal
that the rate-determining step shifts from a physical step to the radical transfer step with
FnY-p2s, additional pre-steady state experiments were carried out. Qualitatively, the data above
are consistent with a model in which forward radical transfer is slow during turnover.
Consequently, W48*, the residue proposed to oxidize FnY 356 may build up in this process, which
may be observed by SF UV-vis and RFQ EPR experiments. To maximize our chances of
detecting low levels of radicals, we decided to invest some time to elevate the amount of Y122° in
our semisynthetic 32s.
To increase the radical content of semisynthetic P32s, the method of Atkins et al. was
employed. This method failed to increase Y1220 levels of DOPA-P2, presumably due to
participation of DOPA356 in the in vitro reconstitution reaction. However, in the present case,
with intein-generated wt 132 (Y-P2), this procedure yields 1.1-1.2 Y122* per P12 with protein
recoveries ranging from 80 to 95 %. The UV-vis (Figure 8-7A) and EPR spectrum (Figure
8-7B) of Y-12, treated in this fashion, are shown. These spectra are identical to those of
recombinant wt 32 indicating that the Y122* and diferric center are intact.
A similar procedure was carried out with 2,3,5-F 3Y-02 and 2,3,5-F 3Y-PP'. UV-vis and
EPR spectral analysis of the former is shown in Figure 8-7C/D. These spectra, as with Y-132,
indicate that the Y122o and diferric center are intact. A similar result was obtained for
2,3,5-F 3Y-1313' (data not shown). Accordingly, the 2,3,5-F 3Y probe does not interfere with the
reconstitution reaction presumably due to the similarity of its reduction potential (0.84 V) with
that of Y (0.79 V) at pH 7.6.
To ensure that the chelation/reconstitution procedure did not result in loss of nucleotide
reduction activity, spectrophotometric assays were performed with semisynthetic 132s before and
after application of this procedure. The results revealed that the specific activity correlates with
Y122* content before and after chelation/reconstitution (data not shown). In addition, SDS PAGE
analysis, before and after this procedure, yields a similar result (Figure 8-8). Thus, this method
increases the Y122" content without affecting the nucleotide reduction ability of semisynthetic 032s.
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Figure 8-7. Increasing the radical content of Y-32 and 2,3,5-F 3Y-32. UV-vis (A) and EPR (B)
spectra of Y-P2 (1.1 Y122*/dimer) after the chelation/reconstitution procedure. The inset (A) is a
magnified view of the features associated with the diiron Y122* cluster. UV-vis (C) and EPR (D)
spectra of 2,3,5-F 3Y-32 (1.2 Y122*/dimer) after the chelation/reconstitution procedure. The inset (C)
shows a magnified view of the features associated with the diiron Y122* cluster.
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Figure 8-8. SDS PAGE analysis of 2,3,5-F 3Y-32 and 2,3,5-F 3Y-Pp' after chelation/reconstitution.
Lane 1, 4 jtg of 2,3,5-F 3Y-f2; lane 2, 4 jtg of 2,3,5-F 3Y-3Y'.
Diode array SF UV-vis spectroscopy with 2,3,5-F 3Y-PP'/a2. The results in Chapter
3 revealed that semisynthetic heterodimeric DOPA-pp' generates a DOPA* only in the presence
of substrate and effector, similar to DOPA-P2. In addition, by the criteria of EPR spectroscopy,
the DOPA* in DOPA-pp' is in an environment that is very similar to that of the DOPA* in
DOPA-P2. The ability to initiate radical transfer does not require the C-terminal tail in the
second P-monomer. Therefore, we reasoned that heterodimeric 2,3,5-F 3Y-Pf', which is a
major side product of the ligation procedure, may serve as a model for 2,3,5-F 3Y-p2, even
though our sensitivity in detecting intermediates would be 2-fold lower with heterodimeric 32
based on yields of DOPAo in DOPA-PP' vs. DOPA-P2. To optimize conditions for SF UV-vis
experiments with 2,3,5-F 3Y-P2, experiments were first carried out with 2,3,5-F 3Y-pp'. The
most likely species that may build up in the pH range where radical transfer is rate-determining
is W48H*+ (or W 48*). However, the absorption profile of this species may be subject to spectral
shift due to the protein environment. Therefore, diode array SF UV-vis studies were performed
first.
Pre-reduced a2 and ATP were rapidly mixed with 2,3,5-F 3Y-PP' (1.2 Y122*/dimer) and
CDP and a diode array spectrum was recorded at defined time intervals in the spectral range of
400-850 nm. The result is shown in Figure 8-9. Throughout the spectral range, only a minor
absorbance increase is observed at 410 (Figure 8-8B) nm and -630 nm (Figure 8-9C). No
changes are observed at the wavelengths corresponding to We or WH.+. Thus, with
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2,3,5-F 3Y-pI', at pH 8.4, where radical transfer is proposed to be rate-determining, no We or
WH*° is detectable under these experimental conditions.
Experiments were also carried out with substrate GDP and effector TTP, and with
Y730F-ax2. However, using diode array detection, no changes were observed throughout the
spectrum (data not shown).
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Figure 8-9. Diode Array SF UV-vis spectroscopy of 2,3,5-F 3Y-037'a2 (1.2 Y122*/dimer) in the
presence of CDP/ATP at pH 8.4. (A) Reaction conditions were described in the Methods Section.
The reaction time, at which each diode array spectrum was acquired, is indicated. (B) Magnified view
of the spectral region associated with the Y122*. (C) Magnified view of the changes occurring at -630
nm.
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SF UV-vis spectroscopy with 2,3,5-F 3Y-12/a2. To test whether spectral changes
would occur with 2,3,5-F 3Y-32, similar experiments as above were carried out. In this case,
2,3,5-F 3Y-j32 containing 1.2 Y122* per dimer was used. The results are presented in Figure 8-10.
They show that no changes occur at 410 nm, 510 nm and 560 nm. Therefore, under these
experimental conditions, no absorption features that might be associated with a W* or WH*+ are
apparent.
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Figure 8-10. Single wavelength SF
the presence of CDP/ATP at pH 8.4.
(red) and 560 nm (blue).
5 6 7
UV-vis spectroscopy of 2,3,5-F 3Y-f32/a2 (1.2 Y122o/dimer) in
Single X kinetics were monitored at 410 nm (black), 510 nm
RFQ EPR spectroscopy with 2,3,5-F 3Y-02 and 2,3,5-F 3Y-3~3'. The results above
show that a We is not detectable in the first turnover with 2,3,5-F 3 Y-P32. Other than W48, only
the diferric center may be postulated to be involved in oxidation of residue 356. In addition,
EPR is more sensitive to small changes in [W*] or [WH*+], as both of these species have low
extinction coefficients. Thus, to validate the results from SF UV-vis experiments and to
examine whether radicals other than W48 build up, RFQ-EPR experiments were carried.
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RFQ-EPR was carried out under conditions similar to those in the SF UV-vis
experiments. In these experiments a packing factor of 0.60 ± 0.05 was routinely obtained, as
measured with wt P2. Further, the dead time of the instrument was measured at 16 ± 2 ms using
the NaN3/sperm whale myoglobin test reaction (data not shown). The results with
2,3,5-F 3Y-PP' are shown in Figure 8-11. EPR spectroscopy and spin quantitation at 77 K
shows that the [Y122e] does not change relative to the t=0 time point. To examine if perhaps the
diiron center was involved in radical transfer via its (FeI') 2-FeI/Fem redox couple, EPR spectra
were also recorded at low temperatures. The Fen/Fem state has been generated in E. coli P2
before by photolysis at 77 K.21,22 Because of its relaxation properties, the diiron center is only
observed at temperatures <30 K. However, spectra collected at 20 K revealed no features other
than those related to the Y122*.
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Figure 8-11. RFQ EPR spectroscopy of the reaction of 2,3,5-F 3Y-P3' (1.2 Y122*/dimer) and CDP
with c2 and ATP. Contents of the syringes were mixed to yield final concentrations of 70 p.M
2,3,5-F 3Y-PP3'/2, 1 mM CDP and 3 mM ATP at pH 8.4. The reaction was quenched at 55 ms (blue)
and 155 ms (red) and the EPR spectrum recorded at 77 K. Spectra at 20 K did not reveal any
additional featuers (data not shown). The [spin] at these quench times remained constant relative to
the zero time point.
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Similar studies were performed with 2,3,5-F 3 Y-p2. The results are shown in Figure
8-12. EPR spectroscopy at 77 K failed to reveal decay of Y122*. No new features were observed
at this temperature. EPR spectra were also acquired at 20 K and 15 K. As with 2,3,5-F 3Y-PP',
these spectra did not reveal features other than those associated with Y122*.
3275 3300 3325 3350 3375
Field (G)
Figure 8-12. RFQ EPR spectroscopy of the reaction of 2,3,5-F 3Y-p2 (1.2 Y122*/dimer) and CDP
with a2 and ATP. Contents of the syringes were mixed to yield final concentrations of 60 PM
2,3,5-F 3Y-02/a2, 1 mM CDP, and 3 mM ATP at pH 8.4. The reaction was quenched at 72 ms
(black), 138 ms (blue) and 1.9 s (red) and the EPR spectrum recorded at 77 K. An EPR spectrum of
the 1.9 s quench time point was also collected at 15 K (green). EPR spectra of the reactions quenched
at 72 ms (black) and 138 ms (blue) were also recorded at 15 K, however, only the Y122* Signal was
observed (not shown). Additional reactions were quenched at 28 ms and 612 ms and EPR spectra
recorded at 77 K, 20 K and 15 K; however, in no case were features other than those associated with
the Y122* observed (data not shown). In all cases, the [spin] remained constant relative to the zero time
point.
Figure 8-13 presents a comparison of the EPR spectrum 2,3,5-F 3Y-32 and the spectrum
obtained after reaction of 2,3,5-F 3Y-02/a2 with CDP/ATP quenched after 612 ms. Comparison
of these spectra indicates that a low intensity signal may be masked by the Y12 2' profile.
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Subtraction and quantitation reveals the red trace in Figure 8-13. This spectrum consists of 5 %
of the total spin and may in fact represent a new species that forms in the first turnover. A
similar subtracted spectrum was observed with the 1.9 s time point. However, in both cases, the
difference between the observed quenched spectrum and that of 2,3,5-F 3Y-P2 may also be due
to a small changes in the spectrum of Y122* upon complex formation.
The RFQ-EPR experiments in this section have failed to reveal build up of any
intermediates during radical propagation. Additional studies are necessary to examine whether
the signal observed in Figure 8-13C is associated with a new intermediate in the pathway. A
kinetic model to account for the lack of observable intermediates is necessary.
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Figure 8-13. RFQ EPR spectroscopy of the reaction of 2,3,5-F 3Y-12 (1.2 Y122*/dimer) and CDP
with a2 and ATP. Contents of the syringes were mixed to yield final concentrations of 60 pM
2,3,5-F 3 Y-32/a2, 1 mM CDP and 3 mM ATP at pH 8.4. The reaction was quenched at 612 ms and
the EPR spectrum recorded at 77 K (black trace). (A) The spectrum was analyzed by subtracting the
Y 122 * (blue trace) yielding a signal (red trace) which accounts for 5 % of the total spin. (B) Magnified
view of the resulting spectrum after subtraction of Y122* spectrum. (C) Magnified view of the resulting
subtraction spectrum after application of a 12-point smoothing procedure.
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Rationale for kinetic simulations of the a2/FY-032 catalytic cycle. The results above
show that no intermediates are detected even though the rate constant for radical transfer appears
to have been diminished, as we suggested in Chapter 7. To try to understand why no
intermediates appear to build up in the experiments above, kinetic simulations were performed.
Our aim was to see whether radical transfer could be rate-limiting during turnover without
resulting in intermediate buildup, and if so, which step, forward or reverse radical transfer, would
be affected. We also wanted to find a kinetic model that would reproduce the pH dependence of
activity presented in Chapter 7. A suitable kinetic model should recapitulate three main
experimental observations, which were delineated above: (1) As reported by DOPA-j32, in the
presence of CDP/ATP, a conformational change with a kobs of -1 S- 1 occurs prior to radical
transport, (2) no intermediates build-up is observed in the pre-steady state and (3) there is no
burst of dCDP formation in the pre-steady state. The models that were assessed are based on
our previous kinetic models of the wt RNR reaction, which we were able to reproduce in the
current study.'3
First, we wanted to generate a model for the Y-f32 reaction. Using our previous kinetic
scheme, we tested the minimal model for Y-P32 shown in Figure 8-14. This model is based on
that shown in Figure 8-2, except that the &K for CDP has been replaced with 0.1 mM (Figure
8-14A) and the rate constant for active-site chemistry has been replaced with 100 s- 1 (Figure
8-14D). The Kd for CDP has been changed because a Kd of 0.25 mM and 0.1 mM have been
measured in the presence of TIP and dATP, respectively. 14 In our reactions, we are using ATP
as the allosteric regulator of CDP, however, the Kd for CDP in the presence of ATP has not been
determined. In the current simulations, we prefer the Kd measured for CDP under low [dATP]
because the effects of low [dATP] and high [ATP] are similar on the activity of RNR and
because ATP/dATP represent the natural effectors for CDP. The rate constant for the nucleotide
reduction chemistry has only been determined in the class II RNR from L. leichmannii. There, a
kobs 55 s-1 was determined for substrate ATP in the presence of its allosteric regulator dGTP.2 3,24
We chose a nucleotide reduction rate constant of 100 s- 1 because it is closer to the actual
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measured rate constants in the class II case. The result of this kinetic scheme is shown in Figure
8-14. As observed in RCQ experiments for Y-02, a linear production of dCDP is recapitulated
by this model. Changes in concentration of other intermediates are minimal, as exemplified by
the time course of C439* in Figure 8-14. The kat of 0.75 s- 1, which results from this simulation,
is similar to the measured keat for Y-P2 (-0.6 s-1). This model thus reproduces the main
observations with Y-02 and allows us to examine the reaction of 2,3,5-F 3Y-p2.
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Figure 8-14. Kinetic model and result of simulation for the reaction of Y-02. (A) Binding to CDP,
see text for a KI choice of 0.1 mM. (B) Conformational change preceding radical transfer. The
forward rate constant of 1 s- ' is observed with DOPA-02, the reverse rate constant has been chosen
based on studies of Ge et al where a 10-fold larger reverse k was used. (C) Forward radical transfer,
rate constants based on Ge et al.13 (D) Nucleteotide reduction, see text for choice of rate constant. (E)
Reverse radical transfer, rate constant based on Ge et al. (F) Dissociation of dCDP. The simulation
shows a time course of dCDP formation (black) and thiyl radical formation, species 1.
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Kinetic simulations: forward or reverse radical propagation? We first wanted to test
whether radical transfer can be rate-determining without leading to observable intermediates.
Several models were tested. In the first model, it was assumed that reverse radical transfer is
solely rate-determining. In the second model, we assumed that forward radical transfer is solely
rate-determining. In the third model, we make the assumption that forward and reverse radical
transfer are both partially rate-determining.
The model, in which reverse radical transfer is assumed to be solely rate-limiting is
shown in Figure 8-15. In this model, all steps are identical to the parameters in Figure 8-14,
except step F. We have assumed that this step, hopping between Y731* and 2,3,5-F 3Y is slow in
reverse radical transfer. This assumption is based on the measured reduction potentials of
2,3,5-F 3Y and Y in solution, which are 0.85 V and 0.74 V at pH 8.4, respectively (Chapter 6).
In the forward direction, this step is highly favorable, in the reverse direction however, oxidation
of 2,3,5-F 3Y by Ye is thermodynamically uphill. Therefore, the measured steady state rate
constant of -0.2 s- 1 (Chapter 7) at pH 8.4, where we have proposed slow radical transfer, has
been assigned to step F. The simulation shows that this kinetic model yields a build-up of Y73 10
to 15 pM. In addition, production of dCDP occurs with an initial lag followed by a linear phase.
In our experiments, SF UV-vis may fail in detecting build-up of Y7 319, as depletion of Y122* and
build-up of another Y*, are spectroscopically indistinguishable. However, the RFQ-EPR studies
would have detected this large build-up of another Ye. Changes in concentration of other
intermediates were below our lower level of detection as demonstrated for C439* in Figure 8-15.
Thus, the current model and the chosen parameters suggest reverse radical migration cannot be
solely rate-limiting.
We reconsidered the parameters in the model of Figure 8-15 to see if changes in these
parameters could reflect our experimental observations. However, changing the parameters for
step B (0.5-1 s- 1 for forward k), step C (100-200 s- 1 and 100-300 s- 1 for forward and reverse k,
respectively), step D (50-100 s- 1) and step E (300-1000 s- 1) all yielded >14 pM of Y73 19. Thus,
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we conclude that in the current kinetic frame work, reverse radical transfer is likely not the solely
rate-determining step.
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Figure 8-15. Kinetic model and result of simulation for the reaction of 2,3,5-F 3Y-32 in which
reverse radical transfer is rate-limiting. (A) Binding to CDP, see text for a Kd choice of 0.1 mM. (B)
Conformational change preceding radical transfer. The forward rate constant of 1 s- 1 is observed with
DOPA-j32, the reverse rate constant has been chosen based on studies of Ge et al where a 10-fold
larger reverse k was used. (C) Forward radical transfer, rate constants based on Ge et al. (D)
Nucleteotide reduction, see text for choice of rate constant. (E) Reverse radical transfer, rate constant
based on Ge et al. (F) The slow step in the model, oxidation of 2,3,5-F 3Y by Y731*, see text for
details. (G) Dissociation of dCDP. The simulation shows a time course of dCDP formation (black
line), thiyl radical formation, species 1 (green line), and Y731* formation, species 2, (red line).
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We next examined the effect of a rate-determining forward radical transfer step in our
simulations. The model used is shown in Figure 8-16. In this case we have assumed that
oxidation of 2,3,5-F 3Y by W48* is the slow hop in the forward direction. This is consistent with
the solution reduction potentials of 2,3,5-F 3Y and We, which are 0.85 V and 0.8 V at pH 8.4,
where we have proposed that radical transfer is slow. Therefore, the measured steady state rate
constant of -0.2 s- 1 at pH 8.4 (Chapter 7) has been assigned to this step. The parameters for the
remaining steps are unchanged. The results of this simulation are shown in Figure 8-16. They
show a build-up of We (or WH*÷) to 2.5 jgM. We and WH*+ have E of 2200 and 3000 M- 1 cm - 1
at 510 and 560 nm, respectively. 20 Therefore, a build-up of W* or WH*÷ would have resulted in
an observable AA of 0.0055 and 0.0075 AU, respectively. We conclude that with the chosen
parameters in this kinetic model, forward radical transfer is not solely rate-determining.
We undertook changes in the parameters of our kinetic scheme to examine whether our
experimental results could be replicated. We varied the rate constant of step E (nucleotide
reduction chemistry) in Figure 8-16 between 100 and 250 s- 1 and the rate constant for step B
(forward k for conformational change) between 0.7 to 1 s- 1. However, these changes still
resulted in an experimentally detectable build-up of We (21.5 lpM). We also varied the reverse
rate constants of step D and F between 2-100 s- 1 and 500-1000 s- 1, respectively. These changes
also resulted in build up of W* to Ž2 pM. Combining changes in the rate constants in steps B
and E to 0.7 and 250 s-', respectively, also gave a build-up of W* to -2.0 pM. Therefore,
changes in the rate constant for steps B, D, E and F do not appear to diminish the build-up of W*.
However, variation in the formation rate constants of W* (step C) resulted in a decrease in the
concentration of We to levels that would not be observable in our experiments. Specifically,
when the reverse rate constant for step C was equal to or greater than the forward rate constant,
We build-up to only <1 pM was observed. This kinetic model is shown in Figure 8-17 and is
identical to the model in Figure 8-16 except that the parameters in step C have been reassigned.
A simulation with this model shows that We builds up to -0.9 or 1.4 WiM, when the reverse rate
constant for step C is 300 or 200 s- ', respectively. This concentration of We is not detectable by
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our methods. Thus, the simulations under conditions in which we assume forward radical
propagation to be slow, show that the experimental observations can be replicated with the
model and rate constants in Figure 8-17.
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Figure 8-16. Kinetic model and result of simulation for the reaction of 2,3,5-F 3Y-32 in which
forward radical transfer is rate-limiting. (A) Binding to CDP, see text for a Kd choice of 0.1 mM. (B)
Conformational change preceding radical transfer. The forward rate constant of 1 s-1 is observed with
DOPA-02, the reverse rate constant has been chosen based on studies of Ge et al where a 10-fold
larger reverse k was used. (C) Forward radical transfer, rate constants based on Ge et al. (D) The
slow step in the model, oxidation of 2,3,5-F 3Y by W48*, see text for details. (E) Nucleteotide
reduction, see text for choice of rate constant. (F) Reverse radical transfer, rate constant based on Ge
et al. (G) Dissociation of dCDP. The simulation shows a time course of dCDP formation (black line),
W48* formation, species 1 (blue line), and thiyl radical formation, species 2, (green line).
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Figure 8-17. Kinetic model and result of simulation for the reaction of 2,3,5-F 3Y-32 in which
forward radical transfer is rate-limiting with an altered Y122* reformation rate constant. This Figure is
identical to Fig. 8-16, except that the Y122* reformation rate constant in step C has been changed to
200 or 300 s- 1. (A) Binding to CDP, see text for Kd choice of 0.1 mM. (B) Conformational change
preceding radical transfer. The forward rate constant of 1 s- 1 is observed with DOPA-P2, the reverse
rate constant has been chosen based on studies of Ge et al where a 10-fold larger reverse k was used.
(C) Forward radical transfer, rate constants based on Ge et al. The reverse k in this step has been
changed to 200 or 300 s- 1 to reproduce lack of observable intermediates. (D) The slow step in the
model, oxidation of 2,3,5-F 3Y by W48*, see text for details. (E) Nucleteotide reduction, see text for
choice of rate constant. (F) Reverse radical transfer, rate constant based on Ge et al. (G) Dissociation
of dCDP. The simulation shows a time course of dCDP formation (black line), W48° formation,
species 1 with 200 s-' (blue line) or species 2 with 300 s- ' (orange line), and thiyl radical formation,
species 3 (green line).
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Finally, we examined a kinetic model in which both forward and reverse radical transfer
are both partially rate-determining. The model is shown in Figure 8-18 and is a combination of
the models in Figures 8-15 and 8-16. In the forward direction, oxidation of 2,3,5-F 3Y by W48•
has been assigned as the partially rate-limiting step. In the reverse direction, oxidation of
2,3,5-F 3Y by Y73 1* has been attributed with the slow rate constant of -0.2 s- 1, which was
measured in Chapter 7 at pH 8.4. All other parameters are identical to those in Figure 8-15 (or
8-16). The result shows that a build-up of We to 2.6 gLM would occur under these conditions,
similar to the simulations in which only forward radical propagation was slow. As discussed
above, this build-up of We would be observable by SF UV-vis and EPR methods. We varied
the parameters to see which set of rate constants would recapitulate our experimental
observations. As above, a change in the reverse rate constant for step C, results in diminished
build-up of We, to levels that are not observable by our methods. Therefore, these parameters
also reproduce the main features of our experimental observations.
The simulations in Figure 8-18 show a prolonged lag phase in dCDP formation when
forward and reverse radical transfer are partially rate-determining. While we have observed lag
phases in our RCQ experiments, they are not as pronounced as those in Figure 8-18. Thus, the
model reproduces our lack of observation of intermediates, however, a long lag phase is
inconsistent with our data. This issue will be explored further below, when we attempt to
simulate the kinetics of dCDP formation as a function of pH.
We have also examined the effect of the conformational change that precedes radical
transfer by omitting it from the model. In this case, the simulations indicate a major rapid
build-up of W48* to 60 % or 12 gM out of the initial 20 pM (data not shown) and a concomitant
loss in Y122*. Thus, the slow conformational change maintains a low concentration of W48* even
with FnY-032s, where we propose that radical transfer has become rate-limiting during turnover.
We conclude from the simulations above that within our kinetic frame work, based on
previous results (Chapter 7) and experimental observations presented in this Chapter, that reverse
hole propagation cannot be solely rate-determining. The simulations are consistent with a
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rate-determining step in forward radical propagation and perhaps with partially limiting forward
and reverse radical transfers. However, the reverse rate constant for formation of Wo (step C,
Figure 8-17) must be equal to or greater than the forward rate constant, the implications of
which will be discussed below.
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Figure 8-18. Kinetic model and result of simulations for the reaction of 2,3,5-F 3Y-02 in which
forward and reverse radical transfer are partially rate-limiting. (A) Binding to CDP, see text for a Kd
choice of 0.1 mM. (B) Conformational change preceding radical transfer. The forward rate constant of
1 s-' is observed with DOPA-02, the reverse rate constant has been chosen based on studies of Ge et
al where a 10-fold larger reverse k was used. (C) Forward radical transfer, rate constants based on Ge
et al. The reverse k in this step is either to 100 s- 1 (left panel) or 300 s- (right panel) to reproduce lack
of observable intermediates. With 100 s-', an observable build-up of W48* occurs (left), with 300 s-1,
however, the amount of W48* is below our level of detection (right). (D) The partially rate-limiting
step in the model, oxidation of 2,3,5-F 3Y by W48*, see text for details. (E) Nucleteotide reduction, see
text for choice of rate constant. (F) Reverse radical transfer, rate constant based on Ge et al. (G) The
partially rate-limiting step in the model, oxidation of 2,3,5-F 3Y by Y731*, see text for details. The
simulation on the left shows a time course of dCDP formation (black line), W48* formation (species 1)
with 100 s-1 in step C (blue line), and Y731* formation, species 3 (red line). The simulation on the right
shows a time course of dCDP formation (black line), W48" formation (species 1) with 300 s-1 in step C
(blue line), thiyl radical formation, species 2 (green line) and Y731* formation, species 3 (red line).
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Kinetic simulations: reproducing the effect of pH on kcat with 2,3,5-F 3Y-02. The
simulations above show that radical transfer may be rate-determining without resulting in a
build-up of observable intermediates. Further, they suggest that only forward hole propagation
or forward and reverse propagation are rate-determining in turnover. To examine our kinetic
model further, we explored whether the effect of pH on steady state activity, which was
presented in Chapter 7, could be reproduced.
We used the models in Figure 8-14 and Figure 8-17 to reproduce the pH rate profile of
2,3,5-F 3Y-02 (Chapter 7). Within the pH range, where the conformational change was
rate-determining (pH 6.5-7.6), we used the model in Figure 8-14 and replaced the forward rate
constant of step B with the measured kcat in Chapter 7. Within the pH range, where we have
proposed a switch in the rate-determining steps (pH 8-9), we used the model in Figure 8-17
(with 200 s- 1 for reverse k of step C) and replaced the forward rate constant for step C with the
rate constants that were measured as a function of pH in Chapter 7. The rates of dCDP
formation were then simulated. These were compared to the actual measured values as shown in
Table 8-2. The results reveal that the kinetic model can only reproduce the observed pH effect
on activity in the low pH range. In the range, where we have postulated a change in the
rate-limiting step, the kinetic model is not sufficient.
We examined the basis for the inconsistency between the observed and simulated rates of
dCDP formation. Variation in the parameters of steps B, C, E, and F in Figure 8-17 did not pose
a solution. However, changing the parameters in steps D in Figure 8-17 provided solutions,
which both kept the [We] low and yielded dCDP formation rates consistent with those measured
in Chapter 7. The observed results can be simulated by directly varying the decay rate constant
of We (step D) in the model of Figure 8-17. Comparison of the decay rate constant for We (step
D), the simulated and measured rates of dCDP formation are shown in Table 8-3. All other
parameters in Figure 8-17 (with 200 s- 1 for reverse k of step C) were kept constant. This Table
shows that the rate of dCDP formation can be fit to the data in Chapter 7 by only altering the
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decay rate constant of Wo in our current model. Thus, the dCDP formation rate correlates with
the decay rate constant of W* (step C, Figure 8-17).
Table 8-2. Measured and simulated
model in Figure 8-17.
pH
6.5
7.0
7.5
8.45
8.5
8.65
8.85
keat for 2,3,5-F 3Y-32 as a function of pH using the kinetic
Measured
kcat (s-1)a
0.2
0.32
0.5
0.1
0.07
0.03
0.02
Simulated
kcat (S- 1)
0.16 b
0.25b
0.39b
0.017c
0.031c
0.0013c
0.001c
a Rate constants determined in Chapter 7 with 2,3,5-F 3Y-132. b Rate constants simulated by inserting
the measured kcat at the same pH into step C of the model in Fig. 8-14. c Rate constants simulated by
inserting the measured kcat at the same pH into step D of the model in Fig. 8-17.
Similar simulations were carried out with the model in Figure 8-18 (with 200 s- 1 for
reverse k of step C). These results are also summarized in Table 8-3 and show that the
experimental kcat is approximated by this model reasonably well. In this case, the dCDP
formation rate directly correlates with the W48* and Y731* decay rate constants. However, the
pronounced lag phase, as shown in Figure 8-18, remained under all conditions shown in Table
8-3 above pH 8.45. Therefore, we prefer the model in which only forward radical transfer is
rate-determining. The validity of the model in Figure 8-18 requires further theoretical and
experimental assessment.
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In conclusion, the kinetic simulations in this chapter have provided one possible solution
for the catalytic cylcle of 2,3,5-F 3Y-02 and for explaining the lack of observable intermediates,
a linear rate of dCDP formation and, as presented in Chapter 7, dependence of kcat on the
reduction potential difference between 2,3,5-F 3Y and Y in the pH range of 8-9. Two models
have been found that are consistent with a slow radical transfer model in the forward or forward
and reverse directions. To obtain direct evidence for a switch in the rate-limiting step as a result
of 2,3,5-F 3Y incorporation, we considered the use of NH2Y-ao2 as a readout of the rate constant
for forward radical transfer using SF UV-vis spectroscopy.
Table 8-3. Measured and simulated kcat for 2,3,5-F 3Y-32 as a function of pH using the kinetic
models in Figures 8-17 and 8-18.
pH Measured We Decay k (s- ') Simulated [We] Simulated [We]
kcat (S- 1) a (forward, reverse) b kcat ( - 1) c (M) d kcat (s - 1 e (M) f
6.5 0.2
7.0 0.32
7.5 0.5
8.45 0.1 1.0, 1.0 0.065 1.3 0.059 1.2
8.5 0.05 0.8, 1.0 0.054 1.3 0.048 1.2
8.65 0.03 0.5, 1.0 0.034 1.4 0.030 1.3
8.85 0.02 0.2, 1.0 0.014 1.4 0.009 1.3
a Rate constants determined in Chapter 7 with 2,3,5-F 3Y-j32. b Forward and reverse rate constants
inserted into step D of the model in Figure 8-17 or steps D and G of the model in Figure 8-18. c
Simulated kcat determined using the model in Figure. 8-17. Note that the rate constants for step D
have been changed as listed in this Table. d The concentration of We from the simulation in Figure
8-17. e Simulated kcat determined using the model in Figure. 8-18. Note that the rate constants for
steps D and G have been changed as listed in this Table. f The concentration of We from the
simulation in Figure 8-18.
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SF UV-vis spectroscopy with 2,3,5-F 3Y-f2, NH 2Y-a2 and CDP/ATP as a readout
for forward radical transfer. The simulations above are consistent with rate-limiting radical
propagation despite the lack of observable intermediates during this process. As pointed out, the
simulations are also consistent with a rate-determining forward or forward and reverse radical
transfer. To directly interrogate whether forward radical transfer has in fact become slow during
turnover, we took advantage of NH2Y-a2s, which were prepared in Chapter 4. Because reaction
of NH2Y-a2s with P2, substrate and effector results in NH2Y* formation, NH2Y-U2 offers a
readout of forward radical transfer. This includes the step that was modeled as the
rate-determining step in the simulations above, oxidation of 2,3,5-F 3Y by W48*. One caveat
with these experiments is that NH2Y-(2s are competent in turnover, as we proposed in Chapter
4. However, we also pointed out that formation of NH2Y* (biphasic, 12 s- 1 and 2.5 s- 1 for
NH2Y730*) is much more rapid than decay of NH 2Y* (monophasic, 0.26 min - ' for NH2Y 730o).
Thus, within the time scale of our experiment, we may treat NH2Y as an irreversible trap
reporting on the rate constant of forward radical propagation.
If forward radical transfer is slow, then the pre-steady state pH rate profile for NH2Y*
formation with 2,3,5-F 3Y-P2 and CDP/ATP should be similar to the steady state pH rate profile
of dCDP formation with 2,3,5-F 3Y-p2 and wt a2, which was determined in Chapter 7; that is,
the rate constant for NH 2Y* formation as a function of pH should reveal a similar profile as the
pH rate profile of 2,3,5-F 3Y-12. If, however, forward radical transfer is not slow, then the
pre-steady state pH rate profile of NH2Y* formation should approximate that of Y-P2, which
was also determined in Chapter 7.
To distinguish between these mechanistic possibilities, SF UV-vis experiments were
carried out. In these experiments pre-reduced Y730NH 2Y-a2 or Y731NH2Y-a2 and ATP were
mixed with 2,3,5-F 3Y-P2 (1.2 Y 122*/dimer) and CDP to yield final protein concentrations of 4
gM. It was necessary to choose a final protein concentration similar to those used in the steady
state pH rate profiles (3 tM), as higher concentrations may result in a change in the rate-limiting
step, which has been observed with wt RNR. The high extinction coefficients of the NH 2Y 730*
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and NH 2Y 731*, which were determined in Chapter 4, and our ability to reconstitute the Y122* of
2,3,5-F 3Y-P2 to wt levels, allowed these experiments to be carried out at protein concentrations
similar to those used in the steady state pH rate profiles.
The results of pH-dependent SF UV-vis experiments with Y730NH 2Y-a2 and
2,3,5-F 3Y-p2 are shown in Figure 8-19. Representative data and fits for the reaction of
Y730NH2Y-a2 with 2,3,5-FY-P2 at pH 8.3 are shown in Figure 8-19A/B. Representative data
and fits for the reaction of Y730NH2Y-a2 at pH 6.6 are shown in Figure 8-19C/D. The kinetic
traces for all pHs examined for Y730NH2Y-o2 and Y731NH2Y-a2 are shown in Figures 8-20A
and 8-20B, respectively. Qualitatively, it can be seen that the pH has a discernible effect on the
rate constant for NH2Y* formation. To analyze these quantitatively, iterative rounds of fitting
and calculation of the R2 correlation value and residual plot were carried out until the R2 value
was maximized (Ž0.99) and the residual plot was randomly scattered around zero with a
maximal scatter of 0.001 AU. The kinetic parameters thus obtained are shown in Table 8-4 for
Y730NH 2Y-o2 and Y731NH 2Y- a2.
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Figure 8-19. Representative time courses for the reaction of NH2Y-a2s with 2,3,5-F 3Y-32 and
CDP/ATP monitored by SF UV spectroscopy. (A) Reaction of 2,3,5-F 3Y-32 (1.2 Y122./dimer) with
Y730NH2Y-a2 and CDP/ATP at pH 8.35 and 4 pM final protein concentration. (B) Magnified view of
the initial 3 s of the trace in (A). (C) Reaction of 2,3,5-F 3Y-02 (1.2 Y122*/dimer) with Y731NH2Y-oa2
and CDP/ATP at pH 7.0 and 4 pM final subunit concentration. (D) Magnified view of the initial 0.8 s
of the trace in (C).
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Figure 8-20. SF UV spectroscopy of NH2Y-a2s with 2,3,5-F 3Y-p2 and CDP/ATP as a function of
pH. (A) Reaction of 2,3,5-F 3Y-p2 (1.2 Y122*/dimer) with Y730NH2Y-ox2 (A) or Y731NH2Y-a2 (B) as
a function of pH with CDP/ATP. Each trace is an average of 5-7 traces. Black lines describe
tri-exponential fits to the data. See Table 8-4 for kinetic parameters.
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Table 8-4. Summary of the kinetic parameters for NH2Y* formation in the reaction of
Y730NH2Y-a2 or Y731NH2Y-a2 with 2,3,5-F 3Y356-p2 in the presence of CDP/ATP.
1st Phase 2nd Phase 3rd Phase
p ko(s ) Amp b Amp b Amp bpH kobs (S-1) a Amp kobs (S - 1) a Amp kobs (S- 1) a Amp(% Y122*) (% Y122*) (% Y1220)
Y730NH2 Y-a2
6.85 31.6 + 2.2 10 ± 1 2.4 + 0.2 14 ± 1 0.30 ± 0.02 14 ± 1
7.18 37.0 ± 2.6 7 1 2.4 ± 0.2 17 ± 2 0.33 ± 0.02 14 ± 1
7.55 48.5 + 3.4 6 ± 1 3.8 + 0.3 12 + 1 0.52 ± 0.04 10 + 1
8.15 21.7 + 1.5 5 + 1 2.8 + 0.2 13 + 1 0.23 + 0.02 8 + 1
8.35 50.5 + 3.5 4 ± 1 1.0 ± 0.1 10 + 1 0.20 + 0.02 13 + 1
8.65 4.0 ± 0.3 2 ± 1 0.45 ± 0.03 8 ± 1 0.10 + 0.01 10 ± 1
Y731NH2 Y-2
6.5 17.9 +1.3 11 +1 1.4 ± 0.1 21 2 0.14 ± 0.01 12 ± 1
6.9 26.2 ± 1.8 6 + 1 2.5 ± 0.2 18 + 2 0.40 + 0.03 12 ± 1
7.5 13.5 ± 1.0 7 ± 1 2.6 + 0.2 15 ± 2 0.42 + 0.03 10 ± 1
8.45 6.7 + 0.5 7 ± 1 1.0 + 0.1 14 ± 1 0.12 ± 0.01 8 ± 1
8.6 9.0 ± 0.6 7 + 1 0.63 + 0.04 13 + 1 0.09 + 0.01 9 ± 1
9.2 - - - - - -
a Estimated error not based on fits but on reproducibility of rate constant from multiple separate
experiments. b The amount of NH 2Y* trapped has been reported as a % of total initial Y122*, which in
these experiments was 4.8 jtM. Estimated error based on systematic factors.
Analysis of all kinetic traces required three exponentials to fit the data. This is similar to
results with DOPA-12, which contains the V35 3G/C354S mutations that are also present in
2,3,5-F 3Y-32 and revealed three kinetic phases in the presence of CDP/ATP. As with
DOPA-P2, the physical nature of the two fast rate constant is not understood. Our interpretation
has been that the slow rate constant is indicative of the conformational change that gates radical
transfer and limits turnover in the steady state.
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Inspection of the data in Table 8-4 reveals that the three kinetic phases have different pH
dependencies. For Y730NH 2Y-a2, the kobs of the 1st kinetic phase varies from 21.7 to 50.5 s- 1 in
the pH range of 6.85-8.35. The trace at pH 8.65 is unusual with a kobs of 4.0 s- 1. The
amplitudes in this phase account for -10-25 % of the total change. This kinetic phase reveals no
discernible pH dependence. The second kinetic phase occurs with kobs of 0.45-3.8 s- 1 with
amplitudes of 37-50 % of the total absorbance change. Interestingly, the pH profile of this phase
has a very similar shape to that of the activity of 2,3,5-F 3Y-02 determined in Chapter 7 (Figure
8-21A); however, the rate constants are ~4-fold higher. The kobs for the slow kinetic phase,
varies from 0.1-0.52 s- 1 with amplitudes of 30-50 % of the overall change. The pH profile of
this phase is also very similar to the activity profile of 2,3,5-F 3Y-02 in that it peaks at pH 7.55
and drops sharply between pH 7.55 and 8.65 (Figure 8-21B). The implications of this will be
elaborated below.
For Y731NH 2Y-a2, the kobs of the 1st kinetic phase varies from 6.7 to 26.2 s- 1. The
amplitudes in this phase account for -17-25 % of the total change, similar to the results with
Y730NH2Y-a2. No trend in the pH dependence of this phase is apparent. The kobs for the second
phase varies from 0.63 s-' at pH 8.6 to 2.6 s- 1 at pH 7.5. This phase contains 45-50 % of the
overall change and the shape of its pH dependence is marked by a peak at pH 7.5 and a sharp
drop between pH 7.5 and 8.6 (Figure 8-21A). This is reminiscent of the pH rate profile of
2,3,5-F 3Y-02, although it is -4-fold faster than the keat measured in activity assays (Chapter 7).
The rate constants for NH2Y* formation in the slow kinetic phase vary from 0.09 s- 1 at pH 8.6 to
0.42 s- 1 at pH 7.5 accounting for 27-31 % of the total absorbance change. Similar to the 2nd
phase, the pH dependence of this is phase reminiscent of the pH rate profile of 2,3,5-F 3Y-p2
(Figure 8-21B).
As noted above, we have interpreted the slow phase as the physical gating step that
initiates radical propagation. To examine the pH dependence of this step further, the kobs
obtained in this phase with Y730NH2Y-a2 and Y731NH2Y-a2 have been overlaid with the pH
rate profile of 2,3,5-F 3Y-32 activity (Figure 8-21C). This analysis shows that the three profiles
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overlap in all three activity regimes, which we described in Chapter 7. Thus, the pre-steady
state pH rate profile for NH2Y* formation is very similar to that measured by the radioactive
assay for [14C]-dCDP formation in the steady state. Consistent with the kinetic simulations,
these results strongly suggest that at high pH, the rate-determining step has shifted from a
physical step to radical transfer in the 2,3,5-F 3Y-P2 analogue.
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Figure 8-21. pH rate profile for NH2Y* formation in the reaction of NH2Y-a2 with 2,3,5-F 3Y-f2.
(A) pH dependence of the rate constant from the second kinetic phase determined from the
tri-exponential fits in Fig. 8-20 and Table 8-4. The rate constant from the reaction with
Y730NH2Y-a2 (blue dots) and Y731NH2Y-cx2 (red dots) have been plotted against pH. (B) pH
dependence of the rate constant from the third (slowest) kinetic phase determined from Figure 8-20
and Table 8-4 with Y730NH2Y-a2 (blue dots) or Y731NH2Y-a2 (red dots). (C) The data in (B) has
been overlaid with the pH rate profile for [14C]-dCDP formation with 2,3,5,-F 3Y-132 and wt a2,
determined in Chapter 7 (black dots).
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DISCUSSION
Amino acid radicals are a hallmark of class I RNRs. The 132 subunit contains the stable
Y 122*, the in vitro generation of which requires formation of a transient W4 8H*+.25 29 The active
site chemistry in xa2 involves formation of a transient C439* and a C225-C46 2 disulfide radical
anion,4' 30,31 and the radical transfer event contains three Tyr residues, in addition to Y1220, W48
and C439, that are redox active (Chapters 2-5). However, despite extensive efforts, a transient
amino acid radical has never been observed in active wt RNR turnover. 32 It appears the system is
poised to avoid build-up of any oxidized amino acid intermediates during catalysis. This is
accomplished by rapid electron hopping between the residues in the radical transfer pathway and
by a slow physical change that precedes rapid chemistry.
To study this pathway the rate-limiting step must be changed from a conformational to
the radical transfer step. In chapter 6, we synthesized a series of FnY analogues and showed that
they span ranges of 320 mV in reduction potential and almost 4.5 units in pKa. Our hypothesis
was that insertion of these analogues into residue 356 would provide an energetic barrier by
changing the driving force to slow hole migration. The results in Chapter 7 showed that
replacing Y356 with FnYs had a profound effect on nucleotide reduction activity, presumably by
altering radical transfer. We proposed that the correlation between reduction potential difference
and nucleotide reduction activity indicated that the rate-determining step had shifted from the
conformational change to radical transfer. In this Chapter, we conducted a series of steady state
and pre-steady state experiments and theoretical studies to test this hypothesis.
At least three models may be envisioned to explain the results in Chapter 7: the
rate-determining step has changed to forward radical transfer, or reverse, or both. If forward
radical transfer is solely rate-limiting, then the elementary step most likely affected is oxidation
of FnY by W48*. Presumably, the rate constant for oxidation of W48 by Y122* is not affected by
insertion of FnY at residue 356. Further, oxidation of Y731 by FAY 356* is thermodynamically
more favorable than oxidation by Y356*. Consequently, W48* would be expected to form rapidly,
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and decay slowly, leading to a build-up of W48*. Thus, if forward radical transfer is slow with
FnY-p2s at high pH, one may expect to see formation of W48*, which may be detected by SF
UV-vis and EPR spectroscopies.
If reverse radical transfer has become solely rate-determing, then the elementary step
most likely affected is oxidation of FnY 356 by Y731*. Presumably, other reactions in reverse
radical transfer (i.e. oxidation of Y731 by Y730*) are unaffected by insertion of FnY at residue 356.
In addition, oxidation of W48 by FnY* is now more favorable than oxidation by Y356*. In this
case, Y731* would be formed rapidly, but would decay slowly leading to a build-up of Y7310
which could be detected by RFQ EPR studies. Also if reverse radical transfer is slow, a burst in
dCDP production would be expected, followed by a linear dCDP formation phase.
If both forward and reverse electron transfers are partially rate-limiting, then build-up of
intermediates will depend on the relative rate constants for formation and decay in the forward
and reverse directions.
To test whether any intermediates occur in the reaction of 2,3,5-F 3Y-j2 at high pH,
where radical transfer was proposed to be rate-limiting, SF UV-vis and RFQ EPR experiments
were carried out. These studies failed to reveal build-up of any oxidized amino acid
intermediates in pre-steady state or steady state turnover with 2,3,5-F 3Y-P2 or 2,3,5-F 3Y-PP'.
In these experiments, an intermediate build-up of 210 % would have been detected based on the
extinction coefficients Y*s and Wos, and EPR quantitation methods. Thus, any intermediates
formed are below the lower limit of detection.
Compelling evidence, however, for a shift in the rate-limiting steps as a result of
2,3,5-FnY insertion was obtained in SF UV-vis experiments with NH2Y-a2s. Reaction of
2,3,5-F 3 Y-[2 with NH2Y-a2s monitors all the steps up to and including NH2Y* formation.
Therefore, NH2Y-a2s offer a readout of forward radical transfer. Experiments with NH 2Y-a2s
are complicated by two factors: First, all kinetic traces for NH 2Y* formation with 2,3,5-F 3Y-32
were tri-phasic. The slow phase observed likely corresponds to the conformation that is
catalytically active in multiple turnover. This is because RCQ studies monitoring dCDP
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formation with intein-generated wt 32 (see below), no longer show a burst of dCDP formation
(as with wt 132) but exhibit a single rate constant of -0.7 s- 1. Second, the NH2Y* has been
proposed to partition between decay and C439* formation as discussed in Chapter 4. However,
these reactions are slow relative to NH2Y• formation. Therefore, for the purposes of the current
experiment, NH2Y-oc2s report solely on forward radical transfer.
The results show that the pH rate profile for pre-steady state NH 2Y* formation with
2,3,5-F 3Y-j32 is similar to that of steady state dCDP formation, and not like that of intein wt 132.
The latter would have been expected if (1) reverse radical transfer was slow in turnover, or (2)
the activity profiles observed in Chapter 7 were not the result of a shift in the rate-limiting step.
Therefore, these results establish that with 2,3,5-F 3Y-132, a step in forward radical transfer has
the same pH-dependent rate constant as that measured by multiple turnover assays with
2,3,5-F 3Y-j32,. This strongly suggests that insertion of 2,3,5-F 3Y results in a decrease in the
rate constant for forward radical transfer as the reaction pH is increased.
RCQ experiments reveal two important findings. First, the mutations necessary for intein
chemistry result in 132 variants that no longer display burst kinetics in pre-steady state dCDP
production. Therefore, the mutations have slowed down a step prior to formation of dCDP.
Second, with FnY-132s, where radical transfer is thought to be rate-limiting in turnover, linear
(F4Y-f32, pH 6.8) or lag phase (F4Y-0i2, pH 7.6 and 2,3,5-F 3Y-12, pH 8.4) kinetics in
pre-steady state dCDP formation is observed. Thus, the results may be consistent with forward
radical transfer, reverse or both being rate-determining in catalysis.
To distinguish between these options, and to test whether lack of intermediate build-up is
consistent with rate-limiting hole migration, kinetic simulations were carried out. The kinetic
paramters for these simulations were based on previously measured rate constants and binding
constants, as well as on simulations of the wt RNR catalytic cycle. An important insight from
these simulation, which is corroborated by the experimental results discussed above, is that
reverse radical propagation is not solely rate-determining in the current kinetic frame work. The
simulations show a build up of Y731* to >14 gM, which would detectable.
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Perhaps the most important conclusion from the simulations is that radical transfer can be
slow during turnover without resulting in a build-up of oxidized amino acid intermediates. Thus,
lack of observation of transient amino acid radicals and rate-limiting hole transfer are kinetically
not inconsistent. We were able to generate two kinetic models which reproduced the pre-steady
state kinetics results presented in this Chapter. In one of these models, forward radical transfer is
the rate-determining step. The results show that one explanation for the lack of Wo build up is
that while oxidation of 2,3,5-F 3Y by W48* is slowed, the rate constant for reformation of Y122*
(reverse k, step C, Fig. 8-17) is increased. This is required to obtain agreement between our
model and experimental results. Therefore, formation of W48* is followed by its rapid decay and
reverse hole migration to Y122*, where the radical is stable. Consequently, though we have
managed to diminish the rate constant of radical transfer to the extent that it is rate-limiting in
turnover, this model indicates that intermediate build-up does not occur because of rapid reverse
hole transfer to Y122*. A second model consistent with the results of the current Chapter is one in
which forward and reverse radical transfer are both partially rate-determining. In this case
build-up of intermediates appears to be avoided by the same reasoning as described above, i.e.
rapid reverse hole migration to Y1220.
These two models were also able to reproduce the trend of our pH rate profiles in Chapter
7. Both models show, even though the slowest step in turnover is assigned to an elementary step
within radical transfer, no detectable build-up of intermediates occurs. In addition, we were able
to recapitulate the trends in kcat as function of pH by only changing the rate constant for a step in
forward radical migration (decay of Wo). Therefore, both models are consistent with the lack of
observable intermediates and dCDP formation as a function of changes in radical transfer rate
constants. However, the second model, where forward and reverse radical transfer are partially
rate-determining predicts a prolonged lag phase which was not observed in our experiments.
Therefore, we prefer the first model, in which only forward hole propagation is rate-determining
in turnover.
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Our studies have suggested a model that describes the pH rate profiles of Chapter 7
where the reduction potential difference between FaY and Y was found to be inversely
proportional to the forward radical transfer rate. Another model that is worth considering is that
the reduction potential difference is inversely proportional to the fraction of active enzyme: the
larger the reduction potential difference between FnY and Y, the smaller the fraction of RNR
competent in turnover. In this model, the kinetics of forward radical transfer are similar to those
in Y-32, however, the larger activation barrier for radical transfer renders the enzyme inactive,
rather than slowing down hole migration. The major drawback of this model is that it is
inconsistent with the NH2Y-a2 experiments, which clearly show a decrease in the rate constant
for NH2Y* formation as a function of reduction potential increase at residue 356.
In conclusion, the experiments and simulations performed in this Chapter validate the
hypothesis that insertion of FnYs at residue 356 results in a change in the rate-limiting step when
the reduction potential difference between FnY and Y is between 80 and 200 mV. Kinetic
simulations and SF UV-vis experiments with NH2Y-a2s suggest that forward radical transfer,
presumably oxidation of FnY by W48*, has become rate-limiting. This model further indicates
that the changes in the pH rate profile are due to changes in the decay rate constant of W48°
during forward radical transfer. However, detection of intermediates is hampered by a slow
conformational change that precedes radical transfer and by the increase in the rate constant for
Y122° reformation in forward hole migration. Perhaps tweaking of the reduction potential of W48
by incorporation of unnatural W analogues in conjunction with 2,3,5-F 3Y will result in
observable build-up of an intermediate during radical transport.
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